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Zusammenfassung 
Die Arbeit zielte darauf ab, unser Wissen in Bezug auf metabolische Kompartimentierung im 
Stoffwechsel von Säugerzellen voranzubringen. Im Mittelpunkt stand die Untersuchung des 
Zentralmetabolismus und dessen Kontrolle in Chinese hamster ovary (CHO) Zellen. Eine 
notwendige Voraussetzung für diese Arbeit war die Entwicklung und Umsetzung einer Reihe von 
innovativen Methoden, u.a. die Analyse von extra- und intrazellulären Markierungsdynamiken, 
nicht-stationäre 13C metabolische Flussanalyse, Bestimmung von kompartiment-spezifischen 
Enzymaktivitäten sowie Elementarmodenanalyse des mitochondrialen Stoffwechsels in selektiv 
permeabilisierten Zellen. Die Ergebnisse dieser Arbeit erweitern unser Verständnis der 
metabolischen Kontrolle an der Grenzfläche zwischen Zytosol und Mitochondrien, einschließlich 
der Kontrolle durch mitochondriale Transporter. Darüber hinaus werden Aspekte der Verknüpfung 
zwischen Glykolyse und TCA Zyklus, Mikrokompartimentierung und Channeling, 
Metabolitenaustausch zwischen Zellen und extrazellulärem Medium, sowie allgemein die Dynamik 
des Stoffwechsels beleuchtet. Die umfassenden Erkenntnisse tragen dazu bei, die Komplexität des 
Säugerstoffwechsels sowie die verschiedenen Spielarten von Stoffwechselkompartimentierung 
besser zu begreifen. Wissen über die Kontrolle des Stoffwechsels eröffnet neue Perspektiven zur 
Verbesserung von biotechnologischen Produktionsprozessen sowie zur Behandlung von schweren 
Krankheiten. 
Abstract 
The thesis aimed at advancing our knowledge about metabolic compartmentation in the metabolism 
of mammalian cells. The focus of the study was the central metabolism and its control in Chinese 
hamster ovary (CHO) cells. An essential part of the work was the development and implementation 
of innovative methods, e.g. the analysis of extra- and intracellular labeling dynamics, non-stationary 
13C metabolic flux analysis, determination of compartment-specific enzyme activities, and 
elementary mode analysis of the mitochondrial metabolism in selectively permeabilized cells. The 
results of this thesis increase our understanding of metabolic control at the cytosol-mitochondria 
interface, including control by mitochondrial transporters. In addition the work highlights aspects in 
the connection of glycolysis and TCA cycle, microcompartmentation and channeling, metabolite 
exchange between cells and extracellular medium, as well as metabolic dynamics in general. The 
comprehensive findings contribute to a deeper understanding of the complexity of mammalian 
metabolism and the various manifestations of metabolic compartmentation. Understanding the 
control of metabolism opens up new perspectives for improving biotechnological production 
processes and designing successful therapies for the treatment of severe diseases. 
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Extended abstract 
The presented thesis provides an in-depth quantitative characterization of the central metabolism 
and its control in Chinese hamster ovary (CHO) cells. The work focused on studying the dynamics 
of metabolic compartmentation with a special emphasis on the connection between cytosolic 
glycolysis and mitochondrial TCA cycle. Different innovative experimental strategies and advanced 
computational methods were developed and implemented to approach the complexity of metabolic 
dynamics and compartmentation. The work is composed of seven subprojects that are structured 
into three major parts that build on each other. 
In the first part, general characteristics of the CHO-K1 cell metabolism are described using 
metabolite balancing methods. 
The combination of dynamic metabolic flux analysis (MFA) and determination of compartmental 
enzyme activities was used to investigate the CHO-K1 cell central metabolism in chapter 2. 
Different metabolic phases in CHO cell batch cultivation were distinguished and characterized by 
their dominating metabolic state, (i) overflow metabolism, (ii) balanced metabolism, and (iii) 
maintenance metabolism. The time-resolved analysis of specific metabolic ratios was demonstrated 
as useful strategy to assess metabolic efficiency and to monitor very sensitively metabolic shifts 
between different growth phases. Furthermore, we studied metabolic control at the cytosol–
mitochondria interface in different growth phases of CHO cells. By integrating the information 
about in situ enzyme activities including their compartmental localization with in vivo metabolic 
fluxes, we were able to gain knowledge about metabolic regulation at overflow metabolism and 
balanced metabolism. We identified the hexokinase and the mitochondrial isocitrate dehydrogenase 
activities as rate-limiting steps in glycolysis and TCA cycle, respectively. Fine-tuning of glycolytic 
regulation was facilitated by a dynamic shift between glycolytic channeling and free diffusion of 
glycolytic intermediates. We propose that glycolytic channeling affects the availability of pyruvate 
for the mitochondria. In addition, we demonstrated that changing availabilities of TCA cycle 
substrates can be compensated and balanced by a tailored adjustment of the activities of 
aminotransferases and anaplerotic enzymes. Two follow-up studies presented in chapters 3 and 4 
focused on investigating the availability of glutamine and pyruvate as the two most significant 
carbon sources for the mitochondrial metabolism in more detail. 
In chapter 3, we analyzed the dynamics of growth and metabolism controlled by glutamine 
availability. A refined and improved dynamic metabolic flux analysis method was applied to 
capture metabolic dynamics in eight batch- and fed-batch cultivations with different glutamine 
supply (excess, sufficiency, scarcity, limitation). Varying glutamine availability resulted in global 
metabolic changes. We observed dose-dependent effects of glutamine in batch cultivation. 
Identifying metabolic links from the glutamine metabolism to specific metabolic pathways, we 
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showed that glutamine feeding results in its coupling to TCA cycle fluxes and in its decoupling 
from metabolic waste production. Furthermore, we analyzed the cellular responses upon mild or 
severe glutamine limitation and upon ammonia stress due to glutamine excess and provide a 
mechanistic explanation for the transition between these extreme states. Increased ammonia levels 
resulted in reduced growth rates. Mild glutamine limiting conditions stimulated growth and 
supported culture longevity. Glutamine limitation and ammonia stress were successfully 
compensated in CHO-K1 cells by flux rearrangements in the pyruvate and amino acid metabolism. 
In chapter 4, we studied the perturbation of the mammalian pyruvate metabolism and resulting 
rearrangement of central metabolic fluxes. Two different biochemical effectors, dichloroacetic 
acid (DCA) and -cyano-4-hydroxy-cinnamic acid (CHC), were used to either stimulate or inhibit 
the flux of pyruvate into the TCA cycle. Metabolic perturbation was successful at low CHC and 
DCA concentrations. High effector concentrations, in contrast, resulted in efficient metabolic 
compensation confirming the remarkable robustness and flexibility of CHO cells. However, an 
efficient compensation of CHC and DCA effects was strictly dependent on glutamine availability. 
Glutamine depletion provoked emergence of the anticipated effects at high CHC and DCA 
concentrations later in the cultivation. We demonstrated that the cellular energy state of CHO-K1 
cells remained robust upon severe perturbation of the cellular pyruvate metabolism. However, 
susceptibility to low effector concentrations and at glutamine depletion reveals limitations of 
robustness. 
In the second part of the thesis, we provide a more in-depth analysis of the CHO cell metabolism 
aiming at the resolution of very detailed metabolic networks with respect to compartmentation. This 
was achieved using highly informative 13C labeling experiments in combination with non-
stationary 13C metabolic flux analysis (INST-MFA). 
In chapter 5, non-stationary 13C metabolic flux analysis in CHO cell batch culture using 
extracellular labeling was successfully applied to highlight metabolic reversibility and 
compartmentation. We determined the mass isotopomer dynamics of eight extracellular 
metabolites derived from [U-13C6] glucose as labeled substrate. The consideration of metabolic 
compartmentation and extracellular transport reversibility was essential to successfully describe the 
labeling dynamics. In parallel, we demonstrated that a simpler network neglecting metabolic 
compartmentation failed to reproduce the data. This highlights the importance of including 
metabolic compartmentation to obtain a meaningful representation of cellular physiology. Pivotal 
reactions in the connection of C3 and C4 pools (phosphoenolpyruvate carboxykinase, malic enzyme 
and pyruvate carboxylase) as well as simultaneous synthesis and degradation of several amino acids 
were successfully determined. Furthermore, the results of the parameter estimation confirm the idea 
of a mixed outcome of glycolysis by partial channeling and partial free diffusion of glycolytic 
intermediates as previously proposed in chapter 2. Most metabolites were reversibly exchanged with 
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the media. The reversibility of pyruvate and alanine production rates changed dynamically even if 
their net fluxes remained constant. 
High resolution 13C metabolic flux analysis in CHO cells using extra- and intracellular labeling 
dynamics derived from parallel labeling experiments using [U-13C6] glucose and [U-
13C5] glutamine 
as substrates is presented in chapter 6. INST-MFA was applied to resolve the metabolic fluxes, 
reversibilities and intracompartmental concentrations in a complex metabolic network that included 
mitochondrial transport, metabolite compartmentation and channeling. Compared to the highly 
efficient reactor cultivation described in chapter 5, these shake flask cultivations were characterized 
by (1) a higher lactate/glucose ratio, (2) smaller TCA cycle flux, (3) lower connectivity between 
glycolysis and TCA cycle and (4) reduced catabolism of essential amino acids. On the other hand, a 
high pentose phosphate pathway activity, simultaneous catabolism and production of non-essential 
amino acids and excessive metabolite exchange with the extracellular media were observed 
consistently for both cultivation conditions. Malate and glutamate were cycled via several 
transporters between cytosol and mitochondria. The labeling dynamics of lactate and pyruvate 
indicate various metabolite channeling effects in the cytosol and the mitochondria as well as the 
existence of a mitochondrial lactate pool that serves most likely as intramitochondrial short-term 
redox buffer. 
The last part of this thesis brings the focus on detailed mitochondrial studies using selectively 
permeabilized cells. 
In chapter 7, we demonstrated a high-throughput respiration screening for functional in situ 
mitochondrial studies in permeabilized CHO cells. Determination of oxygen uptake rates verified 
transporter-mediated uptake and metabolization of mitochondrial substrates and allowed a 
distinction of substrates according to TCA cycle regulation. Metabolic regulation was different for 
reactions (i) in the first half, (ii) in the second half and (iii) at the initiation of the TCA cycle. 
Metabolization of substrates entering the first half was highly controlled by the energy state, while 
respiration on metabolites entering the second half of the cycle was less controlled. Metabolization 
of pyruvate was very strictly regulated by several independent mechanisms; energy state, 
phosphorylation as well as availability of CoA. A moderate stimulation of pyruvate metabolization 
could be accomplished by feeding both pyruvate and aspartate simultaneously. 
The outcome of the respiration screening served as starting point for designing detailed 
mitochondrial studies presented in chapter 8. We accessed the mitochondrial metabolism of CHO 
cells by selective permeabilization and quantified mitochondrial uptake and production of several 
substrates without and with addition of ADP. Elementary mode analysis of the mitochondrial 
metabolism was applied to establish the contribution of different pathways to the metabolism of a 
substrate or substrate combination. Metabolic stimulation with ADP favored full metabolization of 
substrates to CO2 while production of byproducts from partial TCA cycle was not enhanced. 
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Consistent with the findings of the respiration screening, the controlling effect of ADP was more 
pronounced when we supplied metabolites to the first part of the TCA cycle. Interestingly, 
mitochondrial aspartate uptake occurred only in combination with pyruvate but not alone suggesting 
a complex regulation of these reactions. Isocitrate dehydrogenase was confirmed as key control 
element of the TCA cycle. 
The results of these different studies are synergistically discussed in the final conclusion (chapter 9) 
in order to provide a comprehensive picture of the central metabolism in CHO cells. Potential 
implications of these findings as well as future applications of the established novel methods are 
presented. The outlook proposes future steps towards increasing our knowledge about the 
compartmented mammalian metabolism (chapter 10). 
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1 General introduction 
1.1 Chinese hamster ovary cells – major workhorse of the 
biopharmaceutical industry and mammalian model system for 
more than 50 years 
1.1.1 Applications and impact of mammalian cell cultures in research, 
production and therapy 
Mammalian cell cultures are an indispensable tool in basic research, biotechnological production 
and therapeutic applications. Our current knowledge about cell function and physiology is mainly 
derived from studying basic biological questions in vitro using cultivated primary cells or stable cell 
lines (Freshney, 2010). Furthermore, cultured mammalian cells are increasingly used for toxicity 
assessment and drug screening thereby contributing to replace, reduce and refine animal testing in 
the development of drugs and cosmetics (Beckers et al., 2009; Niklas et al., 2009; Noor et al., 2009; 
Strigun et al., 2011a; Strigun et al., 2011b; Strigun et al., 2012). More recently, significant progress 
in cell culture technology, including specific media development and the use of scaffolds, allow 
mimicking the natural in vivo environment of cells and tissues and facilitate a longer maintenance of 
cell cultures (Gunness et al., 2013; Klein et al., 2014a). This makes them also amenable for long-
term toxicity studies (Mueller et al., 2013; Mueller et al., 2014) as well as for tissue engineering 
approaches for the replacement or repair of damaged tissue (Berthiaume et al., 2011; Fisher and 
Mauck, 2013). Cell- and gene-based therapies provide new therapeutic strategies and have great 
potential in the targeted treatment of severe diseases (Fischbach et al., 2013; Ye et al., 2013). 
Biotechnological production is another major field of application for mammalian cells. Especially 
continuous cell lines play an important role in the industrial production of biopharmaceuticals and 
viruses. Viruses are produced for viral vaccines in human and veterinary use and for gene therapy 
using viral vectors (Genzel and Reichl, 2009). Vaccine production in cultured mammalian cells 
represents a safe and efficient alternative to more conventional vaccine production in chicken eggs. 
It is expected to become increasingly important in the future. The large scale manufacture of 
recombinant proteins using mammalian cell lines continues to revolutionize the medical sector 
(Wurm, 2004). Monoclonal antibodies and other proteins are produced for diagnostic and 
therapeutic use. The clinical applications of these therapeutic proteins open up new opportunities in 
the treatment of pathological conditions and give new hope to patients suffering from life-
threatening diseases. 
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1.1.2 The global biopharmaceutical market 
The biologics (biopharmaceutical, biologic medical product) sector represents the fastest growing 
market in pharmaceutical industry worldwide. In Germany, the biopharmaceutical market grew by 
11% in 2012 (to ~ €6 billion) (Biotech-Report 2013, Verband forschender Arzneimittelhersteller 
and Boston Consulting Group, www.vfa.de). In the United States, the total sales of biologics even 
increased by 18.2% (to $63.6 billion) in 2012 (Aggarwal, 2014). This is a more than seven-fold 
higher growth compared to the overall pharmaceutical industry. More than 200 biopharmaceutical 
products are currently on the market and many more are going to be launched in the coming years 
(Walsh, 2010a). Monoclonal antibodies are the best-selling class of biologics accounting for 38.5% 
of the total biopharmaceutical market in 2012 in the United States (Aggarwal, 2014). Future 
prospects for the biopharmaceutical industry are optimistic. While worldwide sales of biologics 
accounted for $99 billion in 2009 (Walsh, 2010a), global sales of $178.4 billion in 2017 were 
recently forecasted by the business information company Visiongain (www.visiongain.com). 
1.1.3 Industrial production of recombinant therapeutic proteins in  
Chinese hamster ovary cells 
Mammalian cells are the primary cultivation system for the industrial production of 
biopharmaceuticals. In contrast to microbial production systems, mammalian cells are able to 
perform human-compatible post-translational modifications, such as proper assembling, folding and 
glycosylation, which are critical for activity, stability and safety of therapeutic proteins (Walsh, 
2010b; Walsh and Jefferis, 2006). Chinese hamster ovary (CHO) cells are the most commonly used 
cell factories for the large-scale commercial production of recombinant proteins (e.g. antibodies, 
growth factors, hormones, blood factors) (Datta et al., 2013). Due to their favorable characteristics 
CHO cells outperform several other mammalian cell lines including hybridoma, myeloma, human-
derived and embryonic-stem-cell-derived cell lines (e.g. NS0, BHK, HEK-293, Per.C6). CHO cells 
are easily adapted to grow in suspension in serum-free, chemically-defined media. The use of media 
containing undefined animal components (e.g. fetal calf serum) is undesirable in biopharmaceutical 
manufacturing because they exhibit high batch-to-batch variability leading to unpredictable results. 
Even more importantly, there are serious safety concerns since they bear the risk of virus or prion 
contamination. Furthermore, CHO cells have been demonstrated as safe host for the production of 
biologics. In particular, they do not allow replication of many human pathogenic viruses (HIV, 
influenza, hepatitis B, polio, herpes, measles etc.). A common disadvantage of using mammalian 
host cells for recombinant protein production is a low specific productivity compared to microbial 
systems. This can be overcome by a number of efficient gene amplification systems that are 
established for CHO cells (e.g. DHFR/methotrexate, glutamine synthetase/methionine sulfoxamine) 
(Wurm, 2004). In addition, they can be easily genetically modified, achieve very high cell densities 
and have the capacity for high expression levels reaching yields on the order of 5 g/liter and more 
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(Walsh, 2010a). Currently, about 70% of all biopharmaceuticals are produced in CHO cells (Datta 
et al., 2013; Jayapal et al., 2007). Although recent advances in cell culture technology and process 
development have achieved significant improvements in productivity, further optimization of host 
cell lines and production processes are required to meet the demand of a rapidly increasing market 
(Dietmair et al., 2011; Kim et al., 2012; Walsh, 2010a). So far, optimization strategies were mostly 
based on empirical findings and/or used screening methods in combination with design of 
experiments (DoE) principles. However, emerging new technologies and systems biology studies 
are expected to pave the way for more rational engineering and optimization strategies in the 
development of high-yielding producer cells in the future (Schaub et al., 2012). 
1.1.4 A retrospect on the history of Chinese hamster ovary cells 
Chinese hamsters have been introduced as laboratory species in 1919 and have been mostly used in 
epidemiological and radiation research. The first stable CHO cell line has been established in 1957 
(Puck et al., 1958). Since then, they have been used in numerous studies of basic biological and 
biomedical research resulting in their terming as “the mammalian equivalent of the model bacterium 
E. coli” (Jayapal et al., 2007). Their immense adaptability to various culture conditions and ease in 
genetic manipulation made them an interesting system for heterologous protein production. In 1987, 
the first recombinant therapeutic protein manufactured in a mammalian system and approved by the 
Food and Drug Administration (FDA) was produced in CHO cells (tissue plasminogen activator, 
Activase, Genentech) (Kaufman et al., 1985). This marked the beginning breakthrough of CHO 
cells as major workhorse for the biopharmaceutical industry. After the foundation of the Consortium 
on Chinese hamster ovary cell genomics in 2006, the long-awaited draft genomic sequence of the 
ancestral CHO-K1 cell line has finally been published in 2011 (Xu et al., 2011). However, due to 
inherent genetic instability and intentional mutagenesis large genome rearrangements have occurred 
in different CHO cell lines since their first isolation in 1957. Even small variations in culture 
conditions, media composition, and process parameters (e.g. pH, kLa) can induce clonal selection to 
CHO cell subpopulations (Wurm, 2007). In 2013, the genome sequences of the Chinese hamster 
(Cricetulus griseus) along with the sequences of seven CHO cell lines derived from the major CHO 
cell lineages have been published (Lewis et al., 2013). This provides a more complete picture of the 
genomic heterogeneity in different CHO cell lines and a sound starting point for further studies. 
1.1.5 The emerging CHO cell systems biology era 
Considering the immense importance of CHO cells as mammalian model system and industrial host 
cell line, knowledge about CHO cell physiology is surprisingly limited and rudimentary compared 
to other (microbial) cell factories (e.g. Escherichia coli, Saccharomyces cerevisiae) (Kildegaard et 
al., 2013). The availability of genomic resources for CHO cells (Lewis et al., 2013; Xu et al., 2011) 
opens up new opportunities for systems biology studies and optimization of biopharmaceutical 
protein production. The application of different ‘omics technologies, including genomics, 
Chapter 1 General introduction 
 
16 
transcriptomics (Becker et al., 2011), proteomics (Baycin-Hizal et al., 2012), glycomics (North et 
al., 2010), metabolomics (Chong et al., 2012; Chong et al., 2011; Selvarasu et al., 2012) and 
fluxomics (Ahn and Antoniewicz, 2012; Niklas and Heinzle, 2012; Wahrheit et al., 2011), and the 
integration of these data sets into mathematical models will provide a fundamental understanding of 
the complex CHO cell physiology. This is expected to guide cell line development and metabolic 
engineering to further improve protein production in CHO cells. 
1.2 The central carbon metabolism in Chinese hamster ovary cells 
A simplified scheme of the metabolism in cultivated mammalian cells is depicted in Figure 1-1. 
Glucose and glutamine are the major carbon sources fueling catabolism. ATP and NADPH 
produced by catabolic processes drive anabolic reactions for biomass production and possibly 
synthesis of the product of interest (e.g. therapeutic proteins such as antibodies, hormones, growth 
factors, blood factors). The formation of the (amplified) recombinant protein product can impose a 
substantial and very specific metabolic burden regarding biosynthetic precursors, energy demand 
and required post-translational modifications (Klein et al., 2014b; Niklas et al., 2013). Mammalian 
cells are usually cultivated in very nutrient-rich culture media. High uptake rates of glucose, 
glutamine and other substrates exceeding anabolic requirements are correlated with the 
accumulation of by-products, such as lactate, ammonia and alanine. The following section will give 
a short overview about the central metabolic pathways in mammalian cells, highlight the cellular 
localization of metabolic activities and illustrate the current knowledge about characteristics that are 
specific for CHO cells. 
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Figure 1-1. Scheme of the central metabolism in cultivated mammalian cells. The figure was inspired 
and modified from (Glacken, 1988). 
1.2.1 Glycolysis and lactate metabolism 
The glycolytic pathway converts glucose (and other hexoses) into 2 pyruvate generating 2 ATP and 
2 NADH. It contains three irreversible steps with potential regulatory functions, namely the 
hexokinase (HK), the phosphofructokinase (PFK) and the pyruvate kinase (PK). The HK has been 
proposed as the rate-limiting step of glycolysis in cultivated mammalian cells (Neermann and 
Wagner, 1996). Recently, the significance of the early glycolytic reactions in limiting the overall 
glycolytic flux has been confirmed using a kinetic model of the glucose metabolism in CHO cells 
(Chen et al., 2012). Besides the catabolic function of this pathway, glycolytic intermediates serve as 
precursors for anabolic processes, e.g. glucose-6-phosphate (G6P) for synthesis of carbohydrates, 
dihydroxyacetone phosphate (DHAP) for lipid synthesis, and 3-phosphoglycerate (3-PG) for serine 
and glycine synthesis. The final product of glycolysis, pyruvate, is transported into the mitochondria 
via the recently identified mitochondrial pyruvate carrier (MPC) (Bricker et al., 2012; Herzig et al., 
2012). Eventually, pyruvate is oxidatively decarboxylated by the mitochondrial pyruvate 
dehydrogenase (PDH) to form acetyl-CoA which enters the tricarboxylic acid (TCA) cycle. 
Since the glycolysis generates two reducing equivalents in the form of NADH, the oxidized form 
NAD+ needs to be restored to sustain glycolytic activity. Under normal (aerobic) conditions, NAD+ 
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regeneration is achieved by the respiratory chain in the mitochondria which enables additional ATP 
synthesis. The inner mitochondrial membrane is impermeable to reducing equivalents NAD(P)H. 
The transfer of cytosolic NADH across the inner mitochondrial membrane is indirectly 
accomplished via the malate-aspartate shuttle (Figure 1-2) (Michal and Schomburg, 2012). Inside 
the mitochondria, NADH is oxidized by complex I of the respiratory chain (NADH dehydrogenase). 
The complete cycle further involves activities of cytosolic and mitochondrial malate dehydrogenase 
(MDH), cytosolic and mitochondrial aspartate aminotransferase (ASAT), and the malate/-
ketoglutarate (OGC) and aspartate/glutamate (AGC) antiporters. An alternative system for 
transferring electrons into the mitochondria is the glycerol-3-phosphate shuttle (Michal and 
Schomburg, 2012). However, this shuttle system is thought to be of secondary importance due to its 
lower energetic efficiency and low expression in most tissues (Mracek et al., 2013). 
 
Figure 1-2. The function of the malate-aspartate shuttle for transfer of electrons across the inner 
mitochondrial membrane (IMM). (A) Competition of cytosolic and mitochondrial NAD+ regeneration at 
lactate production. (B) Dependence on mitochondrial NAD+ regeneration at lactate consumption; GLC – 
glucose, LAC – lactate, PYR – pyruvate, OAA – oxaloacetate, MAL – malate, AcCoA – acetyl-CoA, AKG 
– -ketoglutarate, GLU – glutamate, ASP – aspartate, LDH – LAC dehydrogenase, PDH – PYR 
dehydrogenase, MDH – MAL dehydrogenase, ASAT – ASP aminotransferase, AGC – ASP/GLU carrier, 
OGC – MAL/AKG carrier, MPC – mitochondrial PYR carrier. Subscript m and c indicate mitochondrial 
and cytosolic. 
However, most mammalian cell lines cultured under in vitro conditions, including CHO cells, 
exhibit aerobic glycolysis, also known as “Warburg effect” (Warburg, 1956). Aerobic glycolysis 
refers to a situation where glucose is preferentially converted to lactate as usually under hypoxic 
conditions although oxygen is available in sufficient amounts. The conversion of pyruvate to lactate 
via the lactate dehydrogenase (LDH) enables a direct cytosolic regeneration of NAD+ (Figure 1-2A, 
grey box). Since neither pyruvate nor NADH enter the mitochondrial metabolism, this happens at 
the expense of metabolic efficiency. As a consequence, the mitochondrial NAD+ regeneration using 
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the malate-aspartate shuttle (Figure 1-2A, white box) competes with this direct NADH oxidation via 
LDH (Figure 1-2A, grey box). 
High glycolytic rates likely depend on a fast NAD+ regeneration, thereby stimulating LDH activity 
and favoring aerobic glycolysis over pyruvate transport into mitochondria. It has been hypothesized 
that this represents an effective means to maximize growth under conditions of excess nutrient 
supply in highly proliferating cells (Vander Heiden et al., 2009). The theoretical maximum yield of 
lactate produced per glucose consumed is 2 mol/mol. A lactate/glucose ratio of 1.5 is often observed 
in CHO cell cultivations (Ahn and Antoniewicz, 2011; Ahn and Antoniewicz, 2013; Martinez et al., 
2013; Neermann and Wagner, 1996). However, much higher metabolic efficiency with 
lactate/glucose ratios significantly lower than 1 (Carinhas et al., 2013; Goudar et al., 2010; 
Sheikholeslami et al., 2013b; Templeton et al., 2013) but also much lower metabolic efficiency with 
ratios close to 2 (Zamorano et al., 2010) have been reported depending on the particular cell clone, 
growth phase and culture condition. Lactate accumulation is related to increasing the osmolarity and 
decreasing the pH of the culture medium and thus represents a critical issue in industrial production 
processes. High lactate levels can inhibit cell proliferation and product formation (Lao and Toth, 
1997) and can affect product quality (Li et al., 2012). 
A remarkable feature of CHO cells is that they are able to switch from lactate production (Figure 1-
2A) to lactate consumption (Figure 1-2B). Lactate accumulates during the early exponential growth 
phase while its reuptake can occur in later cultivation phases. This metabolic shift is usually 
correlated with a higher metabolic efficiency and desirable in terms of improved process 
performance and productivity (Martinez et al., 2013). However, the onset or absence of this 
metabolic shift to lactate consumption depends on various influencing factors. Several recent studies 
focused on an improved understanding and control of CHO cell lactate metabolism and its 
exploitation for process control. Changing glucose availability and altered expression levels of 
glycolytic enzymes (e.g. reduced expression levels of LDH, PK, PFK) are thought to be major 
influencing effectors (Baeza et al., 2011). Zagari et al. detected a correlation between high lactate 
production and an impaired mitochondrial oxidative capacity (Zagari et al., 2013a). Furthermore, it 
was shown that concentrations of the substrates glucose and glutamine (Zagari et al., 2013a) as well 
as specific media components (e.g. copper) (Luo et al., 2012) can modulate the lactate profile. 
Nolan et al. developed a kinetic model of CHO cell metabolism and successfully predicted the 
timing and magnitude of the lactate shift by including a redox variable (Nolan and Lee, 2011). Their 
simulation results suggest that the shift is triggered by an insufficient supply of NADH from the 
cytosol to the mitochondria, in other words, when the mitochondrial NADH demand exceeds the 
cytosolic NADH production. In a comprehensive gene expression study investigating a range of 
CHO cell clones with distinct lactate profiles cultivated in different cell culture media, the activity 
of the malate-aspartate shuttle (Figure 1-2) has been identified as a key factor to promote the switch 
from lactate production to its consumption in CHO cells (Zagari et al., 2013a). A low expression of 
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Aralar1, encoding the mitochondrial aspartate/glutamate carrier, (AGC, Figure 1-2A) and Timm8a1, 
involved in the correct localization of AGC, was correlated with a high lactate producing 
phenotype. The gene expression was strongly influenced by the media composition. Furthermore, 
the overexpression of either Aralar1 or Timm8a1 was sufficient to induce a switch to lactate 
consumption regardless of the media composition and the specific glucose uptake rate (Zagari et al., 
2013a). As schematically depicted in Figure 1-2B, lactate consumption is strictly dependent on a 
mitochondrial NAD+ regeneration and thus requires malate-aspartate shuttle activity to accomplish a 
transfer of cytosolic NADH into the mitochondria. The control of glycolysis and lactate metabolism 
is central to metabolic efficiency in CHO cells. Recent findings clearly illustrate the high 
complexity of its metabolic regulation and suggest that many components and their interplay are not 
yet understood or not even identified. 
1.2.2 Pentose-phosphate pathway 
The pentose-phosphate pathway (PPP) is an alternative cytosolic by-pass of glycolysis with mostly 
anabolic functions. It consists of the oxidative phase and the non-oxidative phase. In the oxidative 
PPP, G6P is irreversibly converted to ribose-5-phosphate (R5P) losing one carbon by CO2 
production and generating 2 NADPH. In the non-oxidative branch, R5P is reversibly converted to 
sugar phosphates with three to seven carbons and eventually to glyceraldehyde-3-phosphate and 
fructose-6-phosphate which reenter the glycolytic pathway. The PPP intermediate R5P is an 
essential precursor for the synthesis of nucleic acids (RNA, DNA). NADPH is required for 
reductive biosynthesis reactions (e.g. fatty acid synthesis) but also to reduce oxidized glutathione 
via glutathione reductase. Glutathione is an important antioxidant scavenging reactive oxygen 
species (ROS) and eventually preventing cellular damage. Thus, the PPP plays a crucial role both in 
cell proliferation and in the generation of reducing equivalents to counteract oxidative stress. The 
first enzyme of the oxidative branch, glucose-6-phosphate dehydrogenase (G6PDH), represents the 
rate-limiting step of PPP and is stimulated by high NADP+ levels. G6PDH-deficient CHO cells are 
characterized by a higher susceptibility to apoptosis (Tuttle et al., 2000). 
The determination of the carbon split between glycolysis and PPP requires the application of 13C-
tracer studies or accurate knowledge about cofactor balances (Niklas and Heinzle, 2012). However, 
mass balances of NADH and NADPH are generally not reliable due to the activity of 
transhydrogenases and the existence of enzymes that accept both NADH and NADPH as cofactor 
(e.g. glutamate dehydrogenase and different isoenzymes of isocitrate dehydrogenase). For classical 
studies on CHO cell metabolism using stoichiometric balancing, simplified metabolic models are 
applied to obtain a determined system. Usually, the non-oxidative PPP is neglected and the 
oxidative PPP is assumed to be limited to anabolic requirements of nucleic acids resulting in an 
underestimation of the actual PPP flux (Ahn and Antoniewicz, 2012). Goudar et al. compared the 
metabolic flux distribution obtained by metabolic flux analysis (MFA) using metabolite balancing 
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and 13C MFA and determined the sensitivity to varying PPP fluxes. They concluded that the PPP 
flux has limited impact on most fluxes of the central metabolism which can be accurately 
determined by metabolite balancing alone (Goudar et al., 2010). In the few 13C-MFA studies that are 
available for CHO cells, a wide range of PPP activities between 2% and 162% of the glucose uptake 
flux has been reported (Ahn and Antoniewicz, 2011; Ahn and Antoniewicz, 2013; Goudar et al., 
2010; Sengupta et al., 2011; Templeton et al., 2013). A PPP flux exceeding the glycolytic flux was 
interpreted as substantial cycling of carbons between both pathways involving a conversion of 
fructose-6-phosphate to glucose-6-phosphate via phosphoglucose isomerase. These studies 
demonstrate the high variability of PPP activities in CHO cells depending on cultivation conditions, 
cell line and growth phase. High PPP fluxes might be accompanied by a significant loss of carbons 
due to CO2 release. This should not be neglected in detailed investigations. An accurate estimation 
of the PPP activity is thus crucial for the determination of more complex metabolic networks. 
1.2.3 Tricarboxylic acid cycle and amino acid metabolism 
The tricarboxylic acid (TCA) cycle is a central metabolic pathway located in the mitochondria with 
both catabolic and anabolic functions. It requires NAD+ regeneration by the respiratory chain and is 
therefore strictly aerobic. The cycle starts with the condensation of oxaloacetate (OAA) (C4-unit) 
and acetyl-CoA (C2-unit) to form citrate. Through a series of reactions, citrate is converted to OAA 
producing 2 CO2, 1 GTP, 3 NADH and 1 FADH2. The regenerated OAA restarts the TCA cycle by 
accepting another C2-unit from acetyl-CoA. The reducing equivalents NADH and FADH2 are 
oxidized in the respiratory chain to drive ATP synthesis by oxidative phosphorylation. This 
represents the most efficient way to generate cellular energy. The phosphate/oxygen (P/O) ratio of 
oxidative phosphorylation describes the amount of ATP produced per oxygen atom reduced by the 
respiratory chain (Hinkle, 2005). P/O ratios of 2.5 ATP/NADH and 1.5 ATP/FADH2, respectively, 
are consistent with most reports (Hinkle, 2005; Michal and Schomburg, 2012). A maximum of 
32 mol ATP/mol glucose can be generated by complete glucose oxidation via oxidative 
phosphorylation while only 2 mol ATP/mol glucose are produced in aerobic glycolysis when 
glucose is converted to lactate (Michal and Schomburg, 2012). Constant concentrations of TCA 
cycle intermediates are crucial for the functioning of this metabolic pathway and are therefore 
strictly controlled by the cell. TCA cycle intermediates are removed from the cycle serving as 
precursors for the biosynthesis of other molecules, e.g. non-essential amino acids (NEAA). Citrate 
is exported from the mitochondria to the cytosol and cleaved by the ATP-dependent citrate lyase to 
provide cytosolic acetyl-CoA, e.g. for fatty acid synthesis. This carbon loss is balanced by 
anaplerotic reactions. On the other hand, a carbon excess in the TCA cycle has to be adjusted by 
cataplerotic reactions facilitating the exit of intermediates. The TCA cycle is strictly regulated by 
the cellular redox and energy state via the enzymes citrate synthase (CS), isocitrate dehydrogenase 
(IDH) and -ketoglutarate dehydrogenase (AKGDH). In addition, the PDH supplying the CS 
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substrate acetyl-CoA plays a crucial role in TCA cycle regulation. Distinct metabolite pools in the 
mitochondria and the cytosol exist for TCA cycle intermediates, e.g. citrate, isocitrate and AKG. 
The cytosolic NADPH-dependent isoform of the IDH enzyme might be involved in cytosolic 
NADPH balance and -ketoglutarate (AKG) supply. The compartmentation of these metabolites 
has not been taken into account in previous studies about CHO cell metabolism. 
Amino acids can contribute to catabolism by degradation to pyruvate and TCA cycle intermediates. 
Besides pyruvate as major precursor for the C2-unit acetyl-CoA, glutamine is an important carbon 
source for the TCA cycle in mammalian cells. The mitochondrial enzyme glutaminase catalyzes the 
hydrolysis of glutamine to ammonia and glutamate which is further converted into the TCA cycle 
intermediate AKG by the mitochondrial glutamate dehydrogenase (GDH). Alternatively, AKG is 
generated by transfer of the amino group from glutamate either to pyruvate by alanine 
aminotransferases (ALAT) or to OAA by aspartate aminotransferases (ASAT). Both 
aminotransferases exist in a cytosolic and a mitochondrial isoform. The expression of different 
ASAT isoenzymes plays a crucial role in metabolic efficiency due to their involvement in the 
malate-aspartate shuttle (Figure 1-2). The cellular glutamine metabolism and additionally its non-
enzymatic extracellular decomposition due to its non-stable nature represent the major sources of 
ammonia production (Tritsch and Moore, 1962). Accumulation of the toxic by-product ammonia 
can inhibit cell growth and negatively affect production and glycosylation of recombinant proteins 
(Yang and Butler, 2000; Yang and Butler, 2002). It is therefore a critical issue in industrial 
bioprocesses. In contrast to many other mammalian cell lines, CHO cells express low levels of 
glutamine synthetase (GS) and are therefore able to grow in glutamine-free medium (Zhang et al., 
2006). Overexpression of the GS gene by co-transfection with the gene of interest is one of the most 
important gene selection systems in CHO cell engineering for production of recombinant proteins 
(Wurm, 2004). Essential amino acids (ESAA) have to be supplied in the cell culture medium to 
allow protein synthesis and partially contribute to catabolism. Non-essential amino acids (NEAA) 
can be simultaneously degraded and synthesized in CHO cells. This has been proven by 
incorporation of labeling into NEAA in 13C-tracer studies (Ahn and Antoniewicz, 2012; Deshpande 
et al., 2009). However, the simultaneous consumption and production of amino acids has hardly 
been considered in metabolic studies so far. 
1.2.4 Pyruvate metabolism and C3-C4 node 
The metabolic reactions around the cellular pyruvate node are in the center of intermediary 
metabolism connecting glycolysis and TCA cycle and various other pathways (Figure 1-3). These 
key reactions take place in cytosol and mitochondria with separate metabolite pools in both cellular 
compartments. Pyruvate is taken up from the extracellular medium and/or is generated as end 
product of glycolysis from phosphoenolpyruvate (PEP) through PK (1) and has several metabolic 
fates. The highly regulated and irreversible PDH reaction catalyzes the conversion to acetyl-CoA 
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which enters the TCA cycle (2). Glycolysis and TCA cycle are further connected by reactions of 
malic enzyme (ME) (3), pyruvate carboxylase (PCX) (4) and PEP carboxykinase (PEPCK) (5). 
PDH and PCX are exclusively located in the mitochondria, while different isoforms with cytosolic 
or mitochondrial localization can potentially exist for ME and PEPCK (Michal and Schomburg, 
2012). Furthermore, pyruvate can be reduced to lactate via LDH (6) and converted to alanine via 
alanine aminotransferase (ALAT) (7). 
 
Figure 1-3. Metabolic reactions around the cellular pyruvate node. (1) pyruvate kinase, (2) pyruvate 
dehydrogenase, (3) malic enzyme, (4) pyruvate carboxylase, (5) phosphoenolpyruvate carboxykinase, (6) 
lactate dehydrogenase, (7) alanine aminotransferase. Potentially reversible reactions are indicated by an 
arrow in the opposite direction. Dashed arrows indicate connections to major metabolic pathways. 
Neermann and Wagner were unable to detect significant activities of PDH, PEPCK and PCX in 
several CHO, BHK and hybridoma cell lines (Neermann and Wagner, 1996) indicating a low 
connection between glycolysis and TCA cycle. However, 13C-tracer studies provide strong evidence 
for activity of these enzymes in CHO cells (Ahn and Antoniewicz, 2011; Ahn and Antoniewicz, 
2013; Goudar et al., 2010). Dean and Reddy proved the expression of PEPCK and ME in CHO cells 
by Western Blot analysis (Dean and Reddy, 2013). Niklas et al. presented a valuable method for the 
high-throughput determination of compartmented enzyme activities using selective permeabilization 
techniques (Niklas et al., 2011a). They observed cytosolic and mitochondrial ME activity in an 
antithrombin-producing CHO cell line. PCX, ME and PEPCK play an essential role in anaplerosis 
of the TCA cycle. Furthermore, PCX and PEPCK are key enzymes initiating gluconeogenesis. The 
accurate determination of the compartmented reactions around the cellular pyruvate metabolism 
represents a significant challenge in the resolution of complex metabolic networks. Previous studies 
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of CHO metabolism usually present simplified descriptions of this highly branched metabolic hub in 
the intermediary metabolism. 
1.3 Reconstruction of relevant network models for metabolic 
studies in CHO cells 
The devil is in the details. This is especially true for detailed studies of mammalian metabolism 
which is highly complex particularly related to metabolite compartmentation and exchange 
(Wahrheit et al., 2011). Considering a relevant network structure is of utmost importance to 
calculate physiologically meaningful flux distributions. It is the first and potentially most important 
step in metabolic flux analysis (MFA). Although the number of MFA studies in mammalian systems 
rapidly increased in the last few years, published metabolic networks used for CHO cell studies are 
highly controversial and largely simplified. Given the high complexity of mammalian metabolism, 
certain assumptions might be necessary for model reduction (Zamboni, 2011). Quek et al. proposed 
a large list of model reductions based on literature supposing negligible activity for many enzymes 
(Quek et al., 2009). However, model reduction and oversimplification can produce misleading 
results and conclusions. Particular care has to be taken when introducing simplifications. A priori 
assumptions of negligible activity for certain enzymes followed by their exclusion from the 
metabolic model can only be an acceptable approach if evidence on the expression or activity level 
is available for the investigated cell clone and given condition (Wahrheit et al., 2011). Transferring 
knowledge derived from a different context, e.g. from another cell line or from a different 
environmental condition, is generally not valid. 
Unfortunately, published model reductions for CHO cell network models seem rather arbitrary than 
reasonable and specific. It is common practice that cytosolic and mitochondrial metabolite pools are 
lumped assuming a rapid equilibrium between compartments (Templeton et al., 2013). Even if 
metabolic compartmentation is at least partially considered, there is no consensus with respect to 
localization and parallelization of pathways, reaction and transport reversibility as well as the 
occurrence of anaplerotic and gluconeogenic fluxes. In order to reconstruct a realistic metabolic 
network for CHO cells, one has to consider at least three compartments; the extracellular space, the 
cytosol and the mitochondria. 
1.3.1 Enzyme localization 
The analysis of compartmented metabolic networks is complicated by separation and parallelization 
of pathways. Metabolic pathways can span several compartments and the existence of isoenzymes 
creates parallel pathways in different subcellular locations (Wahrheit et al., 2011). Distinct 
metabolite pools in cytosol and mitochondria have different pool sizes and are involved in different 
pathways. In terms of 13C-labeling experiments, one has to keep in mind that cytosolic and 
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mitochondrial metabolites are most likely differently labeled and exhibit different labeling dynamics 
(Figure 1-4A). There is general consensus about the cytosolic localization of glycolytic and PPP 
enzymes and the mitochondrial localization of the TCA cycle (Berg et al., 2012; Michal and 
Schomburg, 2012). However, reactions of the amino acid metabolism are sometimes misplaced or 
spuriously considered only in one compartment and in many cases experimental evidence for the 
enzyme localization is scarce. Based on current knowledge collected in various data bases (Brenda, 
Reactome, KEGG, UniProt), the glutaminase reaction is located in the mitochondria, while the 
glutamine synthesis takes place in the cytosol. However, most metabolic models published for CHO 
cells assume a cytosolic glutaminase localization (Ahn and Antoniewicz, 2011; Ahn and 
Antoniewicz, 2013; Sheikholeslami et al., 2013b; Templeton et al., 2013). Although, alanine and 
aspartate transaminases can be located in the cytosolic and the mitochondrial compartment (Michal 
and Schomburg, 2012), the existence of separate isoenzymes converting respective distinct 
metabolite pools in cytosol and mitochondria is rarely taken into account. Most published CHO cell 
models include only the cytosolic (Ahn and Antoniewicz, 2011; Ahn and Antoniewicz, 2013; 
Templeton et al., 2013) or only the mitochondrial isoenzymes of ALAT and ASAT (Sheikholeslami 
et al., 2013a; Sheikholeslami et al., 2014). CHO cells often conduct synthesis and degradation 
pathways of non-essential amino acids simultaneously as clearly proven by tracer studies (Ahn and 
Antoniewicz, 2012; Deshpande et al., 2009). The separation of these opposite pathways into distinct 
cellular compartments is a general means of metabolic regulation and should not be neglected. 
Compartmental enzyme activity determinations can help identifying the correct localization of 
enzymes (Niklas et al., 2011a). The isocitrate dehydrogenase (IDH) exists in three isoforms; the 
NAD+-dependent isoenzyme is located in the mitochondria (IDH3), while the NADP+-dependent 
isoforms exist in the cytosol (IDH1) and the mitochondria (IDH2), respectively (Henderson, 1965; 
Michal and Schomburg, 2012). Interestingly, it was found that the major part of total cellular IDH 
activity was located in the cytosol and not in the mitochondria in mammalian cells (Niklas et al., 
2011a; Vriezen and van Dijken, 1998b). However, a cytosolic IDH reaction has so far never been 
considered in MFA studies of CHO cells (Ahn and Antoniewicz, 2012). This reaction is thought to 
have a crucial function in cytosolic NADPH balance and has been shown to be involved in cancer, 
diabetes, and oxidative stress (Dang et al., 2009; Ronnebaum et al., 2006; Turcan et al., 2012; Xu et 
al., 2004; Yan et al., 2009). 
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Figure 1-4. (A) Metabolic compartmentation results in distinct metabolite pools in different compartments 
(B1 and B2). Due to the disruptive nature of current metabolite extraction protocols it is not possible to 
separate and distinguish different metabolite pools. As a result, only the mixed labeling of all cellular pools 
of a specific metabolite can be determined (Bmeasured). (B) The consumption of multiple non-labeled 
substrates (X, Y) and the reversible exchange with significantly larger extracellular metabolite pools (Bex) 
results in a dilution of intracellular labeling and slow labeling dynamics. 13C-labeled metabolites are 
represented by black and grey circles, unlabeled metabolites by white circles. 
1.3.2 Mitochondrial transport 
A large set of specific transport systems links pathways, transfers precursors and cofactors, and 
mediates communication between interdependent compartments. The operation of mitochondrial 
carrier systems with regard to stoichiometry, specificity and reversibility is still a matter of 
discussion. Transport systems can be redundant and the relative contribution of different 
transporters is often uncertain. Many transport systems are poorly characterized or not even 
identified. Only very recently, the long awaited mitochondrial pyruvate carrier (MPC) gene has 
been identified (Bricker et al., 2012; Herzig et al., 2012). Some studies consider the MPC to be 
reversible with exchange fluxes thousand-fold exceeding the net import into the mitochondria (Ahn 
and Antoniewicz, 2011; Sheikholeslami et al., 2013b), while other studies include an irreversible 
pyruvate uptake (Ahn and Antoniewicz, 2013; Sheikholeslami et al., 2013a; Sheikholeslami et al., 
2014). With respect to its coupling to the mitochondrial proton gradient (pyruvate enters the 
mitochondria via symport with a proton), it is likely that the import into mitochondria is irreversible. 
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Sheikholeslami et al. presented the first metabolic network of CHO cells that accounts for transport 
stoichiometry by including citrate/malate antiport via tricarboxylate carrier, malate transport via 
dicarboxylate carrier and aspartate transport via glutamate/aspartate antiport (Sheikholeslami et al., 
2013b). However, in most MFA studies, metabolic compartmentation and mitochondrial transport is 
not considered. Much work remains to be done to shed light on some uncertainties regarding 
mitochondrial transport specificities and activities. 
1.3.3 Reversible exchange with the extracellular medium 
The extracellular space has to be treated as a distinct compartment, similar to the cellular 
compartments cytosol and mitochondria. CHO cells are cultivated in nutrient rich, complex media 
containing multiple carbon sources. Tracer studies revealed that a range of metabolites, e.g. lactate 
and pyruvate and many non-essential amino acids (NEAA), that are taken up at high net fluxes are 
in fact reversibly exchanged with the extracellular medium (Ahn and Antoniewicz, 2012). That 
implies that degradation and synthesis of NEAA have to be considered separately in the model. The 
consumption of non-labeled substrates and the high exchange fluxes with the extracellular medium 
significantly slow down the labeling dynamics in tracer studies (Figure 1-4B). Nevertheless, the 
reversible exchange of metabolites with the extracellular medium has not been included in previous 
studies of CHO metabolism. 
1.3.4 Micro-compartmentation and metabolic channeling effects 
Although the glycolytic pathway is entirely located in the cytosol, it is subject to metabolic 
compartmentation. The association of glycolytic enzymes into protein complexes and binding to 
cellular structures is involved in glycolytic regulation (Michal and Schomburg, 2012). Binding of 
the HK to the outer mitochondrial membrane substantially promotes glycolytic flux by providing 
preferential access to mitochondrially generated ATP. The channeling of intermediates results in a 
micro-compartmentation of the glycolytic pathway within the cytosolic compartment. Micro-
compartmentation and channeling effects have also been proposed for the cellular pyruvate 
metabolism in CHO cells (Ahn and Antoniewicz, 2013). 
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1.4 Computational methods for the investigation of metabolic 
networks 
The emerging systems biology era has substantially influenced the whole scientific world. Biology 
has moved from mere qualitative investigations to comprehensive quantitative descriptions followed 
by an integration of these quantitative data sets into mathematical models. In addition, instead of 
focusing on single aspects, biological studies aim more and more at gaining a holistic understanding 
of a biological system including dynamic interactions between single components. Metabolic fluxes 
integrate information of all upstream components of the cellular hierarchy (genome, transcriptome, 
proteome, metabolome) including their interactions and regulation on different levels. Therefore, 
the fluxome reflects the functional endpoint of a biochemical network (Figure 1-5A) (Sauer, 2006). 
Metabolic flux analysis (MFA) aims at quantifying the in vivo intracellular reaction rates of a 
metabolic network. It represents the most comprehensive way to quantify cell physiology and to 
provide a meaningful representation of the cellular phenotype. MFA has been extensively used in 
basic and applied research to characterize and understand physiological, pathological, or 
toxicological conditions as well as to identify therapeutic targets or to guide metabolic engineering 
and optimization of industrial production processes (Niklas and Heinzle, 2012; Niklas et al., 2010). 
The quantification of metabolic fluxes by MFA can be performed using simple metabolite balancing 
(Figure 1-5B) or by more sophisticated 13C metabolic flux analysis (13C MFA) (Figure 1-5C). 
1.4.1 Metabolic flux analysis using metabolite balancing 
Metabolic flux estimation using the metabolite balancing method (Figure 1-5B) only requires 
extracellular measurements of substrate uptake (S), product excretion (P) and biomass formation 
(BM). From these known (measurable) extracellular metabolic fluxes (rm), the unknown 
intracellular flux distribution (rc) can be calculated using a stoichiometric network model of the 
metabolism and material balances around the intracellular metabolite pools (Niklas and Heinzle, 
2012). Metabolic flux estimation using metabolite balancing is the most commonly applied method 
for the investigation of mammalian systems. Due to the utilization of multiple carbon sources in 
mammalian cell cultures, a large number of extracellular measurements is usually available. In CHO 
cells, this classical MFA method has been used in various applications (Altamirano et al., 2006; 
Altamirano et al., 2001b; Burleigh et al., 2011; Carinhas et al., 2013; Goudar et al., 2006; Goudar et 
al., 2014; Nyberg et al., 1999b). 
The application of metabolite balancing relies on metabolic steady state conditions which implies 
that the intracellular metabolite concentrations are constant with time (dM/dt = 0) (Figure 1-6, 
metabolic stationary state). In other words, at metabolic steady state, the sum of metabolite 
consumption rates equals the sum of their production rates. This is easily achieved in continuous 
cultivation experiments. Furthermore, a pseudo steady state assumption is usually valid at balanced 
Chapter 1 General introduction 
 
29 
growth conditions, i.e. exponential growth and constant metabolite yields (Deshpande et al., 2009). 
However, for a range of mammalian cultivation systems (e.g. monolayer cultures), certain process 
modes (e.g. industrially relevant fed-batch cultivations), and generally at changing environmental 
conditions and cellular state, it is questionable if balanced growth and a (pseudo) metabolic steady 
state are truly achieved (Figure 1-6, metabolic instationary state). One possibility is to divide the 
cultivation profile into distinct metabolic phases for which balanced growth conditions are valid and 
calculate average rates for each separate phase (Niklas et al., 2011c). 
An elegant way to deal with this challenge and circumvent the necessity of a metabolic steady state 
are dynamic approaches which calculate the evolution of metabolic fluxes over time (Antoniewicz, 
2013b; Leighty and Antoniewicz, 2011; Llaneras and Pico, 2007b; Niklas et al., 2011c). Dynamic 
metabolic flux analysis (DMFA) methods are usually based on (1) data smoothing, e.g. using spline 
fitting, followed by (2) separation into very small time intervals, (3) taking derivatives of 
extracellular measurements and (4) successive application of classical MFA to calculate time-
resolved fluxes (Niklas et al., 2011c). Special software tools, e.g. the user-developed Shape 
Language Modeling (SLM) tool for MATLAB (MathWorks), can be applied to include additional 
constraints and significantly improve the quality of fitting (e.g. avoid over-fitting). Other 
approaches of DMFA are based on a piecewise linear flux function describing the cultivation profile 
as a whole (Leighty and Antoniewicz, 2011) or on simulating the flux dynamics by including 
kinetic information and using a hybrid stoichiometric-kinetic model (Nolan and Lee, 2011). 
The metabolite balancing method is very useful to resolve simple networks. However, more 
complex networks including cyclic pathways, alternative pathways, and reaction reversibilities 
cannot be resolved with metabolite balancing alone. In particular, information about metabolic 
compartmentation cannot be obtained by this simple MFA technique (Allen et al., 2009; Wahrheit et 
al., 2011; Zamboni, 2011). If the available extracellular measurements are insufficient, the 
metabolic network is underdetermined. Several variants of MFA and extensions of the metabolite 
balancing method have been proposed to calculate underdetermined parts in metabolic networks. 
Different constraints (e.g. on reaction reversibility, negligible enzyme activities) or specific 
objective functions (e.g. maximizing growth) assuming optimal behavior of an organism as applied 
in flux balancing analysis (FBA) can be introduced to reduce the solution space (Martinez et al., 
2013; Orth et al., 2010). Furthermore, several groups proposed methods for the determination of 
upper and lower boundaries for non-calculable fluxes, sometimes referred to as flux spectrum 
approach (FSA) (Llaneras and Pico, 2007a; Llaneras and Pico, 2007b; Zamorano et al., 2010) 
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Figure 1-5. (A) The biochemical network is composed of the hierarchical components genome, 
transcriptome, proteome and metabolome. The fluxome reflects the integrated network response including 
regulation at the genomic, transcriptional, translational and metabolic level and eventually determines the 
cellular phenotype. (B) Different steps of metabolic flux analysis using the metabolite balancing method. S 
substrate, P product, BM biomass, M internal metabolite, r reaction rate, rm measured fluxes, rc calculated 
fluxes, Am and Ac stoichiometric matrices of the measured and calculated fluxes, respectively. (C) 
13C 
metabolic flux analysis (13C MFA). Positional and mass isotopomers constitute the labeling state of a 
metabolite. Isotopomer distribution vectors (IDV) and mass distribution vectors (MDV) mathematically 
quantify the fractions of positional and mass isotopomers as shown for an example of a metabolite with 
three carbons (Wittmann, 2002). Isotopomer mapping matrices (IMM) define the transition of isotopomers 
between reactants and products.  refers to an element wise multiplication. The metabolic flux distribution 
is calculated by minimizing the deviation between measured and simulated 13C labeling patterns. 
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Figure 1-6. Overview of different metabolic flux analysis (MFA) methods, experimental conditions with 
regard to metabolic and isotopic state and the characteristics of determined or assumed parameters: 
intracellular concentrations c, metabolic fluxes r, and isotopomers expressed as mass distribution vector 
(MDV). Metabolic stationary conditions (metabolic steady state) imply that intracellular metabolite 
concentrations and metabolic fluxes are constant with time (dM/dt = 0). If metabolite concentrations and 
fluxes are changing with time, the metabolic state is called instationary or dynamic. Metabolite balancing 
and dynamic MFA methods can be applied for metabolic flux calculation at metabolic stationary or 
instationary state, respectively, without the use of labeling. The application of 13C MFA requires the 
determination of 13C labeling patterns in specific readout metabolites. The isotopic state is stationary if the 
isotopomers of a metabolite are invariant with time. Metabolic steady state is a prerequisite for isotopic 
steady state. In this case, metabolic fluxes can be calculated by classical 13C MFA. At isotopic instationary 
state with dynamically changing isotopomers, flux calculation requires the application of either isotopically 
non-stationary MFA (INST-MFA) at metabolic stationary state or dynamic 13C-MFA at metabolic 
instationary conditions, respectively. The figure was adapted and extended from (Wahl et al., 2008). 
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1.4.2 13C metabolic flux analysis 
Additional information to resolve complex metabolic networks can be obtained from stable isotope 
labeling experiments. 13C-based metabolic flux analysis (13C MFA, Figure 1-5C) is an established 
standard method for the quantification of intracellular fluxes in detailed metabolic networks and has 
been widely applied for various different biological systems (Wiechert, 2001). This approach 
involves the feeding of substrates with one or more 13C-labeled carbons and the metabolization of 
the labeled substrate (tracer) by the cell (Zamboni et al., 2009). The distribution of 13C throughout 
the metabolic network is a function of the respective pathway activities resulting in specific labeling 
patterns of metabolites (Niklas and Heinzle, 2012). For classical 13C MFA, the labeling patterns are 
sampled at isotopic steady state (Figure 1-6, metabolic and isotopic stationary state). Thus, the 
metabolic flux distributions can be reconstituted from the isotopic enrichment in metabolic 
intermediates or macromolecules. The most commonly applied labeled substrates in 13C MFA of 
mammalian cells are different glucose and glutamine tracers (Metallo et al., 2009), since glucose 
and glutamine constitute the most important carbon sources in mammalian cell cultures (Eagle, 
1955). It is essential to consider the atom-% purity of 13C-labeled compounds, e.g. for [U-13C6] 
glucose with 99 atom-% isotopic purity the abundance of fully labeled glucose is not 99% but 0.996 
= 94% (Yang, 2013). Optimal design of isotope labeling experiments is crucial for the precision of 
13C MFA-based flux estimates. The information of parallel labeling experiments can be combined to 
significantly improve the flux calculation (Antoniewicz, 2013a; Yang et al., 2006a; Yang et al., 
2006b). The consumption of multiple carbon sources in mammalian cell cultures is a particular 
advantage in this respect (Wahrheit et al., 2011). 
The labeling state of a metabolite is constituted by its isotopomers (Wittmann, 2002). Positional 
isotopomers define the exact position of labeled carbons, while mass isotopomers only describe the 
number of 13C atoms present in a specific molecule. A metabolite with n carbons has 2n different 
positional isotopomers which sum up to n + 1 different mass isotopomers (Figure 1-5C). The 
fractions of positional and mass isotopomers are mathematically quantified by isotopomer 
distribution vectors (IDV) (Schmidt et al., 1997) and mass distribution vectors (MDV). The 13C 
labeling patterns of metabolites can be analyzed by nuclear magnetic resonance (NMR) 
spectroscopy (Teixeira et al., 2008; Zupke and Stephanopoulos, 1995) resolving positional 
isotopomers or mass spectrometry (MS) techniques, usually GC/MS, resulting in mass isotopomer 
data (Wittmann, 2002; Wittmann, 2007; Wittmann and Heinzle, 1999). GC/MS data has to be 
corrected for naturally occurring isotopes considering both the atoms of the analyte and 
derivatization residues, e.g. using correction matrices (van Winden et al., 2002; Wittmann and 
Heinzle, 1999; Yang et al., 2009). 
The concept of atom mapping matrices (AMM) describes the carbon transition in a metabolic 
network in form of a m  n matrix where m is the number of carbons in the product and n is the 
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number of carbons in the reactant (Zupke and Stephanopoulos, 1994). The AMM concept has been 
further expanded to isotopomer mapping matrices (IMM) which map each positional isotopomer of 
a reactant to a product (Schmidt et al., 1997). The corresponding AMM is thereby converted into a 
2m  2n IMM. The IDV of a product is calculated from the IMM and IDV of the reactants. The 
metabolic flux distribution is eventually determined by combination of isotopomer and metabolite 
balancing. Starting from initial random values that fulfill the constraints, the flux distribution is 
estimated based on minimizing the deviation between measured and simulated labeling patterns by 
applying suitable optimization routines (Figure 1-5C). More detailed descriptions on the concept of 
13C MFA can be found in relevant review articles (Sauer, 2004; Sauer, 2006; Wiechert, 2001; 
Zamboni et al., 2009; Zamboni and Sauer, 2009). Labeling experiments and 13C MFA studies are 
still the exception in metabolic studies of CHO cells but are becoming more and more popular in the 
last few years (Ahn and Antoniewicz, 2013; Goudar et al., 2010; Sengupta et al., 2011; 
Sheikholeslami et al., 2013a; Sheikholeslami et al., 2013b; Sheikholeslami et al., 2014; Templeton 
et al., 2013). 
1.4.3 Isotopically non-stationary metabolic flux analysis 
In 13C-labeling experiments of mammalian cell cultures, the utilization of several carbon sources 
and their reversible exchange with significantly larger extracellular metabolite pools results in 
considerable dilution of intracellular labeling and slows down the dynamics of label incorporation 
(Figure 1-4). The concept of non-stationary 13C MFA (INST-MFA, isotopically non-stationary 
MFA) presented by the group of Wiechert (Wahl et al., 2008; Wiechert and Nöh, 2005; Wiechert 
and Nöh, 2013) is a powerful advancement of classical stationary 13C MFA. While steady state 13C 
MFA requires metabolic and isotopic steady state conditions (Figure 1-6, metabolic and isotopic 
stationary state), the INST-MFA method is applied to systems at metabolic steady state yet isotopic 
non-stationary conditions (Figure 1-6, metabolic stationary and isotopic instationary state). This 
approach uses the information of the transient period of label incorporation before isotopic steady 
state is reached. Following the isotopomer dynamics yields much richer information than the 
isotopic steady state (Nöh and Wiechert, 2011). This is particularly conducive for addressing very 
challenging questions, such as resolving the compartmented fluxes of a complex metabolic network. 
Metabolic compartmentation generally increases the number of alternative pathways, introduces a 
number of reversible transport reactions, and creates new cycles, thus increasing the degrees of 
freedom. Alternative pathways include shuttles involving the same metabolites and isoenzymes that 
catalyze the same reaction in different compartments (Wahrheit et al., 2011). INST-MFA can 
provide information about intracellular and intracompartmental concentrations, metabolic fluxes, 
reversibility, and network structure, however, requires demanding experimental techniques and 
sophisticated modeling efforts (Wahrheit et al., 2011). Additional parameters (e.g. metabolite pool 
sizes) have to be determined or estimated. This methodology offers new opportunities to investigate 
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the metabolism of more complex, higher organisms (in particular animal cells and plant cells), 
industrially relevant non-stationary bioprocesses and other biological systems where steady state 13C 
MFA is not applicable but also when experiments at short time scales are preferred (Nöh et al., 
2007; Nöh et al., 2006; Nöh and Wiechert, 2011). INST-MFA studies in mammalian cells are still 
very rare. Ahn and Antoniewicz determined metabolic fluxes in growth and non-growth phases of a 
CHO-K1 monolayer culture using intracellular labeling dynamics and INST-MFA (Ahn and 
Antoniewicz, 2011). However, there exists no INST-MFA study in mammalian suspension cells to 
date. 
1.4.4 Metabolic pathway analysis using elementary mode analysis 
Elementary mode analysis (EMA) is a mathematical tool for analyzing metabolic pathways. It 
allows for a more general characterization of cellular metabolism and metabolic network 
functionality than MFA. Similar to metabolite balancing, EMA only relies on the stoichiometric and 
thermodynamic properties of a metabolic network and does not require any kinetic information. A 
network with internal and external metabolites and reactions is reconstructed, where the steady state 
assumption is valid for internal metabolites (Figure 1-7A). However, MFA methods are applied to 
calculate a single in vivo flux distribution for a given condition, thus providing only one specific 
solution for the metabolic network under investigation (Figure 1-7B, asterisk). Different cultivation 
conditions will result in distinct metabolic flux distributions (different solutions). In contrast, EMA 
aims at identifying all possible solutions that can exist for a particular metabolic network, i.e. all 
elementary modes (EM) (Figure 1-7B, circles spanning the entire solution space or flux cone). An 
EM can be defined as “a unique, minimal set of enzymes to support steady state operation of a 
metabolic network with irreversible reactions to proceed in appropriate directions” (Trinh et al., 
2009). Four elementary flux modes exist for the example network shown in Figure 1-7. For each 
metabolic network there exists a set of non-decomposable EM that describes all biochemically 
feasible pathways converting a certain substrate to a resulting product. In other words, EMA defines 
the capabilities of a metabolic genotype, while an actual metabolic flux distribution calculated by 
MFA determines the physiological phenotype for a specific condition. A steady state flux 
distribution can therefore be expressed as a non-negative linear combination of EM, i.e. a weighted 
average of all active EM. 
EMA can be used to assess and predict inherent properties of the metabolic network structure for a 
wide range of applications. It assists in exploring the network topology and network functionality, 
e.g. concerning the flexibility of a network regarding redundancy and robustness. EMA can be 
applied to estimate metabolic capacities or limitations. The importance of individual reactions can 
be estimated based on the relative participation in a pathway. EMA can be used to find the optimal 
pathway for maximizing the product yield on specific substrates or to generally assess the potential 
of a producer strain. The identification of essential and expendable reactions, enzyme deficiencies, 
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and metabolic bottlenecks is another application. This is also useful in the analysis of network 
fragility and helps identifying metabolic engineering or drug targets. EMA allows the investigation 
of all physiologically relevant and meaningful states for a metabolic system. In CHO cell studies, 
EMA has been used to design predictive macroscopic models (Provost et al., 2006; Zamorano et al., 
2013). 
 
Figure 1-7. Elementary mode analysis. (A) A simple metabolic network composed of the internal 
metabolites M1, M2, and M3 with dM/dt = 0 and the external metabolites A, B, and C that do not fulfill the 
steady state condition. (B) Geometric representation of the solution space. The flux cone represents all 
feasible metabolic pathways that can exist. It is spanned by four elementary modes (EM) as represented by 
circles. However, if there exist more EM they can also lie inside of the cone. The EM describe the 
capabilities of a metabolic network. A metabolic flux distribution under a given condition represented by 
the asterisk is a specific solution lying inside of the cone. It can be expressed by a linear combination of 
EM. (C) The four existing EM for the metabolic network shown in (A). The example was taken from 
(Papin et al., 2004). 
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1.5 Aim and outline of the thesis 
The aim of the presented thesis was to increase the knowledge about metabolic dynamics and 
compartmentation in Chinese hamster ovary (CHO) cells. Compartmentation and inter-compartment 
transport substantially complicate the analysis of metabolic pathways. Especially the investigation 
of metabolic compartmentation in mammalian cells has been mostly neglected in the past. A major 
objective was the development and implementation of novel experimental techniques, theoretical 
concepts and computational methods in order to provide a sound basis for approaching this 
exceptionally challenging issue. 
A special focus of the project was directed on the dynamics of cytosolic glycolysis and 
mitochondrial tricarboxylic acid (TCA) cycle and the metabolic reactions in the connection of these 
pathways. These include in particular the key reactions around the cellular C3-C4 node that involves 
conversions of pyruvate, phosphoenolpyruvate, malate and oxaloacetate, with distinct metabolite 
pools in cytsosol and mitochondria. CHO cells have been chosen as an example organism 
considering their importance as mammalian model system and preeminent industrial relevance. 
First, the applied CHO-K1 cell line was characterized by investigating the dynamics of in vivo 
metabolic fluxes and in situ enzyme activities during batch cultivation (chapter 2). Here, two 
powerful methods, dynamic metabolic flux analysis and time-resolved determination of 
compartmental enzyme activities, were combined to study metabolic shifts and metabolic control at 
the cytosol-mitochondria interface. In two follow-up studies, we explored the impact of the 
metabolism of glutamine (chapter 3) and pyruvate (chapter 4) as major substrates of the TCA cycle 
on the physiology of CHO-K1 cells by metabolic flux analysis using metabolite balancing. 
The second part of the thesis aimed at a more in-depth understanding of the CHO cell metabolism. 
We applied non-stationary 13C metabolic flux analysis based on different labeling studies using 
either only glucose (chapter 5) or glucose and glutamine in parallel (chapter 6) as tracer substrates. 
We were able to resolve the details of the highly complex metabolism of CHO cells. Here, a special 
emphasis was put on metabolic compartmentation including inter- and intracompartmental fluxes 
and concentrations, reaction and transport reversibilities and the distinction of amino acid synthetic 
and catabolic pathways. 
The last section of the work focused on mitochondrial studies with selectively permeabilized cells. 
In a high-throughput respiration screening, we identified single mitochondrial substrates and could 
draw first conclusions about control of mitochondrial metabolic activities (chapter 7). These data 
served as starting point to design further in-depth studies. Using elementary mode analysis of 
functional mitochondria within permeabilized cells we explored the mitochondrial metabolic 
pathways in more detail (chapter 8). 
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2 Metabolic control at the cytosol–mitochondria interface 
in different growth phases of CHO cells 
2.1 Abstract 
Metabolism at the cytosol–mitochondria interface and its regulation is of major importance 
particularly for efficient production of biopharmaceuticals in Chinese Hamster Ovary (CHO) cells 
but also in many diseases. We used a novel systems-oriented approach combining dynamic 
metabolic flux analysis and determination of compartmental enzyme activities to obtain systems 
level information with functional, spatial and temporal resolution. Integrating these multiple levels 
of information, we were able to investigate the interaction of glycolysis and TCA cycle and its 
metabolic control. We characterized metabolic phases in CHO batch cultivation and assessed 
metabolic efficiency extending the concept of metabolic ratios. Comparing in situ enzyme activities 
including their compartmental localization with in vivo metabolic fluxes, we were able to identify 
limiting steps in glycolysis and TCA cycle. Our data point to a significant contribution of substrate 
channeling to glycolytic regulation. We show how glycolytic channeling heavily affects the 
availability of pyruvate for the mitochondria. Finally, we show that the activities of transaminases 
and anaplerotic enzymes are tailored to permit a balanced supply of pyruvate and oxaloacetate to the 
TCA cycle in the respective metabolic states. We demonstrate that knowledge about metabolic 
control can be gained by correlating in vivo metabolic flux dynamics with time and space resolved 
in situ enzyme activities. 
 
This chapter was published as 
Wahrheit J, Niklas J, Heinzle E. (2014). Metabolic control at the cytosol–mitochondria interface in 
different growth phases of CHO cells. Metabolic Engineering 23 9-21. 
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2.2 Introduction 
Although the knowledge of metabolic pathways is very broad, methods for analyzing metabolic 
control mechanisms in mammalian cells at a systems level are still very limited. A huge number of 
valuable studies exploring various individual aspects of mammalian metabolism and of its 
regulation can be found in the literature. Investigated cells range from different mammalian cell 
lines, e.g. Chinese hamster ovary (CHO) cells, Baby hamster kidney (BHK) cells, hybridoma cells, 
or myeloma cells, to primary cells or tissues. Usually, a single aspect, e.g. the metabolic flux 
distribution in a specific growth phase, is analyzed and sometimes different conditions, such as 
nutrient availability, genetic background, or different biological systems are compared. Such studies 
are well suited for a qualitative description of differences between distinct conditions. However, 
detailed quantitative understanding of mammalian metabolism and its control requires systems-
oriented combined studies, e.g. of in vivo activity and its regulation. 
Metabolic compartmentation is a major characteristic in all eukaryotes and represents an essential 
means of metabolic regulation (Wahrheit et al., 2011). The interaction of cytosolic glycolysis and 
mitochondrial TCA cycle is central for cellular energy generation and metabolic efficiency. It often 
represents a bottleneck in production processes (Niklas et al., 2012a; Niklas et al., 2012b; Niklas et 
al., 2011b) and is at least partially impaired in a wide range of diseases including diabetes, cancer 
and neurodegenerative disorders (Fernyhough et al., 2010; Haas, 2010; Rosenstock et al., 2010; 
Schrauwen and Hesselink, 2008; Stacpoole, 2012). Despite this central role in metabolism, many 
aspects of this metabolic hub are still unknown and remain the target of current studies. Although 
the existence of a specific mitochondrial pyruvate transporter has been demonstrated in the 1970s, 
the coding gene was only very recently identified (Bricker et al., 2012; Herzig et al., 2012). 
Increasing our knowledge in metabolic compartmentation and in particular in understanding the 
interconnection of glycolysis and TCA cycle at the cytosol–mitochondria interface will substantially 
advance the optimization of producer cell lines and biotechnological processes as well as the 
development of novel therapeutic approaches. 
CHO cells have been used as a mammalian model system for more than 50 years (Jayapal et al., 
2007; Puck et al., 1958) and have therefore been termed as “the mammalian equivalent of E. coli” 
(Puck, 1985). Furthermore, CHO cells are of substantial significance for the biopharmaceutical 
industry serving as the predominant cultivation system for the production of therapeutic proteins 
(Wurm, 2004). 
In our study, we provide a comprehensive view on CHO central metabolism and its regulation. We 
used a unique combination of dynamic metabolic flux analysis (MFA) to obtain the time-resolved in 
vivo flux distribution and determination of compartmental in situ enzyme activities in different 
growth phases. This provides systems level information with functional, spatial and temporal 
resolution. In the first part of our study, we performed dynamic MFA to capture the dynamics of 
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growth and metabolism upon changing environmental conditions. The cellular adaptation to 
changing environmental conditions during a batch cultivation leads to metabolic shifts resulting in 
different growth phases with distinct metabolic states (Niklas et al., 2011c). We identified and 
characterized different metabolic phases addressing the following questions: (a) what distinguishes 
the distinct growth phases, (b) which metabolic characteristics determine the metabolic state of each 
phase, (c) what triggers the phase shifts, and (d) how do the cells respond to these metabolic shifts? 
Three distinct metabolic states were distinguished, namely overflow metabolism, balanced 
metabolism and maintenance metabolism. 
In order to assess and predict metabolic efficiency at different metabolic states, we expand the 
concept of metabolic flux ratios. The lactate/glucose ratio is an often-used parameter to characterize 
the metabolism of mammalian cells (Ahn and Antoniewicz, 2011; Niklas et al., 2012a). We propose 
the TCA cycle/glycolysis ratio as additional indicator of metabolic efficiency. Furthermore, we 
analyze the dynamics of these metabolic flux ratios to monitor metabolic shifts. 
The first two growth phases are further investigated in the second part by determining specific 
enzyme activities in distinct growth phases. Applying selective permeabilization techniques in 
combination with conventional enzyme assays, we were not only able to quantify total enzyme 
activity but even more important their compartmental distribution (Niklas et al., 2011a). 
The last part of our study focused on analyzing the metabolic shift from phase I, characterized by 
inefficient overflow metabolism, to an efficient and balanced metabolism in phase II by integrating 
the different data sets. The correlation of in situ enzyme activities indicating possible maximum 
enzyme rates with in vivo metabolic rates representing the actual activities represents a powerful 
approach to gain insight into metabolic control. In situ enzyme activities and in vivo fluxome 
integrate information of all upstream functional levels (genome, transcriptome, and proteome), 
including regulatory events (Sauer, 2006). Additional important information about enzyme 
localization was obtained from compartmental enzyme activity assays (Niklas et al., 2011a). We 
integrated information about in situ and in vivo metabolic activities (functional resolution), 
metabolic state (time resolution), and compartmental localization of activities (spatial resolution). 
This allowed us to draw conclusions about metabolic efficiency, rate-limiting steps, glycolytic 
channeling, and metabolic interactions at the cytosol–mitochondria interface. We demonstrate that 
metabolic control in the central metabolism and eventually potential targets for process optimization 
and biomedical research can be identified by correlating in vivo metabolic flux dynamics with 
respective time and space resolved in situ enzyme activities. 
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2.3 Material and methods 
2.3.1 Cell culture 
The CHO-K1 cells were cultivated in protein free and chemically defined TC-42 medium 
(TeutoCell, Bielefeld, Germany) supplemented with 4 mM glutamine in 250 ml baffled shake flasks 
in a shaking incubator (2 inches orbit, 185 rpm, 37°C, 5% CO2 supply). Two parallel cultivations of 
100 ml volume were inoculated with 2 × 105 cells/ml. Cell density, cell viability and average cell 
diameter were determined using an automated cell counter (Invitrogen, Darmstadt, Germany). 
2.3.2 Analytics 
Quantification of glucose, organic acids and proteinogenic amino acids in supernatants were 
performed by HPLC as described previously (Strigun et al., 2011b). 
2.3.3 Metabolic flux analysis 
Time resolved metabolic flux analysis was carried out using the method and metabolic network 
model described by Niklas et al. (2011c). The stoichiometric matrix of the metabolic network model 
is depicted in Supplementary Table S1. 
2.3.4 Enzyme assays 
For determination of specific enzyme activities in different growth phases, cells from two different 
cultures, the first one being between 48 h and 96 h cultivation time (phase I) and the second one 
between 96 h and 144 h after seeding (phase II), were harvested in parallel. Enzyme assays were 
performed in 96-well plates as described in Niklas et al. (Niklas et al., 2011a) using selective 
permeabilization techniques for discrimination between cytosolic and mitochondrial activities. For 
each condition, complete permeabilization with Triton X-100, selective permeabilization with 
digitonin, and respective negative controls were performed with four technical replicates each. The 
change of absorbance at 340 nm was monitored over time for all NADH or NADPH dependent 
enzyme assays (340 nm=6.22 M
-1 cm-1). For the citrate synthase assay, absorbance of 
dithionitrobenzoic acid (DTNB) at 412 nm was measured (412 nm=14.15 M
-1 cm-1). In the applied 
96-well format, layer thickness (d=0.746 cm) was experimentally determined with NADH solutions 
at different concentrations using Lambert-Beer’s law. 
Assays for glucose-6-phosphate isomerase (PGI; EC:5.3.1.9), lactate dehydrogenase (LDH; 
EC:1.1.1.27), glucose-6-phosphate dehydrogenase (G6PDH; EC:1.1.1.49), fructose-1,6-
bisphosphatase (FBPase; EC:3.1.3.11), NAD+- and NADP+-dependent isocitrate dehydrogenase 
(IDHNAD; EC:1.1.1.41, and IDHNADP; EC:1.1.1.42), malic enzyme (ME; EC:1.1.1.40), and glutamate 
dehydrogenase (GDH; EC:1.4.1.3) were carried out according to Niklas et al. (2011a). Assay 
solutions for other enzymes were as follow: Hexokinase (HK; EC:2.7.1.1): 1 mM MgCl2, 6 mM 
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ATP, 1 mM NADP+, 10 mM glucose, 0.35 U glucose-6-phosphate dehydrogenase, and PBS. 
Phosphofructokinase (PFK; EC:2.7.1.11): 5 mM MgCl2, 0.15 mM NADH, 0.05 mM ATP, 0.1 U 
aldolase, 0.6 U glycerol phosphate dehydrogenase, 9.4 U triose phosphate isomerase, 0.25 mM 
fructose-6-phosphate, and PBS. Pyruvatekinase (PK; EC:2.7.1.40): 15 mM MgCl2, 0.25 mM 
NADH, 1 mM ADP, 1.2 U lactate dehydrogenase, 12 mM phosphoenolpyruvate, and PBS. After 
permeabilization the cell suspension was diluted 1:5 before used for this assay. Citrate synthase 
(CS; EC:2.3.3.1): 0.1 mM acetyl-Coenzyme A, 0.2 mM 5,5'-dithiobis-2-nitrobenzoic acid (DTNB), 
0.5 mM oxaloacetate, and PBS. Phosphoenolpyruvate carboxykinase (PEPCK; EC:4.1.1.32): 1 mM 
MgCl2, 0.15 mM NADH, 1 mM phosphoenolpyruvate, 1.5 mM GDP, 5 mM KHCO3, >12 U malate 
dehydrogenase, and PBS. Alanine aminotransferase (ALAT; EC:2.6.1.2): 0.15 mM NADH, 
0.02 mM pyridoxalphosphate, 200 mM alanine, 10 mM -ketoglutarate, >17 U lactate 
dehydrogenase, and PBS. Aspartate aminotransferase (ASAT; EC:2.6.1.1): 0.15 mM NADH, 
0.02 mM pyridoxalphosphate, 50 mM aspartate, 10 mM -ketoglutarate, >12 U malate 
dehydrogenase, and PBS. Enzyme activities are related to dry cell mass [g] making those directly 
comparable to metabolic rates. The cellular dry weight was determined to be 290 pg/cell. 
The total activity, rT,i, was measured after permeabilization with Triton X-100. It comprises two 
different activities, rD,i and rR,i, where i indicates the corresponding enzyme. 
                  (1) 
The activity rD,I represents the part of activity that is measured after selective plasma membrane 
permeabilization using digitonin. The activity rR,i corresponds to the cellular activity that is 
additionally measured after Triton X-100 treatment. 
The isocitrate dehydrogenase activity that is available for the TCA cycle, IDHTCA, was calculated as 
the sum of the activities rR,IDHNAD (NAD
+-dependent isocitrate dehydrogenase, IDHNAD) and rR,IDHNADP 
(NADP+-dependent isocitrate dehydrogenase, IDHNADP). 
                               (2) 
2.4 Results 
2.4.1 Growth and extracellular metabolite profile of CHO-K1 cells 
The growth profile could be divided into three phases with distinct specific growth rates (Figure 2-
1A). During the first 96 h of cultivation (phase I), we observed exponential growth at a high specific 
growth rate (µ = 0.037 ± 0.001 h-1; R2 = 1.00). During phase II, lasting from 96 to 144 h, the cells 
grew at a reduced rate (µ = 0.017 ± 0.002 h-1; R2 = 0.99). The last phase (phase III) was 
characterized by further growth retardation. However, viability was kept constant for another 48 h. 
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These characteristic phases were clearly reflected in the extracellular metabolite profile (Figure 2-
1B and Supplementary Figure 1). The major substrate in phase I was glucose. Glutamine, 
asparagine, serine and pyruvate were additionally consumed in substantial amounts. Mainly lactate, 
alanine, glycine, and much less glutamate were excreted as overflow products. At the end of 
phase I, glutamine was depleted. Besides glucose, lactate was the main substrate in phase II. 
Asparagine, aspartate, glutamate, and pyruvate were completely consumed during the second phase 
resulting in a lack of nutrients in phase III. Glucose and lactate were completely consumed during 
the last phase. In addition, alanine, which has been accumulated during former phases, was 
eventually taken up as well. 
 
Figure 2-1. The cultivation profile of CHO-K1 batch cultivation. (A) Growth curve of CHO-K1. Total 
(black), viable (blue), and dead (red) cell densities [cells/ml] are plotted over the cultivation time [h]. (B) 
Extracellular metabolite profile of CHO-K1. Selected extracellular metabolite concentrations [µmol/l] over 
the cultivation time [h] are shown. The complete set of extracellular metabolites is provided in 
Supplementary Figure 1. The dashed vertical lines indicate the end of phase I (green) and II (red). Mean 
values and standard deviations from two parallel cultivations are shown. Abbreviations: Glc glucose, Lac 
lactate, Pyr pyruvate. For amino acids, the standard three-letter code is used. 
2.4.2 Time-resolved metabolic flux distribution 
Dynamic metabolic flux analysis (MFA) (Niklas et al., 2011c) was applied to calculate metabolic 
fluxes over time. Selected fluxes are shown in Figure 2-2. The complete set of extra- and 
intracellular fluxes is presented in Supplementary information (Supplementary Figures 2 and 3). 
Generally, rates are only shown starting from 24 h due to inherent difficulties and high uncertainty 
in determining rates from very small changes in concentrations. Even the application of spline 
fitting does not well enough solve this problem (Wahrheit et al., 2014a). 
2.4.2.1 Glycolysis and pentose-phosphate pathway 
Fluxes of glucose uptake, glycolysis, and lactate production were very high in the beginning but 
then decreased rapidly within the first phase. In phases II and III, lactate and glucose were 
consumed in parallel, although at much lower rates. Glycolytic rates were nearly constant in phase 
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II. Glucose depletion stopped glycolytic activity. PPP activity related to anabolic demand was 
estimated highest in the first 72 h matching the high specific growth rate during phase I. Afterwards 
it was constantly decreasing. 
2.4.2.2 Pyruvate metabolism and TCA cycle 
In phase I, pyruvate uptake rate, pyruvate transport into mitochondria, pyruvate dehydrogenase 
reaction, and TCA cycle fluxes were quite variable, reaching a maximum value within the first 48 h. 
Pyruvate consumption was lower in phase II and nearly 0 in phase III (Supplementary Figure 2). 
Mitochondrial pyruvate transport and TCA cycle fluxes were relatively constant in the second phase 
and only slightly decreasing towards the end of cultivation (Figure 2-2). 
2.4.2.3 Amino acid metabolism 
Conversion of pyruvate to alanine via alanine aminotransferase (ALAT) resulted in high excretion 
of alanine in the first two phases. In phase III, alanine was converted back to pyruvate. Between 48 
and 144 h, flux from serine to pyruvate, comprising glycolytic intermediates from 1,3-
bisphosphoglycerate to pyruvate, was negative indicating serine biosynthesis from 3-
phosphoglycerate in addition to the high serine uptake in phases I and II. Glycine synthesis from 
serine, resulting in the formation of activated C1-units, and glycine excretion rates were high and 
relatively constant within the first 72 h. Then they dropped until the end of phase II before slightly 
increasing again in phase III. 
Glutamine and asparagine were initially taken up at high rates and further converted to glutamate 
and aspartate. They were feeding the TCA cycle by conversion into -ketoglutarate and 
oxaloacetate via glutamate dehydrogenase (GDH) and aspartate aminotransferase (ASAT), 
respectively. However, at the end of phase I and in phase II, GDH worked in the direction of 
glutamate formation draining carbons from the TCA cycle (Figure 2-2). 
After a relatively high initial uptake of the essential amino acids (arginine, histidine, threonine, 
leucine, isoleucine, valine, lysine, methionine, phenylalanine, tyrosine, and tryptophan) and proline, 
their consumption fluctuated around 0 indicating no significant contribution to catabolic processes. 
Despite an excess supply in the extracellular medium, their uptake was just matching the anabolic 
demand (Supplementary Figure 2). 
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Figure 2-2. Time-resolved metabolic flux distribution and compartmental enzyme activities in the 
first two growth phases. Selected metabolic fluxes [µmol g-1 h-1] over time [h] and enzyme activities 
[µmol g-1 h-1] in phases I and II in the central metabolism of CHO-K1 are shown. All activities are related to 
dry cell mass [g]. The complete set of fluxes and in vitro enzyme activities are provided in Supplementary 
Figures 2, 3 and 4. Note that the timescale starts at 24 h because of high uncertainty of determination of 
initial slopes using splines. The arrows in the flux plots indicate the sampling times for the respective in 
vitro enzyme assays. Blue and red bars indicate activities rD,i and rR,i, respectively. For definition of 
activities rD,i and rR,i, see also Equation (1). The activity rD,I represents the part of activity that is measured 
after selective plasma membrane permeabilization using digitonin. The activity rR,i corresponds to the 
residual cellular activity that is additionally measured upon Triton X-100 treatment (rR,i=rT,i–rD,i). 
Abbreviations: Glc – glucose, G6P – glucose-6-phosphate, P5P – pentose-5-phosphate, F6P – fructose-6-
phosphate, GAP – glyceraldehyde-3-phosphate, Pyr – pyruvate, Lac – lactate, AcCoA – acetyl-CoA, Mal – 
malate, Cit – citrate, AKG – -ketoglutarate, PEP – phosphoenolpyruvate, OAA – oxaloacetate. For amino 
acids, the standard three letter code is used. Subscript c and m indicate cytosolic and mitochondrial 
metabolite pools, respectively. HK – hexokinase, PGI – phosphoglucose isomerase, PFK – 
phosphofructokinase, FBP – fructose-1,6-bisphosphatase, PK – pyruvate kinase, ALAT – alanine 
aminotransferase, ASAT – aspartate aminotransferase, GDH – glutamate dehydrogenase, CS – citrate 
synthase, IDHTCA – (mitochondrial part of) NAD- and NADP-dependent isocitrate dehydrogenases (see also 
Equation (2)), PEPCK – phosphoenolpyruvate carboxykinase, ME – malic enzyme. 
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2.4.3 Metabolic ratios 
Time-resolved analysis of specific flux ratios allows the determination of the phase-shift timing and 
the identification of plateaus indicating stable metabolic states. The lactate/glucose ratio and the 
TCA cycle/glycolysis ratio were determined to assess metabolic efficiency (Figure 2-3A and B). 
2.4.3.1 Lactate/glucose ratio 
Glucose and lactate represent the most important carbon sources. On the other hand, lactate is also 
the most significant waste product. The lactate/glucose ratio (vLac exLac in/vGlc exGlc in) gives an 
indication about waste product formation relative to consumption of the major carbon sources 
(Figure 2-3A). In phase I, a nearly constant value of -1.5 indicates a stable metabolic state. The 
theoretical maximum ratio is 2 moles lactate per mole glucose. The value of -1.5 means that 75% of 
carbon originating from glucose was initially lost by lactate excretion and only 25% was further 
metabolized. After 72 h, a metabolic shift was induced. The lactate/glucose ratio changed the sign at 
96 h determining the end of phase I. In phase II, glucose and lactate were consumed in parallel as 
shown by a positive ratio around 0.6 moles lactate per mole glucose. In this phase, glucose and 
lactate were simultaneously consumed in equal molar amounts. Therefore the carbon contribution 
from lactate was 50% that of glucose. At the end of phase II, decreasing availability of glucose led 
to an increasing contribution of lactate as carbon source as shown by an increasing lactate/glucose 
ratio in phase III. 
2.4.3.2 TCA cycle/glycolysis ratio 
The relative activities of TCA cycle and glycolysis as well as their coordinated interplay are crucial 
for cellular efficiency. The ratio of the fluxes from F6P to GAP (vF6PGAP), representing glycolytic 
activity, and the formation of citrate (vOAACit), an indicator for TCA cycle activity, provides 
information about the type of energy generation and about the connection of these pathways (Figure 
2-3B). In phase I, the TCA cycle/glycolysis ratio showed a large variation between 1.3 and 
0.2 mol/mol. This indicates a variable connection between both pathways. A ratio below 1 indicates 
a significant glycolytic contribution to energy generation. In the phases II and III, TCA cycle 
activity was clearly exceeding glycolytic activity as shown by a ratio higher than 1. A nearly 
constant value of 2.5 in phase II indicates a stable metabolic state with high connectivity between 
glycolysis and TCA cycle and mainly aerobic energy generation. The ratio was further increasing in 
phase III when extracellular glucose concentration and glycolytic activity dropped but TCA cycle 
fluxes were maintained at high rates. 
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Figure 2-3. Metabolic ratios of selected metabolic fluxes. (A) Lactate/glucose ratio, the lactate uptake 
rate relative to the glucose uptake rate (vLac exLac in/vGlc  exGlc in [mol/mol]). (B) TCA cycle/glycolysis ratio, 
the TCA cycle activity relative to the glycolytic activity (vOAACit/vF6PGAP) [mol/mol]). Ratios and standard 
deviations were calculated by Monte Carlo simulation using the fluxes estimated by dynamic metabolic flux 
analysis. Note that the timescale starts at 24 h because of high uncertainty of determination of initial slopes. 
2.4.4 In vitro enzyme activities and their compartmental localization in 
different growth phases 
We applied selective permeabilization methods for discrimination of different enzyme activities 
(Niklas et al., 2011a) (Figure 2-2, Supplementary Figure 4). The total activity rT,i corresponds to the 
activity that was measured after Triton X-100 treatment. The activity rD,i is the fraction of activity 
that was measured after selective plasma membrane permeabilization with digitonin (Equation (1)). 
If rD,i is equal to rT,i the enzyme is cytosolic and the active center is freely accessible after digitonin 
treatment. The effects of digitonin treatment are weaker than those of Triton X-100 and leave 
intracellular structures including protein complexes intact. Residual activity rR,i is additionally 
measured after Triton X-100 treatment (see also Equation (1)). This activity is related to that 
fraction of enzymes that is not accessible after selective permeabilization with digitonin. This can be 
due to two reasons: (1) The enzyme is confined in a different compartment that is not permeabilized 
by digitonin treatment. In this case, the activity rR,i corresponds to the mitochondrial activity. (2) 
The enzyme is cytosolic but either the active site of the enzyme is not accessible or its activity is 
reduced by binding to intracellular structures. In this case, we define activity rR,i as concealed. When 
Triton X-100 is applied, such protein complexes dissociate permitting the measurement of the 
activity of the then solitary enzymes. Differences between the distinct metabolic phases are 
summarized in Table 2-1. 
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Table 2-1. Specific enzyme activities in phase II relative to activities measured in phase I. The total 
activity, rT,i, is measured after permeabilization with Triton X-100. It comprises two different activities, rD,i 
and rR,i, where i indicates the corresponding enzyme (Equation (1)). The activity rD,i represents the part of 
activity that is measured after selective plasma membrane permeabilization using digitonin. The activity rR,i 
corresponds to the cellular activity that is additionally measured after Triton X-100 treatment. The isocitrate 
dehydrogenase activity that is available for the TCA cycle, rIDHTCA, was calculated as the sum of the 
activities rR,IDHNAD and rR,IDHNADP ((Equation (2)). Abbreviations: HK – hexokinase, PGI – glucose-6-
phosphate isomerase, PFK – phosphofructokinase, PK – pyruvate kinase, LDH – lactate dehydrogenase, 
G6PDH – glucose-6-phosphate dehydrogenase, FBP – fructose-1,6-bisphosphatase, CS – citrate synthase, 
IDH – isocitrate dehydrogenase, PEPCK – phosphoenolpyruvate carboxykinase, ME – malic enzyme, GDH 
– glutamate dehydrogenase, ALAT – alanine aminotransferase, ASAT – aspartate aminotransferase, and 
n.a. – no activity. Statistical significance as determined by two-tailed, unpaired student’s t-test is indicated 
by asterisks 
  Activity relative to phase I [%] 
Enzyme rT,i rD,i rR,i 
HK 37 *** 104  11 * PGI 125 ** 119 * 208 
 
PFK 115 * 151 ** 68 *  
PK 102 
 
102 
 
n.a. 
 
LDH 93 
 
93 
 
91 
 
FBP 84 
 
84 
 
n.a. 
 
G6PDH 93 
 
84 
 
Activation 
 
CS 102 
 
n.a. 
 
102 
 
IDHNAD 333 *** n.a.  
333 *** 
IDHNADP 121 ** 118 ** 126 * 
IDHTCA 134 ** n.a.  
134 ** 
ME 56 ** n.a. 
 
56 ** 
PEPCK 60 ** 60 ** n.a. 
 
GDHNAD(P) 95  
n.a. 
 
95 
 
ALAT 62 ** 90 
 
0 *** 
ASAT 87   46 ** Activation *** 
* p < 0.05. 
** p < 0.01. 
*** p < 0.001. 
 
  
Chapter 2 Metabolic control at the cytosol–mitochondria interface 
 
50 
2.4.4.1 Total activities in glycolysis, gluconeogenesis and pentose-phosphate 
pathway 
Hexokinase (HK) and phosphofructokinase (PFK) exhibited the lowest total activities of all 
glycolytic enzymes investigated (Figure 2-2). In phase II, HK activity was even reduced to 37% of 
phase I (1800 and 660 µmol g-1 h-1 for phases I and II, respectively; Figure 2-2 and Table 2-1). In 
contrast, PFK activity was slightly increased by 15% (1300 and 1500 µmol g-1 h-1 for PFK in phases 
I and II, respectively; Figure 2-2 and Table 2-1). The phosphoglucose isomerase (PGI) connecting 
the HK and the PFK reactions had a much higher activity (5500 and 6800 µmol g-1 h-1, Figure 2-2). 
The PGI activity increased significantly by 25% in phase II (Table 2-1). The in vitro activity of the 
pyruvate kinase (PK) was similar in both phases (Table 2-1). It was at least ten times higher than the 
HK and PFK activities (15300 and 15500 µmol g-1 h-1, Figure 2-2). The highest specific activity of 
all enzymes investigated in the central metabolism was observed for the lactate dehydrogenase 
(LDH) (20500 and 19200 µmol g-1 h-1, Figure 2-2). No significant difference was detected between 
phases I and II (Table 2-1). The fructose-1,6-bisphosphatase activity (FBPase) representing the key 
enzyme of gluconeogenesis was low (190 and 140 µmol g-1 h-1, Figure 2-2). The activity of glucose-
6-phosphate dehydrogenase (G6PDH) catalyzing the first and irreversible reaction of the PPP was in 
the same range (190 and 180 µmol g-1 h-1, Figure 2-2). Both activities were slightly but not 
significantly reduced in phase II (Table 2-1). 
2.4.4.2 Localization of glycolytic enzymes 
It is well established that glycolytic enzymes are located in the cytosol (Michal and Schomburg, 
2012). However, they are partially bound to cellular structures (cellular membranes, the 
mitochondria, and the cytoskeleton) and are associated with each other (Michal and Schomburg, 
2012). We found that for several glycolytic enzymes (HK, PGI, PFK, LDH; however not PK) the 
activity measured after Triton X-100 treatment, rT,i, was higher than after digitonin treatment, rD,i. 
This indicates that a significant part of activity is not detectable after digitonin treatment, rR,i. In the 
case of HK and PFK, we found significant differences between the two growth phases (Figure 2-2 
and Table 2-1). rD,HK and rD,PFK increased and rR,HK and rR,PFK decreased with time. About 72% in 
phase I but only 18% in phase II of the total HK activity was additionally measured after 
permeabilization with Triton X-100 (Figure 2-2). The fraction of residual PFK activity decreased 
constantly from 50% after 48 h to 18% after 120 h of cultivation (Figure 2-4). 
It was found that although the total HK activity (rT,HK) was largely reduced in the second phase, the 
‘free’ part of activity (rD,HK) was not significantly altered. Only the ‘concealed’ activity (rR,HK) was 
significantly reduced to 11% (Table 2-1). The total PFK activity (rT,PFK) was only slightly increased 
in phase II. However, the ‘free’ activity (rD,PFK) was increased to 151% and the ‘concealed’ activity 
(rR,PFK) reduced to 68% relative to phase I (Table 2-1). Concerning the distribution of ‘free’ (rD,i) and 
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‘concealed’ (rR,i) activities, no significant differences between the two growth phases were found for 
PGI and LDH (Table 2-1). 
 
Figure 2-4. Relative distribution of the 
phosphofructokinase activity at different time points 
during cultivation. Blue diamonds indicate the fraction 
of enzyme activity that was detected after digitonin 
treatment, rD,PFK (Equation (1)). Read circles indicate 
the fraction of activity that was additionally detected 
after Triton X-100 treatment, rR,PFK (Equation (1)). 
 
2.4.4.3 TCA cycle and anaplerotic enzymes 
Citrate synthase (CS) activity was only detected after Triton X-100 treatment (rT,CS=rR,CS) indicating 
a mitochondrial localization (2490 and 2450 µmol g-1 h-1 for phases I and II, respectively; Figure 2-
2). No significant difference was observed for the two growth phases (Table 2-1). For isocitrate 
dehydrogenase (IDH), different isoenzymes could be identified due to cofactor dependence 
(Supplementary Figure 4). NAD+-dependent IDH activity (IDHNAD) was very low in both phases (20 
and 66 µmol g-1 h-1, Supplementary Figure 4). However, in the second growth phase, its activity was 
more than three times higher (Table 2-1). Corresponding to its exclusive mitochondrial localization 
(Michal and Schomburg, 2012), its activity was only measured after Triton X-100 treatment 
(rT,IDHNAD=rR,IDHNAD). NADP
+-dependent IDH (IDHNADP) activity was measured in different fractions 
after both treatments. This indicates localization in cytosol and mitochondria. The major part was 
located in the cytosol (rD,IDHNADP=850 and 1000 µmol g
-1 h-1 for phases I and II, respectively). Only 
30% of total cellular activity (rT,IDHNADP=1200 and 1450 µmol g
-1 h-1) was found in mitochondria 
(rR,IDHNADP=360 and 450 µmol g
-1 h-1). In phase II, the activity increased equally in both 
compartments so that the relative subcellular distribution did not change (Table 2-1). The sum of 
mitochondrial IDH activities, representing the TCA cycle activity (IDHTCA in Figure 2-2, see also 
Equation (2)), was significantly increased by 34% in phase II (Table 1). 
Low activities of phosphoenolpyruvate carboxykinase (PEPCK) and malic enzyme (ME) were 
found in both growth phases (Figure 2-2). For PEPCK almost identical activities were measured 
after Triton X-100 treatment and digitonin treatment (rT,PEPCK=rD,PEPCK). This indicates exclusive 
localization in the cytosol (150 and 90 µmol g-1 h-1 in phases I and II). ME activity was only 
detected after Triton X-100 treatment indicating exclusive mitochondrial localization (rT,ME=rR,ME). 
Both activities were significantly reduced in phase II to 60% and 56%, respectively (Table 2-1). 
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2.4.4.4 Amino acid metabolism 
It is well known that glutamate dehydrogenase (GDH) activity is exclusively found in mitochondria 
(Michal and Schomburg, 2012). This was confirmed in our experiments (Supplementary Figure 4). 
No significant difference was observed for the two growth phases (570 and 570 µmol g-1 h-1 for 
rR,GDHNAD and 530 and 490 µmol g
-1 h-1 for rR,GDHNADP, Figure 2-2, Table 2-1). Similar activities 
measured with NADH and NADPH indicate that there is only one isoenzyme using both cofactors 
as has been described in literature (Michal and Schomburg, 2012). Alanine (ALAT) and aspartate 
(ASAT) aminotransferase activities were quite different in distinct growth phases. In phase I, ALAT 
was active in both compartments. One third of total activity (rT,ALAT=540 µmol g
-1 h-1) was located in 
mitochondria (rR,ALAT=150 µmol g
-1 h-1, Figure 2-2). In phase II, only the cytosolic activity was 
maintained (rD,ALAT=350 µmol g
-1 h-1, Figure 2-2), which was not significantly different from phase I 
(rD,ALAT=390 µmol g
-1 h-1, Figure 2-2, Table 2-1). Mitochondrial activity was not detected any more. 
For ASAT, only a small difference in total cellular activities was observed (rT,ASAT, 300 and 
260 µmol g-1 h-1, Figure 2-2, Table 2-1). However, in phase I, only cytosolic activity was measured 
while in phase II half of the total activity (rT,ASAT=260 µmol g
-1 h-1, Figure 2-2) was located in 
mitochondria (rR,ASAT = 130 µmol g
-1 h-1, Figure 2-2). 
2.4.5 Comparison of in vitro enzyme activities with respective in vivo fluxes 
Specific in vitro activities represent the potential maximal activity. These were related to respective 
in vivo fluxes representing actual rates by determination of in vitro/in vivo ratios (Figure 2-5). Low 
ratios indicate that the enzyme is highly saturated and that the in vivo rate is only limited by the 
enzyme concentration. High ratios mean that, at least in Michaelis-Menten type kinetics, the 
enzyme operates in the first order region where in vivo rates depend on both the concentration of 
enzyme and substrates. The lower the ratio the higher is its contribution to metabolic control. Most 
enzymes showed a substantial overcapacity with in vitro activities largely exceeding the respective 
in vivo activities. However, for some reactions the in vivo activities were close to the specific in 
vitro activities. Of the five glycolytic enzymes investigated, HK and PFK had the lowest in vitro/in 
vivo ratios in both growth phases. This emphasizes their importance for glycolytic flux control. 
Ratios of all glycolytic enzymes were significantly higher in the second growth phase. The first 
reaction of the PPP catalyzed by the G6PDH had similar ratios in phases I and II. In phase I, CS and 
IDHTCA had low in vitro/in vivo ratios of 5 and 1, respectively. The ratios of the GDH and the 
aminotransferases were also relatively low. The ALAT and ASAT reactions had quite similar ratios 
in both growth phases. The in vitro/in vivo ratios of the GDH and the TCA cycle enzymes were 
increased in phase II, but were still low. None of them showed such a high overcapacity as PGI, PK, 
or LDH. 
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Figure 2-5. Ratios of specific in vitro enzyme activities and respective in vivo fluxes determined by 
dynamic metabolic flux analysis in growth phase I (green bars) and phase II (red bars). Glycolysis: 
HK/vGlcexGlcin, PGI/vG6PF6P, PFK/vF6PGAP, PK/vGAPPyr, LDH/vLacexLacin; PPP: G6PDH/vG6PP5P; TCA 
cycle: CS/vOAAmCitm, IDHTCA/vCitmAKGm; Amino acid (AA) metabolism: GDH/vAKGmGlu, ALAT/vPyrAla, 
ASAT/vAspOAA. The in vitro/in vivo ratios were calculated by Monte Carlo simulation including the 
standard deviations of the enzyme assays and the flux calculation, respectively. Statistical significance as 
determined by student’s t-test is represented by asterisks: *** = p < 0.001, ** = p < 0.01, and * = p < 0.05. 
2.5 Discussion 
2.5.1 Metabolic flux dynamics and compartmental enzyme activities 
The unique combination of dynamic MFA and determination of compartmental enzyme activities in 
distinct growth phases using selective permeabilization represents a novel approach for a 
quantitative and thorough analysis of metabolism. 
Metabolite balancing is the most commonly used MFA method for the analysis of mammalian cells 
(Niklas and Heinzle, 2012). The applied time-resolved MFA method offers particular advantages 
over classical MFA techniques. It allows capturing the complete time-course of batch cultivation, 
thus monitoring metabolic shifts caused by environmental changes (Wahrheit et al., 2014a). 
Conventional stationary flux analysis using metabolite balancing methods often considers only a 
single growth phase, usually the exponential growth phase (Niklas et al., 2009), or distinct separate 
phases (Altamirano et al., 2006; Altamirano et al., 2001b), thereby neglecting the phase transitions. 
In addition, we investigate metabolic flux ratios. The lactate/glucose ratio is a commonly applied 
parameter for characterizing the metabolism of mammalian cells (Ahn and Antoniewicz, 2011; Ahn 
and Antoniewicz, 2013). In our study, we extend the concept of metabolic ratios (1) by proposing 
additionally the TCA cycle/glycolysis ratio as a meaningful parameter to assess metabolic 
efficiency, and (2) by analyzing the dynamics of these metabolic ratios. The time-resolved analysis 
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of these metabolic flux ratios as sensitive parameters of metabolic changes represents a powerful 
tool for characterizing the central metabolism and metabolic efficiency in CHO batch cultivation. 
Furthermore, we applied a simple, fast, and robust protocol that allows the determination of total 
enzyme activity levels as well as discrimination of mitochondrial and extra-mitochondrial enzymes 
(Niklas et al., 2011a). The applied selective permeabilization method allows a high throughput. It 
requires little cell material and does not require laborious isolation of mitochondria. Very few 
former studies differentiated between cytosolic and mitochondrial enzyme activities. Vriezen and 
van Dijken studied enzyme activities in mouse myeloma cells (Vriezen and van Dijken, 1998b). 
They used sonication and differential centrifugation to separate a particulate fraction containing the 
mitochondria and a soluble fraction containing cytosol and other cell components. To obtain 
necessary high cell numbers, sampling from a chemostat was done over a period of 16 h. Loss of 
enzyme activity may occur and could affect total activities and subcellular distribution patterns. The 
neglect of compartmental information can result in inaccurate assumptions about the availability of 
enzymes for certain pathways that would lead to biased conclusions. Including this information on 
the other hand allows deriving additional constraints for the set-up of metabolic network models and 
can provide information about limiting steps of metabolic pathways. 
The combination of these two powerful methods represents the most important part of this study. 
Previous metabolic studies rarely considered more than one aspect. They focused rather on the 
description than on a thorough and comprehensive understanding of metabolism. The integration of 
multiple data sets as proposed in our study allows drawing conclusions about metabolic control 
(Figure 2-6). 
 
Figure 2-6. Scheme of the applied methodology. Step 1: Time-resolved measurements creating in vivo 
and in situ data. Step 2: Data analysis. Step 3: Data interpretation. 
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2.5.2 Metabolic shifts and metabolic efficiency 
The successive consumption of available substrates during batch cultivation results in changing 
environmental conditions. This forces the cells to adapt their activities resulting in characteristic 
metabolic shifts and distinct growth phases. These different metabolic phases are characterized by 
distinct metabolic states with different metabolic efficiency. Since metabolic efficiency in this 
particular context is not a priori clearly defined, we determine the following features to characterize 
metabolic efficiency: (1) a low level or the absence of waste product excretion, i.e. no carbon 
spilling, (2) energy generation rather by aerobic pathways than by glycolysis, i.e. efficient energy 
generation, (3) a high connectivity between glycolysis and TCA cycle, i.e. a reliable carbon transfer 
between the two major pathways of central metabolism, and (4) matching catabolic and anabolic 
activities, i.e. no energy spilling. In Figure 2-7, the flow of energy is used as a measure for 
metabolic efficiency and is schematically depicted for the different metabolic phases. It was 
estimated by calculating the heat of combustion for consumed substrates, excreted waste products, 
and biomass production (Villadsen et al., 2011). 
CHO cells are characterized by a remarkable adaptability to changing nutrient availability and high 
flexibility of metabolism due to their ability to utilize a wide range of substrates. The three growth 
phases were characterized by (1) overflow metabolism, (2) balanced metabolism and (3) 
maintenance metabolism. 
When nutrients were abundant in phase I, the preferred substrates were glucose and glutamine taken 
up at high rates indicated by the thick arrow in Figure 2-7A. Such behavior is usually observed in 
CHO cells (Altamirano et al., 2000; Martinez et al., 2013) and other mammalian cell cultures like 
hybridoma or myeloma cells (Doverskog et al., 1997). High glycolytic and glutaminolytic rates led 
to an excess energy and carbon supply. This enabled a high anabolic activity as shown by excessive 
growth. However, the more complex anabolic processes cannot keep up with this excess catabolism. 
This results in a typical overflow metabolism characterized by energy spilling and significant waste 
product excretion. This has been observed already in earlier studies on CHO cells (Doverskog et al., 
1997) and other organisms (Russell, 2007). The constant lactate/glucose ratio of -1.5 (Figure 2-3A) 
emphasizes the stability of this metabolic state. The observed value is in accordance with former 
studies of CHO cells(Ahn and Antoniewicz, 2011; Neermann and Wagner, 1996). In addition, we 
observed a low and variable TCA cycle/glycolysis ratio (Figure 2-3B) pointing to an unbalanced 
metabolism with a compromised connectivity between glycolysis and TCA cycle. This indicates a 
significant glycolytic contribution to ATP generation. In summary, the excess energy supply in 
phase I resulted in a high anabolic activity but also in high carbon and energy spilling activities 
(Figure 2-7A). The overflow metabolism represents the predominant activity determining the 
metabolic state and low metabolic efficiency in this phase. 
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Glutamine depletion resulted in a reduced specific growth rate in phase II (Figure 2-1) (Wahrheit et 
al., 2014a; Zhang et al., 2006) with almost matching catabolic and anabolic activities. The 
metabolism shifted from lactate excretion to lactate consumption as often observed in CHO cultures 
(Altamirano et al., 2006; Luo et al., 2012; Martinez et al., 2013; Zagari et al., 2013a). Lactate and 
glucose were consumed in approximately equal molar amounts (Figure 2-3A, lactate/glucose ratio 
~1). In contrast to phase I, where the major substrates glucose and glutamine were introduced at 
very different entry sites of metabolism, glucose and lactate were both feeding the cytosolic 
pyruvate pool resulting in an efficient transport of cytosolic pyruvate into mitochondria. The high 
and constant TCA cycle/glycolysis ratio (Figure 2-3B) indicates a tight connection between 
glycolysis and TCA cycle. A metabolic shift from a low to a high connectivity between glycolysis 
and TCA cycle was also observed by Sengupta et al. studying the late non-growth phase of CHO 
cells (Sengupta et al., 2011). The moderate growth and altered substrate spectrum result in a 
balanced metabolism with high energy efficiency in the second phase (Figure 2-7B). Nearly all 
catabolically available energy is used for anabolic purposes. 
Nutrient limitation initiated a shift to the last phase characterized by drastically reduced growth. 
Although various substrates were depleted (e.g. glutamine, asparagine, glutamate, aspartate, 
pyruvate), the culture viability was kept constant for another 48 h by efficient use of lactate and 
alanine as sole carbon sources. Lactate and alanine, both feeding the cellular pyruvate pools, were 
sufficient to maintain a high TCA cycle activity. A significant amount of produced energy was used 
for maintenance metabolism and heat which was the predominant metabolic activity in phase III 
(Figure 2-7C). 
 
Figure 2-7. The flow of energy in the different growth phases. The flow of energy was estimated by 
calculating the heat of combustion for consumed substrates (catabolism), excreted waste products (overflow 
metabolism), biomass (anabolism), and maintenance metabolism (Villadsen et al., 2011). Line thickness of 
arrows indicates relative flux distributions. 
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2.5.3 Control points in the central metabolism 
We apply the concept of in vitro/in vivo ratios to infer limiting steps in glycolysis and TCA cycle. 
2.5.3.1 Hexokinase activity levels determine the glycolytic flux 
The glycolytic pathway contains three irreversible enzyme reactions, HK, PFK, and PK. For HK 
and PFK specific activities were in a similarly low range and relatively low in vitro/in vivo ratios 
were measured in both phases (3 and 7 for HK, 2 and 13 for PFK). In contrast, PK showed a high 
overcapacity (32 and 109 for phases I and II, respectively) (Figure 2-5). This indicates a higher 
importance of HK and PFK and only a minor contribution of PK for controlling glycolytic flux. 
Similar observations were made in former studies of different CHO, BHK, hybridoma and myeloma 
cell lines (Neermann and Wagner, 1996; Vriezen and van Dijken, 1998a). In phase II, all glycolytic 
enzymes showed significantly higher in vitro/in vivo ratios (Figure 2-5). However, for HK the ratio 
was only slightly increased, from 3 in phase I to 7 in phase II. HK was the only glycolytic enzyme 
showing a significantly decreased total in vitro activity (37%, Table 2-1) matching the lower 
glycolytic flux in phase II (Figure 2-2). Based on these observations, we conclude that the HK 
reaction represents the rate-limiting step in the glucose metabolism of CHO-K1.  
2.5.3.2 Mitochondrial isocitrate dehydrogenase activity is rate-limiting for TCA 
cycle fluxes 
CS and IDHNAD were exclusively found in the mitochondria. IDHNADP had much higher in vitro 
activities than IDHNAD and was active in both compartments. We found 70% of total IDHNADP 
activity to be located in the cytosol which is in accordance with former studies of CHO cells (Niklas 
et al., 2011a) and mouse myeloma cells (Vriezen and van Dijken, 1998b). Cytosolic IDHNADP 
activity cannot contribute to mitochondrial TCA cycle fluxes. Instead it could be involved in 
cytosolic NADPH supply. In phase I, we found an in vitro/in vivo ratio of 1 for IDHTCA. This 
indicates that the available enzyme activity was just matching the actual in vivo activity. 
Furthermore, IDHTCA activity was significantly increased in phase II (134%, Table 2-1) matching 
the higher TCA cycle activity in vivo, while CS activity was not significantly altered. Including 
information about activity localization, we were able to identify the mitochondrial IDH reaction as 
the rate-limiting step of the TCA cycle, although total cellular IDH activity was high. 
2.5.4 Metabolic control and metabolic switches at the cytosol–mitochondria 
interface 
The metabolic shift from an inefficient overflow metabolism in phase I to a highly efficient 
balanced metabolism in phase II was going along with a switch from a low to a high connectivity 
between glycolysis and TCA cycle. The most important fuels for the mitochondrial metabolism are 
pyruvate and glutamine. Pyruvate is mainly derived from glucose via glycolysis and in phase II 
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additionally from lactate due to a switch from net lactate production to net lactate consumption. 
Depletion of glutamine during phase I is compensated by consumption of glutamate and aspartate in 
phase II. 
2.5.4.1 Fine-tuning of glycolytic regulation is achieved by micro-
compartmentation of glycolytic enzymes and seems to affect pyruvate 
availability 
Using two different permeabilization methods, we found that activities of several glycolytic 
enzymes measured upon complete permeabilization using Triton X-100 were higher than after 
selective plasma membrane permeabilization using digitonin. Protein complexes are well preserved 
after mild digitonin treatment resulting in lower apparent enzyme activities. Two different 
explanations are possible: (1) due to occlusion of the active site, it is not accessible for substrates 
used in the enzyme assay or (2) due to conformational changes induced by binding, the catalytic 
properties of the enzyme are altered. Reported varying release of proteins to the supernatant after 
treatment with different digitonin concentrations supports our findings. Soluble cytosolic proteins 
were released upon treatment with low digitonin concentrations while a particular cytoplasmic 
protein pool that was thought to associate with intracellular structures exhibited a restricted 
diffusion and was only released after complete cell disruption using much higher digitonin 
concentrations (Kelner et al., 1986). 
As a consequence, two different enzyme activities, (1) ‘free’ activity representing the soluble, 
accessible part of enzymes (rD,i) and (2) ‘concealed’ activity representing the part of enzymes that is 
organized into protein complexes or attached to cellular structures (rR,i), have to be differentiated. 
Significant differences observed for HK and PFK activities between distinct growth phases as well 
as the reproducibility indicate a physiological relevance. Our findings point to a significant 
contribution of protein association and substrate channeling to glycolytic regulation. Although there 
has been an ongoing debate whether or not substrate channeling plays a role in glycolytic regulation 
(Gutfreund and Chock, 1991; Ovadi, 1991; Ovadi and Saks, 2004; Spivey and Ovadi, 1999; Wu et 
al., 1991), increasing evidence supports the concept of a cytosolic sub-compartment with restricted 
diffusion. Different groups have shown that glycolytic channeling can be preserved in dextran 
sulfate permeabilized mouse fibroblasts (L-929 cells) (Clegg and Jackson, 1990) and permeabilized 
vascular smooth muscle cells from hog (Hardin and Finder, 1998). Comparing intact, dextran 
sulfate permeabilized and sonicated L-929 cells, Jackson et al. showed that the glycolytic activity 
increased with increasing degree of cell disruption (Jackson et al., 1990). The permeabilized cells 
more closely reflected the in vivo situation in intact cells. The rates were much lower than in 
sonicated cells which were characterized by freely diffusing enzymes and intermediates. Based on 
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experiments with 14C labeled glucose, they proposed a ‘leaky’ form of glycolytic channeling which 
allows some release and entry of intermediates into the pathway (Clegg and Jackson, 1990). 
However, instead of a ‘leaky’ channeling we rather postulate a mixed response of attached and 
soluble enzymes. Glycolytic regulation via metabolite channeling is continuously changing during 
cultivation. It is likely that both forms, attached and soluble enzymes, exist in a dynamic, but 
relatively slow equilibrium. The extent to which protein association occurs depends on the 
metabolic state (Batke, 1989). Two different situations can occur: (a) glycolytic channeling 
characterized by a direct transfer of intermediates from one active site to the next without leaving 
the glycolytic chain or (b) free diffusion of glycolytic intermediates (Figure 2-8). Both states seem 
to coexist at all times throughout cultivation. However, either glycolytic channeling or free diffusion 
is more or less favored depending on the metabolic state. The relative distribution of soluble and 
attached enzymes is likely to be a powerful mechanism for metabolic flux regulation (Graham et al., 
2007). 
Since the 1970s much evidence has been presented that glycolytic enzymes can be associated with 
each other (MacGregor et al., 1980; Mowbray and Moses, 1976; Ovadi et al., 1986; Tompa et al., 
1986) or with subcellular structures like the mitochondria (Sagrista and Bozal, 1987b; Wilson, 
1982) or the cytoskeleton (Roberts et al., 1988; Westrin and Backman, 1983). For HK, between 
72% (phase I) and 18% (phase II) of the total activity was found to be ‘concealed’ upon digitonin 
treatment. Vriezen and van Dijken studied enzyme localization in mouse myeloma cells by 
separating a particulate (mitochondrial) and a soluble (cytosolic) fraction using differential 
centrifugation (Vriezen and van Dijken, 1998b). They found 20% of total HK activity in the 
particulate fraction which they suggested to be attached to the outer mitochondrial membrane. In 
our study, up to 50% of total PFK activity could not be detected after digitonin treatment. 
Campanella et al. studied the location of glycolytic enzymes in human erythrocytes using confocal 
microscopy (Campanella et al., 2005). In their study, 50% of PFK protein was bound to cellular 
structures. Thus, the extent to which we observe this ‘concealed’ activity seems to be in a 
representative range. 
The ‘concealed’ part of HK activity was mainly found in phase I when glucose was highly 
abundant. A shift from the free cytosolic HK to the mitochondrially-bound and more active form of 
HK was shown to be induced by high glucose concentrations in rat pancreatic islets (Rabuazzo et 
al., 1997). On the other hand, dissociation of HK from mitochondria was induced by elevated lactate 
levels in different tissues from mouse (Leite et al., 2011). At low glycolytic rates in phase II, this 
activity was significantly reduced to 11% relative to phase I. Several HK isoenzymes are known 
differing in catalytic and regulatory properties as well as in their localization (Wilson, 2003). In 
studies of rat brain it was shown, that HK that is bound to the outer mitochondrial membrane binds 
as a tetramer (Xie and Wilson, 1990). It is functionally coupled to the adenine nucleotide 
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translocase (ANT) via binding to the voltage-dependent anion channel (VDAC) (Beutner et al., 
1998; Beutner et al., 1996; Buhler et al., 1998; Hashimoto and Wilson, 2000; Vyssokikh and 
Brdiczka, 2003) (Figure 2-8). As a consequence, bound HK selectively uses intra-mitochondrial 
ATP as substrate and does not respond to extra-mitochondrial ATP (Wilson, 2003). Our results are 
in accordance with these findings since the activity of mitochondrially-bound HK would not be 
detectable in the enzyme assay due to inaccessibility of ATP contained in the reaction buffer. 
Similarily, the ‘concealed’ part of PFK activity was higher during overflow metabolism and 
decreasing over time (Figure 2-4). 
 
Figure 2-8. Pyruvate transport into the mitochondria at glycolytic channeling and free diffusion.  
(A) Glycolytic channeling. High glucose concentrations induce binding of hexokinase HK as tetramers to 
the outer mitochondrial membrane. This favors association of glycolytic enzymes and glycolytic 
channeling. Via binding of HK to the voltage-dependent anion channel VDAC, HK is functionally coupled 
to the adenine nucleotide translocase (ANT). This provides preferential access to mitochondrially generated 
ATP and stimulates glycolytic flux. Glycolytic channeling results in formation of a distinct cytosolic 
pyruvate pool (Pyrg) that is preferentially converted into lactate. The mitochondrial pyruvate carrier (PyC) 
has restricted access to cytosolic pyruvate (Pyrc) resulting in a variable pyruvate transport into the 
mitochondria. (B) Free diffusion. At lower glucose and elevated lactate concentration, the soluble form of 
glycolytic enzymes and free diffusion of glycolytic intermediates is favored. Cytosolic pyruvate is 
additionally fed by consumption of extracellular lactate and is freely available to the mitochondrial pyruvate 
carrier (PyC) resulting in a constant pyruvate transport into the mitochondria. 
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It still needs to be determined which cellular stimuli control the relative distribution of soluble and 
attached enzymes. The most remarkable difference between phase I and phase II is the switch from 
net lactate production to net lactate consumption. A continuous drop in pH of culture supernatant 
during phase I and subsequent increase of pH in phase II was directly correlated to the lactate 
profile. The accumulation of lactate in the cells would lead to an acidification of the cytosol. Clegg 
and Jackson have shown that the glycolytic rates in dextran sulfate permeabilized cells are highly 
pH dependent and decrease with decreasing pH (Clegg and Jackson, 1990). Furthermore, it has been 
shown that the assembly of glycolytic enzymes is oxygenation-dependent in murine erythrocytes 
(Campanella et al., 2008). Graham et al. found that the proportion of glycolytic enzymes associated 
with the mitochondria correlates with the respiration rate in Arabidopsis cells (Graham et al., 2007). 
Inhibition of respiration reduced the degree of association while stimulation of respiration increased 
mitochondrial association of glycolytic enzymes. A decreased mitochondrial membrane potential 
and a decreased mitochondrial oxidative capacity has also been correlated with the lactate 
metabolism in CHO cells (Zagari et al., 2013a). HK binding to the outer mitochondrial membrane 
was found to be affected by the mitochondrial membrane potential (Vyssokikh and Brdiczka, 2003). 
In addition, it was shown that high glucose levels induce the binding of HK to mitochondria 
(Rabuazzo et al., 1997) while high lactate levels induce the dissociation of HK from mitochondria 
(Leite et al., 2011). These studies demonstrate that the association of enzymes can be regulated by 
the metabolic state and vice versa. The fact, that we observed these changes in the relative 
subcellular distribution of soluble and attached enzymes only for HK and PFK is in accordance with 
the results of the in vitro/in vivo ratios where we identified HK and PFK as most important enzymes 
of glycolytic control (Figure 2-5). We conclude that the glycolytic flux is not only determined by 
total activity levels of HK and PFK but also by their relative involvement in substrate channeling. 
We hypothesize that the extent of glycolytic channeling affects the pyruvate availability and 
eventually the connectivity between glycolysis and TCA cycle (Figure 2-8). We propose the 
following mechanism: High glucose concentrations induce HK binding to mitochondria. This 
triggers the association of glycolytic enzymes. Glycolytic flux is stimulated by an improved supply 
of ATP to HK due to the preferential use of mitochondrially generated ATP and by a more active 
HK isoform. Cytosolic pyruvate might be only partly released from the glycolytic chain and is 
instead directly channeled into lactate providing NAD+ for glycolysis to maintain the redox balance. 
Eventually, this leads to a high excretion of lactate and overflow metabolism. The existence of two 
cytosolic pyruvate pools with one pool tightly connected to the glycolytic chain (Pyrg, Figure 2-8) 
and thus not directly available to the mitochondrial pyruvate carrier (PyC, Figure 2-8) has been 
hypothesized in former studies with isolated perfused rat heart (Peuhkurinen et al., 1983) and rat 
hind limbs (Schadewaldt et al., 1983). As a consequence, this would result in a compromised 
pyruvate transport into mitochondria when glycolytic channeling is favored during overflow 
metabolism in phase I. Lactate accumulation during phase I results in a drop of cytosolic pH and 
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affects the mitochondrial membrane potential. This might shift the metabolic state to a situation 
where free diffusion is more favored. In phase II, free diffusion of glycolytic intermediates is 
favored and the cytosolic pyruvate pool is additionally fed by consumption of lactate. At the same 
time we observe a high connectivity between glycolysis and TCA cycle due to constant pyruvate 
transport into mitochondria. The exact molecular mechanism of this regulation remains, however, 
unclear. 
2.5.4.2 The aminotransferases together with malic enzyme and 
phosphoenolpyruvate carboxykinase support the carbon supply into the 
TCA cycle 
The two major inputs into the TCA cycle are via the pyruvate dehydrogenase reaction generating 
acetyl-CoA (C2-unit) from pyruvate and the GDH generating AKG from glutaminolysis that is 
further converted to oxaloacetate (OAA) (C4-unit). To obtain a balanced TCA cycle, equimolar 
amounts of C2- and C4-units have to be available to form citrate. However, due to glycolytic 
channeling during overflow metabolism as well as because of glutamine limitation and lactate 
consumption during balanced metabolism, availabilities of C2- and C4-units are changing from 
phase I to phase II. 
During overflow metabolism in phase I, cytosolic pyruvate was mainly converted to lactate and 
alanine. Pyruvate transport into mitochondria was variable resulting in a low connectivity between 
glycolysis and TCA cycle. High glutaminolytic rates provide an excess supply of C4-units. This 
would result in a relative depletion of mitochondrial pyruvate and eventually reduce or even stop 
TCA cycle fluxes. In phase I, ALAT was active in both compartments but ASAT was only detected 
in the cytosol. The in vivo fluxes, e.g. significant consumption of asparagine and aspartate, indicate 
that ASAT is working in the direction of OAA formation. However, OAA could not directly enter 
the mitochondrial TCA cycle, since ASAT was only active in the cytosol. It can however be 
reduced to malate that can be transported into the mitochondria where it can oxidatively 
decarboxylate to pyruvate by mitochondrial ME, The high alanine excretion in phase I clearly 
indicates that the cytosolic ALAT catalyzes the formation of alanine. However, since cytosolic and 
mitochondrial isoforms were active, both reactions, alanine formation and pyruvate formation, can 
potentially take place in different compartments. In order to prevent the TCA cycle from slowing 
down dramatically, mitochondrial ALAT together with the mitochondrial ME, both fueling the 
mitochondrial pyruvate pool, can compensate for an insufficient pyruvate transport capacity from 
the cytosol. Cytosolic PEPCK and ASAT further support these metabolic reactions (Figure 2-9A). 
In phase II, lactate was no longer excreted but consumed, now fueling the cytosolic pyruvate pool. 
In addition, free diffusion of glycolytic metabolites was favored resulting in freely available 
cytosolic pyruvate derived from glycolysis. Pyruvate was efficiently transported into mitochondria 
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resulting in a constant connection between glycolysis and TCA cycle. Additional feeding of the 
mitochondrial pyruvate pool might not be necessary. Accordingly, we observed reduced activities 
for all enzymes involved in such pyruvate supply; cytosolic ASAT, cytosolic PEPCK and 
mitochondrial ME activity were significantly decreased and a complete inactivation was observed 
for the mitochondrial ALAT (Figure 2-9B). However, glutamine limitation in phase II leads to a 
relative shortage of C4-units compared to the high C2-unit supply. We observed an activation of 
mitochondrial ASAT providing mitochondrial OAA now directly feeding into the TCA cycle. This 
compensates for the reduced carbon input at AKG that supplied C4-units in phase I (Figure 2-9B). 
 
Figure 2-9. Carbon supply into the TCA cycle at overflow metabolism in phase I and after glutamine 
limitation in phase II. (A) Overflow metabolism. High lactate excretion and variable pyruvate transport 
into the mitochondria lead to a relative shortage of C2-units. The mitochondrial pyruvate pool is 
additionally fed by the combined action of cytosolic aspartate amino transferase cASAT, cytosolic 
phosphoenolpyruvate carboxykinase cPEPCK, mitochondrial malic enzyme mME, and mitochondrial 
alanine amino transferase mALAT. This supports C2-unit supply into the TCA cycle to match the high 
carbon input due to excess glutaminolysis. (B) Balanced metabolism. Lactate consumption enables an 
efficient pyruvate transport into the mitochondria. Anaplerotic enzymes involved in fueling the 
mitochondrial pyruvate pool in phase I have significantly reduced activities. A relative shortage of C4- units 
due to glutamine depletion in phase II is compensated by activation of mitochondrial aspartate amino 
transferase mASAT to feed OAA directly into the TCA cycle. Statistical significance as determined by 
student’s t-test is represented by asterisks: *** = p < 0.001, ** = p < 0.01,* = p < 0.05, n. s. not significant. 
2.6 Conclusions and future applications 
In this study, we propose a novel approach for the quantitative analysis of metabolic dynamics in 
CHO cultivation. The presented methodology is transferable to all kinds of different biological 
systems and scientific issues. 
With the extended concept of time-resolved analysis of metabolic flux ratios as sensitive parameters 
of physiological changes, we provide a useful tool for a schematic characterization of the metabolic 
state and metabolic efficiency. Metabolic efficiency reflects a healthy state of cellular metabolism 
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and represents a target for optimization in industrial production processes. The assessment and 
prediction of metabolic efficiency is therefore of equal importance for biotechnological and 
biomedical questions. 
We further demonstrate that knowledge about metabolic control can be generated by integrating 
several data-sets with resolution in different dimensions; (1) time resolution, i.e. phase I vs. phase II, 
(2) spatial resolution, i.e. cytosolic vs. mitochondrial localization of activities, and (3) functional 
resolution, i.e. in situ vs. in vivo activity. Using this systems-oriented approach, we were able to 
identify the HK reaction and the mitochondrial IDH reaction as rate-limiting steps in glycolysis and 
TCA cycle, respectively. Our findings strongly indicate that the dynamics of substrate channeling 
play a crucial role in glycolytic regulation in CHO cells and affect the intracellular pyruvate 
availability. Finally, our data point to a coordinated interplay of transaminases and anaplerotic 
enzymes to compensate an unbalanced carbon input into the TCA cycle. These conclusions could 
only be drawn by correlating different levels of information. 
The identification of rate-limiting steps as well as understanding metabolic implications of different 
metabolic efficiencies, in particular at the cytosol–mitochondria interface as most important hub in 
the central metabolism, helps characterizing cellular phenotypes, different producer strains or 
pathophysiological conditions. The acquired knowledge can be used to understand disease 
mechanisms or toxic effects, to develop medical therapies or identify metabolic targets for process 
optimization to achieve an improved biopharmaceutical production (e.g. by genetic engineering, 
media optimization, feeding strategies). 
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3 Dynamics of growth and metabolism controlled by 
glutamine availability in Chinese hamster ovary cells 
3.1 Abstract 
The physiology of animal cells is characterized by constantly changing environmental conditions 
and adapting cellular responses. Applied dynamic metabolic flux analysis captures metabolic 
dynamics and can be applied to industrially relevant cultivation conditions. We investigated the 
impact of glutamine availability or limitation on the physiology of CHO-K1 cells in eight different 
batch- and fed-batch cultivations. Varying glutamine availability resulted in global metabolic 
changes. We observed dose-dependent effects of glutamine in batch cultivation. Identifying 
metabolic links from the glutamine metabolism to specific metabolic pathways, we show that 
glutamine feeding results in its coupling to tricarboxylic acid (TCA) cycle fluxes and in its 
decoupling from metabolic waste production. We provide a mechanistic explanation of the cellular 
responses upon mild or severe glutamine limitation and ammonia stress. The growth rate of CHO-
K1 decreased with increasing ammonia levels in the supernatant. On the other hand, growth, 
especially culture longevity, was stimulated at mild glutamine limiting conditions. Flux 
rearrangements in the pyruvate and amino acid metabolism compensate glutamine limitation by 
consumption of alternative carbon sources and facilitating glutamine synthesis and mitigate 
ammonia stress as result of glutamine abundance. 
 
This chapter was published as 
Wahrheit J, Nicolae A, Heinzle E. (2014) Dynamics of growth and metabolism controlled by 
glutamine availability in Chinese hamster ovary cells. Applied Microbiology and Biotechnology 98 
1771-1783. 
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3.2 Introduction 
Metabolic studies of mammalian cells are increasingly important in biological, biomedical and 
biotechnological research. An in-depth analysis of mammalian metabolism is crucial for the 
understanding of physiological, pathophysiological and toxicological mechanisms. This is required 
to identify potential drug targets or biomarkers as well as to determine a strategy for metabolic 
engineering, media optimization and feeding in the development of efficient large-scale production 
processes (Niklas and Heinzle, 2012). 
In mammalian cells, the glutamine metabolism is of particular interest due to its importance as 
cellular energy, carbon and nitrogen source (Neermann and Wagner, 1996; Newsholme et al., 
2003a; Newsholme et al., 2003b). The glutamine metabolism represents also the primary source for 
ammonia (Glacken, 1988; Kurano et al., 1990; Street et al., 1993). The formation of metabolic by-
products such as lactate and ammonia is a common issue in the cultivation of mammalian cells that 
can have a significant impact on the whole cultivation performance (Ozturk et al., 1992; Schneider 
et al., 1996). In particular the accumulation of the toxic waste product ammonia can inhibit growth 
and, in the case of industrial producer strains, can affect productivity and product quality (Chen and 
Harcum, 2006; Hassell et al., 1991; Priesnitz et al., 2012; Yang and Butler, 2000; Yang and Butler, 
2002). 
Metabolic flux analysis (MFA) is the method of choice for detailed quantitative metabolic studies. 
Classical approaches require metabolic steady-state conditions. However, metabolic steady-state is 
usually not attained under industrially relevant conditions, i.e. batch or fed-batch cultivations. The 
successive consumption and depletion of substrates and the accumulation of specific side-products 
result in the development of different metabolic phases and metabolic shifts (Niklas et al., 2011c). 
One possibility to deal with this issue is to divide the cultivation profile into several phases and 
perform a separate analysis (Niklas et al., 2012a; Niklas et al., 2011c). Often an adjustment of the 
cultivation conditions, e.g. by a special media design, is necessary to achieve steady-state conditions 
in mammalian cell cultures (Deshpande et al., 2009). 
Dynamic metabolic flux analysis represents an elegant way to circumvent several of these 
difficulties and drawbacks. Since extracellular steady-state conditions are not a requirement, this 
time-resolved MFA method can be applied to batch- and fed-batch cultivations. It provides the 
unique possibility to capture metabolic dynamics and metabolic shifts by monitoring the complete 
time-course of cultivation including the phase transitions between different metabolic phases. 
Furthermore, dynamic MFA enables the direct comparison of very different conditions with 
different growth behavior and allows the determination of the exact timing of metabolic events. 
We tested different glutamine start concentrations and different glutamine feeding profiles to study 
the glutamine metabolism in Chinese hamster ovary (CHO) cells using dynamic MFA. The aim of 
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the study was to obtain an in-depth representation of the metabolic changes in CHO-K1 cells as a 
result of (a) excess glutamine supply, (b) controlled glutamine supplementation, (c) glutamine 
limitation, (d) glutamine depletion, and (e) ammonia accumulation. A more detailed understanding 
of physiological and metabolic implications of varying glutamine supply will provide a strong basis 
for design and development of novel producer cells, bioprocesses, as well as therapeutic strategies. 
3.3 Material and methods 
3.3.1 Cell culture and experimental set-up 
The CHO-K1 cell line was kindly provided by the group of cell culture technology of the University 
Bielefeld. The cells were growing in suspension under serum and protein free conditions in the 
chemically defined medium TC-42 (TeutoCell AG, Bielefeld, Germany) at 37°C with 5% CO2 
supply in a shaking incubator (185 rpm, 2 inches shaking orbit, Innova 4230, New Brunswick 
Scientific, Edison, NJ, USA). The pre-culture was performed in a 250 ml baffled shake flask 
(Corning, NY, USA) with a volume of 100 ml in TC-42 supplemented with 4 mM glutamine. The 
main cultures were carried out in 50 ml filter-tube bioreactors (TPP, Trasadingen, Switzerland) at a 
start cell density of 2 × 105 cells/ml and a start volume of 20 ml. For the different test conditions 
TC-42 medium without glutamine or supplemented with different glutamine concentrations was 
prepared. For the fed-batch cultivations a stock solution of 200 mM glutamine resolved in dest. H2O 
was prepared as feeding solution. Six different batch cultivations with 0 mM, 1 mM, 2 mM, 4 mM, 
6 mM or 8 mM glutamine start concentrations and two different fed-batch cultivations starting at 
1 mM glutamine and feeding 1 mM every 24 h or starting at 2 mM and feeding 2 mM every 48 h 
were performed. In total, 8 mM glutamine was added to the fed-batch cultivations. An example for 
reproducibility of growth and metabolite profiles is shown in the supplementary material in Figure 
S1. Samples of 500 µl were taken every day. 50 µl of the sample was diluted with PBS and mixed 
with Trypan Blue for determination of cell density, cell viability and average cell diameter using an 
automated cell counter (Invitrogen, Darmstadt, Germany). The average cell volume was estimated 
from the average cell diameter assuming a sphere. Differences of cell diameters during the 
cultivation were very small and not taken into account. The sample was centrifuged (10,000 rpm, 
5  min, Biofuge pico, Heraeus Instruments, Hanau, Germany), 300 µl of the supernatant transferred 
into fresh tubes and stored at -20°C for further analysis. The rest of the sample was used for pH 
determination (MP 220 pH Meter, Mettler-Toledo, Giessen, Germany). 
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3.3.2 Quantification of metabolites 
Quantification of glucose, organic acids and amino acids via HPLC was carried out as described 
recently (Strigun et al., 2011b). Ammonia was quantified using an ammonia assay kit (Sigma-
Aldrich, Steinheim, Germany) in 96-well plates. 10 µl of sample was mixed with 100 µl of assay 
reagent, mixed on a plate shaker for 5 min and the absorbance measured at 340 nm in a micro plate 
reader. Then, 1 µl of glutamate dehydrogenase was added to each well, the plate mixed on a plate 
shaker for 5 min and the absorbance measured at 340 nm. Standards with different ammonia 
concentrations (2-10 mg/l) were used for calibration. Urea was measured via HPLC as described 
earlier (Clark et al., 2007). 
3.3.3 Dynamic metabolic flux analysis 
The continuous time course of the metabolic fluxes was computed similar to Niklas et al. (Niklas et 
al., 2011c) following the steps: 1. interpolation of the extracellular concentrations of metabolites 
and the cell density with a continuously derivable function, 2. computing the extracellular rates, 3. 
computing intracellular fluxes based on a stoichiometric model. Cell density and extracellular 
concentrations of metabolites from each cultivation were interpolated using SLM (Shape Language 
Modeling), a user-developed fitting tool that uses customized splines (Matlab 2012b, The 
Mathworks, Natick, MA, USA). To avoid overfitting and biological nonsense, all fitted values were 
constrained to positive values, not more than 3 splines per curve were used and, except where 
observed to be otherwise, all curves were monotonous. Glutamine and glutamate concentrations 
were fitted for each fed-batch phase, while for the rest of metabolites the interpolated concentration 
curves were derivable for the whole cultivation time interval. 
Water evaporation was taken into account by correcting the concentration values prior to 
interpolation using the experimentally determined evaporation rate. Both the evaporation rate and 
glutamine degradation kinetics were determined experimentally in a cell-free setup identical to the 
one employed during the cultivation. 
Extracellular fluxes were calculated in [mmol/L × h] units using the numerically differentiated 
concentration slopes 
dt
dCi
: 
cell
i
iu
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v
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,         (1) 
and by considering the spontaneous degradation of glutamine: 
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where vu,i is the uptake rate of metabolite i, Ci is the fitted extracellular concentration, kdGLN is the 
first order degradation constant of glutamine, X is the fitted cell density and Vcell is the volume of 
one cell. Biomass fluxes were calculated using the time-dependent growth rate: 
cell
Xiibio
VX
dtdX
Yv
1/
/,        (3) 
where vbio,i is the biomass rate for metabolite i and Yi/X is the biomass yield coefficient. 
The stoichiometric model of the CHO-K1 metabolism was built based on pathway data presented by 
Ahn and Antoniewicz (Ahn and Antoniewicz, 2012) and adapted to accommodate experimental 
observations (Supplementary material, Figure S2). It comprises the main pathways in the central 
carbon metabolism: biomass production using proteins, fatty acids and carbohydrates; glycolysis, 
pentose phosphate pathway (PPP), tricarboxylic acid (TCA) cycle and amino acids syntheses and 
catabolism. Aminotransferase reactions were always coupled with the conversion of -ketoglutarate 
(AKG) to glutamate. The stoichiometric model was simplified in the following way: 
compartmentation was neglected, anaplerotic reactions were lumped into one flux connecting 
phosphoenolpyruvate (PEP) with oxaloacetate (OAA), serine production and degradation reactions 
were modeled as one reversible flux between serine and pyruvate. The intracellular fluxes were 
calculated using the external fluxes according to the network stoichiometry: 
)()( mmcc vGGinvv        (4) 
where vc and vm are the arrays of intracellular and extracellular fluxes, Gc and Gm are the 
corresponding stoichiometric matrices specified in the supplementary material (Table S1 and Table 
S2). The matrix that corresponds to intracellular fluxes must be invertible. Consequently, the 
stoichiometric model was modified as described above. 
After making all listed simplifications, the PPP flux could still not be calculated directly but had to 
be fixed in order to obtain an invertible Gc. The PPP flux was sampled randomly at each time point 
with a time interval less than one hour and had to fulfill predefined biological constraints 
(Supplementary material Table S3) and the constraints imposed by the whole network. A somewhat 
similar approach but applying elementary modes was recently described and shows that many fluxes 
can be determined within narrow intervals whereas others cover a fairly broad range (Zamorano et 
al., 2010). The resulting fluxes containing the noise generated by random sampling of the PPP flux 
were smoothed by spline fitting and thus time-varying flux values were obtained. Considering that 
the flux space is greatly reduced by the known fluxes and constraints, e.g. reversibility of reactions 
(Wiback et al., 2004), the averaging is expected to have little impact on non-glycolytic fluxes, e.g. 
TCA cycle and glutamine metabolism, that are not closely connected to the PPP carbon flux. 
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3.4 Results 
3.4.1 Influence of glutamine on growth and culture longevity of CHO-K1 
The impact of the glutamine availability on the growth behaviour of CHO cells was analysed by (1) 
the time course of the specific growth rate µ, (2) the maximum viable cell density reached during 
the cultivation period, (3) viability, and (4) the viability-pH profile (Figure 3-1). Furthermore, the 
specific growth rates µ were correlated to the extracellular glutamine rate over time (Figure 3-2). 
Generally, rates are only shown starting from 20 h due to inherent difficulties to determine initial 
rates using splines. The profiles of the specific growth rates of all cultivations had a similar pattern, 
starting at maximum values and rapidly decreasing afterwards (Figure 3-1B and 1F). Interestingly, 
identical initial µ were determined for the cultivations with start concentrations of 4, 6, and 8 mM 
glutamine reaching a maximum specific growth rate of 0.07 h-1 (Figure 3-1B). With increasing 
glutamine start concentration (0 mM to 8 mM glutamine) the specific growth rate µ was initially 
higher but dropped faster (Figure 3-1B). At the beginning of the cultivation, The specific growth 
rate µ increased linearly with increasing glutamine uptake rates (Figure 3-2A, 24 h). For later time-
points (Figure 3-2B-E, 48-120 h), there was still a linear relationship between µ and the 
extracellular glutamine rates. However, we observed a clustering in two groups, (1) low glutamine 
concentrations, 0 to 2 mM glutamine and (2) high glutamine concentrations, 4 to 6 mM glutamine. 
After 48 h of cultivation, we determined higher specific growth rates for lower glutamine 
concentrations (Figure 3-2B and 2C). After glutamine depletion, there was no correlation, as it was 
the case for 0 to 2 mM glutamine after 96 h (Figure 3-2D and 2E). The lowest viable cell density 
was obtained in the glutamine-free cultivation (Figure 3-1A). The highest viable cell densities were 
found in the batch cultivation with 1 mM glutamine start concentration and in the 8 × 1 mM fed-
batch cultivation (Figure 3-1E). Culture longevity, as indicated by longer maintenance of high 
viability and a slower decrease of the specific growth rate, was superior at low glutamine and 
glutamine-free conditions. Specific growth rates decreased faster at high glutamine levels (Figure 3-
1B and Figure 3-2B-E). In the glutamine-free cultivation, the specific growth rate µ was the lowest 
of all tested at the beginning and highest after about 110 h of cultivation where it remained constant 
until the end of cultivation. Cell viability dropped earlier for cultivations with high glutamine levels 
and latest for 0 mM and 1 mM batch and 8 × 1 mM fed-batch cultivations (Figure 3-1C and 1G). 
Interestingly, viability was always high above a pH value of 6.8 (Figure 3-1D and 1H). Upon 
reaching a pH value of about 6.8, viability dropped sharply in all cultures, irrespective of actual 
ammonia levels (Supplementary Material Figure S3B). After reaching a pH value of about 6.8, pH 
does not any more decrease monotonically as is also indicated in the pH-ammonia plot 
(Supplementary Material, Figure S3A and B). Interestingly, the cultivation without supply of 
glutamine does not reach this pH value and viability does not drop as in the other cultures. Towards 
the end of cultivation ammonia concentration increases in all cases (Figure 3-3) and is negatively 
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correlated with pH (Supplementary Material Figure S3A). Plots of specific growth versus ammonia 
concentration showed that in each case it decreased with increasing ammonia concentration 
(Supplementary Material Figure S3C). Remarkably, viability dropped sharply but at different 
ammonia concentrations (Supplementary Material Figure S3B). These results indicate that ammonia 
accumulation is not the primary cause for a decline in pH, viability and growth rate. However, there 
was a clear linear correlation between the pH and the extracellular lactate concentration 
(Supplementary Material Figure S3D). Viability dropped when a lactate concentration of 30 mM 
was reached. 
 
Figure 3-1. Growth profiles of CHO-K1 at different glutamine availabilities. Different batch 
cultivations with 0 mM, 1 mM, 2 mM, 4 mM, 6 mM or 8 mM glutamine start concentrations (Top, A-D) 
and different fed-batch cultivations with feeding of 1 mM every 24 h (8 × 1 mM) or of 2 mM every 48 h 
(4 × 2 mM) compared to respective batch cultivations with 1 mM, 2 mM, or 8 mM glutamine start 
concentrations without additional feeding of glutamine (Bottom, E-H). (A) and (E) Viable cell densities 
[cells/ml] over time [h]. (B) and (F) Specific growth rates µ [h-1] over time [h] (note that the timescale starts 
at 20 h because of high uncertainty of determination of initial slopes using splines). (C) and (G) Cell 
viability [%] over time [h]. (D) and (H) Cell viability [%] relative to the respective culture pH that 
decreased with time (not shown). 
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Figure 3-2. Correlation between the specific growth rates µ and the extracellular glutamine rates of 
different batch cultivations after (A) 24 h, (B) 48 h, (C) 72 h, (D) 96 h and (E) 120 h. Positive glutamine 
rates indicate glutamine uptake, negative rates glutamine excretion. In a, the linear correlation between 
specific growth rates and glutamine uptake rates for the six different batch cultivations are shown. In (B) 
and (C), a linear correlation between cultivations with low glutamine concentrations, 0 mM, 1 mM, and 
2 mM glutamine, and between cultivations with high glutamine concentrations, 4 mM, 6 mM, and 8 mM 
glutamine, are determined separately. In (D) and (E), the linear correlation between cultivations with high 
glutamine concentrations is shown. No linear correlation was determined for cultivations with low 
glutamine concentrations since glutamine was depleted at 96 h (D) and 120 h (E). The fed-batch 
cultivations are not included in the determination of correlation and are only shown for comparison. 
3.4.2 Dynamics of extracellular metabolite concentrations 
Selected extracellular metabolites are presented in Figure 3-3, the complete extracellular metabolite 
profiles are depicted in the supplementary material (Figure S4 and S5). With the exception of 
glutamine, none of the measured extracellular media components was depleted during the 
cultivation. This provides clear evidence that no nutrient limitation occurred (Supplementary 
Material Figure S6 and S7). No urea could be detected in the supernatants. Glucose uptake and 
lactate excretion were similar in all glutamine supplemented cultures but significantly lower in the 
glutamine-free cultivation. Pyruvate uptake was first comparable for all conditions. After 96 h of 
cultivation, pyruvate uptake was lower in the glutamine-free cultivation. Glutamine uptake, alanine 
excretion and ammonia accumulation increased with increasing glutamine start concentration. In the 
fed-batch cultivations, alanine and ammonia excretion were lower than in the batch cultivation with 
a single dose of 8 mM glutamine. Serine uptake was similar in all cultivations. Asparagine uptake 
was similar for all glutamine supplemented cultures but delayed for the glutamine-free cultivation. 
Aspartate was not taken up initially but significantly consumed after 48 h in glutamine 
supplemented cultures and after 96 h in the glutamine-free cultivation. Aspartate uptake was 
decreasing with increasing glutamine start concentration. 
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Glycine and glutamate were first excreted, then consumed and eventually excreted again. Glycine 
excretion and the following re-uptake were highest at 0 mM glutamine and decreased with 
increasing glutamine concentration. For high glutamine levels, glycine re-uptake was almost 
negligible. The shift from glycine excretion to glycine re-uptake was delayed with decreasing 
glutamine concentration. Glutamate excretion increased with increasing glutamine start levels but 
was highest in the glutamine-free cultivation. Consumption of glutamate was more significant and 
started earlier at lower glutamine start levels. Glutamate reuptake was delayed in the glutamine-free 
cultivation. For the fed-batch cultivation an intermediate response between low and high glutamine 
start concentrations was observed. 
 
Figure 3-3. Extracellular metabolite profiles of CHO-K1 at different glutamine availabilities.  
(A) Different batch cultivations with 0 mM, 1 mM, 2 mM, 4 mM, 6 mM or 8 mM glutamine start 
concentrations. (B) Different fed-batch cultivations with feeding of 1 mM every 24 h (8 × 1 mM 24 h) or of 
2 mM every 48 h (4 × 2 mM 48 h) compared to respective batch cultivations with 1 mM, 2 mM, or 8 mM 
glutamine start concentrations without additional feeding of glutamine. Abbreviations: Glc glucose, Lac 
lactate, Pyr pyruvate, for amino acids the standard three letter code is used. 
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3.4.3 Changes in the dynamic flux distribution upon different glutamine 
availabilities 
Selected fluxes in the central energy metabolism and the amino acid metabolism are shown in the 
flux maps in Figure 3-4. The complete set of calculated fluxes is shown in the supplementary 
material (Figure S8-S10 for batch cultivations and Figure S11-S13 for fed-batch cultivations). 
Glycolytic rates started at high values and decreased rapidly over time. The different glutamine 
batch- and fed-batch conditions did not significantly affect glycolytic fluxes. Only the glutamine-
free culture maintained higher rates after 96 h compared to glutamine-supplemented cultures. The 
pyruvate uptake rate was substantially increased in the glutamine-free culture and initially slightly 
increased for the 1 mM batch cultivation compared to higher glutamine levels. After 96 h of 
cultivation, pyruvate uptake rates were similar for all conditions. 
The serine uptake rate increased with decreasing glutamine concentration. In addition, serine was 
initially produced from 3-phosphoglycerate, as indicated by a negative flux from serine to pyruvate. 
Serine synthesis was highest in the glutamine-free culture and at high glutamine concentrations. 
Later in the cultivation, serine was still produced in cultivations with low glutamine start 
concentrations, but slightly degraded to pyruvate at high glutamine start levels and at glutamine-free 
conditions. Glycine excretion rate increased with decreasing glutamine concentrations. Later, 
glycine is still produced from serine but not excreted any longer. Alanine and ammonia excretion 
rates increased with increasing glutamine concentration. In the two fed-batch cultivations, these 
rates were significantly lower than in the 8 mM batch cultivation. 
Glutamine uptake rates and glutamine degradation to glutamate increased with increasing glutamine 
levels. Glutamate was further converted to -ketoglutarate (AKG) feeding the tricarboxylic acid 
(TCA) cycle. At glutamine-free conditions, the glutamate dehydrogenase reaction was initially 
reversed to produce glutamate for glutamine synthesis draining carbons from the TCA cycle. 
Glutamine was first slightly produced in the glutamine-free cultivation and later taken up again. As 
a result, glutamate excretion rates were much higher in the glutamine-free culture than in glutamine 
supplemented cultures through most part of the cultivation. Glutamate excretion rates in glutamine 
supplemented cultures were initially not significantly different for different glutamine 
concentrations. In cultures with low glutamine start levels where glutamine limitation was reached, 
glutamate was consumed later in the cultivation. At high glutamine start concentrations and in the 
fed-batch cultivations, glutamate was continuously excreted. 
Fluxes from AKG to oxaloacetate (OAA) were at least initially affected by the glutamine supply 
resulting in increased rates with increasing glutamine levels. The reflux from TCA cycle to 
glycolysis via reactions of malic enzyme, phosphoenolpyruvate (PEP) carboxykinase, and pyruvate 
carboxylase represented as a combined flux from OAA to PEP was strongly affected by the 
glutamine supply. The flux was increasing with increasing glutamine concentrations removing 
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carbons from the TCA cycle. As a consequence, TCA cycle fluxes from OAA to AKG were not 
dose-dependently affected by increasing glutamine consumption rates. However, at the beginning of 
the cultivation these fluxes were highest for the highest glutamine start concentration, 8 mM 
glutamine. In the glutamine-free cultivation, the anaplerotic flux from PEP to OAA was initially 
feeding carbons into the TCA cycle. Later in the cultivation, after about 60 h, this flux was reversed 
as observed in all glutamine supplemented cultures. In later phases of the cultivation, TCA cycle 
fluxes were highest for the glutamine-free cultivation (Figure 3-4A) and the 4 × 2 mM fed-batch 
cultivation (Figure 3-4B). Overall less variation of TCA cycle fluxes and the flux from OAA to PEP 
was observed in the fed-batch cultures compared to batch cultivations. 
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Figure 3-4. (A) Flux map of CHO-K1 at different glutamine availabilities. Shown are the metabolic 
rates related to the cell volume [mmol/(L × h)]. Different batch cultivations with 0 mM, 1 mM, 2 mM, 
4 mM, 6 mM or 8 mM glutamine start concentrations. Abbreviations: Glc glucose, G6P glucose-6-
phosphate, F6P fructose-6-phosphate, GAP glyceraldehyde-3-phosphate, PEP phosphoenolpyruvate, Pyr 
pyruvate, Lac lactate, AcCoA acetyl-CoA, AKG -ketoglutarate, OAA oxaloacetate, for amino acids, the 
standard three letter code is used. Negative values indicate fluxes in the opposite direction of the arrow. 
This is generally possible for all reactions not constrained as specified in Table S3 of the Supplementary 
Material. Note that the timescale starts at 20 h because of high uncertainty of determination of initial slopes 
using splines. 
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Figure 3-4. (B) Flux maps of CHO-K1 at different glutamine availabilities. Shown are the metabolic 
rates related to the cell volume [mmol/(L × h)]. Different fed-batch cultivations with feeding of 1 mM every 
24 h (8 × 1 mM 24 h) or of 2 mM every 48 h (4 × 2 mM 48 h) compared to respective batch cultivations 
with 1 mM, 2 mM, or 8 mM glutamine start concentrations without additional feeding of glutamine. 
Abbreviations: Glc glucose, G6P glucose-6-phosphate, F6P fructose-6-phosphate, GAP glyceraldehyde-3-
phosphate, PEP phosphoenolpyruvate, Pyr pyruvate, Lac lactate, AcCoA acetyl-CoA, AKG -
ketoglutarate, OAA oxaloacetate, for amino acids, the standard three letter code is used. Negative values 
indicate fluxes in the opposite direction of the arrow. This is generally possible for all reactions not 
constrained as specified in Table S3 of the Supplementary Material. Note that the timescale starts at 20 h 
because of high uncertainty of determination of initial slopes using splines. 
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3.4.4 Metabolic links from glutamine metabolism to specific metabolic 
pathways 
Extra- and intracellular fluxes were related to the extracellular glutamine flux in order to identify 
metabolic links. A linear correlation reveals a metabolic interdependence (coupling) indicating that 
this metabolic pathway can be at least partially controlled by the glutamine uptake. Coefficients of 
determination (R2) are plotted in a heat map for the eight different test conditions (Figure 3-5). 
Deviations from linearity and relatively small changes of the respective fluxes will result in a bad 
correlation, i.e. a low R2 value. 
3.4.4.1 Glutamine-free cultivation 
In the glutamine-free cultivation, the extracellular glutamine flux (changing from glutamine 
excretion to glutamine uptake) was only correlated to the glutamine synthesis or glutaminase 
reaction, respectively, and the ammonia excretion. For all other metabolic fluxes no correlation was 
observed. 
3.4.4.2 Glutamine batch cultivations 
In the glutamine supplemented batch cultures, we observe a linear correlation with the formation of 
alanine and serine from pyruvate, formation of glycine from serine as well as all extracellular 
uptake and excretion rates except asparagine at 2 mM glutamine. The degradation of asparagine to 
aspartate and its conversion to oxaloacetate were strongly connected only to the glutamine uptake at 
1 mM glutamine concentration. Only little correlation was found for higher glutamine 
concentrations. The correlation of glutamate dehydrogenase activity with glutamine uptake was 
increasing with increasing glutamine concentration. 
A good correlation was also found with the glycolytic fluxes and with the gluconeogenic flux from 
TCA cycle to glycolysis (OAA to PEP). In contrast, the pyruvate dehydrogenase reaction and the 
TCA cycle fluxes were much less connected to the glutamine uptake. However, coupling was 
strengthened with increasing glutamine concentrations and a strong connection was observed at 
8 mM glutamine. 
3.4.4.3 Glutamine fed-batch cultivations 
Striking differences could be found between the batch and the fed-batch cultivations. In contrast to 
batch cultivations, the glutamine uptake rate was decoupled from glycolysis and all extracellular 
fluxes. The extracellular glutamine flux was also decoupled from formation of alanine, serine and 
glycine. This effect was more significant in the cultivation where glutamine was fed every day 
(8 × 1 mM) than in the cultivation with feeding every second day (4 × 2 mM). In the cultivation 
with daily feeding, the connection of the glutamine uptake with the glutamate dehydrogenase flux 
and with the anaplerotic flux (OAA to PEP) was maintained. In addition, the TCA cycle fluxes were 
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connected to the glutamine uptake as it was the case for the batch cultivation with a glutamine start 
concentration of 8 mM. 
 
Figure 3-5. Correlation of extracellular uptake fluxes and intracellular fluxes of glycolysis, TCA 
cycle, and amino acid metabolism with glutamine uptake fluxes (Gln in). Metabolic fluxes determined 
using splines are related with the extracellular glutamine rates for the cultivation period between 20 and 
120 h. Linear correlations are determined by the coefficient of determination (R2) indicated by the color 
scale. The different cultivations conditions with varying glutamine supply are shown on the x-axis. 
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3.5 Discussion 
3.5.1 Global metabolic changes controlled by the glutamine availability 
We provide a comprehensive analysis of the glutamine metabolism in CHO cells and the metabolic 
changes controlled by varying glutamine availabilities using dynamic metabolic flux analysis 
(MFA). To our knowledge, this is the first study investigating the complete range of glutamine 
availabilities that can occur in animal cell cultivation, including dose-dependent effects of 
glutamine, mild or severe glutamine limitation, and controlled supplementation of glutamine. 
Numerous studies investigated the glutamine metabolism in different mammalian cell lines, e.g. in 
hybridoma (Kurokawa et al., 1994; Ljunggren and Haggstrom, 1994), myeloma (Ljunggren and 
Haggstrom, 1992), HEK 293 (Nadeau et al., 2000), PER.C6 cells (Maranga and Goochee, 2006), 
however studies of the glutamine metabolism in CHO cells are rather limited (Rajendra et al., 2012; 
Sanfeliu and Stephanopoulos, 1999). Most studies focused only on the comparison of two 
conditions, i.e. high glutamine batch and low glutamine fed-batch cultivations, but do not cover a 
larger range of glutamine availabilities. Moreover, intracellular metabolic fluxes have rarely been 
considered in previous studies (Burleigh et al., 2011; Nadeau et al., 2000; Nyberg et al., 1999a) and 
never using dynamic MFA. 
In addition, our study allows investigating the effects of ammonia accumulation due to its direct 
connection to glutamine metabolism. The effects of increased ammonia concentrations on CHO 
(Chen and Harcum, 2006; Lao and Toth, 1997) and other mammalian cell cultures (Mirabet et al., 
1997; Ozturk et al., 1992; Priesnitz et al., 2012; Schneider et al., 1996) have been studied by 
numerous groups in the past. Most studies supplemented the culture with elevated ammonia 
concentrations to test the effect of ammonia stress on cell cultures. However, since cell culture 
media do usually not contain ammonia this is an artificial condition with limited relevance. We 
propose to study the effects of ammonia accumulation by varying the glutamine concentration as a 
more valid condition for cell cultures. 
According to the glutamine supply applied in the eight different test conditions, four distinct 
situations together with early and late effects can be distinguished: (1) glutamine-free cultivation 
with a constant glutamine limitation from the start (Figure 3-6, no glutamine), (2) low glutamine 
start levels leading to early glutamine depletion during the cultivation (Figure 3-6, low glutamine), 
(3) high glutamine start levels when no or only late glutamine limitation occurs (Figure 3-6, high 
glutamine), and (4) controlled feeding of low glutamine concentrations completely avoiding 
glutamine limitation (Figure 3-6, feeding glutamine). 
Changing glutamine availabilities impose (1) different extreme situations on the cells, (1a) 
glutamine abundance and (1b) glutamine limitation, triggering (2) different cellular responses. The 
cells respond by (2a) adjusting their anabolic activities and their growth behaviour, (2b) rearranging 
Chapter 3 Dynamics of growth and metabolism controlled by glutamine availability 
 
81 
their metabolic fluxes in order to attenuate these extreme situations, which in turn results in (2c) 
adaptation of waste product excretion and substrate consumption leading to (3) alteration of the 
environmental conditions eventually imposing (1) new constraints on the cells. The dynamic 
interdependence of different extreme states with corresponding cellular responses to them and 
transition of different states into each other is schematically depicted in Figure 3-7. 
3.5.2 The glutamine availability affects waste product excretion and substrate 
consumption 
The extracellular metabolite profile gives a first indication of the metabolic changes induced by the 
glutamine availability. Lactate, alanine, and ammonia were excreted as waste products, glutamate 
and glycine were first excreted, then taken up and eventually excreted again, and glucose, pyruvate 
and all other amino acids were consumed during the whole cultivation period. The glutamine 
availability affects waste product excretion and substrate consumption by (a) supporting significant 
waste production of specific metabolites at glutamine abundance and (b) inducing the consumption 
of alternative carbon sources to compensate for glutamine limitation. 
In the batch cultivations from 1 mM to 8 mM glutamine, we observe a clearly dose-dependent effect 
of glutamine on substrate consumption and product excretion. Excretion of ammonia, alanine, and 
glutamate increased dose-dependently with increasing glutamine consumption as expected due to 
their direct connection to glutamine metabolism (Doverskog et al., 1997). In contrast, glycine 
excretion was dose-dependently increased with decreasing glutamine concentration. Our findings 
are in accordance with previous studies on myeloma and hybridoma cells where glutamine 
limitation resulted in reduced production of ammonia and alanine, but increased glycine production 
(Ljunggren and Haggstrom, 1992; Ljunggren and Haggstrom, 1994). Reuptake and consumption of 
glutamate, aspartate and glycine was more significant, the lower the glutamine start concentration 
and the earlier glutamine depletion occurred. At glutamine depletion, these amino acids seem to be 
efficient substrates to compensate for glutamine limitation. 
Interestingly, the outcome of the glutamine-free cultivation was not always an extrapolation of the 
dose-dependent effects observed for the different glutamine supplemented batch cultivations. On the 
contrary, a mixed response was observed for the glutamine-free cultivation. Excretion of alanine 
and ammonia were lowest in the glutamine-free cultivation but that of glycine was highest. 
However, excretion of glutamate was as high as in the 8 mM batch cultivation. Consumption of 
glutamate, aspartate, and glycine occurred as late as for the 8 mM batch cultivation but was larger 
than for the 1 mM batch cultivation. Our findings demonstrate that severe and mild glutamine 
limiting conditions have to be considered separately since they lead to very distinct metabolic 
effects. 
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The extracellular metabolite profiles of the two fed-batch cultivations were consistent with the 
different glutamine supplemented batch cultivations. Concerning the consumption of substrates and 
excretion of products an intermediate response between the 1 mM and 2 mM batch cultivations and 
the 8 mM batch cultivation was observed for the fed-batch cultivations. Waste product excretion 
was less significant than in the respective batch cultivations. Reduced waste product excretion in 
glutamine limited fed-batch cultivations compared to high glutamine batch cultivations was 
commonly observed in different cell lines (Ljunggren and Haggstrom, 1992; Ljunggren and 
Haggstrom, 1994; Maranga and Goochee, 2006). 
3.5.3 Flux rearrangements in the pyruvate and amino acid metabolism 
compensate glutamine limitation and mitigate ammonia stress 
Depending on the availability of glutamine the cells have to cope with different extreme situations, 
(a) glutamine abundance increasing ammonia stress and (b) glutamine limitation (Figures 3-6 and 3-
7). When glutamine was abundant, it was preferentially consumed as major carbon source besides 
glucose. With increasing glutamine availability glutamine consumption and ammonia production 
rates increased. Ammonia stress triggered several cellular adaptations. We observed an increased 
production of alanine and serine serving as nitrogen sinks (Figure 3-6). The latter is correlated with 
a reduction of serine uptake. Glutamate excretion reduced production of ammonia by removing the 
substrate of glutamate dehydrogenase (Figures 3-6 and 3-7). However, the glutamate excretion rate 
was initially not significantly different in batch cultivations from 1 mM to 8 mM glutamine 
indicating that this is not the primary mechanism to reduce ammonia stress as proposed previously 
by Priesnitz et al. for the human cell line AGE1.hn (Priesnitz et al., 2012). Furthermore, we found 
an increased excretion of the two major side products of glutaminolysis, ammonia and alanine. 
Changes in the amino acid metabolism upon ammonia stress in animal cells have been found also 
before by several groups for CHO cells (Hansen and Emborg, 1994b) and other mammalian cell 
lines (Miller et al., 1989; Ozturk et al., 1992; Priesnitz et al., 2012). These adaptations either support 
ammonia fixation or reduce ammonia release by increased production or decreased uptake and 
degradation of specific amino acids, respectively. 
Glutamine depletion resulted in a mild form of glutamine limitation (Figure 3-7). The cells had time 
to adapt to decreasing glutamine concentrations by activating compensation mechanisms. Glutamine 
depletion was first compensated by increased consumption of pyruvate, serine and partially 
asparagine and later by consumption of glutamate and aspartate (Figures 3-6 and 3-7). A severe and 
complete glutamine limitation as induced in the glutamine-free cultivation was also compensated by 
increased consumption of pyruvate and serine. In addition, the cells needed to synthesize glutamine 
from glutamate via glutamine synthetase. As a consequence, the glutamate dehydrogenase flux was 
reversed to produce glutamate for cellular glutamine synthesis (Figures 3-6 and 3-7). Since AKG 
was removed from the TCA cycle in favour of glutamine synthesis, the TCA cycle was additionally 
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fed via the anaplerotic flux from PEP to OAA to compensate for the lack of carbons in the TCA 
cycle (Figures 3-6 and 3-7). In later phases of the cultivation, the glutamine limited cultures had 
higher TCA cycle fluxes than the cultures with high glutamine start levels. This was achieved by an 
efficient management of glutamine limitation with successive recruitment of alternative substrates. 
These compensation mechanisms, however, partially resulted in additional waste production. 
Activation of the glutamine synthesis pathway was accompanied by substantial glutamate excretion 
in the glutamine-free cultivation. Increased uptake of pyruvate and serine led to increased glycine 
production. Increased production of glycine in glutamine limited fed-batch cultivations was 
previously found for myeloma cells. However, they provided no explanation for this observation 
(Ljunggren and Haggstrom, 1992). Genzel et al. showed that pyruvate can be used as a replacement 
for glutamine in different adherent cell lines. Similar to our study, they observed increased excretion 
of glycine at growth on pyruvate (Genzel et al., 2005). 
 
Figure 3-6. Schematic representation of metabolic flux dynamics in the central metabolism. Four 
different situations, no glutamine, low or high glutamine start concentrations, or feeding glutamine (top to 
bottom) with distinction of early (left) and late (right) effects can be distinguished. Abbreviations: Glc 
glucose, Pyr pyruvate, Lac lactate, AKG -ketoglutarate, OAA oxaloacetate, for amino acids, the standard 
three letter code is used, the thickness of the arrows indicate relative values for each individual flux. 
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3.5.4 Low glutamine levels cause moderate growth and improved culture 
longevity 
Growth and culture longevity of CHO-K1 were strongly influenced by the glutamine availability. 
Culture longevity can be seen by longer maintenance of high viability and relatively high specific 
growth rates. A time-resolved description of growth as applied in our study allows the distinction of 
early and late effects. In accordance with previous investigations on hybridoma and myeloma cells, 
specific growth rates reached maximum values early during the cultivation and decreased thereafter 
(Ljunggren and Haggstrom, 1992; Ljunggren and Haggstrom, 1994). Glutamine had an initial 
growth stimulating effect. The initial specific growth rates increased linearly with increasing 
glutamine uptake rates. However, identical maximal growth rates observed for 4, 6, and 8 mM 
glutamine start concentration indicate that there is an upper limit for µ and that the growth rate 
cannot be arbitrarily increased by raising the glutamine concentration. Identical specific growth 
rates in CHO batch cultivations with 4 mM and 8 mM glutamine start concentrations have also been 
described by Burleigh et al. (Burleigh et al., 2011). In contrast to hybridoma or myeloma cells, CHO 
cells are able to grow under glutamine-free conditions due to endogenous glutamine synthetase 
activity (Bebbington et al., 1992; Mercille and Massie, 1994; Street et al., 1993; Zhang et al., 2006). 
The glutamine synthetase catalyzes the ATP-hydrolyzing condensation of glutamate and ammonia 
to form glutamine. However, the initial growth rate in the glutamine-free cultivation was largely 
reduced compared to glutamine supplemented cultures which has been described before for CHO 
cells (Burleigh et al., 2011; Sanfeliu and Stephanopoulos, 1999). 
Excessive growth and glutamine degradation at the beginning of cultivation resulted in acidification 
of the culture medium and in ammonia accumulation. Both, high ammonia concentrations (Hassell 
et al., 1991; Kurano et al., 1990) and a low pH (Trummer et al., 2006) have been shown to inhibit 
growth. As a consequence culture longevity was compromised at high glutamine start levels. At 
lower glutamine start concentrations as well as in the 8 × 1 mM fed-batch cultivation, viability and 
pH dropped later and specific growth rates decreased less. Interestingly, we found a high and 
constant late specific growth rate for the glutamine-free cultivation. A previous study investigating 
CHO batch cultivations at 0 mM, 4 mM and 8 mM glutamine made a similar observation. In 
contrast to the glutamine supplemented cultures, they found a high and constant specific growth rate 
in the glutamine-free cultivation (Burleigh et al., 2011). Improved culture longevity at glutamine 
limiting conditions was observed by several groups (Sanfeliu and Stephanopoulos, 1999; Wong et 
al., 2005). Sanfeliu and Stephanopoulos found that glutamine limitation initiated a slower rate of 
cell cycling protecting the cells from entering apoptosis (Sanfeliu and Stephanopoulos, 1999). The 
high production of glycine and C1 units, two key metabolites of biomass synthesis, observed in 
glutamine limited cultures might also stimulate growth. Glycine synthesis has been strongly 
correlated with elevated proliferation rates in various cancer cells (Jain et al., 2012). As a result of 
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this improved culture longevity, highest viable cell densities were observed in glutamine limited 
cultivations, i.e. in the 1 mM batch and the 8 × 1 mM fed-batch cultivation. 
Varying glutamine availabilities trigger different cellular responses. We propose the following 
cellular mechanism to explain early and late effects of (a) glutamine abundance and (b) glutamine 
limitation on the growth behaviour of CHO cells (Figure 3-7): 
(a) When glutamine is abundant, growth is first stimulated. The growth stimulation is antagonized 
by increasing ammonia accumulation. Elevated ammonia concentrations lead to growth inhibition in 
later stages of the cultivation. (b) At complete glutamine limitation, the cells need time to adapt 
their metabolism towards glutamine synthesis resulting in an early growth inhibition. However, as 
proposed by Sanfeliu and Stephanopoulos, glutamine limitation inhibits the onset of apoptosis 
improving culture longevity (Sanfeliu and Stephanopoulos, 1999). In addition, glutamine limitation 
was accompanied by increased glycine production rates which might further support growth later in 
the cultivation. 
 
Figure 3-7. Cellular responses to ammonia stress and glutamine limitation. Three general conditions of 
glutamine availability triggering different cellular responses are described. Glutamine abundance (blue) 
results in ammonia stress. At severe glutamine limiting conditions (red) the cells need to synthesize 
glutamine. Mild glutamine limiting conditions (black) as a result of (i) controlled feeding or (ii) depletion 
after glutamine abundance or (iii) glutamine synthesis as response to severe glutamine limitation trigger the 
consumption of alternative carbon sources for compensation.  
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3.5.5 Glutamine feeding results in coupling to TCA cycle fluxes and decoupling 
from metabolic waste production eventually preventing cellular stress 
The identification of metabolic links between the glutamine metabolism and specific metabolic 
activities (Figure 3-5) revealed a direct connection between the glutamine supply and all metabolic 
waste producing reactions. Thus, high glutamine availability triggered the production and excretion 
of significant amounts of waste products. 
On the other hand, a high glutamine concentration was needed to create a link to the TCA cycle. 
The glutamate excretion partially prevented corresponding carbon input into the TCA cycle at lower 
glutamine concentrations. A substantial reflux from TCA cycle to glycolysis (OAA  PEP) 
additionally removed carbons from the TCA cycle. Interestingly, the pyruvate dehydrogenase 
reaction was completely decoupled from the glutamine input. In a previous study of CHO cells, a 
similar observation was made. The TCA cycle fluxes from AKG to OAA were influenced by the 
glutamine uptake, however, the TCA cycle fluxes from OAA to AKG were impaired because 
carbons were removed from the TCA cycle at the site of OAA (Burleigh et al., 2011). 
Controlled glutamine availability as achieved in fed-batch cultivations establishes a link between 
glutamine degradation and TCA cycle fluxes. A reduced glutamine supply decoupled the glutamine 
metabolism from glycolysis and waste producing pathways. By preventing an excessive glutamate 
excretion and reducing the carbon loss via the reflux from OAA to PEP the glutamine input is 
efficiently coupled to the glutamate dehydrogenase reaction and TCA cycle fluxes, eventually 
realizing moderate but stable TCA cycle activity. At the same time, cellular stress either due to 
excess glutamine supply resulting in ammonia accumulation or due to glutamine limitation is 
successfully avoided. 
In summary, we propose a dynamic metabolic flux analysis method that takes into account the 
dynamic changes of growth and metabolism, thus providing a more valid description of cellular 
physiology than stationary methods. The proposed methodology is well suited for future 
applications in biomedical research and development of bioprocesses. It can be applied in the 
screening of cell clones and selection of efficient producer strains as well as in testing different 
media and feeding profiles. Furthermore, the method can assist in characterizing physiological 
conditions and disease phenotypes. 
In this study, we investigated the impact of glutamine availability or limitation on the physiology of 
CHO-K1 cells. Varying glutamine availabilities resulted in global metabolic changes. We observed 
dose-dependent effects of glutamine in batch cultivation and an intermediate response with reduced 
waste product excretion in fed-batch cultivation. Identifying metabolic links from the glutamine 
metabolism to specific metabolic pathways, we could show that glutamine feeding results in 
decoupling from metabolic waste production and as a result in coupling to TCA cycle fluxes. In 
addition, we propose a mechanistic scheme explaining the cellular responses upon mild or severe 
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glutamine limitation and glutamine abundance and how these extreme situations are linked with 
each other. Flux rearrangements in the pyruvate and amino acid metabolism facilitate glutamine 
synthesis in the glutamine-free cultivation, compensate glutamine limitation by consumption of 
alternative carbon sources and mitigate ammonia stress as a result of glutamine abundance. 
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4 Perturbation of the mammalian pyruvate metabolism 
and resulting rearrangement of central metabolic fluxes 
in CHO cells 
4.1 Abstract 
Chinese hamster ovary (CHO) cells are famous for their extraordinary robustness and flexibility 
making them a popular industrial host cell line and mammalian model system. Cellular pyruvate 
metabolism represents the major metabolic hub bridging glycolysis with tricarboxylic acid (TCA) 
cycle. We perturbed its metabolism applying dichloroacetic acid (DCA) and -cyano-4-hydroxy-
cinnamic acid (CHC) to either stimulate or inhibit the flux of pyruvate into the TCA cycle. The 
response was analyzed using metabolic flux analysis. 
Inhibition or stimulation of pyruvate metabolism was successful at low CHC and DCA 
concentrations. However, high effector concentrations resulted in efficient metabolic compensation 
by readjustment of (1) the glutamate dehydrogenase/pyruvate dehydrogenase activity ratio, (2) the 
fluxes connecting C4 and C3 pools, and (3) feedback regulation of glycolysis. Efficient 
compensation of CHC and DCA effects was strictly dependent on glutamine availability. Glutamine 
depletion provoked emergence of the anticipated effects later in the cultivation.  
Growth and cellular energy state of CHO cells remained robust upon severe perturbation of the 
mitochondrial pyruvate metabolism due to efficient overcompensation. However, metabolic 
inhibition or stimulation (i) at low effector concentrations and (ii) at glutamine depletion 
demonstrates the cell’s limits of robustness. Knowing conditions of limited robustness helps to 
avoid undesired excursion of production processes. On the other hand, leading the cells into a 
susceptible state can be a powerful therapeutic strategy. 
 
This chapter is in preparation for submission 
Wahrheit J, Nonnenmacher Y, Nicolae A, Heinzle E. Perturbation of the Mammalian Pyruvate 
Metabolism and Resulting Rearrangement of Central Metabolic Fluxes in CHO Cells 
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4.2 Introduction 
Pyruvate (Pyr) represents a key branch point of the intermediary metabolism playing a pivotal role 
in several metabolic pathways (Modak et al., 2002; Zeng et al., 2002). As it is the end product of 
glycolysis and a major substrate for the tricarboxylic acid (TCA) cycle, alterations in the Pyr 
metabolism commonly lead to an impaired connection between these pathways. Such metabolic 
alterations have been associated with diabetes, cancer and other pathological states (Gray et al., 
2013; Hanahan and Weinberg, 2011; Kahn et al., 2006; Wu and Zhao, 2013). 
We investigate control of this major hub of the central metabolism by manipulating the 
mitochondrial Pyr metabolism of CHO-K1 cells in opposite directions. Two different biochemical 
inhibitors, with (a) an inhibiting and (b) a potentially stimulating effect, were applied (Figure 4-1). 
(a) The recently identified mitochondrial pyruvate carrier (MPC) (Bricker et al., 2012; Herzig et al., 
2012) was blocked by its specific inhibitor -cyano-4-hydroxy-cinnamic acid (CHC) (Halestrap, 
1975). (b) The pyruvate dehydrogenase (PDH) was indirectly stimulated by addition of 
dichloroacetic acid (DCA) (Sutendra and Michelakis, 2013). DCA is an established inhibitor of the 
PDH-inhibiting regulatory enzyme pyruvate dehydrogenase kinase (PDK). After application of 
CHC or DCA, the utilization of Pyr in the mitochondria, or in other words, the connection between 
glycolysis and TCA cycle, should be either inhibited or promoted, respectively. Both applied 
substances, CHC and DCA, have independently been proposed as promising anti-cancer agents 
(Kumar et al., 2013; Michelakis et al., 2008; Miranda-Goncalves et al., 2013). CHO cells share 
many common features with cancer cells and other pathologically impaired cells; amongst others 
these are: aerobic glycolysis (Warburg effect), increased glutaminolysis, chromosome instability 
leading to genetic heterogeneity, a fast (uncontrolled) proliferation, and most importantly an 
extreme robustness against internal and external perturbations (Altamirano et al., 2013). As 
demonstrated by their long history as mammalian model organism (Jayapal et al., 2007), they are a 
useful system to study general characteristics of this specific metabolic phenotype. Additionally, 
CHO cells are the most important cell factory in the industrial production of therapeutic proteins 
(Wurm, 2004). 
Biological systems are very robust against general perturbations but tend to be extremely vulnerable 
against certain specific perturbations (Kitano, 2004). Generally, robustness is achieved at the 
expense of reduced overall performance or of the emergence of fragility under certain conditions. 
The mammalian energy metabolism can be maintained by glycolysis or by oxidative 
phosphorylation. The balance between these pathways is adjusted according to available resources. 
A metabolic shift to aerobic glycolysis, as it occurs in many diseases, e.g. in cancer metabolism, 
demonstrates cellular robustness, however, at the cost of metabolic efficiency. 
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Our study aimed at analyzing the impact of CHC and DCA on growth and (energy) metabolism of 
CHO-K1 cells. We applied metabolic flux analysis (MFA) to investigate the implication of these 
metabolic perturbations on the intracellular metabolic flux distribution. The following questions 
were considered: (i) Are CHO-K1 cells able to cope with a significant perturbation of the cellular 
pyruvate metabolism? (ii) What are the means by which robustness is achieved, i.e. how do the cells 
compensate such perturbations? (iii) What are the limits of perturbation tolerated by the cells, i.e. 
under which conditions do the cells lose their robustness? Maintaining cellular robustness and 
metabolic efficiency is crucial for industrial processes. On the other hand, limited robustness can be 
desirable state to achieve when treating pathological conditions, e.g. cancer cells. Studying cellular 
robustness and its limits will help us understanding the control of a major metabolic branch point in 
the intermediary metabolism and guide design of medical therapies and efficient biotechnological 
production processes. 
Figure 4-1. Scheme of CHC and DCA effects on the 
pyruvate metabolism. Cytosolic pyruvate (PYRc) is 
transported into the mitochondrial matrix via the 
mitochondrial pyruvate carrier (MPC). Mitochondrial 
pyruvate (PYRm) is further converted into acetyl-CoA 
(AcCoA) via the pyruvate dehydrogenase (PDH) 
reaction. The PDH is inhibited by phosphorylation 
through the PDH kinase (PDK). Inhibition of the 
mitochondrial pyruvate metabolism is achieved by 
application of the specific MPC inhibitor -cyano-4-
hydroxy cinnamic acid (CHC). Stimulation of the 
mitochondrial pyruvate metabolism is achieved by 
inhibition of the PDK using dichloroacetic acid (DCA) 
 
4.3 Materials and methods 
4.3.1 Cell culture 
Cultivation of the CHO-K1 cells was performed in baffled shake flasks (250 ml, Corning, New 
York, USA) in a shaking incubator (Innova 4230, New Brunswick Scientific, Edison, NJ, USA) at 
135 rpm (2 inches orbit), 37°C and 5% CO2. The cells were cultivated in chemically defined, 
protein-free TC-42 medium (TeutoCell, Bielefeld, Germany), supplemented with 6 mM L-
glutamine (Sigma-Aldrich, Steinheim, Germany) from a 240 mM stock solution in dH2O. 
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4.3.2 Toxicity screening of -cyano-4-hydroxy cinnamic acid (CHC) and 
dichloroacetic acid (DCA) in CHO-K1 cells 
CHO-K1 cells in the early exponential phase were harvested by centrifugation (5 min, 125 × g, 
Labofuge 400R, Function Line, Heraeus Instruments, Hanau, Germany) and resuspended in TC-42 
medium (supplemented with 6 mM L-glutamine). The cell number was determined using an 
automated cell counter (Countess® Automated Cell Counter, Invitrogen, Karlsruhe, Germany) and 
set to 2 × 105 cells/ml. 100 µl of the cell suspension were transferred into the wells of a 96-well 
OxoPlate (PreSens, Regensburg, Germany). Tested substances -cyano-4-hydroxycinnamic acid 
(CHC) and dichloroacetic acid (DCA) have been added from 2-fold concentrated stock solutions 
resolved in TC-42 medium to obtain a final volume of 200 µl and a cell density of 1 × 105 cells/ml. 
Tested concentrations were in a range of 10 nM - 5 mM and 50 µM - 100 mM for CHC and DCA, 
respectively, prepared by serial dilution with TC-42 medium. Six replicates were carried out for 
each concentration. Since the 500 mM stock solution of CHC was prepared in DMSO, an additional 
control containing 1% DMSO was carried out, representing the highest DMSO concentration used 
in the screening of CHC. Dissolved oxygen concentration was monitored every 10 min for 70 h 
using a fluorescence reader with integrated incubation unit (FLUOstar, BMG Labtechnologies, 
Offenburg, Germany), placed in an airtight box at 5% CO2 and 37°C. Before each measurement, the 
plate was shaken for 300 s (140 rpm, 4 mm orbit) to prevent sedimentation of the cells. Every 24 h 
one of the replicates of each concentration was removed from the plate. 30 µl of each suspension 
were used immediately for determination of cell densities and cell viability using an automated cell 
counter (Countess® Automated Cell Counter, Invitrogen, Karlsruhe, Germany). The rest was 
centrifuged and the supernatants were frozen at -20°C for subsequent analysis. 
4.3.3 CHO-K1 cell cultivation during treatment with -cyano-4-hydroxy 
cinnamic acid (CHC) and dichloroacetic acid (DCA) 
CHO-K1 cells in the early exponential phase were harvested and resuspended in TC-42 medium 
containing selected concentrations of DCA or CHC. The cell number was determined using an 
automated cell counter (Countess® Automated Cell Counter, Invitrogen, Karlsruhe, Germany). The 
cells were seeded into 250 ml baffled shake flasks (Corning, New York, USA) to obtain a final 
volume of 100 ml TC-42 containing the selected concentrations of CHC (1 and 3 mM) or DCA (3, 5 
and 10 mM) and a viable cell density of 4 × 105 cells/ml. CHC was added from 100× stock solutions 
in DMSO, resulting in a DMSO concentration of 0.5% in every CHC-containing culture. A control 
cultivation containing the same concentration of DMSO (but no CHC) was also performed. The pH 
of all media was determined in advance and set to 7.8 by addition of 30% NaOH. The different 
media were sterile filtered prior to use (pore size: 0.2 µm). 
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Samples of 400 µl were taken every 24 hours. 30 µl were immediately used for the determination of 
growth parameters (cell densities, average cell diameter and viability). The rest of the sample was 
centrifuged (5 min, 6000 × g, Biofuge pico, Heraeus Instruments, Hanau, Germany) and 200 µl of 
the supernatant were frozen at -20°C for subsequent analysis. The remaining supernatant was used 
for determination of the pH value (pH-Meter, Mettler-Toledo, Giessen, Germany). 
4.3.4 Quantification of extracellular metabolites 
Quantification of glucose, organic acids and proteinogenic amino acids in supernatants were 
performed by HPLC as described previously (Strigun et al., 2011b). Since DCA co-eluted with 
glucose in the HPLC analysis, the glucose concentration in culture supernatants containing DCA 
was determined using a D-glucose UV assay kit (Roche, Darmstadt, Germany) according to kit 
instructions. 
4.3.5 Quantification of cellular ATP concentration 
Quantification of intracellular ATP in a luminometer (GloMax® 96 Microplate Luminometer, 
Promega Corporation, Madison, WI, USA) was performed using the CellTiter Glo® Luminescent 
Cell Viability Assay (Promega Corporation, Madison, WI, USA) according to kit instructions. 
4.3.6 Metabolic flux analysis 
Metabolic fluxes were calculated using Matlab R2012b (The Mathworks, Natick, MA, USA) 
applying stationary metabolic flux analysis using metabolite balancing as described in literature 
(Niklas and Heinzle, 2012; Niklas et al., 2011c). The stoichiometry of the applied metabolic 
network model is given as stoichiometric matrix in the supplementary material (Table S1 and Table 
S2). A scheme of the metabolic network model is depicted in Supplementary Figure S1. Fatty acids 
and storage carbohydrates composition of the cell was taken from Altamirano et al. (Altamirano et 
al., 2001b). The amino acid composition of proteins was determined as described previously (Niklas 
et al., 2009). The biomass composition can be found in the supplementary material (Table S3). 
Metabolic rates [mmol/(L × h)] were related to the cell volume. The average cell volume was 
estimated from the average cell diameter assuming a sphere. Differences of cell diameters during 
the cultivation and between different cultivations were very small (~3%) and not further considered. 
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4.4 Results and Discussion 
4.4.1 Determination of effective CHC and DCA concentrations 
A wide range of CHC and DCA concentrations was tested in terms of toxicity and influence on 
metabolism. We performed a toxicity screening in 96-well OxoPlates using respiration analysis and 
calculated EC50 values as described before (Niklas et al., 2009; Noor et al., 2009). After 70 h of 
cultivation, we determined EC50 values of 3.5 mM and 13 mM for CHC and DCA, respectively 
(supplementary Figure S2A and S2B). For both effectors, we observed an influence on extracellular 
pyruvate (Pyr) and lactate (Lac) compared to control cultivations at concentrations of 1 mM and 
above (supplementary Figure S2C to S2F). Based on these results, we selected effective 
concentrations of 1 mM (EC0.002) and 3 mM CHC (EC20) as well as 3 mM (EC0.04), 5 mM (EC0.6), 
and 10 mM DCA (EC20) for further studies. Selected concentrations were in a similar range as 
applied before in cell cultures (Lefort et al., 2013; McKenna et al., 2001; Simpson et al., 2006). 
4.4.2 Cultivation profiles of CHO-K1 cells with CHC or DCA treatment  
The growth and pH profiles, cellular ATP concentration over time as well as the profiles of selected 
extracellular metabolites are depicted in Figure 4-2. The complete set of measured extracellular 
metabolites can be found in the Supplementary Figures S3 and S4. 
The cells treated with 0.5% DMSO (solvent control) and 1 mM CHC showed a similar growth 
behavior to that of the control cultivation. However, the maximum viable cell density (VCD) 
reached during cultivation was reduced by 7% (DMSO) and 12% (1 mM CHC), respectively, 
compared to the control (20.5  106 cells/ml). At 3 mM CHC, growth was significantly slowed 
after 48 h of cultivation and reached a plateau maintaining a constant VCD after 96 h. The 
maximum VCD was decreased by 50% (Figure 4-2A). There was a slight tendency of faster growth 
on 3 mM DCA and slower growth on 10 mM DCA, however, growth was not significantly different 
to the control cultivation (Figure 4-2B). 
Three metabolic phases could be distinguished. The first metabolic phase was characterized by 
glutamine (Gln) consumption and Lac excretion and lasted from 0 to 72 h (phase I). The second 
phase from 72 to 120 h was initiated by Gln depletion and Lac reuptake (phase II). A shift from Lac 
production to consumption is a commonly observed characteristic of CHO cells (Martinez et al., 
2013; Wahrheit et al., 2014b; Zagari et al., 2013a). After 120 h the VCD decreased significantly 
(phase III). The most significant changes in the metabolite profile were observed for extracellular 
Pyr, Lac, and alanine (Ala) which are directly connected to the cellular Pyr metabolism. We 
observed a delayed Pyr uptake at 1 mM CHC. At 3 mM CHC, Pyr was even significantly excreted 
within the first 72 h and then consumed. Lac excretion was slightly delayed for 1 and 3 mM CHC 
(Figure 4-2A) and decreased significantly with increasing DCA concentrations (Figure 4-2B). At 
Chapter 4 Perturbation of the mammalian pyruvate metabolism 
 
95 
3 mM CHC, Lac excretion persisted in phase II and III thereby completely omitting the Lac shift. 
Compared to untreated control cultivations, the maximally reached Lac concentration was increased 
by 40% at 3 mM CHC treatment and reduced by 16%, 20% and 26% for 3, 5, and 10 mM DCA, 
respectively. The pH profile was correlated with the Lac profile. The culture pH decreased during 
Lac excretion and increased during Lac consumption. Accordingly, the pH decreased constantly at 
3 mM CHC (Figure 4-2A). Ala was initially excreted but consumed after 96 h. Ala excretion 
decreased with increasing CHC and DCA concentrations. At 3 mM CHC, Ala was not taken up at 
the end of the cultivation but constantly excreted. Glycine (Gly) excretion decreased dose-
dependently at DCA treatment and was clearly larger during the plateau phase at 3 mM CHC. 
Uptake of glucose (Glc) and serine (Ser) (Figure 4-2A) as well as of other amino acids was reduced 
at 3 mM CHC later in the cultivation matching the reduced growth (Supplementary Figure S3). 
The cellular ATP concentration increased dose-dependently upon DCA treatment within the first 
48 h of cultivation but was not significantly different from the control afterwards (Figure 4-2B). At 
3 mM CHC, the cellular ATP content was unchanged during the first 72 h of cultivation. It was, 
however, significantly reduced during the plateau phase starting at 96 h of cultivation (Figure 4-
2A). At a concentration of 1 mM CHC, ATP levels were not affected. 
While we observed mostly dose-dependent effects for the three DCA test concentrations, there was 
a prominent metabolic shift between the two CHC test cultivations. As is clearly evident from the 
profiles of pH, Lac, Pyr and Ala, the metabolic behavior was very different at low and high CHC 
concentrations. 
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Figure 4-2. Cultivation profiles of CHO-K1 cells upon treatment with CHC and DCA. (A) Cultivation 
profiles upon treatment with 1 mM and 3 mM CHC compared to control cultivations with 0.5% DMSO 
(CHC DMSO) and without CHC and DMSO (CHC control). (B) Cultivation profiles upon treatment with 
3 mM, 5 mM or 10 mM DCA compared to control cultivation without DCA (DCA control). Shown are total 
and viable cell densities [cells/ml], the pH profile, the cellular ATP concentration [fmol/cell] and selected 
extracellular metabolite concentrations [µmol/ml] over time [h]. Abbreviations: CHC -cyano-4-hydroxy 
cinnamic acid, DCA dichloroacetic acid, TCD total cell density, VCD viable cell density, Glc glucose, Lac 
lactate, Pyr pyruvate, for amino acids the standard three-letter code is used. Dashed lines indicate the 
different metabolic phases, phase I (0-72 h), phase II (72-120 h) and phase III (>120h). 
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4.4.3 Metabolic fluxes of CHO-K1 cells with CHC or DCA treatment  
Metabolic fluxes were calculated for the first (Figure 4-3A) and the second metabolic phases 
(Figure 4-3B). A scheme of the metabolic network illustrating the lumping of metabolites is 
depicted in Supplementary Figure S1. The complete set of calculated and measured metabolic 
fluxes can be found in the Supplementary Tables S4 and S5. The results of both experiments, (a) 
inhibition of the MPC by CHC (CHC Experiment) and (b) stimulation of the PDH by DCA (DCA 
Experiment), are presented in the same flux maps for better comparison. For the two control 
cultivations of both experiments without any addition of effectors, mean values with standard 
deviations are shown to reflect the normal metabolic variability between distinct biological 
experiments (Figure 4-3, white bar). 
The overall metabolic effects of DMSO in the applied low concentration were usually very small in 
both metabolic phases (Figure 4-3, black bar). In most cases, fluxes were not significantly different 
from control cultivations or are not expected to have a significant impact on overall metabolic flux 
distributions. DMSO effects did not cover effects of the CHC treatment and are therefore not further 
considered in the discussion. This was justified due to three reasons: (i) although relative differences 
might be large, the absolute differences were rather negligible, (ii) DMSO treatment changed the 
flux in the opposite direction as observed for CHC treatment, or (iii) the effect of CHC was 
substantially larger and could not be explained by DMSO treatment alone. 
4.4.3.1 Metabolic fluxes in the glutamine consumption phase (phase I) 
Glycolytic fluxes and Lac excretion were clearly reduced at DCA treatment (80-89% and 70-79%, 
respectively, relative to untreated control) (Figure 4-3A). Reduced glycolysis upon DCA treatment 
was also found in human fibroblasts (Simpson et al., 2006) and human breast cancer cell lines 
(Lefort et al., 2013). We determined lower glycolytic fluxes at 1 mM CHC (89%) but higher rates of 
Glc uptake (124%), glycolysis (127%) and Lac excretion (138%) at 3 mM CHC. Increased Glc 
uptake rates upon CHC treatment have been previously observed in astrocytes (McKenna et al., 
2001). The Pyr uptake rate increased dose-dependently in DCA-treated cells to 122%, 124% and 
128% for 3, 5 and 10 mM DCA, respectively. In contrast, Pyr uptake was significantly reduced to 
36% at 1 mM CHC. Pyr was even excreted in substantial amounts at 3 mM CHC (Figure 4-3A). 
This points to an accumulation of cytosolic Pyr due to block of the Pyr transport into the 
mitochondria. PDH and TCA cycle fluxes were significantly reduced at 1 mM CHC (52-65%) and 
10 mM DCA treatment (62-75%). In contrast, these fluxes increased to 109-122% of the control at 
3 mM CHC (Figure 4-3A). The reflux from TCA cycle to glycolysis, represented by the cataplerotic 
flux connecting malate (Mal) (C4) and Pyr (C3) pools (see Supplementary Figure S1), was 
increased to 130% at 3 mM CHC treatment and reduced to 68-85% in DCA-treated cells. 
Ser synthesis increased in a dose-dependent manner both upon DCA (105-144%) and CHC 
treatment (147-154%) as indicated by a negative flux from Ser to the C3 pool represented by Pyr 
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(see supplementary Figure S1). Increased Ser production rates were accompanied by reduced Ser 
uptake rates (80-91%) (Figure 4-3A). Similarly, Ala production decreased to 87% and 41% for 1 
and 3 mM CHC, respectively, and by 11-20% in DCA-treated cells (Figure 4-3A). The glutamate 
dehydrogenase (GDH) flux to -ketoglutarate (AKG) increased dose-dependently with increasing 
CHC concentrations (112% and 247% for 1 and 3 mM CHC) and decreased dose-dependently with 
increasing DCA concentrations (80%, 71%, and 29% for 3, 5 and 10 mM DCA, respectively) 
(Figure 4-3A). Gln consumption rates were accordingly higher at CHC treatment and lower at DCA 
treatment compared to control cultivations. The aspartate aminotransferase (ASAT) reaction feeding 
carbons of aspartate (Asp) and asparagine (Asn) into the TCA cycle decreased dose-dependently 
with increasing CHC (82% and 60% for 1 and 3 mM CHC) and also with increasing DCA 
concentrations (88%, 71%, and 20% for 3, 5, and 10 mM DCA). Accordingly, Asn and Asp uptake 
rates were largely reduced in a dose-dependent manner with increasing CHC and DCA 
concentrations (Figure 4-3A). Furthermore, catabolic reactions of branched chain amino acids 
(BCAA) were significantly reduced upon CHC and even more at DCA treatment. 
 
Figure 4-3. Flux maps of CHO-K1 upon treatment with CHC and DCA. (A) Metabolic fluxes in the 
glutamine consumption phase (phase I, 0 – 72 h). (B) Metabolic fluxes in the glutamine depletion phase 
(phase II, 72 – 120 h). Shown are the metabolic rates related to the cell volume [mmol/(Lh)] for CHO-K1 
cells upon treatment with 1 mM and 3 mM CHC and upon treatment with 3 mM, 5 mM or 10 mM DCA. 
For the control cultivation without any addition of effectors, mean values with standard deviations of two 
biological replicates are shown. Since the CHC stock solution was resolved in DMSO, a solvent-control 
cultivation with identical DMSO concentration but without CHC is shown for comparison (DMSO). 
Extracellular metabolites are highlighted in black boxes, intracellular metabolites in grey ones. 
Abbreviations: CHC -cyano-4-hydroxy cinnamic acid, DCA dichloroacetic acid, GLC glucose 
(representing the lumped C6 metabolite pools glucose-6-phosphate, G6P, and fructose-6-phosphate, F6P), 
GAP glyceraldehyde-3-phosphate (representing also dihydroxyacetone phosphate, DHAP), PYR pyruvate 
(representing also the lumped C3 metabolite pools of 1,3-bisphosphoglycerate, 1,3-PG, 3-phosphoglycerate, 
3-PG, and phosphoenolpyruvate PEP), LAC lactate, AcCoA acetyl-CoA, AKG -ketoglutarate 
(representing also citrate, CIT), MAL malate (representing also the lumped C4 metabolite pools of 
succinate SUC, fumarate FUM, and oxaloacetate OAA), BCAA branched chain amino acids (summed up 
fluxes of LEU, ILE, and VAL that are degraded to TCA cycle intermediates acetyl-CoA and succinyl-CoA 
and consume AKG in the transamination reactions), for amino acids, the standard three-letter code is used. 
Negative values indicate fluxes in the opposite direction of the arrow. A negative flux from serine to 
pyruvate indicates serine synthesis from 3-PG. The flux from malate to pyruvate represents the lumped 
cataplerotic reflux from TCA cycle to glycolysis via metabolic reactions connecting C3 and C4 pools. 
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4.4.3.1 Metabolic fluxes in the glutamine depletion phase (phase II) 
Glc uptake rates increased dose-dependently with increasing DCA concentration (87%, 111%, and 
130% for 3, 5, and 10 mM DCA) and decreased dose-dependently with increasing CHC 
concentration (96% and 78% for 1 and 3 mM CHC) (Figure 4-3B). Lac consumption was reduced at 
1 mM CHC treatment (66% of the control) and in DCA-treated cells (66-86% of the control). In 
contrast, Lac excretion persisted in phase II at 3 mM CHC (Figure 4-3B). In phase II, CHC 
treatment increased the Pyr uptake rate (123-212%) while DCA treatment reduced it (75-94%) 
(Figure 4-3B). Similar to the glycolytic fluxes, PDH and TCA cycle fluxes increased dose-
dependently with increasing DCA concentration (82%, 105%, and 117% for 3, 5, and 10 mM DCA) 
and decreased dose-dependently with increasing CHC concentration (95% and 30% for 1 and 3 mM 
CHC). The cataplerotic flux from Mal to the Pyr pool was negligible for the control cultivations and 
DCA-treated cultivations. However, this flux was active at CHC treatment (Figure 4-3B). 
Ser uptake and Gly production rates were elevated upon CHC treatment and significantly reduced in 
DCA-treated cells (Figure 4-3B). Ala production was lower at CHC and DCA treatment compared 
to untreated control. Gln depletion resulted in a reversed GDH flux for control cultivations and 
DCA-treated cells. Upon CHC treatment, GDH was still feeding into the TCA cycle. Catabolism of 
Asn and Asp increased with increasing CHC concentration. BCAA degradation was only 
significantly increased at 1 mM CHC. Anaplerotic fluxes from Asp and BCAA into the TCA cycle 
were very small for DCA-treated cultivations. 
4.4.3.2 Specific metabolic flux ratios indicate metabolic efficiency 
In phase I, the Lac/Glc ratio (LACexLACin/GLCexGLCin) was higher upon CHC treatment 
(122% and 111%, for 1 and 3 mM CHC) but lower at DCA treatment (81%, 88% and 98% for 3, 5, 
and 10 mM DCA), relative to the ratio of -1.07 in the control experiment (Figure 4-4A). This 
indicates more carbon spilling by Lac excretion in CHC-treated but less in DCA-treated cells. In 
phase II, the Lac/Glc ratio was negative for the 3 mM CHC cultivation due to persistent carbon 
spilling (Figure 4-4D). Positive ratios for all other cultivations indicate simultaneous utilization of 
Glc and Lac as carbon sources as observed before in this CHO-K1 cell line (Wahrheit et al., 2014b). 
Significantly lower values for 1 mM CHC and DCA-treated cells compared to the control (55-77%) 
indicate a lower significance of Lac as substrate compared to the control (Figure 4-4D). 
The TCA cycle/glycolysis ratio (OAACIT/F6PGAP) (Wahrheit et al., 2014b) was significantly 
reduced to 59% at 1 mM CHC but restored to 91% at 3 mM CHC (Figure 4-4B) in phase I. We 
determined higher ratios for 3 and 5 mM DCA (122% and 108%, respectively) but a lower ratio at 
10 mM DCA (78%). Higher ratios indicate an enhanced connectivity between glycolysis and TCA 
cycle and a more efficient metabolism of glucose and other glycolytic substrates (Wahrheit et al., 
2014b). In phase II, the ratio was significantly reduced upon 3 mM CHC treatment but in a similar 
range for all other cultivations. 
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The glutamate dehydrogenase/pyruvate dehydrogenase (GDH/PDH) ratio (GLUAKG/ 
PYRAcCoA) describes the relative contribution of AKG and acetyl-CoA in fueling the TCA 
cycle. The relative contribution of AKG as TCA cycle substrate increased with increasing CHC 
concentrations but decreased with increasing DCA concentrations in phase I (Figure 4-4C). In phase 
II, the GDH/PDH ratio was still significant for 3 mM CHC, however, negligibly small for the other 
cultivations (Figure 4-4F). 
 
Figure 4-4. Influence of CHC and DCA on specific metabolic flux ratios. Specific metabolic flux ratios 
[mol/mol] are shown for phase I from 0 to 72 h (top, A-C) and phase II from 72 to 120 h (bottom, D-F). (A) 
and (D) The lactate/glucose ratio was calculated as the ratio between lactate uptake and glucose uptake 
(LACexLACin/GLCexGLCin). A negative ratio indicates lactate excretion. (B) and (E) The TCA cycle 
activity relative to the glycolytic activity was calculated as the ratio between the citrate synthase flux 
(OAACIT) and the phosphofructokinase flux (F6PGAP). (C) and (F) The relative contribution of 
AcCoA and AKG in fueling the TCA cycle was calculated as the ratio between the glutamate 
dehydrogenase flux from GLU to AKG (GLUAKG) and the pyruvate dehydrogenase flux 
(PYRAcCoA) (GDH/PDH ratio). A negative ratio indicates net flux from AKG to GLU. 
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4.4.4 Robustness and susceptibility towards perturbations of the cellular 
pyruvate metabolism in CHO-K1 cells 
In the present study, the cellular Pyr metabolism was investigated by perturbation with two different 
biochemical effectors, CHC and DCA. CHC blocks the mitochondrial pyruvate carrier (MPC) 
(Halestrap, 1975). It should therefore result in (i) an impaired connectivity between glycolysis and 
TCA cycle with reduced Glc oxidation and (ii) a relative shortage of Pyr in the mitochondria. The 
most prominent effect of DCA is PDH stimulation by inhibition of the pyruvate dehydrogenase 
kinase (PDK). However, DCA is expected to show an effect only if the MPC is not the limiting step. 
If the MPC activity limits the mitochondrial availability of Pyr, DCA will not increase the flux into 
the TCA cycle. Furthermore, DCA and its potential metabolites (e.g. oxalate, glycolate, glyoxylate) 
exert multiple, partially even opposite, effects on the cellular metabolism (Crabb et al., 1981; 
Stacpoole, 1989). Nevertheless, PDH stimulation by DCA as predominant effect can theoretically 
result in (i) indirect stimulation of the PDH flux, (ii) higher availability of acetyl-CoA feeding the 
TCA cycle and eventually (iii) an improved connectivity between glycolysis and TCA cycle with a 
shift from Lac production to Glc oxidation. 
4.4.4.1 Susceptibility to low effector concentrations of CHC and DCA  
The direct effects of CHC and DCA on the cellular Pyr metabolism are best evidenced by the 
extracellular Pyr rates and Lac/Glc ratios. Increased Pyr uptake rates (122-128%) (Figure 4-5C and 
D) in combination with reduced Lac/Glc ratios (81-98%) (Figure 4-4) clearly indicate an improved 
metabolization of cellular Pyr at DCA treatment. Upon CHC treatment on the other hand, an 
impaired Pyr metabolization was obvious from a switch to reduced Pyr uptake (36%) or even Pyr 
excretion (Figure 4-5A and B) and from higher Lac/Glc ratios (111-122%) (Figure 4-4). 
Surprisingly, further effects of CHC and DCA on the central metabolism (see above) were only 
evident at low effector concentrations. At 1 mM CHC, expected impaired Glc oxidation resulted in 
increased Lac excretion rates and reduced glycolytic fluxes (Figure 4-5B). The relative shortage of 
mitochondrial Pyr further led to substantially decreased PDH and TCA cycle fluxes (52-65%). An 
impaired connectivity between glycolysis and TCA cycle and concomitant increased overflow 
metabolism was also illustrated by a significantly lower TCA cycle/glycolysis ratio (59%) (Figure 
4-4B) and a higher Lac/Glc ratio (122%) (Figure 4-4A). Although the energy generation from TCA 
cycle was severely impaired at 1 mM CHC (Figure 4-6A) this was not reflected in growth and 
cellular ATP levels which remained almost unaffected (Figure 4-2A and 4-6C). This indicates that 
the remaining TCA cycle activity was sufficient to meet the cellular energy demand. In phase II, the 
central metabolism had completely recovered its functionality suggesting that the MPC-inhibiting 
effect of CHC ceased after 72 h for 1 mM CHC (Figure 4-5F and 4-6B). 
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At 3 mM DCA treatment, PDH and TCA cycle fluxes were slightly increased (Figure 4-5C). The 
lower Lac/Glc ratio (81%) (Figure 4-4A) and higher TCA cycle/glycolysis ratio (122%) (Figure 4-
4B) clearly demonstrate efficient flux redistribution from Lac production to oxidative 
decarboxylation of Pyr as expected at DCA treatment. A dose-dependent increase of cellular ATP 
levels within the first 48 h of cultivation was in agreement with the expected DCA effect in terms of 
PDH and TCA cycle stimulation (Figure 4-2B and 4-6C). This short-term response of elevated ATP 
levels is in accordance with reported fast mode of action of DCA (Simpson et al., 2006). 
 
Figure 4-5. Summary of CHC and DCA effects in different metabolic phases. Specific metabolic 
effects of low and high concentrations of CHC (1 mM and 3 mM CHC, left) and DCA (3 mM and 10 mM 
DCA, right) in metabolic phases of glutamine consumption (phase I, top) and glutamine depletion (phase II, 
bottom). The arrow thickness is proportional to the flux strength relative to the respective glucose uptake 
flux (100%) as indicated in the legend. The arrow color indicates the flux strength relative to the respective 
untreated control cultivations (100%). 
4.4.4.2 Overcompensation of CHC and DCA effects shows robustness towards 
elevated effector concentrations 
Unexpectedly, higher CHC and DCA doses did not result in an extrapolation of the effects observed 
at low effector concentrations. At 3 mM CHC, PDH and TCA cycle activities were completely 
restored and even increased compared to the untreated control (Figure 4-5A). The Lac/Glc ratio 
(111%) and TCA cycle/glycolysis ratio (91%) were closer to control values at 3 mM CHC as well 
(Figure 4-4A and 4-4B). In phase I, cellular ATP levels were not affected (Figure 4-2A and 4-6C) 
and ATP production rates were even increased by 17% (Figure 4-6A) at 3 mM CHC. At higher 
concentration of CHC, the cells respond to a block of the MPC by initiation of a series of 
compensation mechanisms which all aim at increasing the TCA cycle activity and eventually the 
cellular energy status. This is attained by the combination of three complementing strategies: (1) 
Feeding of the AKG pool to fuel the TCA cycle is achieved by (i) stimulation of glutaminolysis and 
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a large increase of the GDH flux (Glu  AKG) (Figure 4-5A and 4-5B), (ii) reduced ASAT activity 
(Asp + AKG  OAA + Glu), and (iii) reduced catabolism of BCAA (BCAA + AKG  acetyl-
CoA/succinyl-CoA + Glu) (Figure 4-3A). (2) Feeding of the mitochondrial Pyr pool is 
accomplished by (i) reduced Ala production and (ii) an increased cataplerotic flux from Mal to Pyr 
pools (Figure 4-5A). (3) Well-known up-regulation of glycolytic fluxes by feedback mechanisms 
(e.g. via AMP and citrate levels) (Michal and Schomburg, 2012) additionally contribute 
significantly to maintain a high ATP production (Figure 4-5A). This requires an increased Lac 
production to maintain the redox balance by regenerating NAD+ (Figure 4-5A). The combined 
interplay of these overcompensating flux rearrangements efficiently restores the cellular energy 
metabolism at 3 mM CHC (Figure 4-5A). 
At DCA treatment, PDH and TCA cycle fluxes as well as the TCA cycle/glycolysis ratio decreased 
dose-dependently with increasing DCA levels (Figure 4-3A and 4-4B). Especially at high DCA 
concentrations, aforementioned potential side effects of DCA, e.g. competitive inhibition of MPC, 
might contribute to reduced PDH and TCA cycle fluxes (Crabb et al., 1981; Stacpoole, 1989). 
However, the short-term dose-dependent increase of cellular ATP levels within the first 48 h of 
cultivation clearly proves the fast stimulating effect of DCA (Figure 4-2B and 4-6C) (Simpson et 
al., 2006). On the other hand, restored cellular ATP levels after 48 h demonstrate a complete 
reversal of the initial DCA effects by metabolic adaptation (Figure 4-2B). The absence of significant 
and lasting metabolic stimulation by DCA indicates a limitation of respiratory capacity or 
mitochondrial pyruvate import via MPC. A dose-dependent increase of average cellular ATP levels 
(Figure 4-6C) was accompanied by a dose-dependent decrease in ATP production rates (Figure 4-
6A). It is well established, that glycolysis and TCA cycle are very strictly regulated by the cellular 
redox and energy state and down-regulated at high ATP levels (Michal and Schomburg, 2012). 
Interestingly, we observed adaptation of the same metabolic key reactions as for compensation of 
CHC effects, however, in the opposite direction. Down-regulation of PDH and TCA cycle fluxes 
during DCA application was achieved by (1) dose-dependent decrease of the GDH flux, (2) reduced 
flux from Mal (C4) to Pyr (C3) pools, and (3) down-regulation of glycolysis (Figure 4-5C and 4-
5D). 
Simpson et al. showed that human fibroblasts maintain normal cellular ATP/ADP levels despite 
reduced glycolytic rates at DCA treatment. This indicates improved metabolic efficiency by 
promoting glucose oxidation (Simpson et al., 2006). Lefort et al. profiled the extra- and intracellular 
metabolome in different human breast cell lines. They found that DCA-induced changes were only 
observed in the exometabolome while the cells efficiently maintained their normal intracellular state 
(Lefort et al., 2013). Both studies demonstrate an efficient intracellular compensation of DCA 
effects. For some metabolic pathways, CHC and DCA treatment led to similar metabolic responses. 
Reduced degradation of Asp, Asn and BCAA in DCA-treated cultures most likely represents a 
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secondary effect of the lower TCA cycle fluxes induced by compensation as proposed previously 
(Lefort et al., 2013). 
  
Figure 4-6. Effect of CHC and DCA on cellular ATP production and cellular ATP content. (A) and 
(B) ATP production rates [mmol/(L cell × h)] with relative contribution of glycolysis, TCA cycle and 
amino acid metabolism in growth phases I and II. ATP production rates were calculated considering P/O 
ratios of 2.5 for NADH and 1.5 for FADH2. (C) and (D) Cellular ATP content [mmol/L cell] for phases I 
and II. Abbreviations: CON control without any effector (n = 2); DMSO control with 0.5% DMSO; CHC 1 
and CHC 3 cultivation with 1 mM or 3 mM CHC; DCA 3, DCA 5 and DCA 10 cultivation with 3 mM, 5 
mM or 10 mM DCA.  
4.4.4.3 Emergence of CHC and DCA effects after glutamine depletion shows 
trade-off with resource demands 
The compensation of CHC and DCA effects depended on Gln availability. In phase I, the cells were 
able to maintain their physiological function despite the presence of high effector concentrations 
imposing substantial stress. After Gln depletion in phase II, however, the anticipated metabolic 
effects, impaired TCA cycle activity at CHC- and promoted TCA cycle activity at DCA-treatment, 
reappeared (Figure 4-5E and 4-5H). 
The mitochondrial Pyr availability induced an instantaneous adaptation of TCA cycle fluxes by 
variation of the GDH flux. This is clearly demonstrated by the GDH/PDH ratio (Figure 4-4C). The 
GDH/PDH ratio increased with increasing CHC concentration, i.e. increasing inhibition of Pyr 
import. On the other hand, it decreased with increasing DCA concentration, i.e. increasing 
decarboxylation of Pyr. In other words, an impaired or improved supply of carbons at the site of Pyr 
was offset by an increased or decreased carbon entry into the TCA cycle at the site of AKG derived 
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mainly from Gln. Therefore, increased glutaminolysis represented an essential adjustment to 
mitigate the effects of CHC and DCA. 
At Gln depletion, we observed increased catabolism of Asn and Asp as well as a switch from Pyr 
excretion to Pyr uptake at 3 mM CHC. In addition, the cataplerotic flux from Mal to Pyr pools was 
significantly higher at CHC treatment. These modifications were, however, not sufficient. As a 
result, PDH and TCA cycle fluxes were dramatically reduced at 3 mM CHC treatment in phase II 
(29-31%) (Figure 4-5E). Growth and cellular ATP content were significantly impaired (Figure 4-2A 
and 4-6D). The cells were able to maintain viability but at a largely reduced cellular performance. 
Thus, the successful compensation of CHC-induced TCA cycle impairment was strictly Gln-
dependent. 
After Gln depletion, the TCA cycle was strongly supported by Lac-derived Pyr in control 
cultivations and also but to a lesser extent at 1 mM CHC. At 3 mM CHC, MPC-inhibition prevented 
an efficient utilization of Pyr. Due to an impaired connection between glycolysis and TCA cycle 
(TCA cycle/glycolysis ratio was 36% of control; Figure 4-4E), the cells relied (i) on glycolysis as 
major ATP source and (ii) on the regeneration of NAD+ by Lac formation. Consequently, Lac 
excretion persisted at 3 mM CHC treatment (Figure 4-5E). 
Interestingly, also the compensation of DCA effects appears to be Gln-dependent (Figure 4-5H). 
Although glycolytic, PDH, and TCA cycle fluxes were slightly decreased at 3 mM DCA compared 
to the control, these fluxes increased with increasing DCA concentrations (Figure 4-3B). The two 
major fluxes influencing the TCA cycle carbon input, namely the cataplerotic flux from Mal to Pyr 
pools and the anaplerotic flux from Gln/Glu to AKG, were either not active or working in the 
opposite direction (Figure 4-5G and 4-5H). In a recent study, we have shown that these fluxes are 
directly correlated with the extracellular Gln flux (Wahrheit et al., 2014a). The manifestation of 
DCA effects at higher concentrations later in the cultivation (Figure 4-5H) might also be the 
consequence of a stabilization and resulting reduced turnover of the PDH complex (Michelakis et 
al., 2008; Simpson et al., 2006; Stacpoole et al., 1983; Stacpoole et al., 1978). 
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4.5 Conclusions and future directions 
The extraordinary robustness and flexibility of CHO cells have substantially contributed to their 
success and popularity as working horse of industrial production and mammalian model system 
(Altamirano et al., 2013; Jayapal et al., 2007; Kildegaard et al., 2013). These features allow a 
reproducible cultivation and easy adaptation of CHO cells to changing environmental conditions. 
On the other hand, an extreme robustness and adaptive compensation mechanisms limit the 
potential of improving cellular performance. A better understanding of cellular adaptation and 
metabolic compensation mechanisms can help to develop new ideas and strategies for increasing 
productivity or identifying therapeutic targets. 
We have shown that CHO-K1 cells can effectively cope with a severe perturbation of cellular Pyr 
metabolism. In the case of MPC inhibition by CHC, they can rapidly activate tailored compensation 
mechanisms that enable the successful restoration of a functional central metabolism and 
physiological energy state. On the other hand, a stimulation of mitochondrial metabolism by DCA is 
only achieved for a very short-term and quickly compensated by down-regulation of the same 
metabolic modules. The compensation of DCA effects most likely aims at avoiding energy spilling 
and preventing oxidative stress that mostly results from increased respiratory chain activity. The 
modules that are adjusted in order to increase or decrease the cellular energy state to physiological 
levels are: (1) readjustment of the GDH/PDH ratio according to Pyr availability, (2) up- or down-
regulation of the fluxes connecting C4 and C3 pools (MAL  PYR), and (3) feedback regulation of 
glycolysis. 
In a recent study, we identified Pyr and Gln as the most important carbon sources fueling the TCA 
cycle in the used CHO-K1 cell line. We demonstrated that a tailored up- and down-regulation of 
aminotransferases and anaplerotic enzymes compensate an unbalanced supply of these two 
substrates to maintain TCA cycle activity (Nicolae et al., 2014b; Wahrheit et al., 2014b). In further 
studies investigating the metabolic implications of different Gln availabilities, we found that low 
Gln availability is compensated by increased Pyr feeding into the TCA cycle (Nicolae et al., 2014b; 
Wahrheit et al., 2014a). Here, we show that a decrease or increase in the PDH flux is offset by 
increased or decreased glutaminolytic rates feeding the AKG pools, respectively. 
Feeding of the TCA cycle by Gln and Pyr working as independent, alternative modules represents a 
“fail-safe” mechanism in a wide range of situations (Kitano, 2004). The system behaves robust at 
high effector concentrations due to available parallel modules (Pyr and Gln) with their redundant 
function of TCA cycle feeding and due to full activation of compensation mechanisms. 
However, we identified two scenarios where the robustness of the system was partially lost. The 
system has been shown to be highly robust towards failure of one module, either Pyr or Gln 
(Wahrheit et al., 2014a). However, the system collapsed at the failure of both modules, namely 
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CHC treatment at Gln depletion. A carbon shortage at both entry sites of the TCA cycle, Pyr and 
Gln, could not be compensated by the cell, thus leading to impaired culture performance, reduced 
energy levels, and growth arrest. Extreme susceptibility in the face of unexpected perturbations is an 
inherent property of highly robust systems (Kitano, 2004; Kitano, 2007; Whitacre, 2012). We 
conclude that a successful manipulation of an extremely robust biological system like CHO cells 
might be feasible if two modules that are able to compensate each other are manipulated 
simultaneously. 
Furthermore, it has been described that a system is more vulnerable when a module behaves in an 
inappropriate way than when a module is completely removed (Kitano, 2004). This might explain 
that the central carbon metabolism showed to be susceptible to low rather than to high CHC and 
DCA concentrations. Gradually increasing the dose of an effector like often applied when setting a 
patient’s medication might be a useful approach to avoid overcompensation and allow a slow 
adaptation to the desired phenotype. 
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5 Non-stationary 13C metabolic flux analysis of Chinese 
hamster ovary cells in batch culture using extracellular 
labeling highlights metabolic reversibility and 
compartmentation 
5.1 Abstract 
Background Mapping the intracellular fluxes for established mammalian cell lines becomes 
increasingly important for scientific and economic reasons. However, this is being hampered by the 
high complexity of metabolic networks, particularly concerning compartmentation. 
Results Intracellular fluxes of the CHO-K1 cell line central carbon metabolism were successfully 
determined for a complex network using non-stationary 13C metabolic flux analysis. Mass 
isotopomers of extracellular metabolites were determined using [U-13C6] glucose as labeled 
substrate. Metabolic compartmentation and extracellular transport reversibility proved essential to 
successfully reproduce the dynamics of the labeling patterns. Alanine and pyruvate reversibility 
changed dynamically even if their net production fluxes remained constant. Cataplerotic fluxes of 
cytosolic phosphoenolpyruvate carboxykinase and mitochondrial malic enzyme and pyruvate 
carboxylase were successfully determined. Glycolytic pyruvate channeling to lactate was modeled 
by including a separate pyruvate pool. In the exponential growth phase, alanine, glycine and 
glutamate were excreted, and glutamine, aspartate, asparagine and serine were taken up; however, 
all these amino acids except asparagine were exchanged reversibly with the media. High fluxes 
were determined in the pentose phosphate pathway and the TCA cycle. The latter was fueled mainly 
by glucose but also by amino acid catabolism. 
Conclusions The CHO-K1 central metabolism in controlled batch culture proves to be robust. It has 
the main purpose to ensure fast growth on a mixture of substrates and also to mitigate oxidative 
stress. It achieves this by using compartmentation to control NADPH and NADH availability and by 
simultaneous synthesis and catabolism of amino acids. 
 
This chapter was published as 
Nicolae A, Wahrheit J, Bahnemann J, Zeng A-P, Heinzle E. Non-stationary 13C metabolic flux 
analysis of Chinese hamster ovary cells in batch culture using extracellular labeling highlights 
metabolic reversibility and compartmentation. BMC Systems Biology. 8, 50 
Chapter 5 Non-stationary 13C MFA highlights metabolic reversibility and compartmentation 
 
112 
5.2 Introduction 
Economic importance and ease of cultivation make CHO cells a desirable candidate for metabolic 
studies in eukaryotic systems. Alongside with being the most important mammalian cell line for 
producing biopharmaceuticals (Butler and Meneses-Acosta, 2012; Kim et al., 2012; Walsh, 2010a), 
CHO cells are able to grow in suspension cultures using chemically defined media (Deshpande et 
al., 2009), use multiple carbon sources simultaneously and maintain a stable metabolism for long 
periods in batch cultivations. This has led to a wealth of studies aimed at exploring CHO 
metabolism. After the decoding of the CHO-K1 cell line genome (Brinkrolf et al., 2013; Xu et al., 
2011) and transcriptome (Becker et al., 2011), we can expect such studies to increase both in 
number and complexity. Metabolic flux analysis (MFA) of CHO cell cultures evolved from flux 
balancing analysis (Altamirano et al., 2001b) to more complex metabolic or isotopomer dynamic 
models (Ahn and Antoniewicz, 2012). Newer studies rely on 13C-MFA applied by fitting the 
summed fractional labeling (Ahn and Antoniewicz, 2011) or by fitting steady-state labeling data 
(Templeton et al., 2013) resulted from using in parallel more labeled substrates for determining the 
intracellular fluxes at metabolic steady state in different growth phases. However, the labeling 
patterns of the intracellular metabolites or of amino acids from hydrolyzed proteins that are usually 
needed for non-stationary 13C-MFA are obtained through a tedious methodology (Zamboni, 2011; 
Zamboni et al., 2009) and are susceptible to errors stemming mostly from the quenching/extraction 
phase (Dietmair et al., 2010; Wahrheit and Heinzle, 2013). In the absence of metabolite exchange 
with the media, intracellular labeling would reach steady state relatively fast, in the order of minutes 
for glycolytic intermediates and few hours for TCA cycle metabolites, as it was determined in 
Pichia pastoris (Jorda et al., 2013). In mammalian cells, exchange with the extracellular pools 
(Divakaruni and Murphy, 2012) delays the intracellular isotopic steady state usually beyond the 
possibility to maintain metabolic steady state. Due to the large extracellular pools of amino acids, 
their exchange will transfer the time constant of the extracellular labeling process, which is in the 
order of days, to the intracellular labeling. One option is to use isotopic non-stationary metabolic 
flux analysis (INST-13CMFA) applied at short time scales (Nöh et al., 2007), but this approach has 
the drawback of requiring accurate determination of intracellular concentrations of metabolites (Nöh 
et al., 2006). 
Metabolite and reaction compartmentation is important for a realistic representation of the 
mammalian cell metabolism, but determining it raises supplementary demands from the 
experimental and modeling procedures, as we have already reviewed in (Wahrheit et al., 2011). In 
the exponential growth phase, a typical culture of CHO is characterized by high uptake rates of 
glucose and glutamine, the Warburg effect and the exchange of non-essential amino acids with the 
extracellular media (Deshpande et al., 2009; Provost et al., 2006). We can expect that by feeding a 
13C labeled substrate, some of the extracellular metabolites will exhibit labeling patterns that can 
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then be detected using GC-MS. As these metabolites will be enriched in 13C dynamically, non-
stationary 13C metabolic flux analysis (INST-13CMFA) applied to extracellular and intracellular 
isotopomers (Becker et al., 2011; Noack et al., 2011; Nöh et al., 2006) provides a suitable 
framework to determine the intracellular fluxes. Extracellular pools have a large time scale for 
labeling (hours) compared to the intracellular pools (seconds/minutes), thus removing the need to 
sample intracellular pools provided that the labeling information in the extracellular metabolites is 
sufficient. 
We show that by using only the labeling patterns of extracellular metabolites produced by feeding 
[U-13C6]glucose as the only labeled substrate, intracellular fluxes can be successfully determined in 
a complex, compartmented metabolic network of the CHO-K1 cell line. In parallel, we prove that a 
simplified, non-compartmented model is not sufficient for describing the metabolism. We also 
underline the importance of considering reversibility when dealing with non-stationary isotopomer 
models. 
5.3 Methods 
5.3.1 Cell culture and experimental set-up 
The CHO-K1 cell line was kindly provided by the Institute of Cell Culture Technology (University 
Bielefeld, AG Noll, Germany). The cells were growing in suspension under serum and protein free 
conditions in the chemically defined medium TC-42 (TeutoCell AG, Bielefeld, Germany) 
supplemented with 4 mM L-glutamine (PAA, Germany). Precultures were cultivated in 125 mL 
baffled Erlenmeyer flasks (Corning Inc., Germany) at an initial cell density of 0.4 × 106 cells/mL 
and a working volume of 50 mL on a shaking device (225 rpm) at 37°C and 5% CO2 in a humid 
atmosphere. For the main cultivation, cells were harvested during the exponential growth phase at a 
viability of ≥ 98% and resuspended in TC-42 medium with 100% [U-13C6] glucose (99%, Euriso-
Top, Saarbrücken, Germany). The main cultivation was performed in a Vario1000 bioreactor 
(Medorex e.K., Nörten-Hardenberg, Germany) at batch mode with a starting culture volume of 
200 mL. The bioreactor was inoculated at a cell density of 0.4 × 106 cells/mL. The cultivation 
temperature was kept constant at 37 °C and the impeller (3-blade marine propeller) speed was set to 
300 rpm. During the cultivation, the pH value was controlled at 7.2 by gassing with CO2 and by 
using 0.5 M sodium carbonate solution. Dissolved oxygen was maintained at 30% of the saturation 
concentration. Samples were taken three times a day. Cell density and viability were determined by 
cell counting using the Trypan blue exclusion method. Supernatants were transferred into fresh 
tubes and stored at -20°C until further analysis. The average cell diameter was determined using an 
automated cell counter (Invitrogen, Darmstadt, Germany) in a separate experiment. This experiment 
was performed in a shaking incubator (2 inches orbit, 185 rpm, 37°C, 5% CO2 supply) using 
250 mL baffled Erlenmeyer flasks (Corning Inc., Germany), an initial cell density of 
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0.4 × 106 cells/mL, a working volume of 100 mL and using the same medium TC-42 medium 
(TeutoCell, Bielefeld, Germany) supplemented with 4 mM glutamine. Differences of cell diameters 
during the cultivation were maximum 5% and not taken into account. Cell volume was computed 
assuming the cells are spherical using a diameter of 10.6 µm. Glutamine degradation kinetics were 
determined experimentally in a cell-free setup identical to the one employed for cell volume 
estimation. The determined glutamine degradation rate constant was kdGLN = 0.0033 h
-1. 
5.3.2 Quantification of metabolites 
Quantification of glucose, organic acids and amino acids via HPLC was carried out as described 
previously by Strigun et al. (Strigun et al., 2011b). 
5.3.3 Analysis of isotopomer labeling patterns 
5.3.3.1 Sample preparation 
For determination of labeling patterns of lactate and amino acids, 50 µl of supernatants were 
lyophilized, resolved in 50 µl N,N-dimethylformamide (0,1 % pyridine) and incubated at 80°C for 
30 min. 50 µl N-methyl-N-t-butyldimethylsilyl-trifluoro-acetamide (MBDSTFA) was added 
followed by another incubation at 80°C for 30 min for derivatization of metabolites into 
corresponding dimethyl-t-butylsilyl derivatives. For determination of the labeling pattern of 
pyruvate, lyophilized supernatants were resolved in 50 µl pyridine containing 20 mg/ml 
methoxyamine hydrochloride and 50 µl MSTFA (Macherey-Nagel, Düren, Deutschland) and 
incubated at 80°C for 30 min for derivatization into the methoxyamine-trimethylsilyl derivative. 
Derivatized samples were centrifuged at 13000 × g for 5 min at 4 °C and supernatants transferred 
into fresh glass vials with micro inlets. 
5.3.3.2 GC-MS measurements 
Extracellular 13C-labeling dynamics were analyzed by gas chromatography mass spectrometry (GC-
MS). The GC-MS measurements were carried out on a GC (HP 6890, Hewlett Packard, Paolo Alto, 
CA, USA) equipped with an HP5MS capillary column (5% phenyl-methyl-siloxane 
diphenylpolysiloxane, 30 m × 0.25 mm × 0.25 µm, Agilent Technologies, Waldbronn, Germany), 
electron impact ionization at 70 eV, and a quadrupole detector (Agilent Technologies). The 
injection volume was 1 µl (7683B Autosampler, Agilent, Waldbronn, Germany; PTV-Injektor, 
Gerstel, Mühlheim a. d. Ruhr, Germany). Helium was used as carrier gas at a flow rate of 
1.1 ml/min for analysis of lactate and amino acids or 0.7 ml/min for pyruvate analysis. The 
following temperature gradient was applied for lactate and amino acid analysis: 135°C for 7 min, 
10°C/min up to 162°C, 7°C/min up to 170°C, 10°C/min up to 325°C, 325°C for 2.5 min; inlet 
temperature: 140°C and heating with 720°C/min up to 320°C; interface temperature 320°C; 
quadrupole temperature 150°C. The temperature gradient for pyruvate analysis was as follows: 
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70°C for 1 min, 1°C/min up to 75°C, 5°C/min up to 315°C, 25°C/min up to 340°C, 340°C for 5 
min; inlet temperature: 70°C and heating with 360°C/min up to 360°C; interface temperature 
320°C; quadrupole temperature 280°C. 
5.3.3.3 Data analysis 
After identification of metabolites in the scan mode using the NIST data bank, quantification of 
labeling enrichment was done in SIM (single ion monitoring) mode in two technical replicates using 
the following unique fragments (m/z) containing the complete carbon skeleton of metabolites: 
pyruvate 174, lactate 261, alanine 260, glycine 246, serine 390, aspartate 418, glutamate 432, 
glutamine 431. Mass isotopomer distributions were corrected for naturally occurring isotopes using 
the method of Yang et al. (Yang et al., 2009). 
5.3.4 Metabolic network models 
Two metabolic networks were established based on experimental observations related to metabolite 
uptake and production and extracellular labeling. Both networks included: glycolysis; TCA cycle; 
anaplerotic reactions; synthesis of fatty acids, proteins and carbohydrates for biomass production; 
amino acid production and degradation. Transport from the extracellular media was reversible in 
both models for all metabolites with the exception of glucose, asparagine and essential amino acids. 
Mitochondrial transport of malate, -ketoglutarate, alanine, and reactions of transaminase, malate 
and lactate dehydrogenase were also reversible. The first model shown in Figure 5-1A considers the 
intracellular space without compartmentation. In the second model (Figure 5-1B), the mitochondrial 
reactions and pools are separated from the cytosol. Both models start from the annotation of the 
genomes of CHO-K1 and Mus musculus (Hammond et al., 2012; Zhu et al., 2003) (KEGG, Kyoto 
encyclopedia of genes and genomes). Enzyme localization was established using information from 
the MGI database and data from J. Wahrheit (Wahrheit et al., 2014b) who measured compartmented 
enzyme activity using a method adapted from Niklas et al. (Niklas et al., 2011a). Mitochondrial 
transport of alanine was included to explain the existence of alanine aminotransferases in both 
compartments. Metabolite pools were lumped where it did not influence the simulated labeling 
dynamics. Pentose phosphate pathway was reduced to one reaction where one carbon atom is lost 
for each G6P molecule and 5/3 molecules of PG are produced. Glycolysis was lumped to three 
fluxes transforming G6P into PYRcyt. Isocitrate and citrate were condensed into one citrate (CIT) 
pool. Succinate, fumarate and malate were condensed into one MAL pool. Two cytosolic pyruvate 
pools were used to describe metabolic channeling to lactate. Non-essential amino acids catabolism 
was lumped to three fluxes fueling the MAL, AcoA and GLU pool respectively. No carbon mapping 
was required in this case as essential amino acids are unlabeled. Glutaminase activity was 
mitochondrial (Xu et al., 2011) and glutamine synthetase was cytosolic (Hayward et al., 1986). 
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Fatty acids, protein and storage carbohydrates composition of the cell was taken from Altamirano et 
al. (Altamirano et al., 2001b). 
In total, the compartmented model consisted of 60 fluxes and 25 metabolites and the non-
compartmented model of 42 fluxes and 16 metabolites. The complete flux list for the two models, 
together with the carbon transfer rules, is provided in the Additional file 1. 
 
Figure 5-1. Compartmented (A) and non-compartmented (B) networks of the CHO-K1 central 
metabolism used for simulations. Irreversibility is indicated by simple arrows, and reversibility by double 
arrows. The reactions depicted in 1B are listed in detail in the Additional file 1 together with fluxes and 
reversibilities determined. Subscripts meaning: ex – extracellular; c – cytosolic; m – mitochondrial. 
Abbreviations: AA –amino acids; AcoA – acetyl CoA; AKG – alpha-ketoglutarate; ALA – alanine; ASN – 
asparagine; ASP – aspartate; CIT/ICI – citrate/isocitrate; G6P – glucose 6-phosphate; GLC – glucose; GLN 
– glutamine; GLU – glutamate; GLY – glycine; MAL – malate; OAA – oxaloacetate; PEP – 
phosphoenolpyruvate ; PG – phosphoglycerate; PYR – pyruvate; SER – serine. 
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5.3.5 Non-stationary-13CMFA methodology 
Isotopic non-stationary metabolic flux analysis (INST-13CMFA) comprises: (1) metabolic steady-
state balancing of intracellular metabolites for determining extracellular rates; (2) dynamic 
extracellular metabolite and isotopomer balance and (3) dynamic balances of intra-compartmental 
isotopomers. 
5.3.5.1 Metabolite balancing 
Net extracellular rates vM_ex were determined for each extracellular metabolite M_ex for the batch 
cultivation situation, under the assumption of metabolic steady state, by fitting the cell density X(t) 
and extracellular concentrations of metabolites CM_ex to an exponential growth model with specific 
growth rate µ (eq. 1.a,b) and constant extracellular rates. Glutamine balance included first order 
degradation in the culture media (eq. 1.c). 
dX/dt = µ∙X(t) (1.a) 
dCM_ex/dt = vM_ex∙X(t) (1.b) 
dCGLN/dt = vGLN∙X(t) – kdGLN∙CGLN(t) (1.c) 
At intracellular metabolic steady state, the n metabolic fluxes that connect the m metabolites are 
constant and satisfy the material balance: 
      0 (2.a) 
vj = φj,   j = 1..Rmeas (2.b) 
i ≤ vi ≤ i, i = 1..n (2.c) 
where G is the m  ×  n stoichiometric matrix and its null space v is the vector of net metabolic fluxes 
which are constrained by Rmeas measured fluxes φj (2.b) and n inequalities (2.c) determined by flux 
direction. To reduce the number of parameters, the free fluxes were extracted from the network as 
described in (Yang et al., 2008) to produce a determined stoichiometric system. 
5.3.5.2 Intracellular and extracellular carbon balance 
The INST-13CMFA framework developed in (Becker et al., 2011; Nöh et al., 2006) was adapted to 
the case of batch culture cultivation. Isotopomer balances for extracellular (eq. 3) and intracellular 
(eq. 4) metabolites were set to be solved together with the extracellular balances (eq. 1.a,b,c). 
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with IDVM_ex, IDVM_cyt, IDVM_in, being the isotopomer distribution vectors of the extracellular, 
cytosolic and intracompartmental pools of metabolite M. IDVM_in,j is the j
th reaction contribution to 
isotopomers of metabolite M, computed using isotopomer mapping matrices as described by 
Schmidt (Becker et al., 2011). Xconc is the cell volumetric concentration expressed in L cell / L 
media. CM_ex is the extracellular concentration of M, 
in
exMv _ is the production flux of M expressed in 
mmol/(L cell × h), out exMv _ is the uptake flux, vj is one of the RM fluxes entering the 
intracompartmental pool of M, CM_in, and 
out
inMv _  is the flux exiting the pool. The metabolite and 
isotopomer balances from equations 1,2 and 4 are then solved simultaneously to obtain the time 
course of the mass isotopomer distributions. Isotopomer balancing employs absolute fluxes that can 
be computed from the net fluxes by introducing a reversibility parameter: 
j
reverse
j
j
v
v
rev
,

 (5) 
where vj is the net flux and vj, forward and vj, reverse are the forward and respectively the reverse exchange 
fluxes, with vj, forward – vj,reverse = vj; vj, forward ≥0 and vj,reverse ≥0. 
The contribution of reaction j was computed using isotopomer mapping matrices (Becker et al., 
2011) that trace carbon from the substrate to the reaction products. The initial mass distribution of 
all metabolites was computed considering the naturally occurring 13C fraction (1.1%) and the 99% 
atom purity of the employed 13C labeled substrate. 
The simulated time course of extracellular mass isotopomer distributions (MID) is compared with 
the experimental values. The objective function to be minimized was expressed as the weighted sum 
of square differences between the experimentally determined and simulated MIDs: 
   exp1exp MIDMIDMIDMIDSSQD simMID
Tsim     (6) 
where SSQD is the objective function, MIDsim is the simulated MID, MIDexp is the measured MID 
and MID is the measurement covariance matrix. The optimal solution was accepted if it satisfied the 
-squared test for model verification with 95% probability, and N-p degrees of freedom, where N is 
the number of sampled points (size of MIDexp) and p is the number of free parameters. To reduce the 
bias in the objective function generated by very small standard deviations, a minimum threshold of 
0.005 was imposed. Accurate confidence intervals and sensitivity analysis of fluxes were computed 
according to (Antoniewicz et al., 2006b). All the code was programmed and simulated in Matlab 
[MATLAB and Simulink Release 2013a, The MathWorks, Inc., Natick, Massachusetts, United 
States]. 
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5.4 Results and discussion 
5.4.1 Metabolic profiling 
The cells exhibited exponential growth for 72 h (Figure 5-2) until glutamine became exhausted and 
a shift in metabolism was observed (data not shown). Estimated specific growth rate as fitted to eq. 
(1.a) was µ = 0.0401 h-1. Uptake and production of most metabolites was balanced, i.e. they were 
proportional to growth for the main carbon sources and produced metabolites (Figure 5-2) and for 
other amino acids (Additional File 2).This means that metabolic steady state was maintained during 
the first 72 h of cultivation. Glucose constituted the main carbon source (Table 5-1), providing 65% 
of the total carbon entering the central carbon metabolism, with an uptake flux of 
371 mmol/(L cell × h). Note that all fluxes are related to the cell volume specified by L cell. 39% of 
the glucose was converted to lactate. The observed pyruvate production rate was 
3.3 mmol/(L cell × h). 
The glutamine uptake flux determined by fitting eq. (1.c) to the glutamine concentration over time 
was 66.4 mmol/(L cell × h), 16% smaller than that in the case when its degradation was ignored. 
Glutamine uptake contributed with 10% to the total carbon pool. The rest of the carbon feeding the 
central carbon metabolism, i.e. 25%, was obtained from amino acids catabolism. 
Table 5-1 Carbon sources for the central metabolism of the CHO-K1 cell line in batch culture during 
the exponential growth phase 
Metabolite Target intracellular 
metabolite 
Uptake flux 
[mmol/(L cell × h)] 
Uptake flux 
[Cmmol/(L cell × h)] 
Percentage of the 
total carbon-flux 
Glucose Pyruvate 371.0 2226.2 64.9 
Glutamine AKG 66.4 331.9 9.7 
AA1* AcoA 92.6 185.2 5.4 
AA2* Malate 49.6 198.4 5.8 
AA3* AKG 11.6 58.2 1.7 
ASP/ASN OAA 68.1 272.3 7.9 
Serine Pyruvate, glycine 48.3 146.4 4.3 
TOTAL - - 3428.53 100 
The contribution of AA1, AA2 and AA3 amino acid groups considers only catabolism. Abbreviations: 
AA1: amino acids catabolized to AcoA (isoleucine, leucine, lysine, phenylalanine, tyrosine); AA2: amino 
acids catabolized to four-carbon dicarboxylic acids (isoleucine, methionine, phenylalanine, threonine, 
tyrosine, valine); AA3: amino acids catabolized to glutamate (arginine, histidine, proline); AcoA: acetyl 
coenzyme A; AKG: alpha-ketoglutarate; ASN: asparagine; ASP: aspartate; OAA: oxaloacetate. 
* Excluding requirements for protein synthesis 
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Alanine, glycine and glutamate were produced (Figure 5-3), while the other amino acids were taken 
up in excess of the quantity required for biomass synthesis. As a consequence of amino acids 
catabolism, a flux of 92.6 mmol/(L cell × h) fueled the mitochondrial acetyl-CoA pool from the 
degradation of isoleucine, leucine, lysine, phenylalanine and tyrosine, while a flux of 39.1 mmol/(L 
cell × h) cytosolic AcoA was directed towards fatty acids synthesis. The catabolism of excess 
isoleucine, methionine, phenylalanine, threonine, tyrosine and valine that remained after protein 
synthesis produced 49.6 mmol/(L cell × h) succinate and fumarate (lumped into one pool of four 
carbon di-carboxylic acids, here represented as MAL). 
Metabolite dilution by growth was neglected due to negligible influence on the total mass balance. 
 
Figure 5-2. Culture profile of the CHO-K1 cells for the first 72 h during the exponential growth 
phase. Experimental values are shown with circles and calculated values are represented by solid lines. 
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Figure 5-3. Compartmentation of the CHO-K1 metabolism and the fate of extracellular metabolites. 
Net fluxes are indicated on the gray arrows in units of mmol product/ (L cell × h), and reversibility 
parameter defined as reverse flux/net flux is shown in the square brackets (n.d. = not determined. The 
thickness of the gray arrows is proportional to the forward flux (= reverse flux + net flux), and shown 
qualitatively for the fluxes with variable reversibility. Net flux direction is shown by the black arrow heads. 
Amino acids catabolism is represented as the sum of the differences between amino acid uptake flux and 
flux required for protein production, reported to the metabolite derived from catabolism. Subscripts 
meaning: ex – extracellular; c – cytosolic; m – mitochondrial. Abbreviations: AAex1 – isoleucine, leucine, 
lysine, phenylalanine, tyrosine catabolized to acetyl-CoA; AAex2 - isoleucine, methionine, phenylalanine, 
threonine, tyrosine, valine catabolized to fumarate and succinate; AAex3 – arginine, histidine, proline 
catabolized to glutamate; AcoA – acetyl CoA; ALA – alanine; ASN – asparagine; ASP – aspartate; CIT/ICI 
– citrate/isocitrate; GLN – glutamine; GLU – glutamate; GLY – glycine; MAL – malate; PYR – pyruvate; 
SER – serine.  
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5.4.2 Non-stationary labeling experiment 
The MID of extracellular pyruvate, lactate, alanine, glutamate, glutamine, aspartate, serine and 
glycine was sampled at 1, 18, 24, 42, 48, 66 and 72 h. During the exponential growth phase of 72 h 
none of the labeling reached steady state as shown in Figure 5-4. Lactate and pyruvate exhibited 
similar labeling dynamics, however with different MIDs towards the end of the growth. This is 
surprising since lactate is obtained from pyruvate through the lactate dehydrogenase reaction. The 
predominant lactate fraction, i.e. M+3, increased to 0.85 and the pyruvate M+3 fraction stabilized at 
0.81, pointing towards glycolytic channeling to lactate achieved by the localized cooperation of 
glycolytic enzymes as observed in rapidly proliferating cells (Mazurek et al., 2001; Vander Heiden 
et al., 2009). From the produced amino acids, alanine, also derived from pyruvate, had a high M+3 
fraction. Glutamate and glycine M+2 fractions increased slowly, with most of the change happening 
in the last 24 h due to the high number of producing cells present in the media., Extracellular 
aspartate, glutamine and serine were found to be labeled although they exhibited a net uptake. 
Glutamine fractional labeling, mostly the M+2 isotopomer, increased sharply at the end of the 
phase, when very little glutamine remained in the media and the contribution of secreted glutamine 
played a large role to the labeling state. 
5.4.3 Isotopomer fitting 
Both the non-compartmented and compartmented isotopomer network models (Figure 5-1) were 
fitted to the experimental mass distributions with the goal of determining unknown fluxes and 
reversibilities. The 7 sampling time points of the 8 metabolites produced a total number of 252 
experimental MIDs.  
Convergence to the optimal solution is difficult in isotopomer models (Srour et al., 2011) and the 
parameter space of the objective function is marked by a multitude of local minima (Chen et al., 
2007), making gradient-based algorithms unreliable. Consequently, we applied a global 
optimization scheme that had the following steps: (1) generate an initial random population of (40 x 
p) parameter sets that satisfy constraints using a simulated annealing-based algorithm, (2) submit 
the population to a 50-generations genetic algorithm optimization, and (3) refine the best solution 
using a trust region reflective algorithm. Convergence to the optimal solution was verified by 
repeating the optimization scheme. One simulation took about 3 s, and the optimization procedure 
required about 40 h on a 2.3 GHz QuadCore CPU. All the numerical integration and optimization 
algorithms are found in Matlab toolboxes.  
We had initial difficulties in fitting pyruvate and alanine labeling dynamics. As it was shown that 
reversibility greatly affects labeling dynamics (Nöh and Wiechert, 2011), we assumed that the 
transport reversibility parameter changes in time, even if the net fluxes remain constant. The 
decrease with time of pyruvate transport reversibility was mechanistically expressed using a 
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hyperbolic function 


time
rev
rev PYRPYR
0
, where pyruvate transport reversibility revPYR decreases from a 
starting value 0PYRrev . To avoid division by zero, a negligible correction factor  was introduced. 
Alanine transport into the cell intensifies as extracellular alanine becomes exponentially more 
abundant. Transport reversibility was expressed in this case as )exp( timerevALA   , where  and 
 are parameters to be determined. 
The 24 free parameters of the non-compartmented model (Figure 5-1A) consisted of 5 fluxes, 18 
reversibilities and the CO2 pool. At convergence, the model failed to fit the data with the minimized 
SSQD of 1572, larger than 2 (0.95, 252-24) = 264.2. Pyruvate, lactate, alanine and glutamate 
labeling were fit poorly even when transport reversibility was variable (Figure 5-4). In consequence, 
the non-compartmented model was rejected. The low labeling content of pyruvate, alanine and 
lactate simulated with the non-compartmented model is explained by the lumping of the cytosolic 
and mitochondrial pyruvate pools. As more than 30% of the carbon feeding the TCA cycle is not 
labeled, it is expected that the cataplerotic reactions catalyzed by phosphoenolpyruvate 
carboxykinase and malic enzyme will produce a large quantity of unlabeled pyruvate, which 
contradicts the experimental observations. 
The compartmented model, consisting of 11 free fluxes and other 27 free parameters (reversibilities) 
depicted in Figure 5-1B, fitted the data successfully with the minimized SSQD = 249.0 slightly 
smaller than  2(0.95, 252-38) = 249.13. The poorer fit of the 66 and 72 h time points for lactate and 
72 h for alanine can be explained by the metabolic shift towards the end of the growth phase. From 
a parameter fitting point of view, exponential growth will add a larger contribution in the objective 
function to the labeling towards the end of the exponential phase compared to the beginning of the 
experiment because the rates of 13C accumulation in the extracellular media will be much larger at 
high cell densities. This is best evidenced in Figure 5-4 where glutamine, aspartate, serine and 
glycine do not become noticeably labeled until 40 h after the introduction of the labeled substrate. 
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Figure 5-4. Non-stationary 13C labeling experiment. Experimental mass isotopomer distributions 
(symbols) with their standard deviations vs. simulated (line) mass isotopomer distributions of labeled 
extracellular metabolites. The plots A-C represent results from using the non-compartmented metabolic 
network specified in Figure 5-1A. For the other eight plots (D-K), the compartmented model provided in 
Figure 5-1B was simulated. 
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5.4.4 Metabolic fluxes in the CHO-K1 cell line 
Glucose was converted to PG mostly by bypassing glycolysis (Figure 5-5) through the pentose 
phosphate pathway (PPP). The estimated PPP flux was 80% of the total molar glucose input flux, a 
high activity contrasting with results obtained by Ahn and Antoniewicz for adherently growing 
CHO cells (Ahn and Antoniewicz, 2011) but observed for hybridoma (Bonarius et al., 1996) and 
cancer cells (Bensaad et al., 2006). A wide range of PPP activities, between 0-160 % of the glucose 
input flux, was determined for a highly-productive CHO line in fed-batch cultivation conditions at 
different growth phases (Templeton et al., 2013). The large quantities of cytosolic NADPH 
produced through PPP are used to drive fatty acids synthesis and possibly to mitigate oxidative 
stress by reducing reactive oxygen species (Anastasiou et al., 2011; Portner and Schafer, 1996; 
Sengupta et al., 2011; Tuttle et al., 2000; Vizan et al., 2009), as it has also been proposed by 
(Templeton et al., 2013). Overflow to lactate comprised 39% of the pyruvate produced from 
glycolysis. From the rest of the cytosolic pyruvate, 42.7 mmol/(L cell × h) were converted to 
alanine, but most of it was transported into the mitochondria and converted to AcoA. The 
channeling flux from PEP to lactate was 122.7 mmol/(L cell × h), accounting for 42% of the total 
lactate being produced. Low reversibility (Figure 5-5) meant no connection between the two 
cytosolic pyruvate pools PYRc1 and PYRc2 existed. However, lactate was produced from both 
cytosolic pyruvate pools, indicating that glycolytic channeling is not the only lactate source in the 
cell. Our possible explanation is that multi-enzyme complexes associated to membrane transporters, 
as characterized by Campanella et el (Campanella et al., 2005), create a micro-compartmented 
environment in the cytosol. Glycolytic enzymes are partly associated and partly soluble, resulting in 
a mixed response in the lactate labeling. 
The carbon flux in the TCA cycle originated mainly from AcoA produced from glycolytic pyruvate 
transported into the mitochondria (Figure 5-5), with significant contributions from glutamine and 
essential amino acids catabolism. Such a high activity of the TCA cycle and high connectivity with 
the glycolysis is in contrast with some previous reports of lower activity during exponential growth 
phase (Ahn and Antoniewicz, 2011; Quek et al., 2009; Zamorano et al., 2010) but similar to 
(Goudar et al., 2010; Sengupta et al., 2011; Sheikholeslami et al., 2013b). The differences can be 
assigned mainly to the use of different cell lines and cultivation conditions like media composition, 
aeration mode, pH control and culture type e.g. suspension or immobilized, batch or fed-batch. The 
lower lactate/glucose molar ratio of 0.78 reported herein means more pyruvate is available for use in 
the TCA cycle, thus making for a more efficient metabolism. 
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Figure 5-5. Estimated net intracellular fluxes [mmol/(L cell × h)] in the CHO-K1 central metabolism. 
Qualitatively shown by the arrow thickness and their 95% confidence intervals (number interval) together 
with reversibility confidence intervals (square brackets). n.d. – not determined. 
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Gluconeogenesis was active through PEP carboxykinase with 10% of the total flux entering the PEP 
pool, a fact explained qualitatively by the presence of M+2 lactate and pyruvate. In the absence of 
gluconeogenesis, only the M and M+3 mass isotopomers of these metabolites would be present after 
feeding fully labeled glucose. Malic enzyme activity was negligible in the cytosol, and this is in 
agreement with compartmented enzyme activity observed by J. Wahrheit (Wahrheit et al., 2014b). 
This observation reaffirms that PPP was the main source of cytosolic NADPH. Mitochondrial malic 
enzyme was highly active, producing one third of the total mitochondrial pyruvate. However, a part 
of the mitochondrial pyruvate was recycled back into the TCA cycle via pyruvate carboxylase. 
Mitochondrial malate net transport flux was small and reversible. This explained the lack of M+1 
labeling in lactate, alanine and pyruvate that would have been otherwise linked to the M+2 malate 
isotopomers that are expected to be obtained in the TCA cycle. As a consequence, the M+2 labeling 
in these metabolites relies on mitochondrial transport of citrate and on the activity of citrate lyase 
producing cytosolic AcoA and OAA, which is then further converted to PEP. 
About one third of the total serine was produced from PG, using cytosolic glutamate for 
transamination. Serine was exchanged with the media, thus explaining extracellular labeling of 
serine. Half of the serine was not used for protein synthesis but was reversibly converted to glycine 
and C1 units to sustain the high anabolic activity. Glycine was then secreted. The remaining excess 
of serine was converted to pyruvate. Alanine was synthesized mainly from cytosolic pyruvate in a 
highly reversible reaction. Connectivity between cytosolic and mitochondrial alanine pools and the 
direction of the mitochondrial alanine aminotransferase flux could not be determined. However, the 
transport flux of alanine to/from mitochondria was confined between -11.6 to 
13.6 mmol/(L cell × h), i.e. ±25% of the alanine production flux. The flux of 68.1 mmol/(L cell × h) 
from asparagine and aspartate uptake to oxaloacetate was split through aspartate aminotransferases 
between cytosolic and mitochondrial oxaloacetate with a 3/1 ratio, but no other details could be 
inferred due to the low labeling level in extracellular aspartate. 
Isocitrate dehydrogenase (IDH) activity in the cytosol could not be reliably determined due to lack 
of information in directly connected metabolites citrate and AKG, but also because it affects the 
labeling pattern in the same way as the mitochondrial isozyme. As a result, the flux in the CITm-
CITc-AKGc-AKGm cycle could not be determined. Nevertheless, a net activity of cytosolic GDH 
towards producing the high glutamate flux needed for cytosolic transamination reactions implies 
that AKG is either produced in the cytosol by IDH or transported from the mitochondria into the 
cytosol. Mitochondrial glutamate pool was fed by transporting cytosolic glutamate into the 
mitochondria and by glutamine through GLS activity at comparable rates. In the mitochondria, 
glutamate was then converted to AKG and fed into the TCA cycle through mitochondrial GDH. In 
the cytosol, the glutamate produced from AKG in the various transaminase reactions was partially 
converted to glutamine, which was then exchanged with the media, leading to the presence of 
labeled glutamine in the media. In conclusion, simultaneous degradation and synthesis pathways for 
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glutamine involve glutamine uptake, transport into the mitochondria and conversion to glutamate, 
glutamate dehydrogenation to AKG, AKG transport to the cytosol or citrate transport and citrate 
conversion to AKG through cytosolic IDH activity, conversion of AKG to cytosolic glutamate, and 
cytosolic glutamine synthesis. 
5.4.5 Transport reversibility 
A very important part in modeling the extracellular labeling was considering the reversible 
exchange between the intracellular pools and the extracellular media, a phenomenon which affects 
the dynamics of the labeling process. All sampled extracellular non-essential amino acids except 
asparagine and proline, either produced or taken up, were exchanged with the culture media (Figure 
5-3). Even if the production flux of alanine remained constant throughout the cultivation, the fitting 
remained poor for alanine when considering a constant reversibility factor. There, the reversibility 
was estimated to increase with time. The function )0.0359exp(0.154 timerevALA   was used to 
compute the forward and reverse exchange fluxes (eq. 5), with both parameters being determined 
with a narrow confidence interval (Additional File 1). Time is computed in hours. This successfully 
explained the dynamics of alanine labeling. The time constant of the reversibility function is a value 
close to the specific growth rate, pointing to the fact that alanine re-uptake is correlated to the 
extracellular concentration. Serine secretion flux, as computed with eq. 5, was up to 35 times higher 
than the net uptake flux. Glycine re-uptake flux was 4.6 times the net production flux. Aspartate, 
glutamate and glutamine exchange fluxes were in the same order with the net uptake/production 
flux, as expressed by the estimated reversibility parameter values of about 1. The confidence 
intervals for the transport reversibility parameters are larger than those for fluxes because at high 
reversibilities the labeling becomes less sensitive to small changes in reversibility. 
Pyruvate transport reversibility is described by the function 
01.0
2700


time
revPYR , where time is 
specified in hours. The hyperbolic function implies that at the beginning of the cultivation, the 
intense exchange of pyruvate (Cruz et al., 2001) eliminates the difference between the labeling of 
the intracellular and extracellular pools. Pyruvate re-uptake decreases because pyruvate 
concentrations changes slightly (Figure 5-1) while lactate accumulates in the media to reach high 
concentrations and competes with pyruvate for the monocarboxylate transporters (Halestrap and 
Price, 1999; Morris and Felmlee, 2008). Lactate transport reversibility parameter could not be 
estimated because at the beginning of the cultivation there is no lactate present in the media that 
could dilute the intracellular pool and affect the labeling dynamics. 
5.4.6 Confidence intervals calculation and sensitivity analysis 
Most of the fluxes depicted in Figure 5-5 were determined with narrow confidence intervals. 
Interval boundaries are not symmetrical due to the non-linear characteristics of the mathematical 
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model. Determining both the flux and exchange in alternative pathways was not possible in the case 
of high reversibility e.g. for determining the compartmentation of alanine metabolism involving 
reversible transaminase reactions. 
The sensitivity coefficients provided quantitative information about the impact of the measured 
fluxes on the estimated flux values (Figure 5-6A). Sensitivity analysis also evidenced correlations 
between external fluxes and network pathways when [U-13C6] glucose is used. In this case, the 
MIDs of metabolites will depend on the interplay between the multitude of non-labeled carbon 
sources and the glucose feed, as opposed to organisms that use only one carbon source (Sellick et 
al., 2011). The determination of anaplerotic fluxes relied on the supply of four carbon metabolites 
from amino acids catabolism. Changes in the glutamine uptake flux (Figure 5-6A) affected most 
fluxes to a large extent. Nevertheless, the high influence was mainly computational, as any increase 
of the flux caused depletion of glutamine at the end of the cultivation and dramatically different 
labeling patterns. Glucose uptake flux affected the estimation of the PPP and TCA cycle fluxes. 
Errors in measuring glucose concentration over time will propagate in the values of these fluxes, as 
the glucose uptake flux determines the fraction of 13C entering the cell. G6P loses one 13C through 
oxPPP, therefore estimating the split between glycolysis and oxPPP depends highly on determining 
correctly all carbon sources. This explains the high sensitivity of the glycolysis/oxPPP split to all 
extracellular fluxes. Unexpected correlations were observed for the glycine production flux that 
influenced most anaplerotic and aminotransferase fluxes. Glycine is produced at the expense of 
serine, which is in turn produced from 3-phosphoglycerate, also converting glutamate to alpha-
ketoglutarate during transamination, and simultaneously converted to pyruvate, thus affecting the 
availability of both cytosolic pyruvate and glutamate. 
Local sensitivity of the SSQD to free parameters computed as the normalized mean deviation of the 
objective function to variations in the estimated parameters shown in Figure 5-6B evidenced the 
determinable parameters and the redundant parameters. Notoriously difficult to determine 
anaplerotic fluxes PEP carboxykinase and mitochondrial malic enzyme induced a noticeable 
sensitivity in the objective function. The increased network connectivity, obtained by coupling ALA 
or ASP deamination to conversion of AKG to GLU, contributed to this fact. Oppositely, most 
intracellular reversibilities did not influence the parameter estimation results. This can be easily 
inferred from the fact that while reaction reversibility affects the dynamics of intracellular 
isotopomers, it does not mirror in the extracellular labeling apart from the reactions altering the 
carbon backbone. Also, in the situation where high values of the reversibilities resulted from 
estimation, local perturbations around these values will not influence the MIDs.  
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Figure 5-6. Sensitivity analysis to measured fluxes and to parameters. The sensitivity represented in the 
heat map (A) was computed for the compartmented network of CHO-K1 when [U-13C6] glucose was used 
as a labeled substrate,       
         
          
   , where       
   is the sensitivity of the estimated 
flux ve, re-estimated using values of the measured flux vm at the border of the confidence interval. vm* is 
the average measured flux. The bar chart below (B) shows the normalized sensitivity of the objective 
function (SensSSQD) to the free parameters (fluxes and rev = reversibilities). The sensitivity was obtained 
as a mean value of 100 perturbations of each parameter around the estimated value:          
                    
   , where SSQD* is the optimized value of the objective function (eq. 6), and 
pi* is the estimated value of parameter i. The rates vi correspond to the rates in the network shown in 
Figure 1.A. Abbreviations: subscripts: c: cytosolic, ex: extracellular, m: mitochondrial; ALA: alanine; 
AcoA: acetyl coenzyme A; AKG: alpha-ketoglutarate; ASN: asparagine; ASP: aspartate; CIT: citrate; G6P: 
glucose 6-phosphate; GLC: glucose; GLN: glutamine; GLU: glutamate; GLY: glycine; LAC: lactate; MAL: 
malate; OAA: oxaloacetate; PEP: phosphoenolpyruvate; PG: phosphoglycerate; PYR: pyruvate; SER: 
serine.  
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5.5 Conclusions 
We have shown that intracellular fluxes of the CHO-K1 cell line central carbon metabolism in batch 
culture can be determined for a complex network by making use solely of the mass isotopomers of 
extracellular metabolites resulted from feeding [U-13C6] glucose as the only labeled substrate. To 
this end, non-stationary 13C metabolic flux analysis proved an effective tool for unraveling 
important details of the CHO-K1 metabolism. Pathway compartmentation, e.g. of anaplerotic 
reactions and amino acid metabolism had to be considered for describing the mass isotopomer 
distribution. We reckon that this fact plays an essential role in controlling the availability of NADH 
and NADPH in mitochondria and cytosol, but also in facilitating amino acid catabolism. A cancer-
like high activity of the pentose phosphate pathway produced reducing NADPH partly to counteract 
the oxidative stress generated by the mitochondrial respiration and partly to fuel fatty acids 
biosynthesis. When considering previous studies concerned with the metabolism of CHO cells, we 
can observe the wide range of metabolic fluxes that different cells lines and cultivation conditions 
are able to induce. Cytosolic pyruvate transport is reversible thousand-fold compared to the net 
production flux, indicating that although it is not a carbon source, pyruvate creates an extracellular 
environment (O'Donnell-Tormey et al., 1987) most probably by functioning as a balancing system 
for cytosolic NADH (Bucher et al., 1972). Considering that metabolite exchange with the media 
played a very important role in determining the intracellular fluxes, we expect that future 13CMFA 
studies of mammalian cells metabolism will include this essential aspect. Compartmentation 
controls the simultaneous degradation and production of non-essential amino acids. Most likely, the 
CHO-K1 cells maintain the exponential growth phase under batch conditions by using a well-
connected multi-pool system involving metabolite and reaction compartmentation, exchange with 
the media and inter-compartment exchange for controlling the metabolite and cofactor pools. 
Further studies on localizing enzyme and transporter activity together with sampling intra-
compartmental concentrations would bring valuable contributions at elucidating the function of such 
cycling pathways. Accurate enzyme kinetics and thermodynamics (Henry et al., 2007) in 
mammalian cells would complement the modeling using INST-13CMFA with information about 
reaction direction and reversibility. The knowledge gained through INST-13CMFA depicts the 
CHO-K1 central metabolism as a robust, highly interconnected network that ensures fast growth 
and mitigates stress generated by reactive oxygen species and the accumulation of lactate in the 
culture media.  
Due to the economic importance of CHO cells, efficient production processes leading to high 
product quality with minimum effort are of utmost importance. In-depth knowledge about CHO 
metabolism is expected to provide valuable assistance in identifying targets for metabolic 
engineering and guiding the design of feeding strategies leading to the development of efficient 
production processes. Overexpression, silencing or knockout of the specific glycolytic enzymes that 
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associate with channeling glucose to lactate could either be used to study the control of the Warburg 
effect in cancer cells or for improving glucose utilization. Because glutamine is a limiting substrate, 
overexpressing glutamine synthetase would enable cells to run a more efficient energy metabolism, 
with higher fluxes in the TCA cycle. However, as we have shown that compartmentation is 
important in managing metabolites, mitochondrial transporters are likely to constitute important 
targets for genetic modifications. Inter-compartmental transport of metabolites is a key factor in 
connecting the cytosol and the mitochondria energetically and we reckon that modifying the genetic 
expression of transporters will have significant, perhaps surprising effects on the overall 
metabolism.  
Our proposed methodology of sampling the MID only in extracellular metabolites for determining 
intracellular fluxes using INST-13CMFA has the potential of broader applications, as it circumvents 
the need to extract intracellular metabolites and it is non-invasive to cells. The information 
contained in the extracellular mass isotopomers has a higher resolution compared to the summed 
fractional labeling used previously. This is sufficient for resolving a complex metabolic network 
when more metabolites are produced and/or exchanged with the culture media. Therefore, we 
foresee future applications in the study of mammalian metabolism at physiological and pathological 
conditions, especially related to compartmentation, as reviewed in (Gutierrez-Aguilar and Baines, 
2013), and oxidative stress, e.g. in cancer, neurodegenerative disorders and ageing. Knowledge 
about the metabolism at the compartment level will be essential for identifying therapeutic targets 
and understanding disease mechanisms. Similarly, the method could be applied to other enzymatic 
systems or prokaryotic cells where an extended metabolite exchange with the media occurs. 
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6 High resolution 13C metabolic flux analysis in CHO cells 
6.1 Abstract 
The metabolism of mammalian cells is characterized by structural and functional complexity with 
respect to reaction compartmentation, metabolite exchange and channeling. Chinese hamster ovary 
cells are of high economic importance for biopharmaceutical production and an ideal model system 
for studying mammalian metabolism. We determined the mass isotopomer distributions from two 
parallel labeling experiments using [U-13C6] glucose and [U-
13C5] glutamine as substrates in a CHO-
K1 suspension culture. Using extra- and intracellular labeling dynamics we applied non-stationary 
13C metabolic flux analysis (INST-13CMFA) to resolve the metabolic fluxes in a complex metabolic 
network that included mitochondrial transport, metabolite compartmentation and channeling. 
Metabolic fluxes, reversibilities and intracompartmental concentrations were determined within 
narrow confidence intervals. The metabolism was characterized by a high pentose phosphate 
pathway activity, high lactate production, low TCA cycle and cataplerotic fluxes, and simultaneous 
catabolism and production of non-essential amino acids. Mitochondrial glutamate was converted to 
-ketoglutarate mostly by aminotransferase action while glutamate dehydrogenase flux was 
negligible. Malate and glutamate were cycled via several transporters between cytosol and 
mitochondria. Cytosolic NADH was partially transported into the mitochondria by the malate-
aspartate shuttle and partially regenerated by cytosolic lactate dehydrogenase. The labeling 
dynamics of lactate and pyruvate indicate various metabolite channeling effects in the cytosol and 
the mitochondria as well as the existence of a mitochondrial lactate pool that serves most likely as 
intramitochondrial redox buffer. INST-13CMFA combined with targeted parallel labeling 
experiments can unravel the details of mammalian metabolism. 
 
 
This chapter is in preparation for submission as 
Nicolae A, Wahrheit J, Heinzle E. High resolution 13C metabolic flux analysis in CHO cells 
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6.2 Introduction 
In the context of a fast-developing biopharmaceutical industry (Birch and Racher, 2006; Walsh, 
2010a) and a continuous need to understand disease mechanisms at the molecular level, in-depth 
knowledge of the mammalian cell metabolism is crucial. This requires a systems biology approach 
that integrates “omics” information to determine the metabolic network structure and function by 
using adequate computational tools. The current challenge in metabolic flux analysis (MFA) of 
mammalian cells is to untangle the details related to compartmentation (Wahrheit et al., 2011). 
Dysfunctions in metabolite management between compartments in mammalian cells can lead to a 
multitude of diseases (Balaban, 2010; Calvo et al., 2006; Duchen, 2004; Nassir and Ibdah, 2014; 
Palmieri, 2008). In addition, metabolite channeling (Jandt et al., 2013; Malaisse et al., 2004; Zhang, 
2011), association of enzymes (Campanella et al., 2005), and microcompartmentation (Holthuis and 
Ungermann, 2013) are phenomena contributing to the control of eukaryotic metabolism by 
assembly or disassambly of supramolecular structures. 
Metabolic flux analysis of mammalian cells can rely only on flux balancing (Altamirano et al., 
2001b; Bonarius et al., 1996; Sidorenko et al., 2008) or use also 13C-labeling information to describe 
more complex metabolic networks (Amaral et al., 2011b; Bonarius et al., 2001; Goudar et al., 2010; 
Niklas et al., 2011b). Non-stationary 13C metabolic flux analysis (INST-13CMFA) is a modeling 
framework (Nöh et al., 2006; Nöh and Wiechert, 2006) that provides a detailed characterization of 
metabolic network function. By using the dynamics of mass isotopomer distributions (MIDs) it is 
possible to obtain detailed information about metabolic fluxes, reversibility and intracompartmental 
concentrations (Nöh et al., 2007; Nöh and Wiechert, 2011; Schmidt et al., 1997). However, the 
experimental and computational costs of this method increase substantially when compared to other 
MFA methods (Figure 6-1). As a tool for detailed metabolic flux analysis, INST-13CMFA also 
allows the estimation of intracompartmental concentrations by using only the labeling dynamics of 
selected metabolites (Wiechert and Nöh, 2005). In eukaryotic cells, INST-13CMFA was applied to 
study the metabolism of Pichia pastoris (Jorda et al., 2014), of hepatic cells (Hofmann et al., 2008; 
Maier et al., 2008) of cultured B-cells (Murphy et al., 2013) and of astrocytes (Amaral et al., 
2011a). We previously applied INST-13CMFA using the extracellular MIDs of metabolites from a 
reactor batch culture of CHO-K1 suspension cells where [U-13C6] glucose was used as labeled 
substrate to determine the fluxes and metabolite exchange with the media in a compartmented 
metabolic network (Nicolae et al., 2014b). 
CHO cells are the main production cell line for biopharmaceuticals (Kim et al., 2012) and 
considered as the “mammalian equivalent of E. coli” given their relevance as mammalian model 
system (Jayapal et al., 2007). Economic importance made CHO cells a target for various MFA 
studies (Ahn and Antoniewicz, 2011; Altamirano et al., 2001a; Altamirano et al., 2001b; Duarte et 
al., 2014; Goudar et al., 2010; Nicolae et al., 2014b; Nolan and Lee, 2011; Provost et al., 2006; 
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Sengupta et al., 2011; Sheikholeslami et al., 2013b; Templeton et al., 2013; Wahrheit et al., 2014a). 
The most detailed MFA studies used parallel labeling experiments applying [1,2-13C2]glucose and 
[U-13C5]glutamine and steady-state labeling to characterize the growth and the non-growth phases in 
monolayer CHO-K1 cells (Ahn and Antoniewicz, 2011). 13CMFA was also applied for analyzing an 
inducible expression system engineered into a CHO cell line (Sheikholeslami et al., 2013b) or to 
characterize the metabolic shifts during antibody production in a highly-productive CHO cell line 
(Templeton et al., 2013). Nevertheless, all previous studies did not succeed in untangling the traffic 
between mitochondria and cytosol, as these models did not accurately take into consideration 
mitochondrial transport and metabolite compartmentation. 
In the present work we studied the CHO-K1 metabolism by applying two labeled substrates, [U-
13C6] glucose and [U-
13C5] glutamine, to shake flask batch cultures of CHO-K1 suspension cells. We 
used the dynamics of intra- and extracellular MIDs to estimate the intracellular fluxes, reversibilities 
and intracompartmental concentrations by applying INST-13CMFA. Such method produces a high-
resolution analysis of the mammalian cell metabolism, as it allows a detailed exploration of 
metabolic compartmentation, mitochondrial transport and metabolic channeling. The metabolic 
network we have resolved offers a new perspective of the complex CHO-K1 cells metabolism in 
particular and more generally on the intricate system of metabolic fluxes in mammalian cells. 
 
Figure 6-1. Experimental requirements for metabolic flux analysis methods. 
Chapter 6 High resolution 13C metabolic flux analysis in CHO cells 
 
136 
6.3 Materials and methods 
6.3.1 Cell culture 
The CHO-K1 cell line was kindly provided by the Institute of Cell Culture Technology of the 
University Bielefeld (Germany). The cells were grown in suspension culture under serum and 
protein free conditions in the chemically defined, protein-free TC-42 medium (TeutoCell, Bielefeld, 
Germany), supplemented with 6 mM L-glutamine (Sigma-Aldrich, Steinheim, Germany) from a 
240 mM stock solution in dH2O. Cultivation of the CHO-K1 cells was performed in baffled shake 
flasks (250 ml, Corning, New York, USA) in a shaking incubator (Innova 4230, New Brunswick 
Scientific, Edison, NJ, USA) at 135 rpm (2 inches orbit), 37°C and 5% CO2. 
6.3.2 Experimental set-up of labeling experiments 
The pre-culture was carried out in a 250 ml baffled shake flask (Corning Inc., Germany) at an initial 
cell density of 4  105 cells/ml and a working volume of 100 ml. For the tracer experiments, cells 
were harvested during the exponential growth phase and resuspended in TC-42 medium with 100% 
[U-13C6] glucose (99%, Euriso-Top, Saarbrücken, Germany) or with 100% [U-
13C5]glutamine (99%, 
Cambridge Isotope Laboratories, Andover, MA, USA). Four parallel tracer experiments were 
performed, two replicates with fully labeled glucose and two replicates with fully labeled glutamine, 
respectively. The main cultures were inoculated at a start cell density of 2  106 cells/ml in a start 
volume of 120 ml medium. 
Extracellular samples of 0.5 ml were taken from all four cultivations every 6 h for cell counting, 
determination of extracellular metabolite concentrations and extracellular labeling dynamics. 50 µl 
of the sample was diluted with PBS and mixed with Trypan Blue for determination of cell density, 
cell viability and average cell diameter using an automated cell counter (Invitrogen, Darmstadt, 
Germany). The sample was centrifuged (10,000  g, 5 min, Biofuge pico, Heraeus Instruments, 
Hanau, Germany), 300 µl of the supernatant transferred into fresh tubes and stored at -20°C for 
further analysis. The rest of the sample was used for pH determination (MP 220 pH Meter, Mettler-
Toledo, Giessen, Germany). 
Intracellular samples of 5 ml were taken alternately from the two replicates after 2 min, 10 min, 
20 min, 30 min, 1 h, 2 h, 4 h, 6 h, 12 h, 18 h, 24 h, 30 h, 36 h, 42 h and 48 h. Quenching and 
extraction for determination of intracellular metabolites was performed as described in detail 
recently (Wahrheit and Heinzle, 2013; Wahrheit and Heinzle, 2014). In short, a sample of 5 ml cell 
suspension was quenched in 45 ml ice-cold 0.9% sodium chloride solution and centrifuged for 
1 min at 2000  g in a pre-cooled centrifuge at 0°C. The supernatant was carefully decanted 
followed immediately by suction of residual liquid using a vacuum pump without touching the cell 
pellet. Washing was performed by carefully rinsing the cell pellet with 50 ml ice-cold 0.9% sodium 
Chapter 6 High resolution 13C metabolic flux analysis in CHO cells 
 
137 
chloride solution without resuspending the cells. After repeating the centrifugation step and removal 
of the supernatant, the cell pellet was frozen in liquid nitrogen. Intracellular metabolites were 
extracted twice in 100% methanol and once in water by repeated freeze-thaw cycles as described 
previously (Wahrheit and Heinzle, 2014) and similar to (Sellick et al., 2011). Extracts were dried in 
a centrifugal evaporator. 
6.3.3 Quantification of extracellular metabolites 
Quantification of glucose, organic acids and amino acids via HPLC was carried out as described 
previously by Strigun et al. (Strigun et al., 2011b). 
6.3.4 Analysis of isotopomer labelling patterns 
6.3.4.1 Sample preparation 
For determination of extracellular labeling dynamics, 50 µl of supernatants were lyophilized, 
resolved in 50 µl N,N-dimethylformamide (0.1 % pyridine) and incubated at 80°C for 30 min. 50 µl 
N-methyl-N-t-butyldimethylsilyl-trifluoro-acetamide (MBDSTFA) was added followed by another 
incubation at 80°C for 30 min for derivatization of extracellular metabolites into corresponding 
dimethyl-t-butylsilyl derivatives. Dried cell extracts were resolved in 50 µl pyridine containing 
20 mg/ml methoxylamine and 50 µl MSTFA (Macherey-Nagel, Düren, Deutschland) and incubated 
at 80°C for 30 min for derivatization of intracellular metabolites into corresponding methoxyamine-
trimethylsilyl derivatives. Derivatized samples were centrifuged at 13000  g for 5 min at 4 °C and 
the supernatants transferred into fresh glass vials with micro inlets. 
6.3.4.2 GC-MS measurements 
Extra- and intracellular 13C-labeling dynamics were analyzed by gas chromatography mass 
spectrometry (GC-MS). The GC-MS measurements were carried out on a GC (HP 6890, Hewlett 
Packard, Paolo Alto, CA, USA) equipped with an HP5MS capillary column (5% phenyl-methyl-
siloxane diphenylpolysiloxane, 30 m × 0.25 mm × 0.25 µm, Agilent Technologies, Waldbronn, 
Germany), electron impact ionization at 70 eV, and a quadrupole detector (Agilent Technologies). 
The injection volume was 1 µl (7683B Autosampler, Agilent, Waldbronn, Germany; PTV-Injektor, 
Gerstel, Mühlheim a. d. Ruhr, Germany).  
Helium was used as carrier gas at a flow rate of 1.1 ml/min for analysis of extracellular metabolites 
or 0.7 ml/min for analysis of intracellular metabolites. The following temperature gradient was 
applied for analysis of extracellular metabolites: 135°C for 7 min, 10°C/min up to 162°C, 7°C/min 
up to 170°C, 10°C/min up to 325°C, 325°C for 2.5 min; inlet temperature: 140°C and heating with 
720°C/min up to 320°C; interface temperature 320°C; quadrupole temperature 150°C. The 
temperature gradient for analysis of intracellular metabolites was as follows: 70°C for 1 min, 
1°C/min up to 75°C, 5°C/min up to 315°C, 25°C/min up to 340°C, 340°C for 5 min; inlet 
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temperature: 70°C and heating with 360°C/min up to 360°C; interface temperature 320°C; 
quadrupole temperature 280°C. 
6.3.4.3 Data analysis 
After identification of metabolites in the scan mode using the NIST data bank, quantification of 
labeling enrichment was done in SIM (single ion monitoring) mode in at least two technical 
replicates. Unique fragments (m/z) containing the whole carbon backbone were chosen for excreted 
extracellular metabolites and selected intracellular metabolites of the central metabolism. Following 
monoisotopic fragments and their corresponding mass isotopomers of extracellular metabolites 
(MBDSTFA derivatization) were analyzed: lactate 261, alanine 260, glycine 246, serine 390, 
aspartate 418, glutamate 432, glutamine 431. Identified monoisotopic fragments and corresponding 
mass isotopomers in cell extracts (MSTFA derivatization) were as follows: pyruvate 174, lactate 
219, alanine 218, fumarate 245, malate 335, citrate 465, -ketoglutarate 304, glycine 276, serine 
278, aspartate 334, glutamate 348. Mass isotopomer distributions were corrected for naturally 
occurring isotopes using the method of Yang et al. (Yang et al., 2009). 
6.3.5 Metabolic network 
A detailed metabolic network of the CHO-K1 cell line was constructed using the annotated CHO 
genome database (Hammond et al., 2012), the Mus musculus genome (Zhu et al., 2003) and the 
KEGG Pathway database (Kanehisa et al., 2014). We included available data base information 
about enzyme compartmentation, mitochondrial transporters and metabolic channeling.  The 
network included compartmentation of cytosolic and mitochondrial alanine and aspartate 
aminotransferases, cytosolic glutamine synthesis and mitochondrial glutaminase, cytosolic and 
mitochondrial isocitrate dehydrogenase. Concerning mitochondrial carriers, we have considered the 
following: irreversible pyruvate carrier (confirmed by own mitochondrial studies, unpublished 
data), reversible dicarboxylate carrier, irreversible citrate carrier, reversible -ketoglutarate carrier, 
reversible glutamate carrier, reversible aspartate-glutamate carrier, reversible alanine transport and 
irreversible glutamine transport into the mitochondria. 
In addition, the network was modified using enzyme activity localization determined by Wahrheit et 
al. (Wahrheit et al., 2014b). The pathways leading to macromolecules e.g. carbohydrates, proteins, 
fatty acids, nucleic acids were lumped as sink fluxes for precursor metabolites. The catabolism of 
amino acids was lumped into fluxes feeding target metabolite pools. The detailed reaction list and 
the carbon transfer rules are given in the Supplementary Table S1.  
6.3.6 Non-stationary-13CMFA 
We applied metabolite and carbon balancing for both intracellular and extracellular metabolites for 
simulating the mass isotopomer distribution (MID) of selected metabolites over time. The 
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mathematical modeling procedure of non-stationary 13C metabolic flux analysis (INST-13CMFA) is 
the same as we have described and applied in Nicolae et al. (Nicolae et al., 2014b). In this study we 
have used also intracellular MIDs and consequently we could estimate intracompartmental 
concentrations of metabolites with sampled MIDs. The sampled intracellular MID of a metabolite is 
an average of the mitochondrial and cytosolic MIDs, weighed by the intracompartmental pools of 
that respective metabolite. For this, we considered the total mitochondrial volume to be 20% of the 
total cell volume (personal communication, Uwe Jandt). For all the metabolites that were included 
in the model but for which the MIDs were not sampled, we considered negligible 
intracompartmental pool values of 0.1 mmol/L cell. The accepted standard deviation of extracellular 
MIDs in the objective function was 0.01 and of intracellular MIDs it was 0.03. 
6.4 Results and Discussion 
6.4.1 Cell growth and extracellular metabolite concentrations 
Growth and extracellular metabolite concentrations were determined from four biological replicates. 
The CHO-K1 cells maintained exponential growth for the whole cultivation period of 48 h 
(Supplementary Figure S1). The parallel cultivations were reproducible, as it can be seen by the low 
standard deviations in Supplementary Figure S1 and Supplementary Figure S2. The estimated 
specific growth rate was µ = 0.034 h-1 (Supplementary Figure S1). Glucose, glutamine, pyruvate, 
serine, asparagine, aspartate and essential amino acids were taken up (Supplementary Figure S2). 
Lactate, alanine, glutamate and glycine were produced throughout the cultivation period. By the end 
of the 48 h, 60% of the glucose was converted to lactate. Although the specific growth rate was 
constant (Supplementary Figure S1), the specific uptake and production rates generally decreased 
over the 48 h, the most marked trend being observed for lactate production (Supplementary Figure 
S2). However, no switch from production to uptake or vice-versa was observed. 
6.4.2 Labeling experiment 
Extracellular MIDs were determined from two biological replicates. For determination of the time 
courses for intracellular labeling dynamics, MIDs were obtained alternatively from two parallel 
cultivations for each labeled substrate. In the experiment where [U-13C6] glucose was used, the 
sampled metabolites became labeled gradually, and no steady state was reached after 48 h 
(Supplementary Figure S3A). The general trend was of increasing labeling fraction, the exception 
being intracellular lactate, whose M3 mass fraction decreased after 36 h. The mass isotopomer with 
the highest proportion for pyruvate, lactate and alanine was M3, while for metabolites related to the 
TCA cycle e.g. citrate, -ketoglutarate, fumarate and malate, it was the M2. Lactate and alanine 
pools were labeled differently intra- and extracellularly. This evidence supports the hypothesis of 
metabolic compartmentation of these two metabolites. Partitioning of lactate dehydrogenase 
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activity, either by channeling (Jandt et al., 2013; Malaisse et al., 2004; Perez-Bercoff et al., 2011) or 
in cellular compartments (Baba and Sharma, 1971; Brooks et al., 1999; Gladden, 2004; Hashimoto 
and Brooks, 2008; Lemire et al., 2008; Philp et al., 2005; Sagrista and Bozal, 1987a) can also be 
inferred by comparing the intracellular labeling of pyruvate and lactate. During the first 24 h, 
intracellular pyruvate and lactate follow similar labeling patterns. Afterwards, a switch in the 
partitioning of lactate dehydrogenase around 18 h after inoculation was evident from different 
labeling patterns of intracellular pyruvate and lactate.  
In the first 2 h, the labeling in pyruvate exhibited a sharp overshooting of the M3 fraction, that was 
manifested later also in lactate (Supplementary Figure S3B). A similar overshooting behavior was 
observed in the M4 isotopomer of malate, and it transmitted to aspartate.  
When [U-13C5] glutamine was used as the 
13C label source, no labeling was observed in serine and 
glycine, indicating that gluconeogenesis was not active. Pyruvate and lactate displayed a sharp 
overshooting in the first 2 h in all mass isotopomers (Supplementary Figure S3B). However, after 
12h, the labeling of pyruvate and lactate returned close to the natural labeling state, indicating the 
absence of fluxes that connect glutamine to pyruvate. The M4 MID fraction in aspartate, fumarate 
and malate increased until 18 h, and then it decreased in favor of the non-labeled fraction. This is 
most likely the result of a metabolic shift occurring around 18 h after inoculation. The shift is 
mirrored in glutamine and glutamate labeling, where the non-labeled fraction increases steadily after 
24 h. The metabolic shift consists most likely of a decrease in the ratio between glutaminolysis and 
glycolysis in contributing to the TCA cycle. 
The specific uptake and production rates were therefore computed for the period of 0-18 h by fitting 
the model of exponential balanced growth in batch culture to the sampled extracellular 
concentrations (Supplementary Figure S2).  
Aspartate, fumarate and malate had similar labeling patterns on both labeled substrates, suggesting a 
high degree of connection and exchange between these metabolites. 
On both labeled substrates, the MID curves that exhibited overshooting returned to a smooth 
behavior after 2 h. We assign the overshooting to a stress response of the cells to media change at 
the beginning of the culture (Wellen and Thompson, 2010). The stress response is characterized by 
very high metabolic rates that quickly convert the fed substrates after being resuspended to 
replenish the depleted intracellular pools. Once these pools were replenished, the metabolism 
followed a steady state behavior, as it can be seen in Supplementary Figure S2. Since there is no 
observable difference in the cell number and extracellular concentrations in the first two hours, 
assessing the extracellular fluxes during this brief period and proving the existence of metabolic 
steady state required for metabolic flux analysis tools is not possible. 
Chapter 6 High resolution 13C metabolic flux analysis in CHO cells 
 
141 
6.4.3 Fitting of MIDs and model re-adaptation 
For applying INST-13CMFA, we considered that the cells were at metabolic steady state between 2-
18 h after the beginning of the labeling experiments (Deshpande et al., 2009; Nöh et al., 2006). This 
is a valid assumption for most metabolites, as it was shown by fitting the extracellular 
concentrations to an exponential growth with balanced uptake and production model 
(Supplementary Figure S2). We have considered the MIDs of 15 extracellular and intracellular 
metabolites, 5 time points for [U-13C6] glucose and 4 time points for [U-
13C5] glutamine, totaling 
675 experimental MID points (Figure 6-2). Because of the noisy data, the MIDs of intracellular 
alanine and -ketoglutarate were exluded from parameter estimation. After several trials in which 
no successful fitting was obtained, the initial model was modified to include: (1) two pools of 
cytosolic pyruvate, of which one is channeled to lactate that is then directly secreted, (2) two pools 
of mitochondrial pyruvate, of which one is converted to acetyl-CoA via pyruvate dehydrogenase, 
(3) a pool of mitochondrial lactate, (4) cytosolic synthesis of glutamine and (5) serine degradation to 
pyruvate. 
The parameter estimation was made using two strategies in parallel: one was using a genetic 
optimization algorithm, as we previously did in (Nicolae et al., 2014b), and the other was to (1) 
generate 1000 random initial points that satisfy constraints, (2) use the point that produced the 
smallest value of the objective function as the starting point of a gradient-based algorithm and (3) 
find the minimum of the trust region reflective algorithm. The second optimization strategy was 
repeated 30 times, and it provided the best fit of the MIDs. One simulation took about 6.5 s, and the 
optimization procedure required about 6 days on a 2.3 GHz QuadCore CPU. A total of 64 
parameters were estimated, of which 13 were free fluxes, 29 were flux reversibilities, 20 were 
intracompartmental pools and 2 additional parameters that expressed the non-labeled CO2 flux 
entering the cytosol and the mitochondria. This flux was needed to evaluate the labeling dynamics 
of CO2 used by carboxylation reactions. 
The best fit (Figure 6-2) resulted in a minimized weighted sum of square differences value of 665, 
which is smaller than the criteria for fitting 2(0.95, 675-64) = 670. Most of the MIDs of 
metabolites were reasonably well fitted, except intracellular lactate when [U-13C6] glucose was used. 
Because the labeling of extracellular lactate is different from the labeling of intracellular lactate 
(Figure 6-2), we have considered more pyruvate pools from which lactate can derive. While this 
assumption produced a much better approximation of lactate labeling, it is still possible that other 
metabolic configurations involving more sophisticated channeling and compartmentation are 
responsible for the observed labeling pattern in lactate. 
Confidence intervals were computed accordingly to (Antoniewicz et al., 2006a) and were very 
narrow for most estimated parameters (Supplementary Table S1). This is a strong indication that 
fitting simultaneously the intracellular MIDs from two parallel labeling experiments that used two 
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different labeled substrates validates INST-13CMFA is an effective methodology for untangling the 
details of complex metabolic networks, as it was also described by (Murphy et al., 2013). 
 
Figure 6-2. Mass isotopomer distributions (MIDs) of sampled metabolites during the first 18 h of 
cultivation of CHO-K1 suspension cells with (A) [U-13C6] glucose and (B) [U-
13C5] glutamine. The 
values of the extracellular MIDs are the average of two biological replicates and the intracellular MIDs are 
obtained alternatively from two parallel cultivations for each labeled substrate. The continuous lines 
represent the best simulated fit of the MIDs. Subscripts meaning: ex – extracellular. Abbreviations: exp – 
experimental; sim – simulated; ALA – alanine; ASP – aspartate; CIT – citrate; FUM – fumarate; GLN – 
glutamine; GLU – glutamate; GLY – glycine; LAC – lactate; MAL – malate; PYR – pyruvate; SER – 
serine. 
Chapter 6 High resolution 13C metabolic flux analysis in CHO cells 
 
143 
6.4.4 Metabolic fluxes, compartmentation and channeling 
Glycolysis was the main carbon source of the CHO-K1 cell metabolism (Figure 6-3A). Consistently 
with our previous finding for the CHO-K1 cell line cultivated in a reactor batch culture (Nicolae et 
al., 2014b), most of the glucose-6-phosphate was metabolized by the oxidative branch of the 
pentose phosphate pathway (PPP) and not by the upper glycolysis. 75% of the glucose was 
converted to lactate that was then secreted. The remaining glucose was converted to pyruvate that 
was transported to the mitochondria. In previous studies of this CHO-K1 cell line, we found that 
partial glycolytic channeling resulted in two cytosolic pyruvate pools (Nicolae et al., 2014b; 
Wahrheit et al., 2014b), a phenomenon observed before in CHO cells (Ahn and Antoniewicz, 2013; 
Deshpande, 2008) and also in other mammalian cells (Campanella et al., 2005; Cruz et al., 2001; 
Peuhkurinen et al., 1983; Zwingmann et al., 2001). In the present study, the channeling effect was 
less pronounced, as the two cytosolic pyruvate pools were estimated to be strongly connected 
(Figure 6-3A). However, we found active exchange from pyruvate towards a second cytosolic dead-
end lactate pool. Also, the exchange between the extracellular and intracellular lactate pool was 
significant. This exchange must be considered to describe the MIDs dynamics of intracellular 
lactate and pyruvate. Furthermore, the model was expanded by a mitochondrial lactate pool and 
channeling of mitochondrial pyruvate to describe the difference in labeling between extracellular 
and intracellular lactate. Since the pyruvate dehydrogenase was found to be associated to the inner 
mitochondrial membrane (Simonot et al., 1997), we assumed that a part of the pyruvate entering the 
mitochondria is directly converted to acetyl-CoA, without mixing with the mitochondrial pyruvate 
pool (Figure 6-3B), as it was also modeled by Ahn et al. (Ahn and Antoniewicz, 2013). This setup 
explained the low 13C fractional labeling of intracellular pyruvate and lactate with [U-13C6] glucose 
feeding. The pyruvate with high 13C fractional labeling produced in the glycolysis is consumed in 
the TCA cycle, and cataplerotic reactions replenish the second mitochondrial pyruvate pool with 12C 
from other carbon sources. The existence of mitochondrial lactate dehydrogenase was already 
confirmed in various tissues, e.g. heart mitochondria (Brooks et al., 1999), breast cancer cells 
(Hussien and Brooks, 2011), muscle cells (Hashimoto et al., 2006), liver cells (Brooks et al., 1999; 
Kline et al., 1986), astrocytoma (Lemire et al., 2008) and neurons (Hashimoto et al., 2008). 
Mitochondrial metabolism of lactate occurs when lactate is being metabolized as a carbon source, 
due to its high intracellular concentration (Brooks et al., 1999). However, in our case, lactate was 
secreted by the cells and it constituted a dead end metabolite in the mitochondria. We therefore 
assume its role is to function as a buffer for mitochondrial NADH, a mediator of redox states 
between compartments (Gladden, 2004). 
Glycolytic pyruvate and glutamine constituted the main fuels of the TCA cycle as we previously 
found for this cell line (Wahrheit et al., 2014a; Wahrheit et al., 2014b). The catabolism of essential 
amino acids was limited to a small flux feeding the acetyl-CoA pool. Otherwise, the uptake of 
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essential amino acids was mostly restricted to the requirements for protein synthesis also previously 
found for this cells line (Wahrheit et al., 2014b). 
At the cytosol-mitochondria boundary, most mitochondrial transporters carried significant fluxes. 
The mitochondrial pyruvate carrier (Bricker et al., 2012; Herzig et al., 2012) was the only 
connection between glycolysis and the TCA cycle, providing most of the mitochondrial pyruvate, as 
the mitochondrial malic enzyme activity was estimated to be very low (Figure 6-3B), consistent 
with enzyme assays (Wahrheit et al., 2014b). The aspartate-malate shuttle (Figure 6-3C) exported 
mitochondrial aspartate via the glutamate-aspartate carrier (Cavero et al., 2003; Lane and Gardner, 
2005) and imported cytosolic malate via the malate--ketoglutarate carrier. The cytosolic aspartate 
was converted to oxaloacetate by the activity of aspartate aminotransferase. Cytosolic malate 
dehydrogenase converted oxaloacetate to malate and consumed a part of the cytosolic NADH. 
Malate was also exported via the malate-citrate carrier to export citrate used for fatty acids synthesis 
(Gnoni et al., 2009; Zara et al., 2005), and then was re-imported in the mitochondria via the malate 
carrier (Fiermonte et al., 1999; Mizuarai et al., 2005) (Figure 6-3C). Phosphoenolpyruvate 
carboxykinase activity was modest as a starting point of gluconeogenesis. Complete 
gluconeogenesis did not occur; a fact that can be can be qualitatively seen by the lack of labeling in 
serine and glycine when [U-13C5] glutamine was used as tracer (Figure 6-2B). 
Glutamine uptake in the mitochondria was 3.6 times higher than the net glutamine uptake. This is 
the result of a considerable cytosolic synthesis of glutamine from glutamate (Figure 6-3D).We have 
observed previously for CHO-K1 cells that the glutamine synthesis pathway was active even at high 
glutamine consumption rates (Nicolae et al., 2014b). In the mitochondria, glutamine feeds the TCA 
cycle via glutamate that is converted to -ketoglutarate not by NADH-producing glutamate 
dehydrogenase, but by transamination reactions. Aspartate was synthesized in the mitochondria, 
exported and re-converted to oxaloacetate in the cytosol. Alanine synthesis was estimated to occur 
mostly in the mitochondria. Glutamate transporter carried a high flux exiting the mitochondria 
(Figure 6-3D). Glutamate was procured in the cytosol either via transport from the mitochondria or 
transamination of -ketoglutarate. Cytosolic glutamate was used to fuel glutamine synthesis and as 
an antiport partner to the aspartate-glutamate transporter. Despite the high activity detected in vitro 
for cytosolic isocitrate dehydrogenase (Wahrheit et al., 2014b), this did not reflect in the labeling 
patterns, regardless of the reaction direction that was considered. Even setting the labeling of the 
CO2 pool as a free parameter did not result in the estimation of a significant activity. The role of 
such a high activity of cytosolic isocitrate dehydrogenase could be to control variations of the 
cytosolic NADPH content and stress response (Lee et al., 2002). 
In what concerns NADH and NADPH metabolism compartmentation, the excess of cytosolic 
NADH produced in the glycolysis is consumed by lactate dehydrogenase and the malate shuttle. 
Cytosolic NADPH is provided only by PPP, as the activity of cytosolic malic enzyme was found to 
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be virtually absent, and also not found in enzyme assays (Wahrheit et al., 2014b). The very low 
activity of mitochondrial malic enzyme means little mitochondrial NADPH was produced via this 
route. The need for NADPH in the mitochondria must be supplied by other reactions, most likely 
the transhydrogenase or NADP-dependent isocitrate dehydrogenase (Ceccarelli et al., 2002; Hatefi 
and Galante, 1977). It was shown by previous enzyme assays that around 90% of mitochondrial 
IDH activity is NADP-dependent (Wahrheit et al., 2014b). 
All aminotransferase reactions and also many of the transport reactions were determined to be 
highly reversible (Supplementary Table S1). This determination relies on the shape of the MID 
curves, as it is significantly influenced by reversibility (Nöh and Wiechert, 2011). Transport 
reversibility explained the reduced summed fractional labeling when [U-13C6] glucose was used as a 
substrate, as the intracellular labeling was diluted by the large extracellular pool of non-labeled 
metabolites, consistent with our previous observations (Nicolae et al., 2014b). 
Using intracellular labeling and two labeling experiments improved considerably the resolution and 
quality of estimated fluxes (Supplementary Table S1) compared to our previous study, where we 
have used the same cell line but only extracellular labeling and one labeling experiment in a batch 
reactor cultivation (Nicolae et al., 2014b). We were able to establish the compartmentation of 
alanine synthesis and to solve the cytosolic and mitochondrial isocitrate – -ketoglutarate – 
glutamate cycling. In terms of the extracellular fluxes values, we reiterate our conclusion that they 
are highly dependent on the cultivation conditions. The major differences of this shake flask 
cultivation compared to the reactor cultivation performed in our previous study (Nicolae et al., 
2014b) are: (1) reduced glucose uptake (~80% of the previous), (2) higher lactate production from 
glucose (75% compared to 39%) , (3) smaller TCA cycle flux, (4) reduced catabolism of essential 
amino acids, (5) low mitochondrial malic enzyme activity and (6) reduced uptake of asparagine. We 
also mark the consistencies in the CHO-K1 metabolism: (1) almost complete diversion of glucose-
6-phosphate through the PPP, (2) absence of cytosolic malic enzyme activity, (3) similar 
phosphoenolpyruvate-carboxykinase activities, (4) simultaneous uptake and production of 
glutamine, (5) simultaneous uptake and production of serine and (6) excessive exchange of 
metabolites with the extracellular media. 
The metabolic flux map we have determined is the most complex to date for mammalian cells with 
respect to metabolic compartmentation, mainly because we have considered mitochondrial transport 
of metabolites based on known mitochondrial transporters. The results of studies that use 13CMFA 
to unravel the eukaryotic cell metabolism are highly dependent on the network structure. Any new 
added reaction can lead to completely different estimated fluxes due to parameter interdependency 
and non-linearity characteristics of carbon balances. It is therefore difficult to compare our results 
with previous 13CMFA studies of CHO cells. We have estimated a high activity of the PPP in the 
early exponential growth phase in a previous study that applied INST-13CMFA of CHO cells 
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(Nicolae et al., 2014b). A high PPP was found to be a characteristic of the late non-growth phase 
(Ahn and Antoniewicz, 2011; Sengupta et al., 2011) or late-exponential (Templeton et al., 2013). A 
high production of NADPH is required to counteract the oxidative stress induced by reactive 
oxygen species generated by mitochondrial respiration (Schafer et al., 2009; Vizan et al., 2009). 
 
Figure 6-3. (A) Metabolic fluxes of the central carbon metabolism of CHO-K1 cells in the 2 – 18 h period 
of cultivation estimated using non-stationary 13C metabolic flux analysis. The thickness of the lines is 
proportional to the net flux values. The full arrows indicate the direction of the net flux, and the empty 
arrows indicate a reversible flux. Subscripts meaning: c – cytosolic; ex – extracellular; m – mitochondrial; 
Abbreviations: AcoA – acetyl-CoA; AKG – -ketoglutarate; ALA – alanine; ASN – asparagine; ASP – 
aspartate; CIT – citrate; FUM – fumarate; GLC – glucose; G6P – glucose-6-phosphate; PG – 
phosphoglycerate; PEP – phosphoenolpyruvate; GLN – glutamine; GLU – glutamate; GLY – glycine; ICI – 
isocitrate; ILE – isoleucine; LAC – lactate; LEU – leucine; LYS – lysine; MAL – malate; MET – 
methionine; OAA – oxaloacetate; PHE – phenylalanine; PYR – pyruvate; SER – serine; SUC – succinate; 
THR – threonine; TYR – tyrosine; VAL – valine.  
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Figure 6-3. (B) Glycolysis and pyruvate metabolism compartmentation in CHO-K1 cells. (C) Metabolism 
of oxaloacetate (OAA), aspartate (ASP) and malate (MAL) in CHO-K1 cells. (D) Metabolism of glutamine 
(GLN), glutamate (GLU), -ketoglutarate (AKG) and citrate (CIT) in CHO-K1 cells. The thickness of the 
lines is proportional to the net flux values. The full arrows indicate the direction of the net flux, and the 
empty arrows indicate a reversible flux. Subscripts meaning: c – cytosolic; ex – extracellular; m – 
mitochondrial; Abbreviations: AcoA – acetyl-CoA; AKG – -ketoglutarate; ALA – alanine; ASN – 
asparagine; ASP – aspartate; CIT – citrate; FUM – fumarate; GLC – glucose; G6P – glucose-6-phosphate; 
PG – phosphoglycerate; PEP – phosphoenolpyruvate; GLN – glutamine; GLU – glutamate; GLY – glycine; 
ICI – isocitrate; ILE – isoleucine; LAC – lactate; LEU – leucine; LYS – lysine; MAL – malate; MET – 
methionine; OAA – oxaloacetate; PHE – phenylalanine; PYR – pyruvate; SER – serine; SUC – succinate; 
THR – threonine; TYR – tyrosine; VAL – valine. 
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6.4.5 Estimated intracompartmental pools 
The use of INST-13CMFA and the MIDs of intracellular metabolites required the simultaneous 
estimation of fluxes, reversibilities and intracompartmental concentrations of certain metabolites. 
Using the available sampled intracellular MIDs (Figure 6-2), we estimated the intracompartmental 
concentrations of 7 metabolites (Figure 6-4) and the intracellular concentration of two more, i.e. 
serine and glycine (Figure 6-4A). Interestingly, pyruvate and lactate cytosolic concentrations were 
very low (Figure 6-4A) and considerably high in the mitochondria. Lactate and pyruvate 
concentration distributions and the considered channeling effects explained the difference between 
extracellular and intracellular labeling in lactate when [U-13C6] glucose was used (Figure 6-2A). 
Malate and fumarate had almost identical MID dynamics (Figure 6-2). This makes simultaneous 
determination of intracompartmental concentrations impossible. We set fumarate intramitochondrial 
concentration to a low value (0.1 mmol/L cell). The estimated malate intracompartmental 
concentration had an upper value of 5.2 mmol/L cell in the mitochondria and 3.9 mmol/L cell in the 
cytosol, and lower values of 2.1 mmol/L cell and 0.8 mmol/L cell respectively. Considering that 
high exchange between compartments equilibrates the labeling between compartments, the exact 
values of malate concentration for each compartment cannot be determined. The -ketoglutarate 
concentration was high in the cytosol, and citrate was concentrated in the mitochondria. The high 
cytosolic -ketoglutarate concentration might provide another reason why there was no estimated 
activity of cytosolic isocitrate dehydrogenase towards -ketoglutarate synthesis. Alanine had 
comparable concentrations in both compartments. Aspartate was concentrated in the mitochondria, 
but only the upper threshold of the cytosolic concentration could be estimated. We also determined 
a relatively high cytosolic concentration of serine and glycine. The most concentrated metabolite 
was glutamate, with a mitochondrial concentration reaching almost 50 mmol/ L cell, which might 
explain why glutamate is transported from the mitochondria. However, the cytosolic concentration 
of glutamate could not be estimated. 
All metabolites except -ketoglutarate were more concentrated in the mitochondria than in the 
cytosol. Also, the estimated concentrations of amino acids are higher than reported intracellular 
concentrations for CHO cells (Hansen and Emborg, 1994a; Lu et al., 2005). By applying INST-
13CMFA, the average intracompartmental concentrations might be overestimated as an effect of 
assigning negligible values to concentrations that are not estimated. However, since the dynamics of 
the MIDs depends on the pool size / flux ratio, the intracompartmental concentrations cannot be 
higher than their estimated upper boundary. Parameter estimation using INST-13CMFA instead of 
experimental determination has the advantage that the concentrations are estimated in vivo, without 
the risk of metabolite leakage during quenching and extraction (Dietmair et al., 2010; Sellick et al., 
2009; Wahrheit and Heinzle, 2013; Wahrheit and Heinzle, 2014). In addition, INST-13CMFA 
provided a method to estimate intracompartmental concentrations of key metabolites of the central 
carbon metabolism, which was not yet achieved experimentally. 
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Figure 6-4. Cytosolic and mitochondrial concentrations of metabolites estimated using non-stationary 13C 
metabolic flux analysis. The error bar represents the 95% confidence interval evaluated by refitting the 
model until the minimized objective function took the value of 2 (0.95, nr. experimental points – nr. 
parameters). Abbreviations: AKG – -ketoglutarate; ALA – alanine; ASP – aspartate; CIT – citrate; GLU – 
glutamate; GLY – glycine; LAC – lactate; MAL – malate; PYR – pyruvate; SER – serine. 
6.5 Conclusions 
We estimated the fluxes and reversibility for the most complex metabolic network to date by 
applying INST-13CMFA and using the intracellular and extracellular MID dynamics of metabolites 
obtained from two parallel labeling experiments with [U-13C6] glucose and [U-
13C5] glutamine as 
labeled substrates. We used the labeling of MIDs during the exponential growth phase in the 2 – 
18 h interval when the cells were at metabolic steady state. In the first 2 h of the labeling 
experiment, the MIDs of intracellular metabolites indicated a stress response to the cultivation 
condition. After 18 h, the metabolic state of the cells changed, visible by a shift in the MIDs of the 
metabolites. Most of the parameters were determined with narrow confidence intervals. They 
included: (1) metabolic fluxes in cycles and alternative pathways, (2) flux reversibility and (3) 
intracompartmental concentrations. This confirms that INST-13CMFA is a powerful method that can 
resolve the metabolic fluxes in a network that included multiple mitochondrial transporters, reaction 
reversibility, metabolite exchange with the media and metabolite channeling. The activity at the 
mitochondria – cytosol boundary is complex, involving intense metabolite trafficking and cycling. 
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Malate and glutamate are both imported and exported via various mitochondrial carriers with the 
purpose of managing NADH in the two compartments and providing antiport partners for other 
metabolites. The anaplerotic and cataplerotic fluxes were negligible with phosphoenolpyruvate-
carboxykinase being the highest cataplerotic flux. The aspartate-malate shuttle consumed cytosolic 
NADH and produced mitochondrial NADH. Aspartate and alanine were synthesized in the 
mitochondria, and then transported to the cytosol. However, this is only a single metabolic state of 
the CHO-K1 cells. We have evidenced that there are significant differences between the metabolic 
fluxes in CHO-K1 cells in different cultivation setups (shake flask vs. reactor), even if the two 
cultivations used the same cell line and the same media and the sampling was done during the 
exponential growth phase.  
A most interesting finding was related to the different labeling patterns in intracellular and 
extracellular lactate, which could not be explained by cytosol-mitochondria compartmentation. We 
included four pyruvate pools, two dead-end lactate pools and lactate production channeling for 
modeling the observed difference in labeling. Our results show that a large mitochondrial lactate 
pool is maintained, most likely to control the mitochondrial NADH content. Also, due to channeling 
of lactate production, the cytosolic lactate concentration is very small. Because the fitting of 
intracellular lactate left room for improvement, it is possible that the network configuration around 
the pyruvate nodes consists of more complex microcompartmented structures (al-Habori, 1995). 
Such complexity is both a hindrance and an opportunity for INST-13CMFA to characterize 
metabolic networks. We therefore believe that a systems biology approach that combines biological 
knowledge from experiments that unravel the spatial structure of the mammalian cell metabolism 
with realistic mathematical models is the strategy to follow when studying metabolic networks. 
Ideally, such strategy accepts feedback for guiding future experiments and creating new modeling 
paradigms that include the spatial organization of the metabolism.  
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7 High-throughput respiration screening of single 
mitochondrial substrates using permeabilized CHO cells 
7.1 Abstract 
We present a high-throughput respiration screening for functional in situ mitochondrial studies in 
permeabilized CHO cells. We verified transporter-mediated uptake and metabolization of single 
mitochondrial substrates and substrate combinations. The determination of oxygen uptake rates 
allowed a quantitative comparison between different conditions and a distinction of substrates into 
three groups providing an insight into TCA cycle regulation. Metabolic regulation was different for 
reactions (i) in the first half, (ii) in the second half and (iii) at the initiation of the TCA cycle. The 
mitochondrial metabolization of citrate, isocitrate, glutamine and glutamate was highly controlled 
by the energy state. In contrast, the metabolization of -ketoglutarate, succinate, fumarate and 
malate was less controlled. Metabolization of pyruvate was very strictly regulated by several 
independent mechanisms. Furthermore, it was restricted by the availability of oxaloacetate required 
for the citrate synthase reaction. A moderate stimulation of pyruvate metabolization could be 
accomplished by feeding both pyruvate and aspartate simultaneously. The presented high-
throughput respiration screening for functional mitochondrial studies allows differentiated and 
comprehensive conclusions about mitochondrial metabolic activities including TCA cycle 
regulation. Our novel approach provides a profound basis for the investigation of biological, 
biotechnological, medical, and pharmacological questions with mitochondrial background on a 
larger scale. 
 
This chapter was submitted for publication as 
Wahrheit J, Nonnenmacher Y, Sperber S, Heinzle E. High-throughput respiration screening of 
single mitochondrial substrates using permeabilized CHO cells 
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7.2 Introduction 
The physiological function of mitochondria is essential for cellular energy metabolism and 
apoptosis, controlling life and death of a cell. Therefore, the assessment of mitochondrial function is 
of great importance for the biotechnological application of eukaryotic organisms. Even more, 
mitochondrial dysfunction has become central in the study and diagnosis of a variety of diseases. 
Essential metabolic pathways of mitochondria include oxidative phosphorylation, TCA cycle, 
initiation of gluconeogenesis, anaplerosis, -oxidation of fatty acids, amino acid metabolism, C1-
metabolism, and the urea cycle (Michal and Schomburg, 2012; Wahrheit et al., 2011). Mitochondria 
are also the primary site for generation and detoxification of reactive oxygen species (ROS) and are 
thus the major cause for oxidative stress (Adam-Vizi and Tretter, 2013). 
The maintenance of an efficient energy metabolism as well as the prevention of apoptosis and 
oxidative stress are particularly critical factors in the energy-intensive production of therapeutic 
proteins using mammalian cell factories (Kim et al., 2012). A profound understanding of the CHO 
mitochondrial metabolism will assist in a more targeted and rational development of efficient 
bioprocesses for the manufacture of biopharmaceuticals. Mitochondrial dysfunction is associated 
with ageing and a wide range of severe diseases including neurodegenerative disorders (Albers and 
Beal, 2000; Chaturvedi and Flint Beal, 2013; Coskun et al., 2012; Saks et al., 1998), cancer (Fogg et 
al., 2012; Martin-Requero et al., 1986; Modica-Napolitano and Singh, 2004; Wallace, 2012), 
diabetes (Newsholme et al., 2012), metabolic syndrome and cardiovascular diseases (James et al., 
2012). In particular an impaired energy metabolism and/or an increased production of ROS are 
thought to be responsible for the onset of pathological conditions (Lenaz, 2001).  
In this study, we present a high-throughput method using permeabilized cells and respiration 
analysis for investigation of the mitochondrial metabolism. The application of selectively 
permeabilized cells and tissues is well established for in situ mitochondrial studies (Kuznetsov et 
al., 2008). Although the assessment of mitochondrial function in vivo has the highest physiological 
relevance, the investigation of intact cells is often not possible due to impermeability to many 
mitochondrial substrates and effectors. The in situ investigation of mitochondria is a useful and 
valuable trade-off between the use of intact cells and isolated mitochondria. Mitochondria within 
selectively permeabilized cells are directly accessible by effectors, thus allowing a comparable 
experimental control as for isolated mitochondria. Many cellular structures and interactions, e.g. 
with the cytoskeleton, are preserved after permeabilization, representing a situation that is closer to 
the actual in vivo situation. Selective permeabilization is faster, easier and requires less cell material 
than the isolation of mitochondria. Furthermore, artifacts due to the isolation procedure itself, e.g. 
mitochondrial damage, biased loss of mitochondrial subpopulations, are avoided. Therefore, 
selectively permeabilized cells represent a convincing model system for mitochondrial studies. It 
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provides a balance between ease of manipulation, precise experimental control and physiological 
relevance (Kuznetsov et al., 2008). 
Respiration analysis as a general measure for mitochondrial function and dysfunction goes primarily 
back to the studies of Chance and Williams in the 1950s (Gosalvez et al., 1974). Since then, it has 
become well-established in the study of physiological and pathophysiological conditions related to 
mitochondrial metabolism. In classical studies, respiration is measured in an oxygraph involving a 
closed, stirred reaction vessel and a Clark electrode. Mitochondrial function is usually assessed by 
testing the functionality of different respiratory chain complexes using a substrate-titration approach 
(Frezza et al., 2007; Kuznetsov et al., 2008). Such closed systems provide the highest precision and 
sensitivity, yet require substantial experimental effort. Also open systems can be used for the 
determination of respiration rates when the volumetric mass (oxygen) transfer coefficient (kLa) is 
known for the applied system (John et al., 2003). Microtiter plate-based assays for monitoring 
dissolved oxygen concentrations have proven to be a valuable tool for the assessment of cell 
viability and mitochondrial function (John et al., 2003), e.g. in toxicity screenings (Beckers et al., 
2009; Noor et al., 2009; Strigun et al., 2012) and medium optimization studies (Deshpande et al., 
2004). It has been used in high-throughput studies of mitochondrial toxicity, although the oxygen 
consumption has not been quantified in absolute terms (Porceddu et al., 2012). 
Here, we apply high-throughput quantification of mitochondrial oxygen consumption using 
microtiter plates with optical oxygen sensors for an in-depth investigation of mitochondrial 
metabolism. In classical mitochondrial studies, the effects of different single substrates are not 
considered. We provide a more differentiated analysis turning the focus towards TCA cycle 
activities, feeding reactions and metabolic reactions not directly involved in the formation of NADH 
or FADH2. A range of metabolites feeding the TCA cycle were selected according to known 
mitochondrial transport mechanisms described in literature (Arco and Satrustegui, 2005; Michal and 
Schomburg, 2012; Palmieri, 1994; Palmieri et al., 1993) and evidence of enzyme activity based on 
previous metabolic flux analysis studies, e.g. active reactions of pyruvate carboxylase and malic 
enzyme in CHO-K1 cells (Nicolae et al., 2014b; Wahrheit et al., 2014b). Selected metabolites were 
tested regarding their ability to stimulate respiration in permeabilized CHO suspension cells. The 
resulting oxygen uptake rates are a function of their transporter-mediated uptake and 
metabolization. The presented high-throughput set-up allows the parallel screening of a wide range 
of different substrates, combinations of substrates, and experimental conditions and most 
importantly a quantitative comparison between them. This represents a particular advancement 
since it facilitates a distinguished and comprehensive study of various mitochondrial activities. This 
provides a profound basis for the investigation of a wide range of biological, biotechnological, 
medical, and pharmacological questions. It allows differentiated conclusions about activities of 
mitochondrial transporters and enzymes and reflects the regulation of TCA cycle reactions. Such 
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detailed investigations will be very useful in complementing classical mitochondrial studies in 
future applications. 
7.3 Materials and methods 
7.3.1 Cell culture 
CHO-K1 cells were cultivated in baffled shake flasks (250 ml, Corning, New York, USA) in a 
shaking incubator (Innova 4230, New Brunswick Scientific, Edison, NJ, USA) at 135 rpm (2 inches 
orbit), 37°C and 5% CO2. The medium used was chemically defined, serum-free TC-42 medium 
(TeutoCell, Bielefeld, Germany), supplemented with 6 mM L-glutamine from a 240 mM stock 
solution in dH2O. The cells were passaged at the latest 72 h after inoculation and seeded with a cell 
density of 4 - 5 × 105 cells/ml. 
7.3.2 Preparation of mitochondrial medium 
The mitochondrial medium used in this study was derived from different media used for the 
assessment of respiration in isolated mitochondria (Madeira, 2012) and optimized with respect to 
osmolarity and ionic strength. The composition of the mitochondrial medium was as follows: 
9.6 mM K2HPO4, 2.4 mM KH2PO4, 80 mM KCl, 75 mM sorbitol, 2 mM MgCl2 and 100 µM EGTA. 
pH was set to 7.4 with 5 N KOH. 
7.3.3 Microscopic characterization of permeabilized CHO cells 
For microscopic investigation of permeabilized CHO cells a IX70 microscope (Olympus, Hamburg, 
Germany) linked with a digital CC12 camera (Olympus, Hamburg, Germany) was used. The 
duration of the permeabilization process was monitored with two different staining methods. For 
recording of the entry of Trypan blue into the cells, the cell suspension (10 × 106 cells/ml) was 
mixed simultaneously with 0.01% (w/v) digitonin and Trypan blue dye. For recording the release of 
Calcein (Invitrogen, Darmstadt, Germany) from the cells, CHO-K1 cells were stained with 4 µg/ml 
Calcein-AM in TC-42 medium prepared from a stock solution of 1 mg/ml in DMSO for 20 min at 
37°C and washed twice with PBS. The diffusion of the blue dye into the cells and the dilution of the 
fluorescent dye (excitation/emission: 495 nm/515 nm) visualize the membrane permeabilization of 
the cells. In both cases, 3 µl of cell suspension was inserted into a Countess® Cell Counting 
Chamber Slide (Invitrogen, Darmstadt, Germany) for recording of videos. The intactness of the 
mitochondrial membrane potential was verified by staining with Rhodamine 123 
(excitation/emission: 535 nm/585 nm). A working solution of 1 mM Rhodamine 123 in 
mitochondrial medium was prepared from a 25 mM stock solution in DMSO. 5 × 106 cells/ml were 
stained with 20 µM Rhodamine 123 by incubation at 37°C (protected from light) and washed in 
mitochondrial medium (centrifugation for 5 min at 380 × g). Cells were either first permeabilized 
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and then stained or pre-stained followed by permeabilization. For counterstaining of nuclei with 
DAPI (100 nM) (excitation/emission: 358 nm/461 nm) permeabilized cells were washed twice in 
mitochondrial medium. The stability of permeabilized cells and mitochondrial functionality in 
mitochondrial medium was investigated by checking the morphology of Trypan Blue and 
Rhodamine 123 stained cells 2 h and 3 h after permeabilization. Between sampling, the 
permeabilized cell suspension was maintained in a shaking incubator to avoid sedimentation of 
cells. 
7.3.4 Experimental set-up of respiration measurements 
CHO-K1 cells were harvested from a culture in the early exponential growth phase (48 - 50 h after 
inoculation) by centrifugation (5 min, 125 × g, Labofuge 400R, Function Line, Heraeus 
Instruments, Hanau, Germany) and resuspended in mitochondrial medium. The cell number was 
determined using an automated cell counter (Countess® Automated Cell Counter, Invitrogen, 
Karlsruhe, Germany) and set to 4 × 106 cells/ml. Selective permeabilization was performed by 
adding 0.005 % (w/v) digitonin from a 0.5 % stock solution in dH2O and verified under the 
microscope using the Trypan blue exclusion method. 100 µl of the permeabilized cell solution were 
transferred per well into a 96-well round-bottom OxoPlate (PreSens, Regensburg, Germany) 
containing 100 µl of the respective substrate solutions (2-fold concentrated in mitochondrial 
medium). The respiration on each substrate (or combination of substrates) was assessed in 
triplicates, all solutions were pre-warmed to 37°C prior to use. The final cell concentration was 
2 × 106 cells/ml. Final concentrations of tested substrates were 4 mM carbon substrate and 2 mM 
ADP if not stated otherwise. 
Dissolved oxygen concentration was measured every 208 s in a fluorescence-reader (FLUOstar, 
BMG Labtechnologies, Offenburg, Germany) with an integrated shaker-unit and temperature 
control at 37°C, placed in an airtight box with 5 % CO2. Before each measurement, the plate was 
shaken for 30 s (140 rpm, 4 mm orbit) in order to prevent sedimentation of the cells. Calibration and 
calculation of dissolved oxygen levels at each time point was performed as described in the 
literature (John et al. 2003). 
7.3.5 Determination of the oxygen transfer coefficient kLa 
Estimation of the oxygen transfer coefficient kLa was performed using a sodium dithionite method 
(John et al. 2003). An oxygen-free solution was prepared by addition of 10 µl 2% (w/w) sodium 
dithionite to 190 µl dH2O in a 96-well OxoPlate. Oxygen measurements in the fluorescence reader 
for kLa determination were carried out in exactly the same way as respiration measurements. The 
dynamics of the re-saturation process were recorded by dissolved oxygen measurement using 
exactly the same set-up and protocol as described for the OUR estimation. This was performed in 
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triplicates for wells at different positions of the microtiter plate to prevent deviations caused by 
evaporation. The following equation (1) was computed in Berkeley Madonna: 
   
  
          
       (1) 
CL : oxygen concentration in the liquid phase 
CL
* : saturation concentration of oxygen in the liquid phase 
The oxygen transfer coefficient was determined by fitting this model to the experimental data using 
the curve fit tool of Berkeley Madonna with kLa as the only variable. 
Calculation of oxygen uptake rates (OUR) 
A liquid phase oxygen balance was set up as follows: 
   
  
         
              (2) 
OUR : maximum specific oxygen uptake rate 
X : cell concentration 
Maximum specific OUR was determined by fitting the model to the experimental data (Figure 7-2). 
Prior to the fitting process, all values were converted from percent oxygen saturation to the 
respective molar concentration based on a maximum solubility for oxygen in water of 0.209 mmol/l 
(at 37°C). For the fitting process, CL
* was set to 0.209 mmol/l. The maximum OUR was determined 
using a moving window technique. The following criteria were used for parameter estimation: (i) 
use at least 5 consecutive data points, (ii) integrate Equation (2) over respective time period, (iii) 
vary OUR and initial concentration of dissolved oxygen until obtaining a least square fit. During 
this procedure, the time window was varied to span the experimental space of each experiment. The 
maximal value of OUR was then used for further evaluations. MATLAB was used for these 
calculations. The initial delay in the decrease of the dissolved oxygen signal is most likely caused 
by small temperature deviations originating from pipetting procedures that had to be carried out at 
room temperature. As stated above, all component solutions were kept at 37 °C in the incubator 
prior to their use. 
7.4 Results and Discussion 
7.4.1 Microscopic characterization of permeabilized CHO cells 
Selective plasma membrane permeabilization using digitonin generates functioning mitochondria 
enclosed in a cell ghost (Bahnemann et al., 2014; Kuznetsov et al., 2008). Since CHO cells have not 
commonly been used as biological system in mitochondrial studies, we performed different 
stainings to characterize the permeabilization of CHO suspension cells as quality control for the 
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preparation of intact, functional mitochondria. The duration of the permeabilization process was 
monitored by recording (1) the entry of Trypan Blue (MW 872.88 g/mol) into and (2) the release of 
Calcein (MW 622.55 g/mol) out of the permeabilized cells. Representative video snapshots are 
shown in Figure 7-1A and B. The staining of the permeabilized cells with Trypan Blue (Figure 7-
1A) as well as the dilution of the fluorescent label Calcein (Figure 7-1B) was completed within 16 
seconds. Calcein-stained cells without digitonin treatment were recorded as control to verify that the 
decrease in fluorescence intensity is due to dilution into the medium and not caused by a bleaching 
of the dye. Rhodamine 123 is a dye that specifically labels mitochondria depending on the 
electrochemical gradient across the inner mitochondrial membrane (Chen, 1988). We verified the 
mitochondrial integrity and intactness of the mitochondrial membrane potential in permeabilized 
cells by Rhodamine 123 staining (Figure 7-1C-E). Rhodamine 123 specifically labeled the 
mitochondria surrounding the nucleus as demonstrated by a counterstaining of the cellular nucleus 
using DAPI (Figure 7-1C). It made no difference if the cells were stained before or after 
permeabilization (Figure 7-1D). Furthermore, we verified the stability of the ghost cells while 
incubating in mitochondrial medium in a shaking incubator (Figure 7-1E). The ghost cell 
suspension remained mostly homogenous. After 3 h a little more aggregates of cells were observed. 
The permeabilized cells have a characteristic morphology that was maintained over at least 3 h. 
They are enlarged and swollen compared to non-permeabilized cells and have a knaggy, uneven 
surface (Figure 7-1E, magnification pictures). As shown in the little inserts (overlay of bright field 
and fluorescence pictures of Rhodamine 123 staining) in Figure 7-1E, the mitochondrial membrane 
potential remained intact during the investigated time period. In contrast, the mitochondria lost their 
metabolic activity when centrifuged after permeabilization most likely due to increased 
susceptibility to shear stress. 
Following conclusions can be drawn from the microscopic characterization of permeabilized CHO 
cells: (1) Selective permeabilization of CHO suspension cells with digitonin is a very fast process 
within the range of seconds. A longer incubation period is not necessary to complete the 
permeabilization. (2) Molecules can freely diffuse in and out of the cell ghost as demonstrated by 
Trypan blue entry and Calcein release. This indicates that soluble components in the extracellular 
medium and the cytosol are quickly equilibrated with each other. (3) Intactness of the mitochondrial 
membrane potential was verified by Rhodamine 123 staining indicating mitochondrial integrity and 
functionality. (4) The cell ghosts maintain a stable cellular morphology containing functional 
mitochondria for at least 3 h during incubation in mitochondrial medium in a shaking incubator. 
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Figure 7-1 Microscopic characterization of selectively permeabilized CHO suspension cells. (A) 
Monitoring of the permeabilization process by Trypan blue entry into permeabilized cells. (B) Monitoring 
of the permeabilization process by Calcein release from pre-stained permeabilized cells. (C) Rhodamine 
123 staining of mitochondria with an intact membrane potential and DAPI staining of cellular nuclei. (D) 
Rhodamine 123 staining of functional mitochondria before and after permeabilization. (E) Morphology of 
Trypan blue stained CHO cell ghosts 0, 120 min, and 180 min after permeabilization. In the small inserts, 
Rhodamine 123 stained permeabilized cells (overlay of bright field and fluorescence pictures) at the 
respective time points are depicted.  
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7.4.2 Screening of mitochondrial substrates with and without ADP stimulation 
We tested different TCA cycle intermediates and selected metabolites feeding into the TCA cycle 
for their ability to stimulate mitochondrial respiration in permeabilized cells. Since it was not 
possible to centrifuge and wash the permeabilized cells without loss of metabolic activity, two 
additional controls were included in order to test the experimental set-up: (1) permeabilized cells in 
mitochondrial medium without substrate and (2) permeabilized cells in mitochondrial medium 
containing only 2 mM ADP but no carbon substrate (Figure 7-2 A, NO SUBSTRATE). No oxygen 
consumption was determined for both negative controls. As reckoned by the microscopic 
characterization of permeabilized cells, the free cytosolic components are quickly equilibrated with 
the surrounding medium after plasma membrane permeabilization. In the applied experimental set-
up, the cytosolic components are approximately diluted by a factor 1000 (volume of 4  105 cells ~ 
2.3  10-7 L; reaction volume in well = 2  10-4 L). Since we observed no respiration in the 
controls, we demonstrated that residual metabolites present in the crude ghost cell suspension are 
sufficiently diluted to not affect mitochondrial respiration studies. 
Mitochondrial respiration was measured on all tested TCA cycle intermediates, citrate (CIT), 
isocitrate (ISO), -ketoglutarate (AKG), succinate (SUC), fumarate (FUM) and malate (MAL), as 
well as on pyruvate (PYR), glutamate (GLU) and glutamine (GLN) feeding into the TCA cycle 
(Figure 7-2A, w/o ADP). Furthermore, for these substrates, a substantial stimulation of respiration 
was achieved by adding 2 mM ADP (Figure 7-2A, w/ ADP). Respiration on PYR with and without 
ADP-stimulation was much lower than for all other substrates. On aspartate (ASP) as substrate, 
respiration was found neither with nor without addition of ADP. 
ISO, AKG, MAL, PYR, GLU can be classified as complex I substrates feeding NADH generating 
reactions, while the complex II substrate SUC directly feeds FADH2 into the respiratory chain. The 
other tested substrates (CIT, FUM, GLN, ASP) do not directly stimulate NADH or FADH2 
generating reactions. They may, however, be converted into complex I or complex II substrates, 
resulting in an indirect stimulation of respiration. Respiration on specific substrates proves their 
transporter-mediated uptake into the mitochondria and indicates activity of the metabolic reactions 
required to metabolize these substrates. A significant increase in the respiration rates upon ADP 
stimulation indicates coupling of electron transport and oxidative phosphorylation. It provides 
evidence for the functionality of the mitochondria within the permeabilized cells (Brand and 
Nicholls, 2011). 
Interestingly, for AKG, FUM, MAL, GLU and GLN, two distinct phases could be distinguished 
upon ADP stimulation. A first phase of strong respiration that was even increasing was followed by 
a second phase characterized by a nearly stabilized respiration as seen by almost constant but low 
dissolved oxygen concentration. The second phase represents a state of ADP depletion as was 
confirmed by a rough estimation of ADP consumption based on OUR and a P/O quotient of 2.5. 
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Due to ATP hydrolyzing reactions, ADP will not be completely exhausted, however, but is limiting 
as ATP synthase substrate. 
The impact of different ADP concentrations was investigated for selected substrates that had shown 
a response in the first respiration screening (Figure 7-2B). We observed an increase in respiration 
with increasing ADP concentrations for ISO, AKG, MAL, and GLN. For PYR, however, respiration 
was not significantly different upon stimulation with different ADP concentrations. In addition, we 
compared the respiration profiles of the first screening with the results of the 2 mM ADP profile of 
the second screening to validate the reproducibility of the experimental set-up (Figure 7-2C). We 
obtained highly reproducible respiration profiles with low standard deviations for separate 
biological experiments. 
Since the application of ASP alone did not stimulate respiration, we hypothesized that we might get 
a response if we add a suitable reaction partner. ASP can enter the mitochondria via the 
aspartate/glutamate antiporter. Inside the mitochondria, it can be converted into oxaloacetate (OAA) 
which is an essential reaction partner for acetyl-CoA in the condensation to CIT via the citrate 
synthase (CS) reaction. No mammalian transporter for OAA has been described (Arco and 
Satrustegui, 2005; Michal and Schomburg, 2012). Thus, we tested the combination of the substrates 
PYR and ASP. The combination of 2 mM PYR with 2 mM ASP resulted in stronger respiration than 
2 mM PYR alone (Figure 7-2D). 
 
 
 
 
 
Figure 7-2 Mitochondrial respiration in permeabilized CHO cells upon stimulation with different 
substrates. (A) Respiration on single metabolites (4 mM) without ADP stimulation (w/o ADP) and upon 
stimulation with 2 mM ADP (w/ ADP). (B) Respiration on selected metabolites (4 mM) upon stimulation 
with 1 mM, 2 mM or 4 mM ADP. (C) Reproducibility of respiration profiles between separate experiments 
(n = 2). Respiration on selected metabolites (4 mM) upon stimulation with 2 mM ADP. (D) Respiration on 
2 mM aspartate, 2 mM pyruvate, and the combination of 2 mM pyruvate with 2 mM aspartate without ADP 
(w/o ADP) and upon stimulation with 2 mM ADP (w/ ADP). In A, B and D mean values of dissolved 
oxygen (DO) [%] with standard deviations of three replicates using the same cell material are shown. In C 
mean values of DO [%] with standard deviations of two biological replicates from experiments with 
separate preparation of permeabilized CHO cells are shown. 
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7.4.3 Comparison of oxygen uptake rates (OUR) between different 
mitochondrial substrates and substrate combinations 
Knowledge on the oxygen transfer coefficient kLa for the applied experimental system facilitates the 
calculation of specific oxygen uptake rates (OUR) (see material and methods section) and a 
quantitative comparison between different substrates and conditions. The different tested substrates 
covered a wide range of OUR (Figure 7-3). The highest OUR were measured for the substrate SUC 
(w/o ADP 3.59 ± 0.35 fmol/(cell  min); w/ ADP 6.65 ± 0.58 fmol/(cell  min)), the lowest for 
PYR (w/o ADP 0.48 ± 0.05 fmol/(cell  min); w/ ADP 1.50 to 1.76 fmol/(cell  min)). This 
accounts for a difference of 4 to 7 times stronger respiration on SUC compared to PYR. The 
combination of 2 mM PYR and 2 mM ASP resulted in a 1.4 to 2.4 times increase of OUR compared 
to 4 mM PYR alone. Most substrates used could be classified into two groups of metabolites 
characterized by a similar response. OUR on CIT, ISO, GLU and GLN were in a similarly low 
range between 0.70 and 0.84 fmol/(cell  min) corresponding to only 20% of the respiration on 
SUC (Figure 7-3). In contrast, the substrates AKG, FUM and MAL were characterized by similarly 
high OUR in a range between 2.71 and 2.77 fmol/(cell  min), which was only 25% lower than the 
respiration on SUC. In accordance with the proposed grouping, stimulation of respiration by ADP 
was modest for AKG, FUM and MAL and while a substantial increase of OUR upon ADP 
stimulation was determined for CIT, ISO, GLU and GLN. OUR increased with increasing ADP 
concentrations approaching a saturation effect. However, on PYR as substrate the stimulation effect 
of different ADP levels was negligible. 
The OUR and stimulating effects of ADP determined in our study were in a similar range with 
literature data presented for permeabilized CHO cells (Kim et al., 2006) and other mammalian cells 
(Clerc and Polster, 2012; Duicu et al., 2013; Manko et al., 2013; Picard et al., 2012) or isolated 
mitochondria from different tissues (Gottlieb et al., 2002; Yao et al., 2003). However, an absolute 
comparison between different studies is difficult since the respiration rates are specific for substrates 
or substrate combinations, tissue, species and cell line and also dependent on experimental 
conditions and history of cells, e.g. the training state and fitness level of cells (Brand and Nicholls, 
2011; Gnaiger, 2009; Gnaiger, 2012). Furthermore, it has been shown, that the mitochondrial 
affinity to ADP is substantially lower in situ in permeabilized cells and closer to the in vivo situation 
compared to isolated mitochondria. In addition, the apparent KM values for ADP were shown to be 
strongly tissue-dependent (Kuznetsov et al., 1996; Kuznetsov et al., 2008; Saks et al., 1993; Saks et 
al., 1998). 
  
Chapter 7 High-throughput respiration screening 
 
165 
 
Figure 7-3 Oxygen uptake rates on different mitochondrial substrates. Oxygen uptake rates (OUR) 
[fmol/(cell  min)] in permeabilized CHO cells on different carbon substrates (4 mM) (w/o ADP) and 
upon stimulation with 1 mM, 2 mM or 4 mM ADP. Shown are mean values and standard deviations of 
three technical replicates. 
7.4.4 Partial reconstitution of the mitochondrial metabolism 
In the following section, we illustrate what information can be derived from such straightforward 
investigations. In contrast to the vast majority of previous mitochondrial studies, the aim of this 
study was neither testing the functionality of different respiratory chain complexes nor evaluating 
maximum capacities of oxidative phosphorylation nor a detailed study of mitochondrial transport. 
We focused on investigating the effects of single mitochondrial substrates and a partial 
reconstitution of the mitochondrial metabolism, i.e. mainly the TCA cycle, feeding reactions and 
mitochondrial transport. The application of substrate combinations, with redundant effects, e.g. 
PYR, MAL and GLU directly yielding NADH for stimulating complex I, as usually applied in 
former studies (Gnaiger, 2012) of mitochondrial bioenergetics, does not allow a distinction of single 
substrate effects. Differences between tested substrates can be explained as a function of enzyme 
activities, transport capacity, as well as specific regulatory events. 
7.4.5 Distinction of low control and high control substrates 
The comparison of OUR between different single substrates enabled a classification into different 
groups. We determined high OUR and relatively low stimulation by ADP for the substrates AKG, 
SUC, FUM and MAL. In contrast, CIT, ISO, GLU and GLN were characterized by low OUR and a 
large stimulation of respiration by ADP addition. This clustering corresponds to a group of highly 
controlled substrates and a group of substrates with lower control (Figure 7-4). PYR and the 
combination of PYR and ASP were characterized by both low OUR and a modest ADP stimulation 
and are therefore discussed separately. 
Chapter 7 High-throughput respiration screening 
 
166 
The four major regulatory enzymes known to control the TCA cycle are (1) the pyruvate 
dehydrogenase (PDH), (2) the citrate synthase (CS), (3) the isocitrate dehydrogenase (IDH), and (4) 
the -ketoglutarate dehydrogenase (AKGDH). These enzymes are strictly regulated by product 
inhibition and by the cellular energy status, i.e. stimulation by ADP and inhibition by high 
concentrations of ATP and NADH (Michal and Schomburg, 2012). The TCA cycle can be separated 
in a highly controlled first half of the cycle, beginning with the reactions of PDH and CS, and a 
second half of much lower control starting after the AKGDH reaction (Figure 7-5A). 
 
Figure 7-4 Distinction of low control and high control substrates by comparison of oxygen uptake 
rates (OUR) with and without ADP stimulation. The tested substrates are sorted in ascending order of 
OUR [fmol/(cell  min)] values of respiration without ADP stimulation (black bars). The fold-change of 
respiration upon ADP stimulation was calculated as the ratio between the OUR with 2 mM ADP 
stimulation and the OUR without ADP stimulation (grey bars). For OUR, mean and standard deviations of 
three replicates are shown (black bars). Mean and standard deviations of OUR ratios (grey bars) were 
determined by Monte Carlo simulation (n = 100) using the standard deviation of the OUR estimations. 
7.4.5.1 Mitochondrial metabolization of -ketoglutarate, succinate, fumarate 
and malate is little controlled 
MAL, FUM and SUC are transported by the mitochondrial dicarboxylate carrier in exchange for 
phosphate (Berg et al., 2012). MAL is a complex I substrate directly generating NADH by malate 
dehydrogenase (MDH). FUM indirectly stimulates complex I respiration after conversion into MAL 
via fumarase. The complex II substrate SUC is converted to FUM by the succinate dehydrogenase 
(SUCDH) reducing FAD to FADH2. The SUCDH participates in both the TCA cycle and the 
respiratory chain, thus allowing for a more direct and probably faster electron transfer than complex 
I substrates. In classical mitochondrial studies, SUC is used in combination with the complex I 
inhibitor rotenone. In our study, however, complex I activity is not excluded. The dehydrogenation 
of SUC fuels fumarase and MDH, the following reactions in the TCA cycle. NADH generation by 
MDH will additionally stimulate complex I respiration. SUC, FUM and MAL enter the TCA cycle 
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in the less regulated second part of the cycle and directly fuel the cycle between malic enzyme (ME) 
and pyruvate carboxylase (PCx) (Figure 7-5A). The existence and activity of this cycle has been 
proven in recent metabolic flux analysis studies of this CHO cell line (Nicolae et al., 2014b). 
The ME-PCx cycle results in the hydrolysis of ATP, thus removing its inhibiting effect and 
stimulating respiration. The dynamics of the dissolved oxygen measurements with a sigmoidal 
increase of OUR that is seen in the sigmoidal decrease of dissolved oxygen tension further indicate 
an autocatalytic effect in stimulating this cycle and respiration (Figure 7-1). The direct feeding of 
electrons into the respiratory chain in combination with a simultaneous stimulation of complexes I 
and II and a strong stimulation of the ATP-hydrolyzing cycle explain that SUC caused the highest 
respiration rates of all tested substrates. The ME-PCx cycle is responsible for the high respiration 
rates on MAL, FUM and SUC when ADP is not supplied and has to be regenerated by this cycle. 
Addition of ADP and the mitochondrial energy status have only a low effect in this little controlled 
part of the TCA cycle. Consequently, we observed relatively high respiration rates with and without 
ADP stimulation. 
AKG is transported by the -ketoglutarate-malate carrier in exchange with MAL or other 
dicarboxylates. As substrate of the feedback inhibited enzyme AKGDH, AKG theoretically belongs 
to the first part of the TCA cycle (Figure 7-5A). However, concerning OUR and ADP stimulation 
its behavior is similar to the little controlled substrates (Figure 7-4). This indicates that the 
downstream reactions of the TCA cycle, namely succinyl-CoA synthetase, SUCDH, fumarase and 
MDH, are fast enough that the feedback inhibition (e.g. by succinyl-CoA) does not come into effect. 
Since AKG enters the mitochondria in exchange with a dicarboxylate removed from the 
mitochondria, the equilibrium is shifted towards forward reactions additionally promoting a fast 
metabolization of AKG. Fueling of these reactions also feeds the ATP-hydrolyzing ME-PCx cycle. 
Therefore, the high respiration rates on AKG can be explained by the proximity to the SUCDH 
facilitating a direct electron transfer, very fast and little controlled downstream reactions and 
additionally a stimulation of the ME-PCx cycle. 
7.4.5.2 Mitochondrial metabolization of citrate, isocitrate, glutamine and 
glutamate is highly controlled 
ISO and CIT enter the mitochondria through the tricarboxylate transporter in exchange with MAL 
or other dicarboxylates. For GLU (Palmieri, 1994) and GLN (Palmieri et al., 1993), different 
transport systems are described. The substrates ISO and GLU represent complex I substrates 
stimulating respiration by NADH generation via IDH and glutamate dehydrogenase (GDH). CIT 
and GLN stimulate respiration indirectly by supplying ISO and GLU via reactions of aconitase and 
glutaminase, respectively. All four substrates enter the TCA cycle in its highly controlled first part 
and converge into the mitochondrial AKG pool (Figure 7-5A). CIT, ISO, GLN and GLU can 
potentially also fuel the following reactions of the TCA cycle. The low respiration on these 
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substrates can be explained by an efficient feedback inhibition at the sites of the IDH and AKGDH 
reactions. However, the high respiration rates on AKG suggest a minor regulatory role for the 
AKGDH. The addition of ADP results in substantial stimulation of respiration (Figure 7-4). Since 
we observed significantly lower OUR on GLU and GLN than on AKG this further points to a 
regulation of GLU and GLN transport. 
7.4.5.3 Initiation of the TCA cycle – the interplay of pyruvate and aspartate 
The application of PYR resulted in the lowest respiration rates of all tested substrates. Although, we 
observed a significant yet moderate stimulation of respiration upon ADP addition, there was no 
concentration dependent effect of ADP. Considering the fact that PYR besides GLN can be 
regarded as the major substrate feeding the mitochondrial metabolism in CHO cells (Wahrheit et al., 
2014a; Wahrheit et al., 2014b), this finding was surprising. The low respiration on PYR might 
indicate a bottleneck in metabolism, either at the site of the pyruvate carrier (PyC) or at the site of 
pyruvate oxidation via the strictly regulated PDH. 
The PDH requires free CoA as a co-substrate that is only available at limited amounts in 
mitochondria. Regeneration is only possible via the reaction catalyzed by CS (Figure 7-5A). The 
PDH uses a reaction mechanism that is equivalent to the AKGDH. High respiration rates found on 
AKG indicate that it is efficiently further metabolized to SUC by succinyl-CoA-synthetase. 
However, different to the succinyl-CoA-synthetase reaction, the CS reaction requires the second 
substrate OAA to proceed in the cycle. The mitochondrial PCx reaction has been shown to be active 
in CHO cells (Goudar et al., 2010; Nicolae et al., 2014b; Templeton et al., 2013). Thus, OAA can be 
supplied via active PCx. The PCx reaction, however, is strictly regulated. It requires acetyl-CoA as 
an essential allosteric activator and ATP as energy source (Michal and Schomburg, 2012). In 
contrast to the AKGDH and to the other regulated enzymes of the TCA cycle, the PDH is 
additionally controlled by reversible phosphorylation through pyruvate dehydrogenase kinase 
(PDK) (Modak et al., 2002; Zeng et al., 2002) (Figure 7-5B). 
The low OUR is explained by a direct competitive inhibition of PDH by its products acetyl–CoA 
and NADH. In addition, acetyl–CoA and NADH allosterically stimulate PDK. ADP competitively 
inhibits PDK, resulting in a partial activation of PDH and a stimulation of NADH generation and 
respiration. However, the missing concentration-dependent effect of ADP stimulation indicates a 
moderate effect of ADP. This finding suggests that the unavailability of free CoA and inhibiting 
effects of acetyl-CoA and NADH are predominating and cannot completely be antagonized by ADP 
stimulation. 
We tested the hypothesis that an additional supply of OAA could stimulate the TCA cycle. In 
contrast to yeast cells, there has been no evidence of a mitochondrial transporter for OAA in 
mammalian cells (Arco and Satrustegui, 2005; Michal and Schomburg, 2012). Therefore, OAA 
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itself could not be used in the set-up using intact mitochondria. MAL is directly converted to OAA 
via MDH and could be used to supply OAA. However, since MAL itself is a complex I substrate 
and stimulates respiration with high OUR, it is not a desirable reaction partner in this question. 
Therefore, we decided to test the combination of PYR and ASP. 
We found a significant stimulation of respiration on PYR by addition of ASP, although no 
respiration on ASP alone was detectable. ASP enters the mitochondria via exchange with GLU 
(aspartate/glutamate carrier). The mitochondrial aspartate aminotransferase (ASAT) converts ASP 
and AKG into OAA and GLU. Thus, catalytic amounts of AKG have to be available to initiate the 
transaminase reaction. Subsequently, AKG can also be regenerated in the process of the TCA cycle 
(Figure 7-5B). 
When the substrates PYR and ASP were combined, the conversion of ASP to OAA via active 
ASAT provides a reaction partner for acetyl-CoA fueling the CS reaction. The condensation of 
acetyl-CoA and OAA via the CS reaction has several consequences. First, the removal of acetyl-
CoA as predominant inhibitor results in a stimulation of PDH. Second, due to the release of CoA, its 
limitation is unmade further stimulating PDH. Third, the production of CIT and following ISO fuels 
the IDH reaction. This leads to an increase in NADH production and a stimulation of respiration. 
However, increased ATP production due to stimulated respiration supports the phosphorylation of 
PDH by the inhibiting PDK, resulting in an efficient feedback inhibition of PDH and of following 
reactions in the TCA cycle and overall moderate respiration rates (Figure 7-5B). 
We conclude that PYR and ASP are both transported into the mitochondria and metabolized. The 
mitochondrial metabolization of PYR is, however, very strictly regulated. A lack of the reaction 
partner OAA for the PDH product acetyl-CoA results in stagnation of the TCA cycle. An increased 
supply of OAA (e.g. by addition of ASP) stimulates PYR metabolization moderately. This 
bottleneck of mitochondrial metabolism might be involved in an impaired coupling between 
glycolysis and TCA cycle. An unbalanced supply of acetyl-CoA and OAA, which are both 
necessary to initiate the TCA cycle, might contribute to the phenomenon of overflow metabolism 
with high lactate excretion as commonly observed in CHO cells (Wahrheit et al., 2014a; Wahrheit et 
al., 2014b). 
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Figure 7-5 Regulation of the TCA cycle and the pyruvate dehydrogenase reaction. (A) High control 
substrates CIT, ISO, GLU, and GLN (Figure 7-4) are highlighted in red. Low control substrates AKG, 
SUC, FUM, and MAL (Figure 7-4) are highlighted in green. (B) Interplay of pyruvate and aspartate in 
fueling the TCA cycle and stimulating mitochondrial respiration. The activity of PDH, CS, IDH, AKGDH, 
PCx and ME, all printed in red, controls the TCA cycle activity (A). NADH or FADH2 generating reactions 
are indicated by solid arrows, reactions feeding these NADH or FADH2 generating reactions are indicated 
by dotted arrows. Inhibition and stimulation by competitive or allosteric effects is indicated by red and 
green arrows where dashed lines are used for ATP, ADP and NADH and solid lines for metabolites. The 
thick solid line in B indicates the inactivation of PDH by phosphorylation. Abbreviations: PDH pyruvate 
dehydrogenase, PDK pyruvate dehydrogenase kinase, CS citrate synthase, ACO aconitase, IDH isocitrate 
dehydrogenase, AKGDH -ketoglutarate dehydrogenase, GDH glutamate dehydrogenase, ASAT aspartate 
aminotransferase, PDK pyruvate dehydrogenase kinase, PCx pyruvate carboxylase, ME malic enzyme. 
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7.5 Concluding remarks 
We present a high-throughput method for a quantitative investigation of the mitochondrial 
metabolism. The experimental set-up was validated by a microscopic characterization of 
permeabilized cells and by showing the specificity and reproducibility of respiration on tested 
substrates. As an example, we tested the effect of ADP stimulation on respiration and we were able 
to obtain valuable information about regulation of mitochondrial metabolism. We demonstrated that 
the feedback inhibition of succinyl-CoA is abrogated by the fast action of downstream reactions in 
the TCA cycle. We further showed the superior effect of CoA limitation and acetyl-CoA product 
inhibition and a lower effect of the regulation by ADP on PDH activity. 
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8 Elementary mode analysis of the mitochondrial 
metabolism in selectively permeabilized CHO cells 
8.1 Abstract 
Metabolic compartmentation is a key feature of mammalian cells. Mitochondria are the powerhouse 
of the cell, responsible for respiration and the TCA cycle. Mitochondrial dysfunctions are related to 
diseases and the aging process. It is therefore important to understand the mitochondrial metabolism 
when searching for eventual targets for treatments. We accessed the mitochondrial metabolism of 
the economically important CHO cells using selective permeabilization. We tested several 
substrates without and with addition of ADP. Based on quantified uptake and production rates, we 
could determine the contribution of different elementary flux modes to the metabolism of a 
substrate or substrate combination. ADP stimulated the uptake of most metabolites, directly by 
serving as substrate for the respiratory chain, thus removing the inhibitory effect of NADH, or as 
allosteric effector. Addition of ADP favored substrate metabolization to CO2 and did not enhance 
the production of other metabolites. The controlling effect of ADP was more pronounced when we 
supplied metabolites to the first part of the TCA cycle: pyruvate, citrate, -ketoglutarate and 
glutamine. In the second part of the TCA cycle, the rates were primarily controlled by the 
concentrations of C4-dicarboxylates. Without ADP addition, the activity of the pyruvate 
carboxylase – malate dehydrogenase – malic enzyme cycle used the ATP produced by oxidative 
phosphorylation. Aspartate was taken up only in combination with pyruvate, whose uptake also 
increased, a fact explained by complex regulatory effects. Isocitrate dehydrogenase and -
ketoglutarate dehydrogenase were identified as the key regulators of the TCA cycle. We have 
shown that selectively permeabilized cells are a suitable system for studying the mitochondrial 
metabolism and regulation. 
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8.2 Introduction 
Eukaryotic cells are able to tune their complex metabolism through compartmentation. This 
involves confining reactions to designated compartments and controlling the access of metabolites 
through specific transporters. Mitochondria play an important part in the organization of the 
eukaryotic cell metabolism (Wahrheit et al., 2011). They work as the powerhouse of the cell, being 
responsible for the TCA cycle, oxidative phosphorylation and other essential reactions in the central 
carbon metabolism. Furthermore, mitochondria play a key role in the signaling processes leading to 
apoptosis (Kroemer et al., 2007). Mitochondrial dysfunctions are associated with the aging process 
and with a wide range of human diseases (Calvo et al., 2006; Duchen, 2004; Lemasters, 2007; 
Moreno-Sanchez et al., 2014; Nassir and Ibdah, 2014; Raimundo et al., 2011; Thiele et al., 2005). 
Metabolite traffic between cytosol and mitochondria is mediated by carriers. These carriers, 
excellently reviewed by Palmieri (Palmieri, 2013), have important roles in physiological and 
pathological processes (Gutierrez-Aguilar and Baines, 2013). Studies related to mitochondrial 
function and metabolism have been so far focused on isolated features, like respiration and the 
respiratory chain (Frezza et al., 2007; Kuznetsov et al., 2008) or on the function of single 
mitochondrial transporters. Even after the advent of the systems biology era, the studies focused on 
the mitochondrial metabolic network as a whole remain scarce (Balaban, 2006). So far, the most 
complex studies related to mitochondrial metabolism used enzyme kinetics, but their results are 
limited by insufficient knowledge about regulation and parameter values (Smith and Robinson, 
2011; Wu et al., 2007). Studying the mitochondrial metabolism in whole cells is complicated by the 
overlapping with other cellular reactions and by the limited accessibility of the mitochondria. 
Selective permeabilization using digitonin (Kuznetsov et al., 2008) is a simple and efficient way to 
access mitochondria while maintaining their functionality (Bahnemann et al., 2014). 
Because mitochondria are capable of taking up several metabolites, either alone or in combination, 
process them through their metabolic network and secrete resulting metabolites, new methods are 
required for analyzing the data obtained from studies of the mitochondrial metabolism. Elementary 
Mode Analysis (EMA) (Papin et al., 2004; Schuster et al., 2000) operates with network 
stoichiometry to generate all minimal subsets of reactions that can function as standalone metabolic 
units. Each flux distribution can be written as a linear combination of elementary modes. Therefore, 
the relevance of a reaction can be assessed by its participation and its flux values in the elementary 
modes. EMA has been used to study metabolic networks (Kaleta et al., 2009; Schwartz and 
Kanehisa, 2006), discover targets for metabolic engineering and drug development (Beuster et al., 
2011) and to identify high-yield mutants of producer strains (Carlson et al., 2002; Neuner and 
Heinzle, 2011). The main application of of EMA remains the microbial metabolism because 
available genome annotations and the relatively small network size allow genome-scale analyses. 
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Stoichiometric analysis is recently gaining an increasingly important role at studying mammalian 
cells (Orman et al., 2010; Orman et al., 2011; Zamorano et al., 2013). 
CHO cells are the mammalian workhorse in the biotechnology industry, responsible for the biggest 
share of biopharmaceuticals production (Jayapal et al., 2007; Walsh, 2010a). The wealth of studies 
using CHO cells as model system has led to them being nicknamed the “mammalian equivalent of 
E. coli” (Puck, 1985). They are characterized by the ability to grow in suspension cultures using 
chemically defined media, can reach high cell densities and high product titers of recombinant 
proteins. The availability of recently published CHO genome and other omics data (Becker et al., 
2011; Brinkrolf et al., 2013; Hackl et al., 2011; Xu et al., 2011) facilitates network studies.  
We think that the application of mitochondria-wide metabolic networks adds a new dimension to 
the analysis of mitochondrial metabolism. It permits access for studying interactions of several 
processes, e.g. transport, metabolite conversion, respiration as well as their control. This can be 
done in a most directed way by using intact mitochondria made accessible by selective 
permeabilization of the cell membrane. We used EMA to study the metabolism of CHO-K1 
mitochondria made accessible through selective permeabilization. Key substrates were screened for 
their ability to be metabolized by the permeabilized cells, both alone or with addition of ADP. We 
then quantified the uptake and production of metabolites. The observations were used to compute 
the contribution of mitochondrial elementary modes to the metabolic flux distribution in each tested 
case. Therefore, this analysis reaches beyond mere metabolic flux analysis by providing additional 
information, e.g. on the coupling of processes or on the control of metabolic pathways. Furthermore, 
we quantified the effect of ADP stimulation and we evidenced metabolic bottlenecks. Overall, we 
demonstrate the great opportunities that arise by applying this methodical methodology to study the 
mitochondrial metabolism. For future studies it can easily be combined with other well-established 
methods, e.g. respiration analysis. 
8.3 Materials and methods 
8.3.1 Cell culture 
Cultivation of the CHO-K1 cells was performed in baffled shake flasks (250 ml, Corning, New 
York, USA) in a shaking incubator (Innova 4230, New Brunswick Scientific, Edison, NJ, USA) at 
135 rpm (2 inches orbit), 37°C and 5% CO2. The cells were cultivated in chemically defined, 
protein-free TC-42 medium (TeutoCell, Bielefeld, Germany), supplemented with 6 mM L-
glutamine (Sigma-Aldrich, Steinheim, Germany) from a 240 mM stock solution in dH2O. The cells 
were passaged at the latest 72 h after inoculation and seeded with a cell density of 4 - 5 × 105 
cells/mL. 
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8.3.2 Preparation of mitochondrial medium 
The mitochondrial medium used in this study was derived from different media used for the 
assessment of respiration in isolated mitochondria (Madeira, 2012) and optimized with respect to 
osmolarity and ionic strength. The composition of the mitochondrial medium was as follows: 
9.6 mM K2HPO4, 2.4 mM KH2PO4, 80 mM KCl, 75 mM sorbitol, 2 mM MgCl2 and 100 µM EGTA. 
The pH was set to 7.4 with 5 N KOH. The individual components have been chosen to minimize 
interactions with the downstream analytics (MALDI-ToF, HPLC). 
8.3.3 Mitochondrial Transport Experiments 
The experimental set-up is schematically depicted in Figure 8-1 and the different tested substrates 
and substrate combinations are listed in Table 1. CHO-K1 cells were harvested from a culture in the 
early exponential growth phase (48 - 50 h after inoculation) by centrifugation (5 min, 125 × g, 
Labofuge 400R, Function Line, Heraeus Instruments, Hanau, Germany). The supernatant was 
discarded quantitatively and the cells were resuspended in mitochondrial medium. Afterwards, the 
cell number was determined using an automated cell counter (Countess® Automated Cell Counter, 
Invitrogen, Karlsruhe, Germany) and set to 107 cells/mL by adding mitochondrial medium. 
Selective permeabilization of the cytosolic membrane was performed by adding 0.01 % (w/v) 
digitonin from a 1 % stock solution in dH2O and verified under the microscope using the Trypan 
blue exclusion method. 5 mL of permeabilized cell suspension were transferred into a 50 mL filter-
tube bioreactor (TPP, Trasadingen, Switzerland) containing 5 mL of the respective substrate 
solution (2-fold concentrated in respiration medium). The final cell concentration was 
5 × 106 cells/mL, the final concentration of tested substrates was 4 mM. Afterwards, incubation was 
performed for 150 min in a shaking incubator (Innova 4230, New Brunswick Scientific, Edison, NJ, 
USA) at 135 rpm (2 inches orbit), 37°C and 5 % CO2. 
For experiments without ADP-stimulation, 400 µl samples were taken every 30 min. The samples 
were centrifuged (5 min, 6000 × g, Biofuge pico, Heraeus Instruments, Hanau, Germany) and the 
supernatants were frozen for subsequent analysis. For experiments with ADP-stimulation, 100 µL of 
100 mM ADP (resolved in respiration medium) were added every 30 min. 350 µL samples were 
taken before and after each addition of ADP. The samples were centrifuged (5 min, 6000 × g, 
Biofuge pico, Heraeus Instruments, Hanau, Germany) and the supernatants were frozen at -20°C for 
subsequent analysis. Metabolites in these samples were identified using MALDI-ToF and quantified 
using HPLC. 
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Figure 8-1. Experimental set-up for mitochondrial transport studies. CHO cells from the early 
exponential growth phase were harvested and resuspended in mitochondrial medium. Selective plasma 
membrane permeabilization with 0.01% (w/v) digitonin was microscopically verified using Trypan blue 
staining. Permeabilized cells were transferred into filter-tube bioreactors, mixed with a mitochondrial 
substrate and incubated in a shaking reactor for mitochondrial transport studies. Sampling (and ADP 
feeding) was performed every 30 min. 
Table 8-1. Substrates and substrate combinations used for metabolization by selectively 
permeabilized CHO-K1 cells. Abbreviations: AKG – -ketoglutarate; ASN – asparagine; ASP – 
aspartate; CIT – citrate; FUM  -fumarate; GLN – glutamine; GLU – glutamate; MAL – malate; PYR – 
pyruvate; SER – serine. 
without ADP stimulation with ADP stimulation 
No. Substrate(s) No. Substrate(s) 
1a PYR 1b PYR, ADP 
2a PYR, ASP 2b PYR, ASP, ADP 
3a CIT 3b CIT, ADP 
4a AKG 4b AKG, ADP 
5a SUC 5b SUC, ADP 
6a FUM 6b FUM, ADP 
7a MAL 7b MAL, ADP 
8a GLN 8b GLN, ADP 
9a GLU 9b GLU, ADP 
10a ASP - - 
11a ASN - - 
12a SER - - 
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8.3.4 Analytical determination of organic acids and amino acids 
Quantification of tested substrates and resulting products was performed by different established 
HPLC methods as described previously (Strigun et al., 2011b). In the presence of ADP, citrate 
could not be quantified at low concentrations because of an unresolvable overlay of 
metabolite peaks in the chromatogram. Identification of organic acids was confirmed by MALDI-
TOF MS (matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry) analysis. 
Since the analytes were negatively charged, the mass spectrometer (ABI 4800, Applied Biosystems, 
Foster City, USA) was operated in negative ion mode. The used laser is a Nd:YAG solid-state laser 
(neodymium-doped yttrium aluminum garnet) emitting UV radiation with a wavelength of 355 nm 
by third harmonic generation. The laser intensity was set to 3700 and the number of shots per spot 
was 1250. The flight distance of the ions was doubled by using the reflector-mode, thus achieving 
an improved mass accuracy. Prior to MALDI-TOF MS measurements, the samples were diluted 
1:10 with dH2O. This was necessary due to the high content of phosphate in the buffer (12 mM), 
which might disturb the measurement by signal suppression. 30 µL of diluted sample were mixed 
with 30 µL of matrix (9 mg/mL 9-aminoacridine in methanol) and 0.5 µL of this mixture were 
spotted on a 384-spot MALDI target (Applied Biosystems, Foster City, USA).  
8.3.5 Mitochondrial network 
The model of the mitochondrial reactions network of the CHO-K1 cells (Figure 8-2) was 
reconstructed using genome annotation (Hammond et al., 2012). The connection with the 
extramitochondrial medium is made through carrier-mediated transport for large molecules (e.g. 
amino acids, organic acids, ATP/ADP) and free diffusion for small molecules i.e. O2, CO2 and NH3. 
The model was then limited to the observed uptake and production of metabolites and included 
information about enzyme activity determined by Wahrheit (Wahrheit et al., 2014b) for the same 
cell line. Accordingly, mitochondrial NADP+-dependent malic enzyme (ME) was active and 
mitochondrial PEP carboxykinase was not active. Carriers that transport C4-dicarboxylates did not 
discriminate between fumarate, succinate or malate. With the exception of -ketoglutarate, 
glutamine, oxygen and pyruvate, all other metabolites are transported reversibly. NAD(P) + 
transhydrogenase was added to account for transferring electrons from NADPH to NADH. The 
stoichiometry of oxidative phosphorylation was 2.5 moles of ATP per mole of NADH and 1.5 
moles of ATP per mole of FADH2 (Hinkle, 2005). 
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Figure 8-2. Metabolic network of the CHO-K1 mitochondria build based on genome annotation.   
- Mitochondrial carrier. Subscripts: m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – -
ketoglutarate; ASP – aspartate; C1 – one-carbon units; CIT – citrate; FUM – fumarate; GLN – glutamine; 
GLU – glutamate; GLY – glycine; MAL – malate; OAA – oxaloacetate; PYR – pyruvate; SER – serine; 
SUC – succinate. 
8.3.6 Elementary mode analysis 
The elementary modes of the mitochondrial network were computed using the EFMtool software 
(Terzer and Stelling, 2008). In our model, succinyl-CoA ligase used only ADP, and isocitrate 
dehydrogenase (IDH) isoenzymes and glutamate dehydrogenase (GDH) used only NAD+. An 
algorithm was then used to identify from the totality of elementary modes the pathways that 
contribute to the metabolite conversion for each tested substrate or substrate combinations. We 
included all possible modes involving CO2, though CO2 itself was not measured. An observed flux 
set v can be expressed as a linear combination of elementary modes  
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  (eq. 1) 
where M is the total number of elementary modes described by the vectors EM containing the mode 
stoichiometry. The weight coefficients j are usually not unique, as the number of elementary 
modes can exceed the dimension of the flux cone. The mode flux representing the contribution of 
each mode to the measured fluxes was computed for the situations where the system from eq. 1 was 
invertible. 
8.4 Results and Discussion 
8.4.1 Mitochondrial uptake and production of metabolites 
In a previous study, we applied a high-throughput respiration screening method to verify the uptake 
and metabolization of a range of potential mitochondrial substrates (chapter 7). The outcome of this 
screening served as starting point to design further in-depth mitochondrial studies. 
Here, we used an extended experimental set-up (Figure 8-1) to investigate the mitochondrial 
metabolism of CHO cells. We stimulated mitochondrial metabolism in selectively permeabilized 
cells by addition of selected substrates or combinations of substrates and quantified mitochondrial 
uptake and production of metabolites (Table 8-2) by fitting the extracellular concentrations over 
time (Supplementary Figure S1). 
Metabolite uptake and production rates remained constant over time (Supplementary Figure S1). 
This proves that the mitochondria remained intact and functioned at metabolic steady state 
throughout the sampling period. No mitochondrial uptake of aspartate or asparagine alone was 
observed. However, aspartate was taken up when fed in combination with pyruvate. Uptake rates 
increased in the order of glutamate, serine, pyruvate, citrate, -ketoglutarate, malate, glutamine, and 
succinate, with the uptake rate for succinate being 7.3 times (C-mole/C-mole) higher than that of 
glutamate (Table 8-2). Addition of ADP stimulated the uptake and excretion of metabolites by the 
mitochondria. With feeding of ADP, uptake rates increased in the order of aspartate, pyruvate, 
malate, succinate, citrate, -ketoglutarate, and glutamine (Table 8-2). In this case, the uptake rate of 
glutamine was 4.6 times higher than the uptake of aspartate (C-mole/C-mole). We observed the 
highest impact of ADP on stimulating the uptake of citrate and -ketoglutarate. ADP addition 
doubled the uptake of aspartate, from 6.1 to 12.2 fmol / (cell  min), but not of pyruvate, that 
increased only by 3.7 fmol / (cell  min) when both substrates were fed in combination. 
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Table 8-2. Uptake and production rates of metabolites by the selectively permeabilized CHO-K1 cells 
[µmole / (109 cells  min)] and the computed 95% confidence intervals (C.I.) given in square brackets. 
n.m. – not measured. Abbreviations: AKG – -ketoglutarate; ASP – aspartate; CIT – citrate; FUM – 
fumarate; GLN – glutamine; GLU – glutamate; GLY – glycine; MAL – malate; PYR – pyruvate; SER – 
serine; SUC – succinate. 
No. Substrate Uptake rate [95% C.I.] Product Production rate [95% C.I.] 
1a PYR 4.6 [3.4, 5.7] CO2 n.m. 
1b PYR 
ADP 
14.2 [12.6, 15.9] 
n.m. 
CO2 
ATP 
n.m. 
n.m. 
2a PYR 
ASP 
11.9 [10.2, 13.5] 
6.1 [4.0, 8.2] 
GLU 
CO2 
3.0 [2.5, 3.6] 
n.m. 
2b PYR 
ASP 
ADP 
15.6 [13.8, 17.3] 
12.2 [6.9, 17.6] 
n.m. 
GLU 
CO2 
ATP 
6.7 [5.4, 8.0] 
n.m. 
n.m. 
3a CIT 5.6 [3.7, 7.5] CO2 n.m. 
3b CIT 
ADP 
38.0 [25.4, 50.6] 
n.m. 
CO2 
ATP 
n.m. 
n.m. 
4a AKG 12.7 [8.1, 17.3] FUM 
CO2 
0.48 [0.46, 0.50] 
n.m. 
4b AKG 
ADP 
40.2 [30.8, 49.6] 
- 
FUM 
CO2 
ATP 
2.5 [2.2, 2.7] 
n.m. 
n.m. 
5a SUC 24.5 [19.1, 29.9] FUM 
MAL 
CIT 
CO2 
2.2 [1.7, 2.8] 
14.5 [11, 17.9] 
1.9 [0.9, 2.8] 
n.m. 
5b SUC 
ADP 
30.5 [27.1, 33.9] 
- 
FUM 
MAL 
CIT 
CO2 
ATP 
2.1 [1.5, 2.8] 
14.6 [10.7, 18.5] 
n.m. 
n.m. 
n.m. 
6a/7a MAL 
FUM 
14.6 [10.2, 19] 
1.9 [0.9, 2.9] 
CIT 
CO2 
4.9 [3.7, 6.0] 
n.m. 
6b/7b MAL 
FUM 
ADP 
19.7 [14.6, 24.8] 
1.7 [0.9, 2.5] 
n.m. 
CIT 
CO2 
ATP 
n.m. 
n.m. 
n.m. 
8a GLN 20.0 [17.9, 22.1] GLU 
ASP 
CO2 
14.4 [11.4, 17.4] 
3.3 [2.4, 4.2] 
n.m. 
8b GLN 
ADP 
44.7 [35.7, 53.7] 
n.m. 
GLU 
ASP 
CO2 
ATP 
19.0 [15.4, 22.6] 
11.4 [9.98, 12.9] 
n.m. 
n.m. 
9a GLU 2.69 [1.22, 4.16] ASP 
CO2 
3.38 [2.61, 4.15] 
n.m. 
9b GLU 
ADP 
3.99 [-14.2, 22.2] 
n.m. 
ASP 
CO2 
ATP 
15.5 [13.0, 18.0] 
n.m. 
n.m. 
12a SER 4.5 [2.3, 6.7] GLY 2.6 [2.0, 3.2] 
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Although an absolute comparison with previous respiration studies is not possible due to different 
experimental setups, similar trends were observed: (1) stimulation of mitochondrial metabolism by 
addition of ADP, (2) without addition of ADP the highest respiration and uptake was observed on 
succinate, (3) relatively minor impact of ADP on stimulating the uptake of malate, fumarate, 
succinate, (4) relatively higher impact of ADP stimulation on the uptake of citrate and glutamine. 
This is in accordance with previous mitochondrial studies using respiration analysis (chapter 7). 
8.4.2 Connection of tested substrates and observed products using elementary 
mode analysis 
We selected the mitochondrial elementary modes that connect tested substrates and observed 
products. Based on the stoichiometry of these modes, we determined the partitioning of a certain 
substrate metabolism into different pathways (Figure 8-3). The production rate of a metabolite from 
a substrate or a combination of substrates is a linear combination of all modes that achieve the 
conversion. The case presented in Figure 8-3 allows to compute the mode fluxes through A, B and 
C if the uptake of Substrate 1 and Substrate 2, as well as the production of Product 1 and Product 2 
are measured. However, there were situations when the linear system that relates mode fluxes to 
external fluxes was not invertible. For our model, we were able to determine the contribution of 
each mode to the metabolism of all substrates except when pyruvate and aspartate were used 
together. While in almost all cases a full metabolization to CO2 was possible, many substrates led to 
partial TCA cycle activity that ended with the secretion of corresponding metabolites. 
 
Figure 8-3. Example of establishing the partitioning of Substrate 1 and Substrate 2 into the elementary 
modes (A), (B) and (C) for yielding Product 1 and Product 2. The thickness of the arrows indicates the 
theoretical flux through each elementary mode. 
8.4.2.1 General characteristics 
All experiments where ADP was supplied exhibited higher uptake rates for all tested metabolites. 
This happens mainly because (1) ADP increases the availability of NAD+ via the respiratory chain 
and (2) ADP stimulates pyruvate dehydrogenase, isocitrate dehydrogenase and -ketoglutarate 
dehydrogenase (AKGDH), three key enzymes responsible for controlling the TCA cycle (Michal 
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and Schomburg, 2012; Strumilo, 2005). In the modes where ADP is not supplied, the pyruvate 
carboxylase (PCX) – malate dehydrogenase (MDH) – malic enzyme (ME) cycle needs to be highly 
active to consume the excess of ATP produced by oxidative phosphorylation. The activity of this 
cycle has been shown in previous MFA studies of CHO cells (Ahn and Antoniewicz, 2011; Ahn and 
Antoniewicz, 2013; Goudar et al., 2010; Nicolae et al., 2014b). In addition, we have shown earlier 
that ME is active in the mitochondria of the used CHO-K1 cell line (Wahrheit et al., 2014b). This 
cycle is the rate-limiting element in metabolizing substrates in the absence of ADP, as accumulated 
ATP and NADH inhibit most enzymes involved in the TCA cycle (Michal and Schomburg, 2012). 
If pyruvate was not provided, ME was responsible for replenishing it from malate to produce the 
acetyl-CoA required for initiating the citrate synthase reaction. 
In the mitochondria, glutamate dehydrogenase and isoenzymes of IDH can use both NAD+ and 
NADP+ as cofactors. When NADPH is produced in excess, the transhydrogenase enzyme can 
oxidize it to produce NADH. The conversion of NADPH is coupled with pumping H+ out of the 
mitochondria thereby contributing to building up the proton gradient across the inner mitochondrial 
membrane. Another option for transferring reducing factors from NADPH to NADH is by the 
reverse functioning (towards isocitrate) of NADP+-dependent IDH (Sazanov and Jackson, 1994). 
Also, ATP synthesis can become partially uncoupled from respiration through the presence of 
uncoupling proteins (Boss et al., 2000; Moreno-Sanchez et al., 2014). This can change the 
stoichiometry of using reducing equivalents to produce ATP, hence of the computed activity of the 
PCX-MDH-ME cycle when ADP is not provided. However, uncoupling proteins were not found to 
be expressed in wild-type CHO cells (Pecqueur et al., 2008) and were shown to play a role in 
thermogenesis, protection against oxidative stress, export of fatty acids or mediation of insulin 
secretion (Rousset et al., 2004). We can therefore assume that the effect of uncoupling is negligible 
for balancing ADP/ATP. 
8.4.2.2 Pyruvate and aspartate 
Pyruvate fed alone sustained a complete TCA cycle. Upon stimulation with ADP, the pyruvate 
uptake flux increased 3.1 times (Table 8-2). In the modes we computed, this requires an active 
mitochondrial pyruvate carrier and all mitochondrial enzymes that metabolize pyruvate to CO2 
(Figure 8-4.A1, 8-4.B1). 
When pyruvate and aspartate were fed together, the two metabolites had a reciprocal stimulating 
effect. In a separate experiment, aspartate alone was not taken up. The uptake of pyruvate in the 
presence of aspartate increased 2.6 times compared to the uptake of pyruvate alone. A double 
amount of aspartate was taken up per amount of glutamate produced (Table 8-2). The activity of 
four possible elementary modes can combine to explain the observations: (1) uptake of pyruvate to 
produce CO2, (2) co-uptake of pyruvate and aspartate to produce CO2 and one mole of glutamate per 
mole of aspartate, (3) uptake of aspartate to produce CO2 and one mole of glutamate per two moles 
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of aspartate and (4) uptake of aspartate to produce only CO2. Aspartate uptake through the 
glutamate-aspartate carrier occurs with equimolar secretion of glutamate. Glutamate must be 
partially re-transported into the mitochondria through a different carrier (Fiermonte et al., 2002) to 
account for the aspartate uptake/glutamate secretion rate ratio of 2.03. Surprisingly, the 
stoichiometry of the mode with co-uptake of pyruvate and aspartate (mode (2)), where aspartate 
provides one mole of oxaloacetate and pyruvate provides one mole of acetyl-CoA to fuel the TCA 
cycle, does not match the observed rates and does not occur. Therefore, aspartate (Figure 8-4.A3, 
B3) and pyruvate (Figure 8-4.A2, B2) must be metabolized individually. Although aspartate is only 
taken up in combination with pyruvate, its metabolization happens only via modes that don’t 
include pyruvate. This is possible by mutual activation of modes, i.e. activation of rate controlling 
enzymes. The first regulatory step in the conversion of aspartate is aspartate aminotransferase, 
which is controlled by its products and substrates in a complex manner (Cascante and Cortes, 1988). 
This enzyme converts aspartate to oxaloacetate simultaneously with converting -ketoglutarate into 
glutamate. Glutamate is exchanged when aspartate enters the mitochondria, as shown in Figure 8-2. 
Production of -ketoglutarate in the TCA cycle is needed to sustain the outflow of glutamate, as 
shown in Figure 8-4.A3. Aspartate accumulation was observed in retina cells treated with an 
inhibitor of the mitochondrial pyruvate carrier (Du et al., 2013), which suggests that aspartate needs 
pyruvate for metabolization. Although oxaloacetate could exert product inhibition on PCX (Barden 
et al., 1972), it is consumed by MDH to produce malate, while the acetyl-CoA synthesized from 
pyruvate activates PCX (Jitrapakdee and Wallace, 1999), thus favoring the PCX-MDH-ME cycle 
towards hydrolyzing the ATP produced from intramitochondrial pool of ADP in the respiratory 
chain. ME activity could be another bottleneck in the conversion of pyruvate and aspartate in the 
absence of ADP. It was shown that AKG inhibits mitochondrial ME and MDH in brain cells 
(McKenna et al., 1995). Therefore, ME activity depends on the efficiency of AKG removal from the 
mitochondria as glutamate. 
Addition of ADP to the pyruvate-aspartate mixture did not change the pyruvate uptake flux, 
compared to when pyruvate and ADP were used. Under ADP stimulation, the PCX-MDH-ME cycle 
is not needed for pyruvate catabolism. The most probable limitation in this case is pyruvate 
transport into the mitochondria, which was shown to influence the respiration capacity in yeast 
(Timon-Gomez et al., 2013) and is suspected to regulate pyruvate metabolism in cancer cells (Schell 
and Rutter, 2013). Aspartate uptake flux increased although the aspartate/glutamate ratio remained 
close to 2 (Table 8-2), comparable to the case without ADP. This result strengthens the assumption 
that the mode which uses aspartate to produce glutamate and CO2 is responsible for aspartate 
metabolism by the mitochondria.  
Pyruvate metabolization to CO2 is limited to approx. 15 fmol/ (cell  min) in all the three cases 
where other substrates were used together with pyruvate (i.e. ADP, aspartate, aspartate and ADP). 
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This suggests the existence of a tightly controlled upper threshold in the mitochondrial pyruvate 
metabolism achieved using the pyruvate transporter and/or allosteric control by the PDH complex. 
 
Figure 8-4. Fluxes of the mitochondrial elementary modes determined after feeding the permeabilized cells 
pyruvate (A1, B1) and a combination of pyruvate and aspartate (A2, A3, B2, B3). Modes from lines 1 and 2 
metabolize pyruvate to CO2. Modes from line 3 metabolize aspartate to glutamate and CO2. The modes in 
the A-column do not use supplied ADP, and the modes in the B-column contained ADP as substrate. The 
fluxes higher than 60 fmol/ (cell  min) are indicated by numbers on the corresponding arrow. Subscripts: 
m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – -ketoglutarate; ASP – aspartate; CIT – 
citrate; FUM – fumarate; GLU – glutamate; MAL – malate; OAA – oxaloacetate; PYR – pyruvate; SUC – 
succinate. 
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8.4.2.3 Citrate 
We observed no metabolite production when citrate was used as substrate, also when ADP was 
added. Because citrate is taken up by antiport with C4-carboxylates, these are taken up again via the 
dicarboxylate carrier (Figure 8-5.A, B) thus explaining their absence in the extramitochondrial 
medium. For this, we can assume more mechanisms: (1) the dicarboxylate carrier can take up 
dicarboxylates at very low extramitochondrial concentrations, (2) reuptake of C4-carboxylates 
occurs via a mechanism that bypasses their dilution into the media by maintaining a high 
concentration in the inter-membrane space, (3) there is a mitochondrial carrier that takes up citrate 
alone, (4) there is collaboration between the citrate carrier (Gnoni et al., 2009) and the dicarboxylic 
one. When ADP was added, there was a significant stimulation of citrate metabolization of 6.8 fold 
increase (Figure 8-5. B), citrate being the metabolite taken up with the highest carbon flux. 
 
Figure 8-5. Fluxes of the mitochondrial elementary modes that completely oxidize citrate to CO2. Mode A 
does not contain added ADP, and mode B uses ADP as substrate. The fluxes higher than 
60 µmol/(cell  min) are indicated by numbers on the corresponding arrow. Subscripts: m – mitochondrial. 
Abbreviations: AcoA – acetyl-CoA; AKG – -ketoglutarate; CIT – citrate; FUM – fumarate; MAL – 
malate; OAA – oxaloacetate; PYR – pyruvate; SUC – succinate. 
ADP and citrate have a joint activating effect on IDH, which is a limiting step of the TCA cycle as 
previously found for this cell line by Wahrheit et al. (Wahrheit et al., 2014b). The effect of citrate 
feeding is also in qualitative accordance with respiration studies performed on selectively 
permeabilized CHO-K1 cells (chapter 7), where a high stimulation of respiration was observed 
when citrate was used together with ADP. Citrate is known to inhibit citrate synthase (Williamson 
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and Cooper, 1980), which would in this case be a bottleneck in the TCA cycle, but the high 
metabolization rate suggests that citrate is consumed quickly by enzymes downstream the TCA 
cycle e.g. IDH and AKGH leading to low citrate and isocitrate concentrations and a release of its 
inhibiting effect. Citrate and isocitrate uptake by the mitochondria is not a typical physiological 
event described for the metabolism of mammalian cells. In contrast, citrate is usually transported 
out of the mitochondria to supply the fatty acid synthesis in the cytosol. However, given the high 
cytosolic IDH activity (Wahrheit et al., 2014b), it is possible that in a physiological state the excess 
of NADPH generated by the pentose phosphate pathway (Nicolae et al., 2014b) drives the reaction 
towards consuming AKG. A reversed functioning of the IDH (Metallo et al., 2012) has been 
described before for mammalian metabolism. Isocitrate and citrate are then produced from cytosolic 
AKG and then taken up by the mitochondria to be used in the TCA cycle. 
8.4.2.4 α-ketoglutarate 
Similarly to citrate, -ketoglutarate could sustain the TCA cycle alone (Figure 8-6.A). -
ketoglutarate was taken up with the highest flux from all metabolites without ADP stimulation 
(Table 8-2). Also, as in the case of citrate, -ketoglutarate enters the mitochondria using C4-
dicarboxylate antiporter (Figure 8-6.A, B1, B2). Though it was shown for astrocytes that -
ketoglutarate inhibits ME (McKenna et al., 1995), this effect was not manifested in our experiments 
considering the high metabolization rate in the absence of ADP and hence the high ME flux (Figure 
8-6). With addition of ADP, the activation of IDH and AKGDH results in a 3-fold increase in -
ketoglutarate uptake rate. 
8.4.2.5 C4 carboxylates 
Succinate and malate were metabolized by the mitochondria with relatively high rate, both with and 
without addition of ADP. They were transported through the dicarboxylate carrier, which requires 
mitochondrial phosphate antiport (Fiermonte et al., 1998). Phosphate is then replenished through 
another transport system e.g. via the phosphate carrier (Hamel et al., 2004). Extracellular fumarate 
was converted before being taken up to malate in a fast equilibrium reaction, probably by 
extramitochondrial fumarase activity (Supplementary Figure S1). The equilibrium explains the 
presence of fumarate in the media when malate is produced from succinate (Figure 8-7.A4, B4). 
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Figure 8-6. Fluxes of the mitochondrial elementary modes that completely oxidize -ketoglutarate to CO2 
in the absence of ADP (A), with added ADP (B1) and the mode that produces extramitochondrial fumarate 
in the presence of ADP (B2). The fluxes higher than 60 fmol/ (cell  min) are indicated by numbers on the 
corresponding arrow. Subscripts: m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – -
ketoglutarate; CIT – citrate; FUM – fumarate; MAL – malate; OAA – oxaloacetate; PYR – pyruvate; SUC 
– succinate. 
 
Figure 8-7. Fluxes of the mitochondrial elementary modes that metabolize succinate to CO2 (A1, B1), 
succinate to malate (A2, B2), succinate to citrate and CO2 (A3, B3) and succinate to fumarate (A4, B4). The 
modes in the A-column do not use supplied ADP, and the modes in the B-column contained ADP as 
substrate. The fluxes higher than 60 fmol/ (cell  min) are indicated by numbers on the corresponding 
arrow. Subscripts: m – mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – -ketoglutarate; CIT – 
citrate; FUM – fumarate; MAL – malate; OAA – oxaloacetate; PYR – pyruvate; SUC – succinate. 
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Figure 8-8. Metabolic fluxes of the mitochondrial elementary modes that metabolize malate to CO2 (A1, 
B1) and malate to citrate and CO2 (A2, B2). The modes in the A-column do not use supplied ADP, and the 
modes in the B-column contained ADP as substrate. The fluxes higher than 60 fmol/ (cell  min) are 
indicated by numbers on the corresponding arrow. Subscripts: m – mitochondrial. Abbreviations: AcoA – 
acetyl-CoA; AKG – -ketoglutarate; CIT – citrate; FUM – fumarate; MAL – malate; OAA – oxaloacetate; 
PYR – pyruvate; SUC – succinate. 
Addition of ADP increased the metabolization rate of succinate to CO2 2.5 times (Figure 8-7.A1, 
B1) and of malate by 1.7 times (Figure 8-8.A1, B1). ADP had no effect on the production of citrate 
from succinate or malate, as shown in Figure 8-7.A3, B3 and Figure 8-8.A2, B2. Succinate was 
converted to malate with the same rate in both non-stimulated (Figure 8-7.A2) and stimulated 
(Figure 8-7.B2) cases. It can be inferred that fast pathway kinetics between succinate and malate 
and reduced activity in disposing of malate in the TCA cycle leads to accumulation that favors 
malate secretion instead of full metabolization. Compared to the high metabolization rates observed 
for CIT and AKG, the supply of C4-dicarboxylates resulted in a lower activity of the TCA cycle. 
This implies that the second part of the TCA cycle, involving C4-dicarboxylates, is mainly 
controlled by the concentrations of C4-dicarboxylates and less by the availability of cofactors. The 
metabolic steady state and therefore the intramitochondrial C4-dicarboxylates concentrations are 
maintained by removing the excess from the mitochondria via the dicarboxylate carrier. Complete 
catabolism to CO2 in the absence of ADP was 17% for succinate and 48% for malate, and with ADP 
it was increased to 33% and 60% respectively. Citrate production from either succinate (Figure 8-
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7.B3) or malate (Figure 8-8.B2) suggests that high cytosolic concentrations of dicarboxylates induce 
de novo fatty acids synthesis by providing citrate to the cytosol, as it was shown on mouse models 
(Mizuarai et al., 2005). 
Analytical determination of citrate was difficult in the presence of ADP due to an overlay of 
metabolite peaks in the chromatogram. Although the uptake fluxes of C4 carboxylates increased, we 
computed the modes under the assumption that the citrate secretion rate does not increase. We based 
our assumption on the fact that ADP enhances significantly the metabolization of citrate, as we have 
shown above. Also, the situation when citrate is produced from C4 and then taken up again for 
metabolization to CO2 is equivalent to a mode that metabolizes C4 to CO2. It is therefore unlikely 
that citrate will accumulate in the media when ADP is added. 
8.4.2.6 Glutamine and glutamate 
The permeabilized cells took up glutamine via the glutamine carrier (Hassanein et al., 2013; Indiveri 
et al., 1998) and used it to produce mostly glutamate, with a conversion of 72% in the absence of 
ADP (Figure 8-9.A3). By adding ADP, the conversion to glutamate decreased to 42% (Figure 8-
9.B3) although the net production rate increased by 32%. This shows that it is possible for 
glutamate to leave the mitochondria through a different transport system than the aspartate-
glutamate carrier, most likely the glutamate carrier (Fiermonte et al., 2002). The glutamate carrier 
has been shown to operate in the reverse direction, hence by facilitating glutamate to exit the 
mitochondria when it is produced in excess. The supply of cytosolic glutamate could then be used in 
vivo for transamination, e.g. the production of alanine, and also for producing glutamine, as we have 
shown previously (Nicolae et al., 2014b). Because GDH is activated by ADP (Fang et al., 2002), 
glutamine catabolism to CO2 by a full TCA cycle increased significantly in the presence of ADP 
(Figure 8-9.A1, B1), indicating that this enzyme is the first step in controlling glutamine 
metabolism. The presence of extramitochondrial glutamate also activated the secretion of aspartate 
(Figure 8-9.A2, B2). Most likely, under the experimental conditions the aspartate-glutamate carrier 
is controlled by the intracompartmental concentrations of these two amino acids and is not subjected 
to allosteric control by other metabolites. 
Glutamate was taken up in modest amounts in the absence of ADP, and aspartate was produced in 
nearly equimolar amounts, considering the confidence intervals of the rates computed for glutamate 
uptake and aspartate production (Table 8-2). Glutamate concentration could not be determined 
reliably when using ADP (Supplementary Figure S1). Nevertheless, an increased production of 
aspartate was observed, which indicates that glutamate uptake increased considerably by adding 
ADP. This means that the preferred uptake system for glutamate is the glutamate-aspartate carrier 
and not the glutamate carrier (Fiermonte et al., 2002). 
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Figure 8-9. Metabolic fluxes of the mitochondrial elementary modes that metabolize glutamine to CO2 (A1, 
B1), glutamine to aspartate and CO2 (A2, B2) and glutamine to glutamate (A3, B3). The modes in the A-
column do not use supplied ADP, and the modes in the B-column contained ADP as substrate. The fluxes 
higher than 60 fmol/ (cell  min) are indicated by numbers on the corresponding arrow. Subscripts: m – 
mitochondrial. Abbreviations: AcoA – acetyl-CoA; AKG – -ketoglutarate; ASP – aspartate; CIT – citrate; 
FUM – fumarate; GLN – glutamine; GLU – glutamate; MAL – malate; OAA – oxaloacetate; PYR – 
pyruvate; SUC – succinate. 
8.4.2.7 Serine 
Serine was taken up by the permeabilized cells in moderate amounts (Table 8-2). Consistent with 
previous studies (Appling, 1991; Barlowe and Appling, 1988; Narkewicz et al., 1996), serine is 
converted by mitochondrial serine hydroxymethyltransferase to produce glycine and C1 units, that 
can subsequently be converted to and secreted as formate (not measured) (Figure 8-2). Only 59% of 
the glycine that could be potentially produced was secreted, the rest being probably converted by 
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the glycine cleavage system into C1 units and CO2. The produced NADH is then consumed by the 
PCX-MDH-ME cycle to maintain the metabolic steady state in the mitochondria. 
8.4.3 Conclusions 
Selectively permeabilized CHO-K1 cells proved to be a useful system for detailed studies of the 
mitochondrial metabolism. The permeabilized cells retain functional mitochondria that are able to 
process at metabolic steady state various single or combinations of carbon sources. By using EMA 
we have evidenced that the mitochondrial reactions involved in the TCA cycle, anaplerotic and 
cataplerotic reactions, reactions involved in amino acid metabolism, as well as the oxidative 
phosphorylation and mitochondrial transport are active. Beyond demonstrating the functionality of 
mitochondrial metabolic pathways, we used EMA to confirm the observations from earlier 
screening experiments (chapter 7). Additionally, we could quantify the contributions of separate 
pathways at processing a certain substrate or combination of substrates. 
In the absence of ADP, substrate uptake was limited in most cases. Full metabolization to CO2 has 
been observed for pyruvate, citrate, -ketoglutarate, C4 dicarboxylic acids and glutamate. This 
requires an active PCX-MDH-ME cycle that disposes of the ATP generated by oxidative 
phosphorylation. The PCX-MDH-ME cycle is the limiting step in processing substrates, as the 
accumulation of ATP and NADH inhibits key enzymes involved in the TCA cycle. Uncoupling 
ATP synthesis from respiration could provide another way disposing of the excess of reducing 
factors, but this hypothesis would need further exploration, also by including ADP/ATP and O2 
measurements. 
Stimulation by ADP enhanced respiration and the metabolization to CO2 of most substrates, as 
shown in chapter 7, with considerable differences for for -ketoglutarate and citrate and less for C4 
dicarboxylic acids. The differences are explained by the way in which the enzymes of the TCA 
cycle are controlled. In the first part of the TCA cycle, IDH and AKGDH are positively modulated 
by substrate and cofactor availability. The second part of the TCA cycle, involving the 
interconversion of C4-dicarboxylates, is subjected to limiting control by the concentration of C4-
dicarboxylates. The high concentrations of C4-dicarboxylates could inhibit enzymes that do not 
process them directly. This effect may lead indirectly to a reduced TCA cycle. Glutamine 
metabolism is controlled by GDH and by removing glutamate from the mitochondria via the 
glutamate carrier. We summarized our conclusions, organized by the feeding experiments that 
support them, in Supplementary Table S4. 
A question mark that is left after analyzing our results is related to the regulatory role played by the 
mitochondrial carriers. Little is known about their function to control metabolite concentrations for 
achieving a specific metabolic state in the mitochondria. We consider that knowledge about 
regulation of mitochondrial transporters would improve the understanding of the mitochondrial 
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metabolic system. Complex regulatory effects that span over more reactions are difficult to establish 
without further information about transporter properties. Our findings indicate a limiting role of the 
pyruvate carrier, a high sensitivity of the aspartate-glutamate antiporter for balancing the content of 
these amino acids in the mitochondria, and a potential cooperation between the citrate and the 
dicarboxylate carrier. Also, determining intracompartmental concentrations under selected feeding 
conditions would be of great value at establishing the control checkpoints in the mitochondrial 
metabolism. Off-gas analysis of O2 and CO2 would add extra constraints to the linear system used to 
calculate the mode fluxes, making possible the resolution of more complex modes, where e.g. more 
substrates are taken up together. Sampling ADP and ATP concentrations would enable the 
quantification of uncoupling effects. 
Using selectively permeabilized cells and flux analysis methods provides a great system for 
metabolic studies that aim at understanding diseases related to mitochondrial dysfunctions or at 
debottlenecking the metabolic connection between mitochondria and cytosol. By removing the 
background noise of cytosolic reactions, it becomes possible to study the effect of transport or 
enzyme inhibitors and of genetic modifications of the mitochondrial enzymes on the mitochondrial 
metabolism. 
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9 Conclusion 
9.1 Summary statement 
Metabolism controls life and death, function and dysfunction of any living cell and organism. 
Increasing our basic understanding of metabolism has an equally considerable impact on significant 
questions in biotechnology and biomedicine. The presented thesis provides an in-depth quantitative 
characterization of the central metabolism and its control in Chinese hamster ovary (CHO) cells 
(Figure 9-1). Focusing on metabolic dynamics and compartmentation, the work tackles a very 
challenging issue. Different innovative experimental strategies and advanced computational 
methods have been developed and implemented breaking fresh ground for detailed metabolic 
studies in higher eukaryotic organisms in the future. The work substantially enhances our 
knowledge about the complex metabolism of industrially highly relevant CHO cells in particular 
and of mammalian cells in general. These fascinating novel findings significantly contribute to 
improved biopharmaceutical production and design of successful therapies for the treatment of 
severe diseases in the future. 
 
Figure 9-1. Three building stones contribute to the bigger picture and an increased understanding of 
metabolic compartmentation in CHO cell metabolism: (1) Metabolite balancing used in three different 
case studies: (i) DMFA in combination with compartmental enzyme activities, (ii) DMFA to describe 
different glutamine availabilities, and (iii) MFA to characterize a perturbed pyruvate metabolism. (2) 13C 
labeling studies for INST-MFA: (i) based on one tracer and extracellular labeling dynamics of readout 
metabolites and (ii) based on two parallel tracers and extra- and intracellular labeling dynamics. (3) 
Mitochondrial studies using selectively permeabilized cells: (i) used in a high throughput respiration 
screening and (ii) used for mitochondrial pathway investigation applying elementary mode analysis.  
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9.2 Future applications of the established methods and concepts 
The variety of novel experimental, analytical, and computational methods and strategies applied in 
this thesis represent a significant technological and conceptual advancement. They provide a solid 
base for in-depth metabolic studies in various contexts. One the one hand, these methods offer new 
possibilities for addressing specific scientific questions that are difficult to access and have therefore 
been neglected in the past. On the other hand, the presented methods and concepts provide guidance 
on how to improve data analysis and increase the information that can be drawn from experimental 
data. In the next paragraphs, particular advantages of the applied methods are summarized and 
future fields of application in industrial and biomedical research are illustrated. 
Mammalian cell cultures are usually characterized by changing environmental conditions and 
adapting cellular responses. Dynamic metabolic flux analysis (DMFA) as applied in the chapters 2 
and 3 is a very elegant and easy to implement tool that allows exploring biological systems at non 
steady state conditions. A time-resolved analysis is particularly useful for studying metabolic 
dynamics and monitoring metabolic shifts (Niklas et al., 2011c). The applicability of DMFA to 
industrially relevant, non stationary process modes like fed-batch cultivations has been 
demonstrated in chapter 3. Understanding the dynamics of a producer strain’s physiology can assist 
in speeding up process development, e.g. by rationally optimizing media and feeding profiles. 
Another example where metabolic steady state is usually not (fully) achieved is adherent cell 
cultivation which is the most common cultivation method in toxicological or medical studies. 
DMFA may be applied to monitor the dynamic cellular response to perturbations, e.g. after 
application of drugs, toxic compounds or other effectors. 
In the past, detailed MFA studies, e.g. using non-stationary 13C metabolic flux analysis (INST-
MFA) methods, were hampered by the lack of reliable methods for intracellular metabolite 
analysis in mammalian suspension cells (Wahrheit et al., 2011). Therefore, a strategy for measuring 
intracellular metabolites in CHO suspension cells including sampling/quenching, metabolite 
extraction, and GC/MS analytics has been developed and implemented as an essential building 
block for the success of this thesis. In this context, different critical steps in the sampling and 
quenching procedure were identified (Wahrheit and Heinzle, 2013; Wahrheit and Heinzle, 2014). 
The method was successfully applied in the experiments presented in chapter 6. In this study, extra- 
and intracellular labeling dynamics were analyzed for the first time in CHO suspension cells to be 
used for INST-MFA (Nicolae et al., 2014a; Wahrheit et al., 2013). The established and validated 
protocol makes a substantial contribution to the challenging and tedious efforts of method 
development for intracellular metabolite analysis in mammalian cells (Wahrheit and Heinzle, 2014). 
Increasing the accessibility of intracellular metabolite data is crucial for in-depth metabolic studies 
in higher organisms and a prerequisite for the application of advanced MFA methods (Wahrheit et 
al., 2011). 
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The enormous potential and particular advantages of non-stationary 13C metabolic flux analysis 
(INST-MFA) over classical stationary MFA approaches have been illustrated in the introduction 
(chapter 1.4.3) and in recent reviews (Wiechert and Nöh, 2013). Although demanding experimental 
and computational methods are required, the high information content of INST-MFA makes it an 
indispensable tool when challenging questions in metabolism are to be addressed. Therefore, its 
application is expected to increase tremendously in the future when the required technologies 
become more and more available. The studies presented in chapters 5 and 6 are the first examples 
describing the application of INST-MFA in mammalian suspension cells. In chapter 5, a useful 
modification of INST-MFA using only the information of extracellular labeling dynamics is 
proposed for the first time. This represents a remarkable technological advancement since it 
eliminates the necessity of sampling intracellular metabolites. The study presented in chapter 6 is 
the first example demonstrating the use of parallel tracers for INST-MFA in CHO cells. Integrating 
the labeling dynamics of 32 readout metabolites derived from two different tracer substrates, this 
study represents at the same time the most comprehensive investigation of CHO cell metabolism 
available at present. INST-MFA is the method of choice when isotopic steady state is not achieved 
in biological systems. Moreover, INST-MFA was demonstrated as a valuable tool in exploring 
complex metabolic networks unraveling details of (i) metabolic compartmentation and micro-
compartmentation, (ii) reactions around the highly redundant and intertwined C3-C4 node, (iii) 
exchange fluxes and reversibilities, (iv) synthesis and degradation pathways occurring 
simultaneously, and (v) intracellular as well as intracompartmental metabolite concentrations. 
Providing the highest resolution of all MFA methods available to date, this methodology provides 
unique opportunities to tackle challenging questions in biology, biomedicine and biotechnology 
related to metabolism. 
Selective permeabilization of the plasma membrane is a well-known and established method to 
generate intact mitochondria enclosed in cell ghosts (Kuznetsov et al., 2008). This technique has 
been employed in several contexts in this thesis. In chapter 2, selective permeabilization of the 
plasma membrane using digitonin and complete cell lysis using Triton X-100 were applied to 
discriminate between cytosolic and mitochondrial enzyme activities. The determination of 
compartment-specific in situ enzyme activities first described by Niklas et al. is a powerful 
enhancement of classical enzyme assays (Niklas et al., 2011a). It is a valuable method in all 
scientific questions where the localization or compartmentation of metabolic enzymes is of 
importance. It can support the set-up of relevant metabolic network models when the activity and 
location of enzymes are uncertain. It helps identifying metabolic bottlenecks by assessing maximum 
capacities of enzymes in the respective compartments, as demonstrated for the examples of IDH and 
aminotransferases in chapter 2. This information can be used to design targeted metabolic 
engineering strategies and overall assist in a rational optimization of industrial producer cells. The 
subcellular distribution of metabolic enzymes has been mostly neglected in the past. Including this 
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additional information will lead to significantly improved metabolic studies yielding much richer 
information about a cell’s physiology. 
In the last part of this thesis, selectively permeabilized cells were successfully applied for 
mitochondrial studies. Illustrating the permeabilized cell’s stability, integrity and, most 
importantly, their function at metabolic steady state, their potential as experimental system for in-
depth studies of mitochondrial metabolism was clearly demonstrated. Permeabilized cells are easier 
to handle and have a higher physiological relevance than isolated mitochondria. Bahnemann et al. 
showed that the mitochondria are kept inside the permeabilized CHO cells, thus maintaining their 
functional connections with cellular structures (Figure 9-2). They also confirmed the superior 
integrity of outer and inner mitochondrial membranes in digitonin-permeabilized CHO-K1 
suspension cells compared to other cell disruption techniques (Dounce homogenization, sonication, 
electroporation). The mitochondrial integrity was efficiently preserved even at digitonin 
concentrations up to 100 or 200 times higher than applied in our studies (Bahnemann et al., 2014). 
 
Figure 9-2. Mitochondria within digitonin-permeabilized 
CHO-K1 cells. Mitochondria were labeled with specific anti-
Tom20 antibody and a secondary green fluorescent antibody 
(AlexaFluor 488, Goat-Anti-Rabbit-IgG) and visualized using 
confocal laser-scanning microscopy. CHO-K1 suspension cells 
were permeabilized with 0.01% (w/v) digitonin. Picture by 
courtesy of J. Bahnemann (group of Prof. Zeng, TUHH, 
Hamburg, Germany). 
 
Two original strategies for investigating the mitochondrial metabolism in permeabilized CHO cells 
are presented in this thesis. First, permeabilized CHO cells were used in a high-throughput 
quantitative respiration screening (chapter 7). Microtiter plates with optical oxygen sensors are an 
easy to handle system suitable for high-throughput studies and requiring little experimental effort as 
shown in numerous previous applications (Beckers et al., 2009; Deshpande and Heinzle, 2004; 
Deshpande et al., 2004; Niklas et al., 2009; Noor et al., 2009; Strigun et al., 2011b; Zitova et al., 
2009). Even more importantly, the presented methodology involves the corresponding kLa 
determination and thus allows a quantification of mitochondrial oxygen consumption without 
establishing an experimentally more complex oxygraph set-up. The outcome of the respiration 
screening was used to design even more in-depth studies of mitochondrial metabolism using 
elementary mode analysis (EMA) (chapter 8). The combination of selective cell permeabilization 
with the concept of EMA allows exploring details of the mitochondrial network. This innovative 
methodology facilitates the investigation of capacities, limitations, significance, and control of 
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mitochondrial pathways isolated from their cytosolic environment. Considering the involvement of 
the mitochondrial metabolism in ageing and various pathological conditions, a wide range of future 
applications can be imagined for both approaches quantitative high-throughput respiration analysis 
and mitochondrial EMA. 
Chapters 3 and 4 aimed at investigating the metabolism of pyruvate and glutamine as major carbon 
sources for the mitochondrial TCA cycle in more detail. As shown in chapter 3, the cellular 
glutamine metabolism was directly connected to the extracellular glutamine supply in CHO cells. In 
contrast, varying the extracellular pyruvate concentration in the medium was found to have only 
little impact on the intracellular pyruvate metabolism (data not shown). However, this was not 
surprising, since the intracellular pyruvate is mainly derived from other sources in CHO cells, 
mostly from glucose and lactate. Therefore, a different strategy was tested. The application of 
biochemical effectors in combination with MFA was shown as a useful approach to investigate 
flux rearrangements as a result of increased or reduced pyruvate flux into the TCA cycle. Such 
experimental set-ups can be used to investigate metabolic flexibility, adaptability and limitations of 
biological systems and may be applied to assess the potential of producer strains or of therapeutic 
strategies. In addition to the combination with classical MFA as described in chapter 3, another 
interesting application is the use of biochemical effectors in combination with permeabilized cells 
and EMA using the set-up described in chapter 8. The feasibility of such an experimental system 
has already been demonstrated (Figure 9-3), e.g. to study mitochondrial transport in more detail. 
However, the corresponding data was not presented in this thesis. 
Figure 9-3. (A) Total and (B) partial 
inhibition of mitochondrial pyruvate 
uptake in permeabilized CHO cells by 
-cyano-4-hydroxy cinnamic acid 
(CHC) compared to mitochondrial 
pyruvate uptake without (w/o) CHC 
addition. 
The determination of metabolic ratios as useful parameters to characterize different physiological 
conditions was stressed at several points within this work, especially in the first part of this thesis 
(chapter 2, 3 and 4). The lactate/glucose ratio is commonly used to describe metabolic efficiency of 
cell cultures. In the presented thesis, the use of metabolic ratios was expanded by introducing 
several novelties. In chapter 2, a time-resolved analysis of metabolic ratios was proposed as means 
to monitor very sensitively metabolic shifts and stable states. New metabolic ratios were suggested 
in order to better explore specific questions. The TCA cycle/glycolysis ratio was demonstrated as a 
useful additional indicator to assess metabolic efficiency (chapters 2 and 4). The relation of all 
metabolic fluxes to the varied parameter, in this case the extracellular glutamine rate, was a 
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successful strategy to identify metabolic links (chapter 3). The relative importance of anaplerotic 
reactions was evaluated by comparing pyruvate dehydrogenase/glutamate dehydrogenase ratios 
between different conditions (chapter 4). The concept of metabolic ratios can be extended to other 
scientific questions. It allows for a more functional and network-oriented characterization of 
biological systems than looking at isolated metabolic rates. Metabolic ratios are usually also more 
sensitive when monitoring changing conditions. In addition, the calculation of ratios represents a 
specific normalization of data. Therefore, the comparison of data derived in various contexts (e.g. 
data from different patients) or when absolute metabolic rates are very different between conditions 
might be more reliable and meaningful for normalized metabolic ratios than for specific single 
fluxes. 
In chapter 2, the combination of different complementary methods was illustrated as a solid 
strategy to significantly enrich data analysis in a rational way. In the age of systems biology, the 
collection of various huge (omics) data sets becomes more and more popular. The possibility to 
produce and store enormous amounts of data offers new prospects and bears certain risks. 
Collecting big data must not be mistaken for generating knowledge. The initial idea and the final 
goal of systems biology is to obtain a meaningful, multidimensional and holistic picture of the 
functioning of a biological system. In this study, it is emphasized that the experimental design 
should rather focus on generating selected data sets with complementary information than on 
collecting as much data as possible. The question on how to integrate these different and well 
chosen data sets has to be put at the beginning. In the presented study in chapter 2, the correlation of 
information from three different, complementary dimensions, (1) time, corresponding to the 
metabolic state, (2) space, i.e. localization of activity, and (3) function within the cellular hierarchy, 
i.e. maximum capacity (in vitro activity) vs. actual flux (in vivo activity) made it possible to derive 
detailed conclusions about the central metabolism and its control in CHO cells. The proposed 
systems-oriented approach can be understood as a general methodology. It demonstrates how an 
integrative interpretation of different selected information can be used to transfer data into 
knowledge.  
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9.3 Novel findings and potential implications 
9.3.1 Glycolytic regulation 
The HK reaction was confirmed as the rate-limiting step in glycolysis in CHO cells (chapter 2). 
Most importantly, the involvement of glycolytic channeling as a key aspect of glycolytic regulation 
in CHO cells was identified and its dynamic behavior described for the first time (chapter 2). It was 
found that the glycolytic enzymes exist partially in a soluble form and partially attached to cellular 
structures or associated with each other. This was especially evident for the two key enzymes of 
glycolytic control, HK and PFK. Binding of the HK to the outer mitochondrial membrane facilitates 
preferential access to mitochondrially generated ATP, stimulates glycolytic flux and was shown to 
inhibit apoptosis (Kim and Dang, 2005; Vyssokikh and Brdiczka, 2003). A fine-tuning of glycolytic 
fluxes matching the metabolic state is most likely achieved by a dynamic shift in the equilibrium 
between bound and soluble glycolytic enzymes. It was concluded that glycolysis in CHO cells 
occurs as a mixed response of partly glycolytic channeling and partly free diffusion. This finding 
was additionally verified by the results of the INST-MFA (chapters 5 and 6). Comparing the results 
of these two in-depth INST-MFA studies, we found that glucose uptake as well as glycolytic 
channeling to either lactate excretion or mitochondrial TCA cycle was significantly affected by the 
cultivation conditions. These findings further support our hypothesis established in chapter 2 that 
the dynamics of glycolytic channeling affect the availability of pyruvate to the mitochondria and 
thus the connection between glycolysis and TCA cycle. On the other hand, it was demonstrated that 
a perturbation of the cellular pyruvate metabolism by CHC and DCA resulted in feedback 
regulation of glycolysis (chapter 4). A decreased or increased pyruvate flux into the TCA cycle was 
partially compensated by up- and downregulation of glycolytic fluxes, respectively. 
9.3.2 TCA cycle control 
The higher glucose uptake and efficient channeling of pyruvate into the mitochondria in the reactor 
cultivation resulted in five times higher TCA cycle fluxes compared to the shake flask cultivations 
which were characterized by significant overflow metabolism. The most important findings 
regarding glycolytic and TCA cycle control are summarized in Figure 9-4. 
The results of the mitochondrial studies indicate a separation of the TCA cycle into an effector-
controlled first half and a concentration-controlled second half of the TCA cycle (chapter 7 and 8). 
The first part of the TCA cycle is tightly controlled by the availability and allosteric effects of 
substrates and cofactors. Activities of the PDH, the IDH and the AKGDH are strongly stimulated by 
ADP and most reactions are inhibited by high levels of ATP and NADH. In addition, the IDH 
activity was identified as rate-limiting reaction in the TCA cycle by determining its maximum 
capacity in the mitochondria (chapter 2). The respective intramitochondrial concentrations estimated 
by INST-MFA (chapter 6), high for citrate and low for -ketoglutarate, additionally point to a 
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limiting function of the mitochondrial IDH reaction. Significantly higher TCA cycle activity and 
higher rates of full metabolization to CO2 could be obtained when supplying intermediates entering 
the first half of the cycle (e.g. citrate, -ketoglutarate, glutamine) compared to supply of C4-
dicarboxylates (succinate, malate, fumarate) entering the second half of the cycle (chapter 8). The 
second half of the TCA cycle is controlled by a relatively constant mitochondrial pool of C4-
dicarboxylates. Identical intracellular labeling dynamics determined for fumarate, malate and 
aspartate also point to a rapid equilibrium between C4 metabolites (chapter 6). An excess of C4 
carbon is removed from the TCA cycle by cataplerotic reactions (chapters 2, 3, and 4) and from the 
mitochondria by the dicarboxylate carrier (chapter 8). High concentrations of C4-dicarboxylates 
potentially inhibit other enzymes involved in the TCA cycle (chapter 8). 
 
Figure 9-4. Metabolic control of glycolysis and TCA cycle in CHO-K1 cells. HK – hexokinasae, mIDH 
– mitochondrial isocitrate dehydrogenase, MPC – mitochondrial pyruvate carrier, PDH – pyruvate 
dehydrogenase, PYR – pyruvate, C2 – acetyl-CoA (two carbon substrate), C4 – oxaloacetate (four carbon 
substrate). Important regulatory events are highlighted in red. 
In addition, the TCA cycle flux is strictly regulated by availability of C2 (acetyl-CoA) and C4 
substrates (oxaloacetate) to initiate the CS reaction. Pyruvate and glutamine were determined as 
most significant carbon sources to supply C2- and C4-units to the TCA cycle in CHO cells (chapter 
2). Integrating the findings of the chapters 2, 3 and 4, it was concluded that the carbon input into the 
TCA cycle at the sites of pyruvate and glutamine can partially work as complementary, redundant 
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modules. It was shown that glutamine limitation was compensated by increased pyruvate 
consumption (chapter 3). On the other hand, an increased or decreased pyruvate flux into the TCA 
cycle upon metabolic perturbation by DCA or CHC, respectively, was offset by an adjustment of 
glutamine fluxes into the TCA cycle (chapter 4). Furthermore, it was found that a tailored 
adaptation of aminotransferases (ALAT and ASAT) and anaplerotic enzymes (ME and PEPCK) 
control a balanced carbon supply into the TCA cycle at varying pyruvate and glutamine 
availabilities in different growth phases of CHO cell batch cultivation (chapter 2). It is noteworthy 
that the highly efficient reactor cultivation was characterized by a significantly higher mitochondrial 
ME activity than the shake flask cultivations (chapter 5 and 6). 
9.3.3 Amino acid metabolism 
CHO cells are able to adapt to a wide range of glutamine availabilities (chapter 3). Flux 
rearrangements in the amino acid metabolism (mainly alanine, glutamate, serine, glycine, 
asparagine and aspartate) effectively mitigate ammonia stress as a result of glutamine excess and 
facilitate the utilization of alternative carbon sources to compensate glutamine limitation. The 
glutamine metabolism affects the growth behavior and partially the waste product excretion in CHO 
cells. A controlled feeding of glutamine avoids both glutamine limitation and glutamine excess 
which eventually reduces ammonia stress and increases culture longevity (chapter 3). 
In particular the alanine production was directly coupled to glutamine consumption. In chapter 2, 
we observed that the mitochondrial ALAT (mALAT) was active at glutamine consumption in the 
first growth phase. After glutamine depletion, however, only cytosolic ALAT was found in the 
second growth phase. At high glutamine consumption rates, ammonia is mostly released in the 
mitochondria suggesting that mALAT is needed as a mitochondrial nitrogen sink. In chapter 2, we 
hypothesized that mitochondrial alanine is a potential source of mitochondrial pyruvate, although 
the contrary might also be true. It is possible that mALAT is consuming mitochondrial pyruvate, 
thereby contributing to the lack of C2 units in the exponential growth phase. The results of the 
INST-MFA favor the second hypothesis demonstrating that alanine is produced 
intramitochondrially and transported out in the cytosol (chapters 5 and 6). However, the high 
reversibilities determined for both ALAT isoenzymes indicate that back and forward reactions, 
pyruvate consumption and pyruvate production, are highly active. Both hypotheses might be 
partially valid and take effect situation-dependently. 
Extracellular concentrations of alanine, glycine and glutamate increased in the exponential growth 
phase and decreased in later growth phases of CHO cell batch culture (chapters 2, 3 and 4). For all 
other amino acids net consumption was observed throughout the cultivation. However, even if net 
uptake was observed, degradation and synthesis of non-essential amino acids (NEAA) (e.g. serine, 
glutamine, aspartate) occurred simultaneously. Even at glutamine excess, glutamine synthesis was 
active (chapters 5 and 6). In addition, an excessive reversible exchange with the extracellular 
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medium, often significantly exceeding their net fluxes, was determined for NEAA (chapters 5 and 
6). 
The consideration of simultaneous synthesis and degradation pathways and exchange with the 
medium as well as the accurate representation of metabolic compartmentation in the metabolic 
model is essential to obtain a realistic picture of the cellular amino acid metabolism. This is 
especially critical to describe the cellular glutamate metabolism which is affected by e.g. 
glutaminase, glutamine synthetase, glutamate dehydrogenase, serine synthesis, alanine and aspartate 
aminotransferases, isocitrate dehydrogenases, and the mitochondrial aspartate-glutamate carrier. 
Integrating the results from two parallel tracer experiments in one parameter estimation of INST-
MFA, it was possible for the first time to resolve a detailed metabolic network including all these 
aspects (chapter 6). Interestingly, mitochondrial glutamate was mostly metabolized by 
mitochondrial ALAT and ASAT and not by glutamate dehydrogenase. The high mitochondrial 
glutamate concentration estimated by INST-MFA favors its efflux into the cytosol. Cytosolic 
glutamate fuels the glutamine synthesis and serves as antiport partner for the aspartate-glutamate 
carrier. 
9.3.4 The cytosol-mitochondria interface 
For a detailed investigation of the cytosol-mitochondria interface a novel approach for in-depth 
quantitative studies of mitochondrial activities was designed and established. The strategy included 
experimental access of CHO cell mitochondria by selective permeabilization as well as a 
quantitative assessment of mitochondrial uptake and production rates integrated by EMA in order to 
resolve a mitochondrial network model. C4 dicarboxylates (e.g. malate and succinate) were 
transported in and out of the mitochondria at high rates. This demonstrates a high capacity of the 
dicarboxylate carrier that is mainly driven by extra- and intramitochondrial concentrations. This is 
additionally supported by the high reversibilities determined for the malate carrier in the two INST-
MFA studies (chapters 5 and 6). 
Citrate and -ketoglutarate are both transported in antiport with a dicarboxylate. From all tested 
mitochondrial substrates, -ketoglutarate and citrate sustained the highest complete TCA cycle 
activity. The findings of the mitochondrial studies suggest a potential cooperation between the 
dicarboxylate carrier and the citrate carrier or the -ketoglutarate carrier, respectively, that prevents 
a dilution of malate into the extramitochondrial space and facilitates its direct reuptake (Figure 9-5) 
(chapter 8). This might result in an autocatalytic effect on the uptake of citrate and -ketoglutarate 
explaining their high metabolization rates. Citrate and isocitrate uptake by the mitochondria is not 
described in a typical physiological context. Usually, citrate is transported out of the mitochondria 
to supply acetyl-CoA for the fatty acid synthesis. In addition, cytosolic citrate affects glycolytic 
activity by inhibiting PFK (Michal and Schomburg, 2012). The removal of citrate from the cytosol 
might be essential in some physiological situations to prevent an inhibition of glycolysis. 
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Considering the high cytsosolic IDH activity with yet uncertain biological significance another role 
can be imagined. In a state of (cytosolic) NADPH excess (e.g. by a high PPP activity as shown in 
chapters 5 and 6), the reversed functioning of cytosolic IDH as described previously (Fendt et al., 
2014; Metallo et al., 2012; Wise et al., 2011; Yoo et al., 2008) might result in cytosolic isocitrate 
and citrate production followed by their uptake into the mitochondria and utilization in the TCA 
cycle. Interestingly, intracompartmental concentrations of citrate and -ketoglutarate as estimated 
by INST-MFA were reversed in cytosol and mitochondria. The high cytosolic and low 
mitochondrial -ketoglutarate concentrations might even hint at a functioning of cytosolic and 
mitochondrial IDH in opposite directions. 
 
Figure 9-5. Cooperation between mitochondrial transporters obviates the dilution of intermediates. 
CIT – citrate, MAL – malate, AKG – -ketoglutarate, C – citrate carrier, D – dicarboxylate carrier, O – 
-ketoglutarate carrier. 
In contrast to the reversible action of dicarboxylate carrier, citrate carrier and -ketoglutarate 
carrier, our results indicate that pyruvate enters the mitochondria via irreversible action of the MPC. 
Although previous MFA studies of CHO cells considered a reversible mechanism of MPC in their 
network model (Ahn and Antoniewicz, 2011; Sheikholeslami et al., 2013b), there was no indication 
that pyruvate can be transported out of the mitochondria. Mitochondrial pyruvate metabolism was 
limited in mitochondrial studies when stimulated with ADP, aspartate, and both ADP and aspartate 
(chapters 7 and 8), but also in vivo when stimulated with DCA (chapter 4). These findings point to 
an upper limit of mitochondrial pyruvate transport by MPC. This suggests that the mitochondrial 
pyruvate supply cannot be adapted by increasing its transport. Alternatively, it can be controlled by 
ME facilitating intramitochondrial pyruvate generation. As illustrated above, an equimolar supply of 
C2 and C4 units is required to initiate the CS reaction and an important aspect of TCA cycyle 
control. Instead of increasing the carbon input from the cytosol by increasing pyruvate uptake, 
pyruvate is rather produced from mitochondrial malate resulting in a redistribution of carbon from 
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C4 to C2 units and in an overall moderated carbon input into the TCA cycle. However, ME activity 
varied significantly at different cultivations conditions and in different growth phases (chapters 2, 5 
and 6). 
Interestingly, mitochondrial aspartate uptake required the presence of pyruvate. This indicates that 
pyruvate activates aspartate transport via the aspartate-glutamate carrier and its metabolization via 
ASAT by a yet unknown regulatory mechanism. Nevertheless, pyruvate and aspartate are 
metabolized individually by separate elementary modes (chapter 8). The aspartate-glutamate 
antiporter exchanges these amino acids across the mitochondrial membrane. Therefore, aspartate 
uptake stimulates glutamate excretion and glutamate uptake induces aspartate production by the 
mitochondria. In addition, glutamate can be transferred by a glutamate carrier in cotransport with 
H+. This was also the preferred system to export glutamate at conditions of excess glutamine 
consumption to prevent mitochondrial glutamate accumulation as shown by the mitochondrial 
studies (chapter 8) and the INST-MFA (chapter 6). 
9.3.5 Metabolic compartmentation controlling the cellular redox balance 
The cellular redox state is crucial in controlling metabolism. A huge number of different metabolic 
processes contribute to it. The NADH produced in glycolysis, TCA cycle and various redox 
reactions is used in the respiratory chain for energy generation. NADPH on the other hand is an 
important electron donor in biosynthesis reactions. In addition, NADPH has an essential role in 
scavenging ROS originating mainly from the respiratory chain as a byproduct. 
Since reducing equivalents cannot pass the mitochondrial membrane, the cytosolic and 
mitochondrial redox balances are also controlled by metabolic compartmentation. In contrast to 
metabolites such as organic acids, amino acids, and ATP, where specific mitochondrial carriers are 
available, the transfer of electrons across the mitochondrial membrane requires the activity of 
mitochondrial shuttle systems. The malate-aspartate-shuttle and to a minor importance the glycerol 
phosphate shuttle usually transfer the electrons of NADH from the cytosol into the mitochondria 
where they contribute to energy generation by oxidative phosphorylation. Interestingly, the lack of 
mitochondrial ASAT activity determined in the exponential growth phase in chapter 2 indicates a 
dysfunctional malate-aspartate-shuttle at certain conditions. Therefore, the high lactate production 
in the first growth phase was responsible for NAD+ regeneration (NADH oxidation) in the cytosol. 
Lactate consumption, on the other hand, was accompanied by an activation of mitochondrial ASAT 
indicating a fully functional malate-aspartate-shuttle in the second growth phase of CHO cell batch 
cultivation (chapter 2). Previous studies reported a connection between a functional malate-aspartate 
shuttle and the lactate shift in CHO cells (Zagari et al., 2013b). The malate-aspartate shuttle was 
found to be active in both INST-MFA studies (chapters 5 and 6). However, the mitochondrial 
studies revealed a complex regulation of mitochondrial aspartate metabolism that needs to be further 
elucidated (chapters 7 and 8). 
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In contrast, so far there has been no shuttle system described for the transfer of electrons of NADPH 
into the mitochondria. Since the mitochondria represent the major site of ROS generation and 
accumulation, the mitochondrial NADPH content is critical for counteracting oxidative stress. 
However, for the conditions studied in the presented thesis, cellular NADPH was mainly produced 
by PPP in the cytosol as consistently found for both INST-MFA studies (chapters 5 and 6). A 
potential source of mitochondrial NADPH is the malic enzyme reaction which has been shown to be 
active in the mitochondria (chapters 2, 5, 6, 7, and 8). In addition, mitochondrial NADPH can be 
generated by the NAD(P)+-transhydrogenase (NNT) that is located in the inner mitochondrial 
membrane (Michal and Schomburg, 2012). Using the mitochondrial proton gradient, NNT enables 
an intramitochondrial reduction of NADP+ using NADH. Yet another possibility is the generation of 
NADPH by glutamate dehydrogenase (GDH) and isocitrate dehydrogenase (IDH). Besides the 
finding, that the IDH was identified as the rate-limiting step in the TCA cycle (chapter 2, 7, 8), 
some remarkable observations were made. Unexpectedly, the major part of the cellular IDH activity 
was found to be NADP+-dependent and less than 5% NAD+-dependent. Another interesting finding 
was that only 30% of IDH activity was mitochondrial while the major part of cellular activity was 
localized in the cytosol. Both cytosolic and mitochondrial NADP+-dependent IDH (IDHNADP) 
isoenzymes have been associated with resistance to oxidative stress. Reduced IDHNADP expression in 
either compartment was shown to induce DNA fragmentation, increased levels of peroxides and 
oxidized glutathione (GSSG) and reduced cellular ATP and NADPH levels in fibroblast cell 
cultures (Jo et al., 2001; Lee et al., 2002). Considering the protective role of IDHNADP, its high 
proportion of more than 95% of cellular IDH activity indicates a successful adaptation of CHO K1 
metabolism to cope with oxidative stress. 
However, in particular the biological importance of the high cytosolic IDH activity remains an 
unanswered question in this respect. Considering the excess cytosolic NADPH production by PPP 
activity and the significant mitochondrial NADPH demand for ROS scavenging, a functioning of 
IDH in opposite directions in different compartments can be imagined. Reductive carboxylation of 
AKG by reverse flux through IDH has been described in various studies of mammalian cells, 
especially in the context of cancer metabolism, high proliferation rates, hypoxia and impaired 
mitochondrial function (Fan et al., 2013; Fendt et al., 2014; Leonardi et al., 2012; Metallo et al., 
2012; Mullen et al., 2014; Mullen et al., 2012; Wise et al., 2011; Yoo et al., 2008). 
Similar to the malate-aspartate shuttle responsible for the transfer of cytosolic NADH to be used in 
the mitochondrial respiratory chain, a shuttle system for cytosolic NADPH to be used for 
mitochondrial defense against oxidative stress can be hypothesized. The proposed shuttle system is 
schematically depicted in Figure 9-6. It involves a reverse cytosolic IDH consuming NADPH, 
import of citrate by the mitochondrial citrate carrier (as demonstrated in chapter 8), release of 
mitochondrial NADPH by forward mitochondrial IDH, and export of -ketoglutarate via the -
ketoglutarate carrier to close the cycle. Malate can cycle between the two antiporters. The shuttle 
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mechanism can involve and would benefit from a cooperation of transporters as hypothesized in the 
previous section and in chapter 8. 
 
Figure 9-6. Mitochondrial shuttle system for the transfer of electrons from cytosolic NADPH into the 
mitochondria. 
Another characteristic of the compartmented redox metabolism has been revealed by the results of 
the INST-MFA in chapter 6. The labeling patterns and dynamics of pyruvate and lactate indicate a 
microcompartmentation of these metabolites in both compartments. Our findings indicate (i) the 
existence of two separate pools in the cytosol for pyruvate and lactate, respectively, (ii) pyruvate 
channeling to extracellular lactate as well as to the mitochondrial TCA cycle and (iii) a 
mitochondrial lactate dehydrogenase (mLDH) reaction. Various previous studies provide either 
hypotheses or clear evidence supporting our findings. Several distinct pools for pyruvate and lactate 
within one compartment have been suggested by different groups (Ahn and Antoniewicz, 2013; 
Cruz et al., 2001; Deshpande, 2007; Peuhkurinen et al., 1983; Sickmann et al., 2005; Zwingmann et 
al., 2001). A mitochondrial lactate dehydrogenase has first been demonstrated in 1971 (Baba and 
Sharma, 1971). Although the existence of a mLDH has been a matter of controversy for several 
decades, the potential presence of mLDH and mitochondrial lactate pools has nowadays been 
proven for several tissues (Brooks et al., 1999; Gladden, 2004; Hashimoto et al., 2006; Kline et al., 
1986; Lemire et al., 2008; Philp et al., 2005; Sagrista and Bozal, 1987b). Recent studies integrating 
respirometry, immunofluorescence/confocal microscopy and immunoblotting approaches finally 
reconciled supporting and contradicting results about mLDH of earlier studies (Elustondo et al., 
2013). These studies are also consistent with our findings that lactate alone cannot induce 
mitochondrial respiration (verified by mitochondrial studies presented in chapter 7, data not shown). 
They demonstrated that the mLDH is most likely localized in the mitochondrial intermembrane 
space and physically and functionally associated with the inner mitochondrial membrane. The 
different cellular pyruvate and lactate pools most likely serve as regulators of cellular redox state. A 
mitochondrial lactate sink might control the mitochondrial NADH levels and therefore TCA cycle 
fluxes since NADH as a negative effector of TCA cycle is reduced (chapter 6). 
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9.3.6 Cellular robustness and its limitations 
Robustness is a fundamental property of complex biological systems that allows maintaining 
functionality in the face of internal and external perturbations. CHO cells are famous for their 
extraordinary robustness and flexibility. Very different metabolic phenotypes have been observed at 
various different cultivation conditions. In the presented thesis, some key players of this robustness 
have been revealed. 
An important aspect in terms of their flexibility is their ability to utilize a variety of different 
substrates. Different metabolites, e.g. lactate, glutamate and alanine, are first excreted as waste 
products but can be consumed as important carbon sources later in the cultivation (chapters 2, 3 and 
4). We demonstrated that the reversible exchange of metabolites with the extracellular medium is in 
the order of their net fluxes or even substantially higher (chapters 5 and 6). Using this strategy the 
cells are able to perceive their environment very sensitively and rapidly shift from net excretion to 
net consumption depending on extra- and intracellular metabolite concentrations and kinetic 
properties of the respective plasma membrane transporters. That indicates that the utilization of 
alternative carbon sources is not a newly occurring event in the course of a cultivation process. 
Available carbon sources are always utilized, only their contribution to overall carbon intake can 
increase tremendously when the availability of other carbon sources decreases. 
In chapter 2, it was observed that the cells maintained their viability and a functional TCA cycle 
over three metabolic phases characterized by (a) initial nutrient excess, (b) depletion of the major 
substrate glutamine and (c) nutrient scarcity towards the end of the cultivation. It was demonstrated 
which key enzymes are dynamically adjusted in different growth phases with respect to their 
activities and their subcellular localization in order to match the metabolism to changing substrate 
availabilities. The enzymes HK, PFK, IDH, ME, PEPCK, ALAT, and ASAT were shown to be of 
crucial importance in controlling the central metabolism in CHO cells. 
The extreme metabolic robustness of CHO cells was further demonstrated in chapters 3 and 4. It 
was shown that CHO cells are able to grow at a wide range of different glutamine availabilities and 
also without glutamine supplementation. Interestingly, it was found that the glutamine synthesis 
pathway is active even at glutamine excess (chapters 5 and 6). In general, the simultaneous 
synthesis and catabolic degradation of NEAA enables an extraordinary flexibility in response to 
changing conditions. It allows a fast adaptation to varying anabolic and catabolic demands in the 
whole culture and in separate cellular compartments. Furthermore, additional carbon sources, 
mainly pyruvate, serine, asparagine, aspartate and glutamate, compensated a shortage of the 
preferred substrate glutamine. On the other hand, CHO cells also tolerate high glutamine abundance 
resulting in substantial ammonia accumulation. Cellular stress due to elevated ammonia levels was 
successfully extenuated by increasing cellular ammonia fixation (e.g. by alanine and serine 
synthesis) and reducing ammonia release from certain amino acids by decreasing their degradation 
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(e.g. asparagine and serine) (chapter 3). In addition, the energy metabolism of CHO cells proved to 
be robust upon perturbation of the cellular pyruvate metabolism with the biochemical effectors CHC 
and DCA (chapter 4). An impaired energy metabolism but also increased ATP levels were 
counterbalanced by effective rearrangements of anaplerotic fluxes (e.g. the glutamate 
dehydrogenase flux) and feedback regulation of the glycolysis. The interplay of pyruvate and 
glutamine input exemplifies this modular system of anaplerosis and cataplerosis that maintains TCA 
cycle activity at various internal and external perturbations (chapters 2, 3, 4). 
Another aspect is the adaptation of the CHO cell redox metabolism towards high resistance to 
oxidative stress. This is facilitated by (i) the high PPP activity, (ii) cytosolic and mitochondrial 
lactate/pyruvate redox buffers, (iii) the substantial proportion of cellular NADP-dependent IDH, and 
(iv) potentially by the hypothesized NADPH shuttle system (Figure 9-6). 
Although robustness is a valuable achievement, there are potential trade-offs with several cellular 
functions. Robustness is achieved at the cost of (i) resource demands, e.g. glutamine dependence 
upon a perturbed pyruvate metabolism (chapter 4), (ii) overall performance, e.g. reduced specific 
growth rate at glutamine free conditions (chapter 2 and 3), (iii) increased susceptibility towards 
unexpected perturbations, e.g. growth arrest and reduced energy levels when glutamine depletion 
and CHC treatment were combined (chapter 4), (iv) metabolic efficiency, e.g. putative substrate 
cycles by simultaneous amino acid catabolism and anabolism. Such compromising characteristics 
are inherent properties of robust systems (Kitano, 2004). 
Understanding the means of cellular robustness is crucial to understand the dynamic nature of 
metabolism. In particular contexts, it is even desirable to avoid cellular robustness. Diseases can be 
regarded as a manifestation of robustness, e.g. the specific metabolic features of cancer cells. The 
development of high-yielding producer strains is often limited by cellular robustness, e.g. when 
genetic modifications do not manifest as intended. It was shown that the CHO cell metabolism was 
susceptible to low CHC and DCA concentrations due to insufficient activation of compensation 
mechanisms (chapter 4). Similarly, culture performance could be improved at mild glutamine 
limiting conditions by avoiding waste production and cataplerotic carbon output from the TCA 
cycle (chapter 3). Mild intervention seems to be a successful way to achieve the desired effect and 
necessary to avoid overcompensation of metabolism. On the other hand, the cellular performance 
could not be maintained or restored by compensation mechanisms when both major carbon sources 
of the TCA cycle, pyruvate and glutamine, failed. Knowing these weak points of the cell’s 
metabolism is desirable either to avoid those conditions or to lead a cell into a vulnerable state on 
purpose to induce its collapse. The targeting of multiple enzymes or pathways that can potentially 
compensate each other (e.g. glycolysis and glutaminolysis) is a promising strategy to increase the 
efficacy of therapeutic treatments. 
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9.3.7 Implications for improving biotechnological production in CHO cells 
Understanding the control of metabolism is crucial for leading cells into a desirable metabolic 
phenotype, and thus for achieving progress in bioprocesses. The results of the presented thesis 
provide novel and detailed insights into the central metabolism of CHO cells. In particular, we stress 
the importance of conducting comprehensive and in-depth studies and emphasize the dynamic 
nature of cellular metabolism. Oversimplifications of metabolism lead to misinterpretations and 
ultimately result in misguided measures and a waste of resources. 
Many strategies for improving cellular performance involve reducing overflow metabolism by 
reducing substrate load (e.g. by low glucose and glutamine feeding) (Altamirano et al., 2004; Wong 
et al., 2005; Xie and Wang, 1994) or genetic engineering strategies (e.g. knockdown of LDH) (Chen 
et al., 2001; Jeong et al., 2001; Kim and Lee, 2007) with the aim of increasing the pyruvate carbon 
flux into the TCA cycle. However, especially genetic modifications do often not lead to the desired 
effect (Ha et al., 2013; Kim and Lee, 2009). Although remarkable improvements have been 
achieved in the past by simple genetic manipulations and screening for favorable cultivation 
conditions, more sophisticated strategies might be necessary in the future to continue progress and 
obtain significant further advancements. Our findings indicate that the wealth of regulatory 
measures, most importantly the universal feedback by the cellular redox and energy state, can in 
many cases not be suspended by targeting a single enzyme (usually only a single isoenzyme) or a 
single pathway. 
In the presented thesis, key control elements in glycolysis, in TCA cycle, and for the first time also 
at the cytosol-mitochondria interface have been unraveled and highlighted as targets for metabolic 
engineering. Influencing glycolytic channeling (the distribution of bound and soluble glycolytic 
enzymes), e.g. by genetic or biochemical manipulation of specific isoenzymes of HK and PFK, 
might be an interesting approach to control glycolytic flux and apoptosis in industrial applications. 
Our findings revealed that the pyruvate flux into the TCA cycle is also affected by channeling 
effects in cytosol and mitochondria. These channeling events are, however, hardly understood, 
highly dynamic and with the current state of knowledge impossible to control by interventions. The 
mitochondrial pyruvate metabolism is strictly controlled by PDH. Activation of PDH by DCA was 
partially counterbalanced by flux rearrangements (e.g. down regulation of malic enzyme and 
glycolysis). However, the mitochondrial studies indicate that also the MPC is a limiting element in 
cellular pyruvate metabolism and thus a potential engineering target. An alternative strategy to 
increase intramitochondrial pyruvate supply is the overexpression of mitochondrial malic enzyme. 
This seems particularly promising because a higher ME activity was associated with a very efficient 
metabolism found for the reactor cultivation (chapter 5). Although glutamine was an important 
carbon source for the TCA cycle, it was found that it is not efficiently utilized in the mitochondria 
due to following efflux of glutamate out of the mitochondria. The efficient uptake and 
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metabolization of citrate by CHO cell mitochondria, however, stimulates ideas for testing citrate as 
an additional carbon source in CHO cell culture media. Nevertheless, all attempts to increase the 
carbon flux into TCA cycle might be effectless if its capacity or the capacity of oxidative 
phosphorylation is limited. Our findings indicate that the TCA cycle flux is very strictly controlled. 
An excess of carbon entering the TCA cycle is directly counterbalanced by cataplerotic reactions. 
Generally, increasing the rate-limiting mitochondrial activity of IDH seems to be a prerequisite for 
realizing higher TCA cycle activities. However, an elimination of feedback inhibition by NADH 
and ATP is most likely additionally required to achieve a higher TCA cycle flux. 
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10 Outlook and future prospects 
The single studies presented in this thesis and most importantly their collective integration and 
interpretation provide deep insights into the functioning of the complex compartmented metabolism 
in CHO cells. However, we end up with more unanswered questions than we posed at the 
beginning. Further steps towards understanding the mammalian metabolism with respect to 
compartmentation should focus on following issues. While there is a wealth of data about enzyme 
properties in general, knowledge about kinetic and regulatory parameters of distinct isoenzymes 
located in different compartments is scarce (Rakhmanova and Popova, 2006). The determination of 
compartment-specific enzyme activities made a first small step towards increasing the awareness of 
the importance of such data. Similarly, information about existence, specificity and regulation of 
mitochondrial transporters is insufficient or uncertain. These data will provide a substantial 
contribution to refining compartmented metabolic models. We have shown that an evaluation of 
intracellular and even intracompartmental metabolite concentrations can be done by means of 
parameter estimation. Nevertheless, a reliable experimental determination of absolute intracellular 
concentrations in CHO suspension cells would significantly enrich MFA studies. Improving 
quenching and extraction methods, potentially implementing microfluidic lab-on-a-chip approaches 
(Rajabi et al., 2012; Wiendahl et al., 2007; Wurm et al., 2010), could eventually succeed in 
obtaining valid intracellular concentrations, yet are unlikely to resolve intracompartmental 
concentrations. FRET-sensors have been successfully applied to monitor the concentration of single 
metabolites in specific compartments (De Michele et al., 2014). For a more broad coverage of 
subcellular metabolite concentrations adaptations of non-aqueous fractionation methods might be a 
promising starting point (Gerhardt and Heldt, 1984; Krueger et al., 2011; Soboll et al., 1979). The 
main focus of this work was the determination of metabolic activities using MFA, EMA, enzyme 
assays and respiration rates. We have demonstrated what rich knowledge can be derived from 
integrating data sets of different hierarchical levels. The availability of CHO genome data paves the 
way for comprehensive systems biology studies. The integration of different omics data is expected 
to achieve a systems understanding of mammalian metabolism. This includes also the correlation 
between metabolism and other cellular processes, e.g. sinalling (Goncalves et al., 2013; Ryll et al., 
2014). The range of distinct metabolic phenotypes described in this thesis for different cultivation 
conditions, different metabolic phases in the course of cultivation, and different perturbations, 
illustrate the metabolic heterogeneity of CHO cell metabolism. Future studies should bring into 
focus this dynamic nature of metabolism. A practical implication of metabolic dynamics is that 
static interventions are not optimal to control metabolism. Flexible and adjustable methods for 
manipulating cell physiology and metabolism, e.g. by genetic switches (Kramer et al., 2004; Mazur 
et al., 1999), are needed to come up to dynamic metabolic control mechanisms. 
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Supplementary Figure S1. Scheme of the central carbon metabolism in CHO cells. The 
dashed boxes indicate which metabolite pools are lumped in the condensed flux maps in Figure 4-
3. Metabolites that are shown in the flux maps in Figure 4-3 are highlighted in grey 
 
Supplementary Figure S2. Screening of CHC and DCA. (A) and (D) Concentration response 
curves of dissolved oxygen measurements for -cyano-4-hydroxy cinnamic acid (CHC) and 
dichloroacetic acid (DCA) after 70 h of cultivation. EC50 values: 3.5 mM (CHC) and 13 mM 
(DCA). Hill coefficients: 8.7 (CHC) and 5.4 (DCA). (B) and (E) Extracellular pyruvate 
concentrations after 70 h of cultivations with different CHC and DCA concentrations. (C) and (F) 
Extracellular lactate concentrations after 70 h of cultivations with different CHC and DCA 
concentrations 
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Supplementary Figure S3. Complete extracellular metabolite profiles of CHO-K1 cell 
cultures upon CHC treatment. Shown are extracellular metabolite concentrations [µmol/l] of 
CHO-K1 cell cultures upon treatment with 1 mM and 3 mM -cyano-4-hydroxy cinnamic acid 
(CHC) compared to control cultivations without CHC and without DMSO (CHC control) and with 
0.5% DMSO (CHC DMSO). Abbreviations: Glc glucose, Lac lactate, Pyr pyruvate, for amino 
acids the standard three letter code is used. Dashed lines indicate the different metabolic phases, 
phase I (0-72 h), phase II (72-120 h) and phase III (>120 h) 
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Supplementary Figure S4. Complete extracellular metabolite profiles of CHO-K1 cell 
cultures upon DCA treatment. Shown are extracellular metabolite concentrations [µmol/l] of 
CHO-K1 cell cultures upon treatment with 3 mM, 5 mM or 10 mM dichloroacetic acid (DCA) 
compared to control cultivation without DCA (DCA control). Abbreviations: Glc glucose, Lac 
lactate, Pyr pyruvate, for amino acids the standard three letter code is used. Dashed lines indicate 
the different metabolic phases, phase I (0-72 h), phase II (72-120 h) and phase III (>120h) 
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Supplementary Table S3. Biomass composition of CHO cells used for flux estimation. 
 
  
Precursor Yield coefficient [pmol/cell]
Ala 0.110
Arg 0.086
Asn/Asp 0.138
Gln/Glu 0.161
Gly 0.149
His 0.034
Ile 0.059
Leu 0.115
Lys 0.094
Met 0.010
Phe 0.050
Pro 0.049
Ser 0.081
Thr 0.067
Trp 0.001
Tyr 0.056
Cys 0.084
Val 0.083
G6P_carbs 0.138
lipids 0.036
R5P_DNA 0.043
R5P_RNA 0.018
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Supplementary Table S4. Complete set of measured metabolic fluxes [mmol/(L  h)]. Selected fluxes 
are depicted in the flax maps in Figure 4-3. 
 
  
flux 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h
glc in 217.64 54.28 224.57 55.67 176.88 52.70 245.91 42.40 179.17 55.12 173.03 47.60 177.48 60.96 161.27 71.17
lac in -236.39 48.22 -263.05 57.27 -230.02 32.55 -292.73 -40.62 -187.90 50.13 -149.02 32.49 -166.08 42.25 -168.56 35.45
pyr in 6.13 1.48 7.68 2.07 2.35 2.70 -22.06 1.56 7.06 1.06 8.07 0.99 8.16 1.19 8.46 0.96
ala in -29.81 -2.73 -30.00 -5.04 -22.94 -0.61 -10.73 -2.06 -22.89 -0.13 -20.95 0.46 -23.36 1.22 -21.84 0.58
arg in 6.54 2.73 6.15 2.78 6.42 2.38 5.90 1.30 6.46 2.37 6.06 1.99 6.22 2.48 6.05 2.61
asn in 19.43 5.77 18.24 6.66 16.81 6.80 16.03 8.48 17.00 3.43 16.53 3.36 16.33 3.54 14.02 4.80
asp in 6.31 3.91 6.74 4.12 6.51 4.04 4.03 5.62 6.18 2.54 6.40 2.41 5.51 2.70 2.88 3.67
cys in 6.38 2.66 5.99 2.71 6.26 2.32 5.75 1.27 5.77 2.31 5.91 1.94 6.06 2.41 5.90 2.54
glu in -0.74 2.18 -1.01 2.32 -0.68 2.18 -0.30 2.29 -0.37 1.54 0.07 1.24 -0.44 1.58 -1.40 1.89
gln in 49.27 0.03 50.58 0.51 48.88 0.68 62.99 2.37 41.11 -0.02 38.22 -0.09 43.15 -0.18 42.80 -0.01
gly in -6.47 -1.32 -6.54 -1.79 -6.33 -1.88 -6.91 -7.13 -4.54 -1.33 -4.47 -0.65 -5.03 -0.84 -6.15 -0.54
his in 2.56 1.07 2.40 1.09 2.51 0.93 2.31 0.51 2.31 0.92 2.37 0.78 2.43 0.97 2.36 1.02
ile in 6.89 2.72 6.42 2.68 6.54 2.56 6.24 1.49 6.65 1.91 6.54 1.55 6.17 1.78 4.81 2.14
leu in 10.77 3.82 10.15 3.94 9.79 3.81 10.13 1.96 9.61 3.15 9.28 2.66 9.11 3.30 8.06 3.47
lys in 10.58 2.99 10.63 3.04 9.69 3.04 11.25 1.43 9.73 2.59 9.61 2.18 9.55 2.71 7.67 2.86
met in 3.47 0.89 3.32 0.91 3.01 0.95 3.03 0.40 3.04 0.55 2.92 0.52 2.93 0.56 2.45 0.77
phe in 3.94 1.58 3.78 1.61 3.72 1.38 3.51 0.76 3.45 1.37 3.51 1.16 3.60 1.44 3.51 1.51
pro in 9.19 1.56 4.44 3.04 8.59 1.87 11.22 0.74 6.03 1.35 6.31 1.14 5.98 1.41 4.49 1.49
ser in 19.31 2.54 18.55 3.45 15.76 3.58 14.24 3.51 16.07 1.67 15.77 1.40 16.08 1.33 14.67 1.79
thr in 5.52 1.59 5.29 2.17 5.28 1.86 4.78 1.02 5.06 1.85 5.03 1.56 4.86 1.94 4.73 2.04
tyr in 4.26 1.78 4.01 1.81 4.18 1.55 3.85 0.85 3.86 1.54 3.95 1.30 4.05 1.61 3.94 1.70
val in 8.11 2.78 7.65 2.78 7.54 2.47 6.51 1.26 7.30 2.28 7.21 1.92 6.80 2.39 5.83 2.51
alabio 8.34 3.48 7.84 3.54 8.18 3.03 7.52 1.66 7.54 3.01 7.72 2.54 7.92 3.16 7.71 3.32
argbio 6.54 2.73 6.15 2.78 6.42 2.38 5.90 1.30 5.92 2.37 6.06 1.99 6.22 2.48 6.05 2.61
aspbio 10.47 4.37 9.84 4.44 10.28 3.80 9.45 2.09 9.47 3.79 9.70 3.19 9.95 3.97 9.68 4.18
glubio 12.21 5.09 11.47 5.18 11.98 4.43 11.01 2.43 11.04 4.41 11.31 3.72 11.60 4.62 11.29 4.87
glybio 11.32 4.72 10.64 4.80 11.11 4.11 10.21 2.26 10.24 4.09 10.48 3.45 10.76 4.29 10.47 4.51
hisbio 2.56 1.07 2.40 1.09 2.51 0.93 2.31 0.51 2.31 0.92 2.37 0.78 2.43 0.97 2.36 1.02
ilebio 4.46 1.86 4.19 1.89 4.37 1.62 4.02 0.89 4.03 1.61 4.13 1.36 4.24 1.69 4.12 1.78
leubio 8.72 3.64 8.19 3.70 8.55 3.17 7.86 1.74 7.89 3.15 8.07 2.66 8.28 3.30 8.06 3.47
lysbio 7.17 2.99 6.74 3.04 7.04 2.60 6.47 1.43 6.49 2.59 6.64 2.18 6.81 2.71 6.63 2.86
metbio 0.76 0.32 0.72 0.32 0.75 0.28 0.69 0.15 0.69 0.28 0.70 0.23 0.72 0.29 0.70 0.30
phebio 3.79 1.58 3.57 1.61 3.72 1.38 3.42 0.76 3.43 1.37 3.51 1.16 3.60 1.44 3.51 1.51
probio 3.73 1.56 3.51 1.58 3.66 1.35 3.37 0.74 3.37 1.35 3.45 1.14 3.54 1.41 3.45 1.49
serbio 6.19 2.58 5.81 2.62 6.07 2.25 5.58 1.23 5.60 2.24 5.73 1.88 5.88 2.34 5.72 2.47
thrbio 5.12 2.14 4.81 2.17 5.02 1.86 4.62 1.02 4.63 1.85 4.74 1.56 4.86 1.94 4.73 2.04
tyrbio 4.26 1.78 4.01 1.81 4.18 1.55 3.85 0.85 3.86 1.54 3.95 1.30 4.05 1.61 3.94 1.70
cysbio 6.38 2.66 5.99 2.71 6.26 2.32 5.75 1.27 5.77 2.31 5.91 1.94 6.06 2.41 5.90 2.54
valbio 6.31 2.63 5.93 2.68 6.19 2.29 5.69 1.26 5.70 2.28 5.84 1.92 5.99 2.39 5.83 2.51
g6pbio 10.50 4.38 9.87 4.46 10.31 3.81 9.47 2.09 9.50 3.80 9.73 3.20 9.98 3.98 9.71 4.19
lipids 2.71 1.13 2.55 1.15 2.66 0.98 2.44 0.54 2.45 0.98 2.51 0.83 2.57 1.03 2.50 1.08
DNA 3.25 1.36 3.06 1.38 3.19 1.18 2.94 0.65 2.94 1.18 3.01 0.99 3.09 1.23 3.01 1.30
RNA 1.35 0.56 1.27 0.57 1.33 0.49 1.22 0.27 1.22 0.49 1.25 0.41 1.29 0.51 1.25 0.54
DCA 5 mM DCA 10 mMCHC control CHC DMSO CHC 1 mM CHC 3 mM DCA control DCA 3 mM
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Supplementary Table S5. Complete set of calculated fluxes [mmol/(L  h)]. Selected fluxes are 
depicted in the flax maps in Figure 4-3. 
 
  
flux 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h 0 - 72 h 72 - 120 h
phgli 202.53 47.98 210.36 49.26 162.05 47.22 232.28 39.39 165.50 49.65 159.03 42.99 163.12 55.24 147.30 65.15
ald 202.53 47.98 210.36 49.26 162.05 47.22 232.28 39.39 165.50 49.65 159.03 42.99 163.12 55.24 147.30 65.15
tri 200.43 47.10 208.39 48.37 159.99 46.45 230.39 38.97 163.60 48.90 157.09 42.36 161.12 54.45 145.36 64.31
gapdh 402.95 95.08 418.75 97.63 322.04 93.67 462.67 78.35 329.11 98.55 316.12 85.35 324.24 109.69 292.67 129.46
pgk 402.95 95.08 418.75 97.63 322.04 93.67 462.67 78.35 329.11 98.55 316.12 85.35 324.24 109.69 292.67 129.46
eno 402.95 95.08 418.75 97.63 322.04 93.67 462.67 78.35 329.11 98.55 316.12 85.35 324.24 109.69 292.67 129.46
pepk 465.18 97.59 478.01 103.57 380.01 100.60 536.37 92.99 380.63 97.58 363.35 85.14 372.42 108.23 331.34 130.68
pdh 189.40 133.87 177.81 147.42 110.81 126.56 192.42 42.57 162.60 138.65 186.30 111.14 175.06 142.58 131.53 157.54
cis 158.82 115.99 150.64 129.29 76.59 113.50 169.43 34.63 135.08 122.22 155.41 97.24 141.00 125.15 91.54 139.47
icidh 158.82 115.99 150.64 129.29 76.59 113.50 169.43 34.63 135.08 122.22 155.41 97.24 141.00 125.15 91.54 139.47
akgdh 200.60 113.11 189.67 128.40 117.74 112.44 228.97 36.86 167.97 119.32 185.24 94.67 174.54 121.93 122.70 136.48
sucdh 207.94 114.14 196.71 129.88 123.78 114.23 234.51 37.72 174.97 119.89 191.54 95.15 179.48 122.29 125.13 137.31
fumarase 211.70 115.65 200.33 131.41 127.33 115.54 237.87 38.44 178.26 121.20 194.89 96.25 182.92 123.66 128.48 138.75
maldh2 211.70 115.65 200.33 131.41 127.33 115.54 237.87 38.44 178.26 121.20 194.89 96.25 182.92 123.66 128.48 138.75
c3c4 62.23 2.51 59.26 5.94 57.97 6.93 73.70 14.64 51.53 -0.97 47.23 -0.21 48.18 -1.46 38.68 1.22
ldh 236.39 -48.22 263.05 -57.27 230.02 -32.55 292.73 40.62 187.90 -50.13 149.02 -32.49 166.08 -42.25 168.56 -35.45
gdh 4.61 1.92 4.33 1.96 4.52 1.67 4.16 0.92 4.17 1.67 4.27 1.40 4.38 1.74 4.26 1.84
gpt -38.14 -6.21 -37.84 -8.58 -31.12 -3.64 -18.25 -3.72 -30.43 -3.15 -28.67 -2.08 -31.29 -1.93 -29.55 -2.74
got 9.35 2.85 9.57 3.82 7.23 4.89 5.26 10.83 8.34 0.04 7.75 0.78 6.25 0.03 1.74 1.93
aspg -19.43 -5.77 -18.24 -6.66 -16.81 -6.80 -16.03 -8.48 -17.00 -3.43 -16.53 -3.36 -16.33 -3.54 -14.02 -4.80
argdeg 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00
cysdeg 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
gls 43.67 -2.30 45.32 -1.86 43.38 -1.35 57.94 1.25 36.04 -2.05 33.03 -1.80 37.83 -2.30 37.62 -2.24
leubcat 2.05 0.19 1.96 0.24 1.24 0.64 2.26 0.23 1.72 0.00 1.20 0.00 0.82 0.00 0.00 0.00
ilebcat 2.43 0.86 2.23 0.78 2.16 0.94 2.22 0.60 2.62 0.30 2.42 0.19 1.94 0.09 0.69 0.36
valbcat 1.80 0.15 1.72 0.11 1.36 0.18 0.82 0.00 1.60 0.00 1.37 0.00 0.81 0.00 0.00 0.00
glud 25.52 -4.48 23.38 -3.94 26.93 3.05 59.07 10.43 22.36 -5.43 19.08 -3.39 17.02 -4.76 6.82 -2.96
shmt 20.10 7.01 19.34 7.57 19.70 6.83 19.20 9.85 16.86 6.26 17.09 4.80 17.97 6.00 18.74 5.97
hisdeg 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
lysdeg 3.41 0.00 3.89 0.00 2.65 0.43 4.78 0.00 3.25 0.00 2.97 0.00 2.74 0.00 1.04 0.00
metdeg 2.71 0.58 2.61 0.58 2.27 0.67 2.34 0.25 2.35 0.28 2.22 0.29 2.20 0.27 1.75 0.47
phedeg 0.14 0.00 0.22 0.00 0.00 0.00 0.09 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
prodh 5.46 0.00 0.94 1.45 4.93 0.51 7.86 0.00 2.66 0.00 2.85 0.00 2.43 0.00 1.04 0.00
serc3 -7.38 -7.22 -7.00 -6.91 -10.41 -5.64 -10.91 -7.65 -6.75 -6.97 -7.43 -5.41 -8.16 -7.16 -10.16 -6.80
thrdeg 0.40 -0.55 0.48 0.00 0.25 0.00 0.16 0.00 0.43 0.00 0.29 0.00 0.00 0.00 0.00 0.00
tat 0.14 0.00 0.22 0.00 0.00 0.00 0.09 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
mthfsink 21.87 7.19 21.08 7.76 21.05 7.16 20.71 9.91 18.38 6.20 18.45 4.81 19.29 5.92 19.63 6.06
DCA 3 mM DCA 5 mM DCA 10 mMCHC control CHC DMSO CHC 1 mM CHC 3 mM DCA control
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Supplementary Table S1. List of metabolic reactions, fluxes and reversibilities in the central carbon 
metabolism of CHO-K1 estimated for the first 2 – 18 h cultivation period. Carbon transfer rules are 
given in the parentheses for each reaction. Reversible reactions are indicated by double arrows. 
Reversibility is computed as the ratio between the reverse flux and the net flux. The 95% confidence 
interval was evaluated by refitting the model until the minimized objective function took the value of 2 
(0.95, nr. experimental points – nr. parameters). Subscripts meaning: c – cytosolic; ex – extracellular; m – 
mitochondrial; Abbreviations: AcoA – acetyl-CoA; ALA – alanine; ASN – asparagine; ASP – aspartate; 
CIT – citrate; FUM – fumarate; GLC – glucose; G6P – glucose-6-phosphate; PG – phosphoglycerate; PEP 
– phosphoenolpyruvate; GLN – glutamine; GLU – glutamate; GLY – glycine; ICI – isocitrate; ILE – 
isoleucine; LAC – lactate; LEU – leucine; LYS – lysine; MAL – malate; MET – methionine; OAA – 
oxaloacetate; PHE – phenylalanine; PYR – pyruvate; SER – serine; SUC – succinate; THR – threonine; 
TYR – tyrosine; VAL – valine. 
Flux Reaction 
Flux 
[mmol/L 
cell  h] 
Lower boundary 
[mmol/L  
cell  h] 
Upper boundary 
[mmol/L  
cell  h] 
Reversibility 
[reverse 
flux/net flux] 
Reversibility 
lower 
boundary 
Reversibility 
upper 
boundary 
v1 
GLCex (abcdef) → G6P 
(abcdef) 
289.7 246.3 333.0 0 0 0 
v2 
G6P (abcdef) → PG 
(abc) + PG (def) 
24.3 18.6 29.2 0 0 0 
v3 
3 G6P (abcdef) → 5 PG 
(def) + 3 CO2(a) 
 87.4 85.4 89.6 0 0 0 
v4 
G6P (abcdef) → Biomass 
(DNA, RNA) 
3.3 3.3 3.3 0 0 0 
v5 PG (abc) → PEPc (abc) 464.9 464.7 465.0 0 0 0 
v6 
PEPc (abc) → PYRc1 
(abc) 
498.2 492.3 500.2 0 0 0 
v7 
PYRc1 (abc)→ PYRm2 
(abc) 
118.9 113.7 119.0 0 0 0 
v8 
PYRm2 (abc) → AcoAm 
(bc) +CO2 (a) 
77.5 77.2 77.6 0 0 0 
v9 
OAAm (abcd) + AcoAm 
(ef) → CITm (efbcda) 
100.8 100.6 100.9 0 0 0 
v10 
CITm (abcdef)→ AKGm 
(abcde)+ CO2 (f) 
58.7 57.0 67.7 0 0 0 
v11 
AKGm (abcde)→ 0.5 
MALm (abcd) + 0.5 
MALm(dcba) + CO2 (e) 
105.6 105.4 105.7 0 0 0 
v12 
MALm (abcd) ↔ OAAm 
(abcd) 
191.6 185.1 198.9 10.3 10.2 11.3 
v13 
PYRc2 (abc) ↔ LACc2 
(abc) 
431.7 391.0 472.3 31.9 18.6 32.0 
v14 
LACc (abc) ↔ LACex 
(abc) 
431.7 391.0 472.3 28.2 28.1 28.3 
v15 
OAAc  (abcd) → PEPc 
(abc) + CO2 (d) 
66.4 61.2 68.5 0 0 0 
v16 
MALc (abcd) → PYRc1 
(abc) + CO2 (d) 
5.4 0 11.0 0 0 0 
v17 
OAAc (abcd) ↔ MALc 
(abcd) 
90.5 88.6 90.7 22.7 21.7 23.0 
v18 
PYRm1 (abc) + CO2 (d) → 
OAAm (abcd) 
23.1 15.1 24.8 0 0 0 
v19 
MALm (abcd) → PYRm1 
(abc) + CO2 (d) 
8.3 5.9 9.2 0 0 0 
v20 PG (abc) → SER (abc) 20.5 20.4 20.5 0 0 0 
Chapter 12 Supplementary material 
 
251 
Flux Reaction 
Flux 
[mmol/L 
cell  h] 
Lower boundary 
[mmol/L  
cell  h] 
Upper boundary 
[mmol/L  
cell  h] 
Reversibility 
[reverse 
flux/net flux] 
Reversibility 
lower 
boundary 
Reversibility 
upper 
boundary 
v21 
SER (abc)↔ GLY (ab) + 
MTHF (c) 
21.9 21.9 21.9 3.8 3.2 3.8 
v22 
SERex (abc) ↔ SER 
(abc) 
20.8 17.8 23.4 13.3 13.1 13.9 
v23 SER (abc)→ Biomass 4.2 4.1 4.2 0 0 0 
v24 GLY (abc) ↔ GLYex (abc) 14.3 8.7 19.9 2.9 1.9 3.1 
v25 GLY (abc) → Biomass 7.6 7.5 7.7 0 0 0 
v26 SER (abc) → PYRc1 (abc) 15.2 15.1 15.2 0 0 0 
v27 
PYRc1 (abc) + GLUc 
(defgh) ↔ ALAc (abc)+ 
AKGc (defgh) 
5.3 4.4 6.0 0.5 0.4 0.5 
v28 ALAc (abc) ↔ ALAex (abc) 26.3 26.1 26.5 2.7 2.7 4.1 
v29 ALAc (abc)→ Biomass 5.6 5.4 5.8 0 0 0 
v30 ALAm (abc)↔ ALAc (abc) 26.6 25.9 27.5 3.7 3.5 4.7 
v31 
PYRm1 (abc) + GLUm 
(defgh) ↔ ALAm (abc)+ 
AKGm (defgh) 
26.6 25.9 27.5 14.4 12.9 14.6 
v32 
PYRex(abc) ↔ 
PYRc1(abc) 
4.0 2.2 5.8 
1714/time 
[h] 
1700/time 
[h] 
>2500/tim
e [h] 
v33 
ASPc (abcd) + AKGc 
(efghi) ↔ OAAc (abcd) + 
GLUc (efghi) 
123.8 118.8 124.0 30.0 1.9 n.d. 
v34 
OAAm (abcd) + GLUm 
(efghi) ↔ ASPm (abcd) + 
AKGm (efghi) 
113.8 108.8 114.0 62.5 0 n.d. 
v35 
ASN (abcd) → ASPc 
(abcd) 
13.9 11.4 16.5 0 0 0 
v36 
ASPex (abcd) ↔ ASPc 
(abcd) 
3.1 0.0 6.7 5.8 4.4 6.4 
v37 ASPc (abcd) → Biomass 7.1 7.0 7.2 0 0 0 
v38 
MALm (abcd) ↔ 
MALc(abcd) 
58.1 53.1 58.2 30.5 29.5 n.d. 
v39 
CITm (abcdef) + 
MALc(ghij) → CITc 
(abcdef)+ MALm(ghij) 
42.1 33.1 43.7 0 0 0 
v40 
CITc (abcdef) → AKGc 
(abcde)+ CO2 (e) 
9.0 0 10.6 3.1 2.9 3.1 
v41 
AKGm (abcde) + 
MALc(fghi) ↔ AKGc 
(abcde)+ MALm (fghi) 
101.1 100.3 105.7 18.0 17.9 18.1 
v42 
AKGc (abcde) ↔  GLUc 
(abcde) 
0 0 0 n.d. - - 
v43 
GLUm (abcde) → GLUc 
(abcde) 
156.1 155.7 156.1 2.4 0 2.7 
v44 
GLUm (abcde) ↔ AKGm 
(abcde) 
7.5 7.5 7.6 9.5 7.1 9.5 
v45 
GLUc (abcde) ↔ GLUex 
(abcde) 
8.1 7.2 8.9 1.3 1.3 1.3 
v46 
GLUc (abcde) → 
Biomass 
8.2 7.9 8.5 0 0 0 
v47 
GLUc (abcde) → GLNc 
(abcde) 
136.8 136.4 137.2 5.2 4.6 5.2 
v48 
GLNc (abcde) → GLUm 
(abcde) 
190.3 189.9 190.7 0 0 0 
v49 
GLNex (abcde) ↔ GLNc 
(abcde) 
53.5 51.3 55.6 0.6 0.5 0.6 
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Flux Reaction 
Flux 
[mmol/L 
cell  h] 
Lower boundary 
[mmol/L  
cell  h] 
Upper boundary 
[mmol/L  
cell  h] 
Reversibility 
[reverse 
flux/net flux] 
Reversibility 
lower 
boundary 
Reversibility 
upper 
boundary 
v50 
CITc (abcdef) → OAAc 
(fcde) + AcoAc (ab) 
33.1 32.7 33.5 0 0 0 
v51 AcoAc (ab) → Biomass 33.1 32.7 33.5 0 0 0 
v52 
AAex (ILE, VAL, MET, 
THR, TYR, PHE) → 
SUCm (AA catabolism) 
8.9 4.9 12.9 0 0 0 
v53 
AAex (LEU, ILE, LYS, 
TYR, PHE) → ACOAm 
(AA catabolism) 
23.3 10.6 36.0 0 0 0 
v54 
AKGc (abcde) → GLUc 
(abcde) (AA catabolism) 
12.2 3.4 20.5 0 0 0 
v55 
AA(PRO, HIS, ARG) → 
GLUc (AA catabolism) 
0.7 0 3.1 0 0 0 
v56 
SUCm (abcd) ↔ FUMm 
(abcd) 
114.5 114.3 114.6 0 0 0 
v57 
FUMm (abcd) ↔ MALm 
(abcd) 
114.7 114.5 114.8 47.6 45.5 83.6 
v58 
PYRc1 (abc) ↔ PYRc2 
(abc) 
398.5 398.0 398.6 0.13 0 0.13 
v59 
PEPc (abc) → PYRc2 
(abc) 
33.2 33.1 33.7 0 0 0 
v60 
AAex (abcd) → 
FUMm(abcd) (AA 
catabolism) 0.2 0.1 0.3 0 0 0 
v61 
GLUc(abcde) + 
ASPm(efgh) ↔GLUm 
(abcde) + ASPc(efgh) 113.8 108.8 114.0 5.6 5.6 5.6 
v62 
PYRm2(abc) ↔ 
PYRm1(abc)  41.4 36.4 41.5 0.06 0 0.06 
 
PYRc1(abc) ↔ 
LACc1(abc) - - - 60.0 59.9 60.2 
 
PYRm1(abc) ↔ 
LACm(abc) - - - 71.3 68.9 80.0 
 
 
Supplementary Figure S1. Growth profile of the CHO-K1 cells in 250 ml baffled shake flask with a 
working volume of 120 ml and the determined specific growth rate µ. The values represent the average 
from 4 parallel cultivation. 
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Supplementary Figure S2. Cultivation profile of the CHO-K1 cells culture during 48 h in 250 ml baffled 
shake flask with a start volume of 120 ml. The represented extracellular concentrations are in [µmol / L] 
and the time is in [h]. The values represent the average from 4 parallel cultivations. The curves are the fitted 
values of extracellular concentrations simulating an exponential growth model with balanced growth 
(metabolic steady state) over the first 18 h.  
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Supplementary Figure S3. (A) Experimentally determined mass isotopomer distributions of intracellular 
and extracellular (subscript ex) metabolites during the 48 h of the labeling experiment using [U-13C6] 
glucose and [U-13C5] glutamine as substrates. (B) The first 5 h of the labeling experiment using [U-
13C6] 
glucose and [U-13C5] glutamine as substrates showing the overshooting behavior in intracellular pyruvate 
(PYR), lactate (LAC), malate (MAL) and aspartate (ASP). Abbreviations: AKG – -ketoglutarate; ALA – 
alanine; ASN – asparagine; ASP – aspartate; CIT – citrate; FUM – fumarate; GLN – glutamine; GLU – 
glutamate; GLY – glycine; Lac – lactate; MAL – malate; PYR – pyruvate; SER – serine. 
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Supplementary Figure S1. Experimental (o) and fitted (-) extracellular concentrations in the experiments 
with permeabilized CHO-K1 cells. r – production rate [fmol/ (cell  min)]. The brackets contain the 95% 
confidence interval for the rate. 
Chapter 12 Supplementary material 
 
257 
 
Supplementary Figure S1. (continued) 
 
 
Supplementary Table S1. Selection of the elementary modes that can describe the observed metabolite 
uptake and production. The modes are selected accordingly to the following criteria: u - the metabolite is 
taken up; p - the metabolite is produced; xu - the metabolite is not taken up; xp - the metabolite is not 
produced; iu - the metabolite is or is not taken up; ip - the metabolite is or is not produced. 
SUBSTATE(S) pyruvate 
pyruvate, 
ADP 
pyruvate, 
aspartate 
pyruvate, 
aspartate, ADP  
citrate citrate, ADP 
PRODUCT(S) - ATP glutamate glutamate, ATP - ATP 
External Flux 1a 1b 2a 2b 3a 3b 
Pyruvate u / xp u / xp iu / xp iu / xp xu / xp xu / xp 
Malate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Succinate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Fumarate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Citrate xu / xp xu / xp xu / xp xu / xp u / xp u / xp 
Aspartate xu / xp xu / xp iu / xp iu / xp xu / xp xu / xp 
α-ketoglutarate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Glutamate xu / xp xu / xp xu / ip xu / ip xu / xp xu / xp 
Glutamine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
CO2 iu / ip iu / ip iu / ip iu / ip iu / ip iu / ip 
Serine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Glycine xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
C1 xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
O2 iu / xp iu / xp iu / xp iu / xp iu / xp iu / xp 
NH3 xp / xp xp / xp xp / xp xp / xp xu / xp xu / xp 
ADP xu / xp u / xp xu / xp u / xp xu / xp u / xp 
ATP xu / xp xu / ip xu / xp xu / ip xu / xp xu / ip 
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Supplementary Table S1. (continued) 
SUBSTATE(S)  α-ketoglutarate 
α-ketoglutarate, 
ADP  
succinate succinate, ADP 
malate 
(fumarate) 
PRODUCT(S) - fumarate, ATP 
fumarate, malate, 
citrate 
fumarate, malate, 
citrate, ATP 
citrate 
External Flux 4a 4b 5a 5b 6a/7a 
Pyruvate xu / xp xu / xp xu / xp xu / xp xu / xp 
Malate xu / xp xu / xp xu / ip xu / ip u / xp 
Succinate xu / xp xu / xp u / xp u / xp xu / xp 
Fumarate xu / xp xu / ip xu / ip xu / ip xu / xp 
Citrate xu / xp xu / xp xu / ip xu / ip xu / ip 
Aspartate xu / xp xu / xp xu / xp xu / xp xu / xp 
α-ketoglutarate u / xp u / xp xu / xp xu / xp xu / xp 
Glutamate xu / xp xu / xp xu / xp xu / xp xu / xp 
Glutamine xu / xp xu / xp xu / xp xu / xp xu / xp 
CO2 iu / ip iu / ip iu / ip iu / ip iu / ip 
Serine xu / xp xu / xp xu / xp xu / xp xu / xp 
Glycine xu / xp xu / xp xu / xp xu / xp xu / xp 
C1 xu / xp xu / xp xu / xp xu / xp xu / xp 
O2 iu / xp iu / xp iu / xp iu / xp iu / xp 
NH3 xu / xp xu / xp xu / xp xu / xp xu / xp 
ADP xu / xp u / xp xu / xp xu / xp xu / xp 
ATP xu / xp xu / ip xu / xp xu / ip xu / xp 
 
Supplementary Table S1. (continued) 
SUBSTATE(S) 
malate (fumarate), 
ADP 
glutamine glutamine, ADP glutamate 
glutamate, 
ADP  
serine 
PRODUCT(S) citrate, ATP 
glutamate, 
aspartate 
glutamate, 
aspartate, ATP 
aspartate 
aspartate, 
ATP 
glycine 
External Flux 6b/7b 8a 8b 9a 9b 11a 
Pyruvate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Malate u / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Succinate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Fumarate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Citrate xu / ip xu / xp xu / xp xu / xp xu / xp xu / xp 
Aspartate xu / xp xu / ip xu / ip xu / ip xu / ip xu / xp 
α-ketoglutarate xu / xp xu / xp xu / xp xu / xp xu / xp xu / xp 
Glutamate xu / xp xu / ip xu / ip xu / xp u / xp xu / xp 
Glutamine xu / xp u / xp u / xp xu / xp xu / xp xu / xp 
CO2 iu / ip iu / ip iu / ip iu / ip iu / ip iu / ip 
Serine xu / xp xu / xp xu / xp xu / xp xu / xp u / xp 
Glycine xu / xp xu / xp xu / xp xu / xp xu / xp xu / ip 
C1 xu / xp xu / xp xu / xp xu / xp xu / xp xu / ip 
O2 iu / xp iu / xp iu / xp iu / xp iu / xp xu / xp 
NH3 xu / xp xu / ip xu / ip xu / ip xu / ip xu / ip 
ADP xu / xp xu / xp iu / xp xu / xp u / xp xu / xp 
ATP xu / ip xu / xp xu / ip xu / xp xu / ip xu / xp 
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Table S2. Mitochondrial fluxes [fmol/cell  min] in selectively permeabilized CHO-K1 cells under various 
feeding conditions. The fluxes were computed using the determined extracellular rates and the 
stoichiometry indicated by reactions R1-R50. By addition of ADP it was assumed that the flux R44=0. 
Abbreviations:c - cytosolic; m - mitochondrial; AcoA – acetyl-CoA; AKG – -ketoglutarate; ASP – 
aspartate; CIT – citrate; FUM – fumarate; GLN – glutamine; GLU – glutamate; GLY– glycine; MAL – 
malate; MTHF– methyl-tetrahydrofolate; OAA – oxaloacetate; PYR – pyruvate; SER - serine; SUC – 
succinate. In the column indicated with red the sampling produced fluxes without biological significance. 
 
Uptake puruvate 
pyruvate, 
aspartate 
citrate α-ketoglutarate succinate 
malate 
(fumarate) 
glutamine glutamate serine 
 Production  -  glutamate  -  -
 fumarate, 
malate, citrate
 citrate
 glutamate, 
aspartate
 aspartate  glycine
Exp. No.
Flux [fmol/cell 
x min]
--> PYRc R1 4.6 11.9 0 0 0 0 0 0 0
<--> MALc R2 0 0 0 0 -14.5 16.5 0 0 0
<--> SUCc R3 0 0 0 0 24.5 0 0 0 0
<--> FUMc R4 0 0 0 -0.48 -2.2 0 0 0 0
<--> CITc R5 0 0 5.6 0 -1.9 -4.9 0 0 0
<--> ASPc R6 0 6.1 0 0 0 0 -3.3 -3.38 0
 --> AKGc R7 0 0 0 12.7 0 0 0 0 0
<--> GLUc R8 0 -3 0 0 0 0 -14.4 2.29 0
 --> GLNc R9 0 0 0 0 0 0 20 0 0
<--> SERc R11 0 0 0 0 0 0 0 0 4.5
<--> GLYc R12 0 0 0 0 0 0 0 0 -2.6
<--> ADPc R24 0 0 0 0 0 0 0 0 0
<--> CO2c R10 -13.8 -45.1 -33.6 -61.58 -19.8 -36.6 -14.8 2.07 -1.9
<--> C1c R13 0 0 0 0 0 0 0 0 -6.4
C1c <--> C1m R14 0 0 0 0 0 0 0 0 -6.4
GLYc <--> GLYm R15 0 0 0 0 0 0 0 0 -2.6
SERc <--> SERm R16 0 0 0 0 0 0 0 0 4.5
CO2c <--> CO2m R17 -13.8 -45.1 -33.6 -61.58 -19.8 -36.6 -14.8 2.07 -1.9
SERm <--> GLYm + MTHFm R18 0 0 0 0 0 0 0 0 4.5
MTHFm --> C1m + THFm R19 0 0 0 0 0 0 0 0 6.4
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm R20 0 0 0 0 0 0 0 0 1.9
--> O2m R21 11.5 34.55 25.2 49.36 27.1 27.45 15.3 0.165 0.95
<--> NH3c R22 0 -3.1 0 0 0 0 -22.3 1.09 0
NH3c <--> NH3m R23 0 -3.1 0 0 0 0 -22.3 1.09 0
<--> ATPc R25 0 0 0 0 0 0 0 0 0
ADPc + ATPm <--> ADPm + 
ATPc R26 0 0 0 0 0 0 0 0 0
PYRc --> PYRm R27 4.6 11.9 0 0 0 0 0 0 0
FUMc <--> FUMm R28 0 0 0 -0.48 -2.2 0 0 0 0
MALc <--> MALm R29 0 0 5.6 12.7 -16.4 11.6 0 0 0
SUCc <--> SUCm R30 0 0 0 0 24.5 0 0 0 0
MALm + AKGc --> MALc + AKGm R31 0 0 0 12.7 0 0 0 0 0
ASPm + GLUc <--> ASPc + 
GLUm R32 0 -6.1 0 0 0 0 3.3 3.38 0
CITm + MALc <--> CITc + MALm R33 0 0 -5.6 0 1.9 4.9 0 0 0
GLNc --> GLNm R34 0 0 0 0 0 0 20 0 0
GLUc <--> GLUm R35 0 3.1 0 0 0 0 -17.7 -1.09 0
PYRm + NADm --> ACOAm + 
NADHm + CO2m R36 4.6 15 5.6 12.22 5.9 11.6 2.3 -1.09 0
ACOAm + OAAm --> CITm R37 4.6 15 5.6 12.22 5.9 11.6 2.3 -1.09 0
CITm + NADm --> AKGm + 
NADHm + CO2m R38 4.6 15 11.2 12.22 4 6.7 2.3 -1.09 0
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m R39 4.6 12 11.2 24.92 4 6.7 7.9 1.2 0
SUCm + FADm <--> FUMm + 
FADHm R40 4.6 12 11.2 24.92 28.5 6.7 7.9 1.2 0
FUMm <--> MALm R41 4.6 12 11.2 24.44 26.3 6.7 7.9 1.2 0
MALm + NADm <--> OAAm + 
NADHm R42 -52.9 -163.85 -120.4 -234.58 -105.1 -125.65 -70.9 1.465 -4.75
MALm + NADPm --> PYRm + 
CO2m + NADPHm R43 57.5 175.85 131.6 259.02 116.9 148.85 78.8 -0.265 4.75
PYRm + CO2m + ATPm --> 
OAAm + ADPm R44 57.5 172.75 126 246.8 111 137.25 76.5 0.825 4.75
AKGm + ASPm <--> GLUm + 
OAAm R45 0 6.1 0 0 0 0 -3.3 -3.38 0
GLUm + NADm <--> AKGm + 
NH3m + NADHm R46 0 3.1 0 0 0 0 2.3 -1.09 0
GLNm --> GLUm + NH3m R47 0 0 0 0 0 0 20 0 0
2 NADHm + O2m + 5 ADPm --> 
2 NADm + 5 ATPm R48 9.2 28.55 19.6 36.9 12.85 24.1 11.35 -0.435 0.95
2 FADHm + O2m + 3 ADPm --> 
2 FADm + 3 ATPm R49 2.3 6 5.6 12.46 14.25 3.35 3.95 0.6 0
NADPHm + NADm <--> NADPm 
+ NADHm R50 57.5 175.85 131.6 259.02 116.9 148.85 78.8 -0.265 4.75
9a 11a1a 2a 3a 4a 5a 6a/7a 8a
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Supplementary Table S2. (continued) 
 
 
Uptake 
pyruvate, 
ADP 
pyruvate, 
aspartate, 
ADP 
citrate, 
ADP 
α-ketoglutarate, 
ADP 
succinate, 
ADP 
malate 
(fumarate), 
ADP 
glutamine, 
ADP 
glutamate, 
ADP 
 Production  ATP
 
glutamate, 
ATP
 ATP   fumarate,  ATP
 fumarate, 
malate, 
citrate, ATP
 citrate, 
ATP
 glutamate, 
aspartate, 
ATP
 
aspartate, 
ATP
Exp. No.
Flux [fmol/cell 
x min]
--> PYRc R1 14.2 15.6 0 0 0 0 0 0
<--> MALc R2 0 0 0 0 -14.6 21.4 0 0
<--> SUCc R3 0 0 0 0 30.5 0 0 0
<--> FUMc R4 0 0 0 -2.5 -2.1 0 0 0
<--> CITc R5 0 0 38 0 -1.9 -4.9 0 0
<--> ASPc R6 0 12.2 0 0 0 0 -11.4 -15.5
 --> AKGc R7 0 0 0 40.2 0 0 0 0
<--> GLUc R8 0 -6.7 0 0 0 0 -19 15.5
 --> GLNc R9 0 0 0 0 0 0 44.7 0
<--> SERc R11 0 0 0 0 0 0 0 0
<--> GLYc R12 0 0 0 0 0 0 0 0
<--> ADPc R24 0 0 0 0 0 0 0 0
<--> CO2c R10 -42.6 -62.1 -228 -191 -43.8 -56.2 -82.9 -15.5
<--> C1c R13 0 0 0 0 0 0 0 0
C1c <--> C1m R14 0 0 0 0 0 0 0 0
GLYc <--> GLYm R15 0 0 0 0 0 0 0 0
SERc <--> SERm R16 0 0 0 0 0 0 0 0
CO2c <--> CO2m R17 -42.6 -62.1 -228 -191 -43.8 -56.2 -82.9 -15.5
SERm <--> GLYm + MTHFm R18 0 0 0 0 0 0 0 0
MTHFm --> C1m + THFm R19 0 0 0 0 0 0 0 0
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm R20 0 0 0 0 0 0 0 0
--> O2m R21 35.5 45.45 171 153.3 48.1 42.15 81.45 23.25
<--> NH3c R22 0 -5.5 0 0 0 0 -59 0
NH3c <--> NH3m R23 0 -5.5 0 0 0 0 -59 0
<--> ATPc R25 177.5 227.25 855 766.5 210 210.75 407.25 116.25
ADPc + ATPm <--> ADPm + 
ATPc R26 -177.5 -227.25 -855 -766.5 -210 -210.75 -407.25 -116.25
PYRc --> PYRm R27 177.5 227.25 855 766.5 210 210.75 407.25 116.25
FUMc <--> FUMm R28 14.2 15.6 0 0 0 0 0 0
MALc <--> MALm R29 0 0 0 -2.5 -2.1 0 0 0
SUCc <--> SUCm R30 0 0 38 40.2 -16.5 16.5 0 0
MALm + AKGc --> MALc + AKGm R31 0 0 0 0 30.5 0 0 0
ASPm + GLUc <--> ASPc + 
GLUm R32 0 0 0 40.2 0 0 0 0
CITm + MALc <--> CITc + MALm R33 0 -12.2 0 0 0 0 11.4 15.5
GLNc --> GLNm R34 0 0 -38 0 1.9 4.9 0 0
GLUc <--> GLUm R35 0 0 0 0 0 0 44.7 0
PYRm + NADm --> ACOAm + 
NADHm + CO2m R36 0 5.5 0 0 0 0 -30.4 0
ACOAm + OAAm --> CITm R37 14.2 21.1 38 37.7 11.9 16.5 14.3 0
CITm + NADm --> AKGm + 
NADHm + CO2m R38 14.2 21.1 38 37.7 11.9 16.5 14.3 0
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m R39 14.2 21.1 76 37.7 10 11.6 14.3 0
SUCm + FADm <--> FUMm + 
FADHm R40 14.2 14.4 76 77.9 10 11.6 40 15.5
FUMm <--> MALm R41 14.2 14.4 76 77.9 40.5 11.6 40 15.5
MALm + NADm <--> OAAm + 
NADHm R42 14.2 14.4 76 75.4 38.4 11.6 40 15.5
MALm + NADPm --> PYRm + 
CO2m + NADPHm R43 14.2 8.9 38 37.7 11.9 16.5 25.7 15.5
PYRm + CO2m + ATPm --> 
OAAm + ADPm R44 -1.84E-15 5.5 38 37.7 11.9 16.5 14.3 0
AKGm + ASPm <--> GLUm + 
OAAm R45 0 12.2 0 0 0 0 -11.4 -15.5
GLUm + NADm <--> AKGm + 
NH3m + NADHm R46 0 5.5 0 0 0 0 14.3 0
GLNm --> GLUm + NH3m R47 0 0 0 0 0 0 44.7 0
2 NADHm + O2m + 5 ADPm --> 
2 NADm + 5 ATPm R48 28.4 38.25 133 114.35 27.85 36.35 61.45 15.5
2 FADHm + O2m + 3 ADPm --> 
2 FADm + 3 ATPm R49 7.1 7.2 38 38.95 20.25 5.8 20 7.75
NADPHm + NADm <--> NADPm 
+ NADHm R50 -1.58E-15 5.5 38 37.7 11.9 16.5 14.3 0
8b 9b1b 2b 3b 4b 5b 6b/7b
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Supplementary Table S3.A Stoichiometry of the modes selected using the Supplementary Table S1 using 
selectively permeabilized CHO-K1 cells [fmol/cell  min]. 
 
  
EXPERIMENT 1a 1b
Substrates pyruvate pyruvate, ADP
Total mode stoichiometry
PYR + 
2.5O2 = 
3CO2
PYR + 12.5ADP + 
2.5O2 = 3CO2 + 
12.5ATP
PYR + ASP 
+ O2 = GLU 
+ 2CO2
ASP + 
0.75O2 = 
1.5CO2 + 
0.5GLU
ASP + 
3O2 = 
4CO2
PYR + ASP + O2 
+ 5ADP = GLU + 
2CO2 + 5ATP
ASP + 15ADP + 
3O2 = 4CO2 + 
15ATP + NH3
ASP + 3.75ADP + 
0.75O2 = 0.5GLU 
+ 1.5CO2 + 
3.75ATP
REACTION FORMULAS Mode 1 Mode 2 Mode 3 Mode 4 Mode 5 Mode 6 Mode 7 Mode 8
--> PYRc 1 1 1 0 0 1 0 0
<--> MALc 0 0 0 0 0 0 0 0
<--> SUCc 0 0 0 0 0 0 0 0
<--> FUMc 0 0 0 0 0 0 0 0
<--> CITc 0 0 0 0 0 0 0 0
<--> ASPc 0 0 1 1 1 1 1 1
 --> AKGc 0 0 0 0 0 0 0 0
<--> GLUc 0 0 -1 -0.5 0 -1 0 -0.5
 --> GLNc 0 0 0 0 0 0 0 0
<--> CO2c -3 -3 -2 -1.5 -4 2 -4 -1.5
<--> SERc 0 0 0 0 0 0 0 0
<--> GLYc 0 0 0 0 0 0 0 0
<--> C1c 0 0 0 0 0 0 0 0
C1c <--> C1m 0 0 0 0 0 0 0 0
GLYc <--> GLYm 0 0 0 0 0 0 0 0
SERc <--> SERm 0 0 0 0 0 0 0 0
CO2c <--> CO2m -3 -3 -2 -1.5 -4 -2 -4 -1.5
SERm <--> GLYm + MTHFm 0 0 0 0 0 0 0 0
MTHFm --> C1m + THFm 0 0 0 0 0 0 0 0
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm + 
NH3
0 0 0 0 0 0 0 0
--> O2m 2.5 2.5 1 0.75 3 1 3 0.75
<--> NH3c 0 0 0 -0.5 -1 0 -1 -0.5
NH3c <--> NH3m 0 0 0 -0.5 -1 0 -1 -0.5
<--> ADPc 0 12.5 0 0 0 5 15 3.75
<--> ATPc 0 -12.5 0 0 0 -5 -15 -3.55
ADPc + ATPm <--> ADPm + 
ATPc
0 12.5 0 0 0 5 15 3.75
PYRc --> PYRm 1 1 1 0 0 1 0 0
FUMc <--> FUMm 0 0 0 0 0 0 0 0
MALc <--> MALm 0 0 0 0 0 0 0 0
SUCc <--> SUCm 0 0 0 0 0 0 0 0
MALm + AKGc --> MALc + AKGm 0 0 0 0 0 0 0 0
ASPm + GLUc <--> ASPc + 
GLUm
0 0 -1 -1 -1 -1 -1 -1
CITm + MALc <--> CITc + MALm 0 0 0 0 0 0 0 0
GLNc --> GLNm 0 0 0 0 0 0 0 0
GLUc <--> GLUm 0 0 0 0.5 1 0 1 0.5
PYRm + NADm --> ACOAm + 
NADHm + CO2m
1 1 1 0.5 1 1 1 0.5
ACOAm + OAAm --> CITm 1 1 1 0.5 1 1 1 0.5
CITm + NADm --> AKGm + 
NADHm + CO2m
1 1 1 0.5 1 1 1 0.5
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m
1 1 0 0 1 1 1 0
SUCm + FADm <--> FUMm + 
FADHm
1 1 0 0 1 0 1 0
FUMm <--> MALm 1 1 0 0 1 0 1 0
MALm + NADm <--> OAAm + 
NADHm
-11.5 1 -5 -4.25 -15 0 0 -0.5
MALm + NADPm --> PYRm + 
CO2m + NADPHm
12.5 0 5 4.25 16 0 1 0.5
PYRm + CO2m + ATPm --> 
OAAm + ADPm
12.5 0 5 3.75 15 0 0 0
AKGm + ASPm <--> GLUm + 
OAAm
0 0 1 1 1 1 1 1
GLUm + NADm <--> AKGm + 
NH3m + NADHm
0 0 0 0.5 1 0 1 0.5
GLNm --> GLUm + NH3m 0 0 0 0 0 0 0 0
2 NADHm + O2m + 5 ADPm --> 2 
NADm + 5 ATPm
2 2 1 0.75 2.5 1 2.5 0.75
2 FADHm + O2m + 3 ADPm --> 2 
FADm + 3 ATPm
0.5 0.5 0 0 0.5 0 0.5 0
NADPHm + NADm <--> NADPm + 
NADHm
12.5 0 5 4.25 16 0 1 0.5
pyruvate, aspartate pruvuvate, aspartate, ADP
2a 2b
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Supplementary Table S3.A (continued) 
 
  
EXPERIMENT 3a 3b
Substrates citrate citrate, ADP
Total mode stoichiometry
CIT + 
4.5O2 = 
6CO2
CIT + 22.5ADP 
+ 4.5O2 = 
6CO2 + 
22.5ATP
AKG + 
4O2 = 
5CO2
AKG + O2 
= CO2 + 
FUM
AKG + 4O2 + 
20ADP = 5CO2 + 
20ATP
AKG + O2 + 
5ADP = FUM 
+ CO2 + 
5ATP
REACTION FORMULAS Mode 9 Mode 10 Mode 11 Mode 12 Mode 13 Mode 14
--> PYRc 0 0 0 0 0 0
<--> MALc 0 0 0 0 0 0
<--> SUCc 0 0 0 0 0 0
<--> FUMc 0 0 0 -1 0 -1
<--> CITc 1 1 0 0 0 0
<--> ASPc 0 0 0 0 0 0
 --> AKGc 0 0 1 1 1 1
<--> GLUc 0 0 0 0 0 0
 --> GLNc 0 0 0 0 0 0
<--> CO2c -6 -6 -5 -1 -5 -1
<--> SERc 0 0 0 0 0 0
<--> GLYc 0 0 0 0 0 0
<--> C1c 0 0 0 0 0 0
C1c <--> C1m 0 0 0 0 0 0
GLYc <--> GLYm 0 0 0 0 0 0
SERc <--> SERm 0 0 0 0 0 0
CO2c <--> CO2m -6 -6 -5 -1 -5 -1
SERm <--> GLYm + MTHFm 0 0 0 0 0 0
MTHFm --> C1m + THFm 0 0 0 0 0 0
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm + 
NH3
0 0 0 0 0 0
--> O2m 4.5 4.5 4 1 4 1
<--> NH3c 0 0 0 0 0 0
NH3c <--> NH3m 0 0 0 0 0 0
<--> ADPc 0 22.5 0 0 20 5
<--> ATPc 0 -22.5 0 0 -20 -5
ADPc + ATPm <--> ADPm + 
ATPc
0 22.5 0 0 20 5
PYRc --> PYRm 0 0 0 0 0 0
FUMc <--> FUMm 0 0 0 -1 0 -1
MALc <--> MALm 1 1 1 1 1 1
SUCc <--> SUCm 0 0 0 0 0 0
MALm + AKGc --> MALc + AKGm 0 0 1 1 1 1
ASPm + GLUc <--> ASPc + 
GLUm
0 0 0 0 0 0
CITm + MALc <--> CITc + MALm -1 -1 0 0 0 0
GLNc --> GLNm 0 0 0 0 0 0
GLUc <--> GLUm 0 0 0 0 0 0
PYRm + NADm --> ACOAm + 
NADHm + CO2m
1 1 1 0 1 0
ACOAm + OAAm --> CITm 1 1 1 0 1 0
CITm + NADm --> AKGm + 
NADHm + CO2m
2 2 1 0 1 0
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m
2 2 2 1 2 1
SUCm + FADm <--> FUMm + 
FADHm
2 2 2 1 2 1
FUMm <--> MALm 2 2 2 0 2 0
MALm + NADm <--> OAAm + 
NADHm
-21.5 1 -19 -5 1 0
MALm + NADPm --> PYRm + 
CO2m + NADPHm
23.5 1 21 5 1 0
PYRm + CO2m + ATPm --> 
OAAm + ADPm
22.5 0 20 5 0 0
AKGm + ASPm <--> GLUm + 
OAAm
0 0 0 0 0 0
GLUm + NADm <--> AKGm + 
NH3m + NADHm
0 0 0 0 0 0
GLNm --> GLUm + NH3m 0 0 0 0 0 0
2 NADHm + O2m + 5 ADPm --> 2 
NADm + 5 ATPm
3.5 3.5 3 0.5 3 0.5
2 FADHm + O2m + 3 ADPm --> 2 
FADm + 3 ATPm
1 1 1 0.5 1 0.5
NADPHm + NADm <--> NADPm + 
NADHm
23.5 1 21 5 1 0
α-ketoglutarate α-ketoglutarate, ADP
4a 4b
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Supplementary Table S3.A (continued) 
 
EXPERIMENT
Substrates
Total mode stoichiometry
SUC + 
3.5O2 = 
4CO2
SUC + 
0.5O2 = 
MAL
SUC + 
1.25O2 = 
CO2 + 
0.5CIT
SUC + 
0.5O2 = 
FUM
SUC + 3.5O2 
+ 16.5ADP = 
4CO2 + 
16.5ATP
SUC + 
1.5ADP + 
0.5O2 = MAL 
+ 1.5ATP
SUC + 
1.25O2 + 
5.75ADP = 
0.5CIT + CO2 
SUC + 0.5O2 
+ 1.5ADP = 
FUM + 
1.5ADP
REACTION FORMULAS Mode 15 Mode 16 Mode 17 Mode 18 Mode 19 Mode 20 Mode 21 Mode 22
--> PYRc 0 0 0 0 0 0 0 0
<--> MALc 0 -1 0 0 0 -1 0 0
<--> SUCc 1 1 1 1 1 1 1 1
<--> FUMc 0 0 0 -1 0 0 0 -1
<--> CITc 0 0 -0.5 0 0 0 -0.5 0
<--> ASPc 0 0 0 0 0 0 0 0
 --> AKGc 0 0 0 0 0 0 0 0
<--> GLUc 0 0 0 0 0 0 0 0
 --> GLNc 0 0 0 0 0 0 0 0
<--> CO2c -4 0 -1 0 -4 0 -1 0
<--> SERc 0 0 0 0 0 0 0 0
<--> GLYc 0 0 0 0 0 0 0 0
<--> C1c 0 0 0 0 0 0 0 0
C1c <--> C1m 0 0 0 0 0 0 0 0
GLYc <--> GLYm 0 0 0 0 0 0 0 0
SERc <--> SERm 0 0 0 0 0 0 0 0
CO2c <--> CO2m -4 0 -1 0 -4 0 -1 0
SERm <--> GLYm + MTHFm 0 0 0 0 0 0 0 0
MTHFm --> C1m + THFm 0 0 0 0 0 0 0 0
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm + 
NH3
0 0 0 0 0 0 0 0
--> O2m 3.5 0.5 1.25 0.5 3.5 0.5 1.25 0.5
<--> NH3c 0 0 0 0 0 0 0 0
NH3c <--> NH3m 0 0 0 0 0 0 0 0
<--> ADPc 0 0 0 0 16.5 1.5 5.75 1.5
<--> ATPc 0 0 0 0 -16.5 -1.5 -5.75 -1.5
ADPc + ATPm <--> ADPm + 
ATPc
0 0 0 0 16.5 1.5 5.75 1.5
PYRc --> PYRm 0 0 0 0 0 0 0 0
FUMc <--> FUMm 0 0 0 -1 0 0 0 -1
MALc <--> MALm 0 -1 -0.5 0 0 -1 -0.5 0
SUCc <--> SUCm 1 1 1 1 1 1 1 1
MALm + AKGc --> MALc + AKGm 0 0 0 0 0 0 0 0
ASPm + GLUc <--> ASPc + 
GLUm
0 0 0 0 0 0 0 0
CITm + MALc <--> CITc + MALm 0 0 0.5 0 0 0 0.5 0
GLNc --> GLNm 0 0 0 0 0 0 0 0
GLUc <--> GLUm 0 0 0 0 0 0 0 0
PYRm + NADm --> ACOAm + 
NADHm + CO2m
1 0 0.5 0 1 0 0.5 0
ACOAm + OAAm --> CITm 1 0 0.5 0 1 0 0.5 0
CITm + NADm --> AKGm + 
NADHm + CO2m
1 0 0 0 1 0 0 0
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m
1 0 0 0 1 0 0 0
SUCm + FADm <--> FUMm + 
FADHm
2 1 1 1 2 1 1 1
FUMm <--> MALm 2 1 1 0 2 1 1 0
MALm + NADm <--> OAAm + 
NADHm
-15.5 -1.5 -4.75 -1.5 1 0 0.5 0
MALm + NADPm --> PYRm + 
CO2m + NADPHm
17.5 1.5 5.75 1.5 1 0 0.5 0
PYRm + CO2m + ATPm --> 
OAAm + ADPm
16.5 1.5 5.25 1.5 0 0 0 0
AKGm + ASPm <--> GLUm + 
OAAm
0 0 0 0 0 0 0 0
GLUm + NADm <--> AKGm + 
NH3m + NADHm
0 0 0 0 0 0 0 0
GLNm --> GLUm + NH3m 0 0 0 0 0 0 0 0
2 NADHm + O2m + 5 ADPm --> 2 
NADm + 5 ATPm
2.5 0 0.75 0 2.5 0 0.75 0
2 FADHm + O2m + 3 ADPm --> 2 
FADm + 3 ATPm
1 -0.5 0.5 0.5 1 0.5 0.5 0.5
NADPHm + NADm <--> NADPm + 
NADHm
17.5 1.5 5.75 1.5 1 0 0.5 0
succinate succinate, ADP
5a 5b
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Supplementary Table S3.A (continued) 
   
EXPERIMENT
Substrates
Total mode stoichiometry
MAL + 
3O2 = 
4CO2
MAL + 0.75O2 
= 0.5CIT + 
CO2
MAL + 3O2 + 
15ADP = 4CO2 
+ 15ATP
MAL + 0.75O2 + 
3.75ADP = 
0.5CIT + CO2 + 
3.75ATP
FUM + 
3O2 = 
4CO2
FUM + 
0.75O2 = 
0.5CIT + CO2
FUM + 3O2 + 
15ADP = 
4CO2 + 15ATP
FUM + 0.75O2 
+ 3.75ADP = 
0.5CIT + CO2 
+ 3.75ATP
REACTION FORMULAS Mode 23 Mode 24 Mode 25 Mode 26 Mode 27 Mode 28 Mode 29 Mode 30
--> PYRc 0 0 0 0 0 0 0 0
<--> MALc 1 1 1 1 0 0 0 0
<--> SUCc 0 0 0 0 0 0 0 0
<--> FUMc 0 0 0 0 1 1 1 1
<--> CITc 0 -0.5 0 -0.5 0 -0.5 0 -0.5
<--> ASPc 0 0 0 0 0 0 0 0
 --> AKGc 0 0 0 0 0 0 0 0
<--> GLUc 0 0 0 0 0 0 0 0
 --> GLNc 0 0 0 0 0 0 0 0
<--> CO2c -4 -1 -4 -1 -4 -1 -4 -1
<--> SERc 0 0 0 0 0 0 0 0
<--> GLYc 0 0 0 0 0 0 0 0
<--> C1c 0 0 0 0 0 0 0 0
C1c <--> C1m 0 0 0 0 0 0 0 0
GLYc <--> GLYm 0 0 0 0 0 0 0 0
SERc <--> SERm 0 0 0 0 0 0 0 0
CO2c <--> CO2m -4 -1 -4 -1 -4 -1 -4 -1
SERm <--> GLYm + MTHFm 0 0 0 0 0 0 0 0
MTHFm --> C1m + THFm 0 0 0 0 0 0 0 0
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm + 
NH3
0 0 0 0 0 0 0 0
--> O2m 3 0.75 3 0.75 3 0.75 3 0.75
<--> NH3c 0 0 0 0 0 0 0 0
NH3c <--> NH3m 0 0 0 0 0 0 0 0
<--> ADPc 0 0 15 3.75 0 0 15 3.75
<--> ATPc 0 0 -15 -3.75 0 0 -15 -3.75
ADPc + ATPm <--> ADPm + 
ATPc
0 0 15 3.75 0 0 15 3.75
PYRc --> PYRm 0 0 0 0 0 0 0 0
FUMc <--> FUMm 0 0 0 0 1 1 1 1
MALc <--> MALm 1 0.5 1 0.5 0 -0.5 0 -0.5
SUCc <--> SUCm 0 0 0 0 0 0 0 0
MALm + AKGc --> MALc + AKGm 0 0 0 0 0 0 0 0
ASPm + GLUc <--> ASPc + 
GLUm
0 0 0 0 0 0 0 0
CITm + MALc <--> CITc + MALm 0 0.5 0 0.5 0 0.5 0 0.5
GLNc --> GLNm 0 0 0 0 0 0 0 0
GLUc <--> GLUm 0 0 0 0 0 0 0 0
PYRm + NADm --> ACOAm + 
NADHm + CO2m
1 0.5 1 0.5 1 0.5 1 0.5
ACOAm + OAAm --> CITm 1 0.5 1 0.5 1 0.5 1 0.5
CITm + NADm --> AKGm + 
NADHm + CO2m
1 0 1 0 1 0 1 0
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m
1 0 1 0 1 0 1 0
SUCm + FADm <--> FUMm + 
FADHm
1 0 1 0 1 0 1 0
FUMm <--> MALm 1 0 1 0 2 1 2 1
MALm + NADm <--> OAAm + 
NADHm
-14 -3.25 1 0.5 -14 -3.25 1 0.5
MALm + NADPm --> PYRm + 
CO2m + NADPHm
16 4.25 1 0.5 16 4.25 1 0.5
PYRm + CO2m + ATPm --> 
OAAm + ADPm
15 3.75 0 0 15 3.75 0 0
AKGm + ASPm <--> GLUm + 
OAAm
0 0 0 0 0 0 0 0
GLUm + NADm <--> AKGm + 
NH3m + NADHm
0 0 0 0 0 0 0 0
GLNm --> GLUm + NH3m 0 0 0 0 0 0 0 0
2 NADHm + O2m + 5 ADPm --> 2 
NADm + 5 ATPm
2.5 0.75 2.5 0.75 2.5 0.75 2.5 0.75
2 FADHm + O2m + 3 ADPm --> 2 
FADm + 3 ATPm
0.5 0 0.5 0 0.5 0 0.5 0
NADPHm + NADm <--> NADPm + 
NADHm
16 4.25 1 0.5 16 4.25 1 0.5
malate malate, ADP fumarate fumarate, ADP
7a 7b6a 6b
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Supplementary Table S3.A (continued) 
ABBREVIATIONS: ACOA - acetyl-CoA; AKG - -ketoglutarate; ASP - aspartate; C1 - One carbon units 
(methenyl, methylene, formate); CIT - citrate; FUM - fumarate; GLN - glutamine; GLU - glutamate; GLY - 
glycine; MAL- malate; OAA - oxaloacetate; PYR - pyruvate; SER - serine; SUC - succinate;  
 
  
EXPERIMENT
Substrates
Total mode stoichiometry
GLN + 
4.5O2 = 
5CO2 + 
2NH3
GLN + 
1.5O2 = 
ASP + 
CO2 + NH3
GLN = 
GLU + 
NH3
GLN + 4.5O2 
+ 22.5ADP = 
5CO2 + 
2NH3 + 
GLN + 
1.5O2 + 7.5 
= ASP + 
CO2 + NH3 
GLN = 
GLU + 
NH3
GLU+ 
4.5O2 = 
5CO2 + 
NH3
GLU + 
1.5O2 = 
ASP + 
CO2
GLU+ 4.5O2 
+ 22.5ADP = 
5CO2 + NH3 
+ 22.5ATP
GLU + 
1.5O2 + 
7.5ADP = 
ASP + CO2 
SER = 
GLY + C1
SER + 
0.5O2= 
CO2 + 
2C1 + 
REACTION FORMULAS Mode 31 Mode 32 Mode 33 Mode 34 Mode 35 Mode 36 Mode 37 Mode 38 Mode 39 Mode 40 Mode 41 Mode 42
--> PYRc 0 0 0 0 0 0 0 0 0 0 0 0
<--> MALc 0 0 0 0 0 0 0 0 0 0 0 0
<--> SUCc 0 0 0 0 0 0 0 0 0 0 0 0
<--> FUMc 0 0 0 0 0 0 0 0 0 0 0 0
<--> CITc 0 0 0 0 0 0 0 0 0 0 0 0
<--> ASPc 0 -1 0 0 -1 0 0 -1 0 -1 0 0
 --> AKGc 0 0 0 0 0 0 0 0 0 0 0 0
<--> GLUc 0 0 -1 0 0 -1 1 1 1 1 0 0
 --> GLNc 1 1 1 1 1 1 0 0 0 0 0 0
<--> CO2c -5 -1 0 -5 -1 0 -5 -1 -5 -1 0 -1
<--> SERc 0 0 0 0 0 0 0 0 0 0 1 1
<--> GLYc 0 0 0 0 0 0 0 0 0 0 -1 0
<--> C1c 0 0 0 0 0 0 0 0 0 0 -1 -2
C1c <--> C1m 0 0 0 0 0 0 0 0 0 0 -1 -2
GLYc <--> GLYm 0 0 0 0 0 0 0 0 0 0 -1 0
SERc <--> SERm 0 0 0 0 0 0 0 0 0 0 1 1
CO2c <--> CO2m -5 -1 0 -5 -1 0 0 -1 0 -1 0 -1
SERm <--> GLYm + MTHFm 0 0 0 0 0 0 0 0 0 0 1 1
MTHFm --> C1m + THFm 0 0 0 0 0 0 0 0 0 0 1 2
GLYm + THFm + NADm --> 
MTHFm + CO2m + NADHm + 
NH3
0 0 0 0 0 0 0 0 0 0 0 1
--> O2m 4.5 1.5 0 4.5 1.5 0 4.5 1.5 4.5 1.5 0 0.5
<--> NH3c -2 -1 -1 -2 -1 -1 -1 0 -1 0 0 -1
NH3c <--> NH3m -2 -1 -1 -2 -1 -1 -1 0 -1 0 0 -1
<--> ADPc 0 0 0 22.5 7.5 0 0 0 22.5 7.5 0 0
<--> ATPc 0 0 0 -22.5 -7.5 0 0 0 -22.5 -7.5 0 0
ADPc + ATPm <--> ADPm + 
ATPc
0 0 0 22.5 7.5 0 0 0 22.5 7.5 0 0
PYRc --> PYRm 0 0 0 0 0 0 0 0 0 0 0 0
FUMc <--> FUMm 0 0 0 0 0 0 0 0 0 0 0 0
MALc <--> MALm 0 0 0 0 0 0 0 0 0 0 0 0
SUCc <--> SUCm 0 0 0 0 0 0 0 0 0 0 0 0
MALm + AKGc --> MALc + AKGm 0 0 0 0 0 0 0 0 0 0 0 0
ASPm + GLUc <--> ASPc + 
GLUm
0 1 0 0 1 0 0 1 0 1 0 0
CITm + MALc <--> CITc + MALm 0 0 0 0 0 0 0 0 0 0 0 0
GLNc --> GLNm 1 1 1 1 1 1 0 0 0 0 0 0
GLUc <--> GLUm 0 -1 -1 0 -1 -1 1 0 1 0 0 0
PYRm + NADm --> ACOAm + 
NADHm + CO2m
1 0 0 1 0 0 1 0 1 0 0 0
ACOAm + OAAm --> CITm 1 0 0 1 0 0 1 0 1 0 0 0
CITm + NADm --> AKGm + 
NADHm + CO2m
1 0 0 1 0 0 1 0 1 0 0 0
AKGm + ADPm + NADm --> 
SUCm + ATPm + NADHm + 
CO2m
2 1 0 2 1 0 2 1 2 1 0 0
SUCm + FADm <--> FUMm + 
FADHm
2 1 0 2 1 0 2 1 2 1 0 0
FUMm <--> MALm 2 1 0 2 1 0 2 1 2 1 0 0
MALm + NADm <--> OAAm + 
NADHm
-21.5 -6.5 0 1 1 0 -21.5 -6.5 1 1 0 -2.5
MALm + NADPm --> PYRm + 
CO2m + NADPHm
23.5 7.5 0 1 0 0 23.5 7.5 1 0 0 2.5
PYRm + CO2m + ATPm --> 
OAAm + ADPm
22.5 7.5 0 0 0 0 22.5 7.5 0 0 0 2.5
AKGm + ASPm <--> GLUm + 
OAAm
0 -1 0 0 -1 0 0 -1 0 -1 0 0
GLUm + NADm <--> AKGm + 
NH3m + NADHm
1 0 0 1 0 0 1 0 1 0 0 0
GLNm --> GLUm + NH3m 1 1 1 1 1 1 0 0 0 0 0 0
2 NADHm + O2m + 5 ADPm --> 2 
NADm + 5 ATPm
3.5 1 0 3.5 1 0 3.5 1 3.5 1 0 0.5
2 FADHm + O2m + 3 ADPm --> 2 
FADm + 3 ATPm
1 0.5 0 1 0.5 0 1 0.5 1 0.5 0 0
NADPHm + NADm <--> NADPm + 
NADHm
23.5 7.5 0 1 0 0 23.5 7.5 1 0 0 2.5
glutamate, ADP serine
9a 9b 11a
glutamine glutamine, ADP glutamate
8a 8b
Chapter 12 Supplementary material 
 
266 
Supplementary Table S3.B Contribution to each mode to the total flux in each feeding experiment using 
selectively permeabilized CHO-K1 cells [fmol/cell  min]. 
 
 * In the experiments 2a and 2b it is assumed that the modes that take up ASP and PYR together are not active 
(Mode 3 and Mode 6) . Also, the modes that use ASP to produce only CO2 (Mode 5 and Mode 7) are considered 
inactive when computing the contribution factors. 
* In the experiments 5b, 6b and 7b the CIT concentration could not be determined. Mode contribution factors were 
computed assuming the same factors for CIT production as in 5a, 6a and 7a respectively. 
* In the experiment 9b, GLU concentration could not be determined reliably, therefore the mode flux was not 
computed. 
* The contribution of Modes 27-30 to FUM metabolism could not be determined due to extracellular conversion of 
FUM to MAL  
EXPERIMENT 1a 1b 2a* 2b* 3a 3b 4a 4b 5a 5b* 6a/7a 6b/7b* 8a 8b 9a 9b 12a
Mode 1 4.6 0 11.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 2 0 14.2 0 15.6 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 4 0 0 6.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 8 0 0 0 12.2 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 9 0 0 0 0 5.62 0 0 0 0 0 0 0 0 0 0 0 0
Mode 10 0 0 0 0 0 38 0 0 0 0 0 0 0 0 0 0 0
Mode 11 0 0 0 0 0 0 12.3 0 0 0 0 0 0 0 0 0 0
Mode 12 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0
Mode 13 0 0 0 0 0 0 0 37.7 0 0 0 0 0 0 0 0 0
Mode 14 0 0 0 0 0 0 0 2.47 0 0 0 0 0 0 0 0 0
Mode 15 0 0 0 0 0 0 0 0 4.07 0 0 0 0 0 0 0 0
Mode 16 0 0 0 0 0 0 0 0 14.5 0 0 0 0 0 0 0 0
Mode 17 0 0 0 0 0 0 0 0 3.7 0 0 0 0 0 0 0 0
Mode 18 0 0 0 0 0 0 0 0 2.23 0 0 0 0 0 0 0 0
Mode 19 0 0 0 0 0 0 0 0 0 10.6 0 0 0 0 0 0 0
Mode 20 0 0 0 0 0 0 0 0 0 14.6 0 0 0 0 0 0 0
Mode 21 0 0 0 0 0 0 0 0 0 3.7 0 0 0 0 0 0 0
Mode 22 0 0 0 0 0 0 0 0 0 2.14 0 0 0 0 0 0 0
Mode 23 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0
Mode 24 0 0 0 0 0 0 0 0 0 0 9.72 0 0 0 0 0 0
Mode 25 0 0 0 0 0 0 0 0 0 0 0 11.6 0 0 0 0 0
Mode 26 0 0 0 0 0 0 0 0 0 0 0 9.72 0 0 0 0 0
Mode 27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 30 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 31 0 0 0 0 0 0 0 0 0 0 0 0 2.31 0 0 0 0
Mode 32 0 0 0 0 0 0 0 0 0 0 0 0 3.29 0 0 0 0
Mode 33 0 0 0 0 0 0 0 0 0 0 0 0 14.4 0 0 0 0
Mode 34 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3 0 0 0
Mode 35 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4 0 0 0
Mode 36 0 0 0 0 0 0 0 0 0 0 0 0 0 19 0 0 0
Mode 37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.69 0 0
Mode 38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mode 41 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.61
Mode 42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.84
Contribution [fmol / cell min]
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